assay_id,doc_id,description,assay_type,assay_test_type,assay_category,assay_organism,assay_tax_id,assay_strain,assay_tissue,assay_cell_type,assay_subcellular_fraction,tid,relationship_type,confidence_score,curated_by,src_id,src_assay_id,chembl_id,cell_id,bao_format,tissue_id,variant_id
7524,9866,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL618647,,BAO_0000218,2113.0,
7525,9866,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL618648,,BAO_0000218,2113.0,
7526,9866,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL618649,,BAO_0000218,2113.0,
7527,9866,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL618650,,BAO_0000218,2107.0,
7528,9866,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL618651,,BAO_0000218,2107.0,
7529,9866,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL876497,,BAO_0000218,2107.0,
7530,9866,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL618652,,BAO_0000218,2048.0,
7531,9866,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL618653,,BAO_0000218,2048.0,
7532,9866,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL618654,,BAO_0000218,2048.0,
7533,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618655,,BAO_0000218,,
7534,1465,Compound was tested for solubility in water,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618656,,BAO_0000218,,
7535,5182,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),P,,,,,,,,,22229,U,0,Intermediate,1,,CHEMBL618657,,BAO_0000100,,
7536,17847,Solubility was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618658,,BAO_0000218,,
7537,15339,solubility in water (ug/mL) at 37 degree C.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618659,,BAO_0000218,,
7538,5202,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618660,,BAO_0000218,,
7539,1088,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618661,,BAO_0000218,,
7540,3169,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873807,,BAO_0000218,,
7541,5353,Half life in Dawley rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618662,,BAO_0000218,,
7542,2864,Half life period after 3 mg/kg iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618663,,BAO_0000218,,
7543,2864,Half life period after 3 mg/kg iv administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618664,,BAO_0000218,,
7544,2864,Half life period after 3 mg/kg iv administration in the rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618665,,BAO_0000218,,
7545,6362,Half life period in female Sprague-Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876498,,BAO_0000218,,
7546,6249,Half life period in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618666,,BAO_0000218,,
7547,3169,Half-life in rats was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620440,,BAO_0000218,,
7548,3169,Half-life in rats with metabolic oxidation,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620441,,BAO_0000218,,
7549,3169,Half-life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620442,,BAO_0000218,,
7550,17260,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620443,,BAO_0000218,,
7551,17260,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620444,,BAO_0000218,,
7552,17260,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620445,,BAO_0000218,,
7553,17260,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620446,,BAO_0000218,,
7554,2879,Biological half-life measured in plasma of rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620447,,BAO_0000218,1969.0,
7555,2879,Biological half-life measured in plasma of rat; 22-25,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621129,,BAO_0000218,1969.0,
7556,2879,Biological half-life measured in plasma of rat; 9-16,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621130,,BAO_0000218,1969.0,
7557,3184,Compound was evaluated for its half life when administered intravenously in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873808,,BAO_0000218,,
7558,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876598,,BAO_0000218,,
7559,429,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621131,,BAO_0000218,,
7560,5656,Half life (T1/2) after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621132,,BAO_0000218,,
7561,4413,Half life of compound after iv administration of 20 mg/kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621133,,BAO_0000218,,
7562,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL621312,,BAO_0000218,,
7563,17267,Half life of compound was determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621313,,BAO_0000218,,
7564,4727,Half life of compound was determined in rat blood,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621314,,BAO_0000218,178.0,
7565,17651,Half life at 1 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621315,,BAO_0000218,,
7566,17651,Half life at 10 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621316,,BAO_0000218,,
7567,401,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621317,,BAO_0000218,,
7568,4942,Half life in rats in hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621318,,BAO_0000218,,
7569,17735,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621319,,BAO_0000218,,
7570,6056,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621377,,BAO_0000218,,
7571,5213,Half life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621378,,BAO_0000218,,
7572,6616,Half life after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876599,,BAO_0000218,,
7573,5937,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621379,,BAO_0000218,,
7574,5819,Half life in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621380,,BAO_0000218,1969.0,
7575,5819,Half life in rat plasma; Not detected,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621381,,BAO_0000218,1969.0,
7576,6803,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618515,,BAO_0000218,,
7577,17804,Half life period of compound was determined after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618516,,BAO_0000218,,
7578,17804,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618517,,BAO_0000218,,
7579,5948,Half life period in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618518,,BAO_0000218,,
7580,1916,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618519,,BAO_0000218,,
7581,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618698,,BAO_0000218,,
7582,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618862,,BAO_0000218,,
7583,4890,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618863,,BAO_0000218,,
7584,17764,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618864,,BAO_0000218,,
7585,4727,Half life time in rat the dose of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618865,,BAO_0000218,,
7586,17509,Half-life 24 hr after 10 mg/kg iv administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618866,,BAO_0000218,,
7587,17509,Half-life 24 hr after 2 mg/kg iv administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618867,,BAO_0000218,,
7588,6597,Half-life consistent with the observed metabolic steady state in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875828,,BAO_0000218,,
7589,17735,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618868,,BAO_0000218,,
7590,6597,Half-life for oxidative metabolic stability was determined using male human,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618869,,BAO_0000218,,
7591,17670,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618870,,BAO_0000218,,
7592,1696,Half-life in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618871,,BAO_0000218,1969.0,
7593,1742,Half-life in rat plasma was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618872,,BAO_0000218,1969.0,
7594,17800,Half-life in rats was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873816,,BAO_0000218,,
7595,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL618873,,BAO_0000218,,
7596,11954,Area under curve after oral dose of 0.1 mg//kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621602,,BAO_0000019,,
7597,11954,Area under curve after oral dose of 0.3 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621603,,BAO_0000218,,
7598,11954,Area under curve after oral dose of 1 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621604,,BAO_0000218,,
7599,11954,Area under curve after oral dose of 10 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621605,,BAO_0000218,,
7600,11954,Area under curve after oral dose of 23.4 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621606,,BAO_0000218,,
7601,11954,Area under curve after oral dose of 3 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621607,,BAO_0000218,,
7602,11954,Area under curve after oral dose of 3.87 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621608,,BAO_0000218,,
7603,5237,Area under curve was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621609,,BAO_0000019,,
7604,4026,Area under curve at a dose of 10 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621610,,BAO_0000218,,
7605,5237,Area under curve was determined; ND=No data,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621611,,BAO_0000218,,
7606,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621612,,BAO_0000218,,
7607,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622308,,BAO_0000218,,
7608,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622309,,BAO_0000218,,
7609,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622310,,BAO_0000218,,
7610,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622311,,BAO_0000218,,
7611,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622312,,BAO_0000218,,
7612,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622931,,BAO_0000218,,
7613,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622932,,BAO_0000218,,
7614,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622736,,BAO_0000218,1969.0,
7615,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622737,,BAO_0000218,1969.0,
7616,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622738,,BAO_0000218,1969.0,
7617,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622739,,BAO_0000218,1969.0,
7618,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622740,,BAO_0000218,1969.0,
7619,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622741,,BAO_0000218,1969.0,
7620,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622742,,BAO_0000218,1969.0,
7621,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622743,,BAO_0000218,1969.0,
7622,11637,AUC in mice,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL622744,,BAO_0000218,1969.0,
7623,11149,Area under curve was measured from the graph obtained from concentration Vs time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624134,,BAO_0000019,,
7624,10016,Area under curve value of compound per hour after oral administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624135,,BAO_0000019,,
7625,17796,Area under curve was determined after oral administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624136,,BAO_0000218,,
7626,17796,Area under curve was determined after oral administration in rats; No data,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624137,,BAO_0000218,,
7627,17796,Area under curve was determined after oral administration in rats;No data,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624320,,BAO_0000218,,
7628,12923,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624321,,BAO_0000218,,
7629,15372,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624322,,BAO_0000218,,
7630,15372,Area under curve was determined for the compound after iv dose of 5.06 in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624323,,BAO_0000218,,
7631,15372,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624324,,BAO_0000218,,
7632,15372,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624325,,BAO_0000218,,
7633,15372,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624326,,BAO_0000218,,
7634,15372,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624327,,BAO_0000218,,
7635,15372,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624328,,BAO_0000218,,
7636,14169,Area under curve was determined in Dogs after peroral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627848,,BAO_0000218,,
7637,14169,Area under curve was determined in Rats after peroral administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627849,,BAO_0000218,,
7638,14258,Area under curve was determined in carotid blood of rat when administered intradermally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627850,,BAO_0000218,,
7639,14258,Area under curve was determined in portal blood of rat when administered intradermally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627851,,BAO_0000218,,
7640,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627852,,BAO_0000218,,
7641,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627853,,BAO_0000218,,
7642,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627854,,BAO_0000218,,
7643,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627855,,BAO_0000218,,
7644,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627856,,BAO_0000218,,
7645,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875339,,BAO_0000218,,
7646,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627857,,BAO_0000218,,
7647,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627858,,BAO_0000218,2106.0,
7648,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627859,,BAO_0000218,178.0,
7649,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627860,,BAO_0000218,955.0,
7650,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627019,,BAO_0000218,948.0,
7651,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627020,,BAO_0000218,2107.0,
7652,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627021,,BAO_0000218,2048.0,
7653,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627022,,BAO_0000218,2385.0,
7654,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627023,,BAO_0000218,,
7655,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627024,,BAO_0000218,2106.0,
7656,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627025,,BAO_0000218,2046.0,
7657,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627026,,BAO_0000218,2113.0,
7658,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627027,,BAO_0000218,178.0,
7659,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627028,,BAO_0000218,955.0,
7660,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627029,,BAO_0000218,948.0,
7661,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627030,,BAO_0000218,2113.0,
7662,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627031,,BAO_0000218,2107.0,
7663,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627032,,BAO_0000218,2048.0,
7664,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627033,,BAO_0000218,2385.0,
7665,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627034,,BAO_0000218,,
7666,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627035,,BAO_0000218,2106.0,
7667,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627036,,BAO_0000218,2046.0,
7668,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875340,,BAO_0000218,178.0,
7669,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627037,,BAO_0000218,948.0,
7670,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627038,,BAO_0000218,2113.0,
7671,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627039,,BAO_0000218,2107.0,
7672,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627040,,BAO_0000218,2385.0,
7673,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL624663,,BAO_0000218,2106.0,
7674,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL625963,,BAO_0000218,2046.0,
7675,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL876799,,BAO_0000218,955.0,
7676,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626133,,BAO_0000218,2048.0,
7677,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626134,,BAO_0000218,,
7678,6295,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626135,,BAO_0000218,,
7679,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626136,,BAO_0000218,,
7680,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626137,,BAO_0000218,,
7681,6295,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626138,,BAO_0000218,,
7682,6296,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626139,,BAO_0000218,,
7683,17260,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626140,,BAO_0000218,,
7684,17260,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626141,,BAO_0000218,,
7685,17686,C24h in rat p.o. at 20 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626142,,BAO_0000218,,
7686,9866,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627930,,BAO_0000218,2385.0,
7687,9866,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627931,,BAO_0000218,2385.0,
7688,9866,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627932,,BAO_0000218,2385.0,
7689,9866,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627933,,BAO_0000218,2106.0,
7690,9866,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627934,,BAO_0000218,2106.0,
7691,9866,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627935,,BAO_0000218,2106.0,
7692,9866,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627936,,BAO_0000218,178.0,
7693,9866,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627937,,BAO_0000218,178.0,
7694,9866,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627938,,BAO_0000218,178.0,
7695,9866,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627939,,BAO_0000218,178.0,
7696,9866,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627940,,BAO_0000218,178.0,
7697,9866,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627941,,BAO_0000218,178.0,
7698,9866,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL876800,,BAO_0000218,178.0,
7699,9866,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627942,,BAO_0000218,178.0,
7700,9866,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627943,,BAO_0000218,178.0,
7701,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627944,,BAO_0000218,178.0,
7702,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627945,,BAO_0000218,178.0,
7703,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628584,,BAO_0000218,178.0,
7704,9866,Biodistribution in rat blood in the presence of GdDTPA at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628585,,BAO_0000218,178.0,
7705,9866,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628586,,BAO_0000218,178.0,
7706,9866,Biodistribution in rat blood in the presence of GdDTPA at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628587,,BAO_0000218,178.0,
7707,9866,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628588,,BAO_0000218,178.0,
7708,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628589,,BAO_0000218,178.0,
7709,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625304,,BAO_0000218,178.0,
7710,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625305,,BAO_0000218,178.0,
7711,9866,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625306,,BAO_0000218,178.0,
7712,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625307,,BAO_0000218,178.0,
7713,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625308,,BAO_0000218,178.0,
7714,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627740,,BAO_0000218,178.0,
7715,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627741,,BAO_0000218,178.0,
7716,9866,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627742,,BAO_0000218,178.0,
7717,9866,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627743,,BAO_0000218,178.0,
7718,9866,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627744,,BAO_0000218,178.0,
7719,9866,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627745,,BAO_0000218,10000001.0,
7720,9866,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627746,,BAO_0000218,10000001.0,
7721,9866,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627747,,BAO_0000218,10000001.0,
7722,9866,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL876810,,BAO_0000218,10000001.0,
7723,9866,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627748,,BAO_0000218,10000001.0,
7724,9866,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627749,,BAO_0000218,10000001.0,
7725,9866,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627750,,BAO_0000218,10000001.0,
7726,9866,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618728,,BAO_0000218,10000001.0,
7727,9866,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618729,,BAO_0000218,10000001.0,
7728,9866,Biodistribution in rat bone in the presence of GdDTPA at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618730,,BAO_0000218,10000001.0,
7729,9866,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618731,,BAO_0000218,10000001.0,
7730,9866,Biodistribution in rat bone in the presence of GdDTPA at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618732,,BAO_0000218,10000001.0,
7731,9866,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618733,,BAO_0000218,10000001.0,
7732,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618734,,BAO_0000218,10000001.0,
7733,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618735,,BAO_0000218,10000001.0,
7734,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL876602,,BAO_0000218,10000001.0,
7735,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618736,,BAO_0000218,10000001.0,
7736,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618737,,BAO_0000218,10000001.0,
7737,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618738,,BAO_0000218,10000001.0,
7738,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618739,,BAO_0000218,10000001.0,
7739,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618740,,BAO_0000218,10000001.0,
7740,9866,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618741,,BAO_0000218,10000001.0,
7741,9866,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618742,,BAO_0000218,10000001.0,
7742,9866,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL618743,,BAO_0000218,10000001.0,
7743,17752,Half-life from rat plasma at a single oral dose of 25 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618744,,BAO_0000218,1969.0,
7744,5610,Half-life in male rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618745,,BAO_0000218,,
7745,5939,Half-life in rat after peroral administration at 10 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620479,,BAO_0000218,,
7746,5939,Half-life in rat after peroral administration at 5 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620480,,BAO_0000218,,
7747,17771,Half-life in rat at a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620481,,BAO_0000218,,
7748,1974,Half-life was evaluated in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620482,,BAO_0000218,,
7749,4239,Half-life was measured in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876603,,BAO_0000218,,
7750,6681,Half-life period for the compound was determined in rats at 50 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620483,,BAO_0000218,,
7751,17752,Half-life period in rats after intravenous administration at 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620484,,BAO_0000218,,
7752,6046,Half-life period in rat at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620485,,BAO_0000218,,
7753,6685,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620486,,BAO_0000218,,
7754,6685,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620487,,BAO_0000218,,
7755,6685,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620488,,BAO_0000218,,
7756,4727,Half-life time in rat the dose of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620489,,BAO_0000218,,
7757,1088,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620490,,BAO_0000218,,
7758,5610,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620491,,BAO_0000218,,
7759,3032,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876604,,BAO_0000218,1969.0,
7760,5199,Oral half life was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620492,,BAO_0000218,,
7761,14941,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620493,,BAO_0000218,,
7762,4408,Pharmacokinetic property (t1/2) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620494,,BAO_0000218,,
7763,2552,Plasma elimination half-life was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620495,,BAO_0000218,1969.0,
7764,5199,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620496,,BAO_0000218,1969.0,
7765,15662,Plasma half life was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620497,,BAO_0000218,1969.0,
7766,1465,Plasma half-life was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620498,,BAO_0000218,1969.0,
7767,1446,Plasma half-life following oral administration in Fisher rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620499,,BAO_0000218,1969.0,
7768,6824,Plasma half-life in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620500,,BAO_0000218,1969.0,
7769,17533,Plasmatic Half-life after intravenous administration to rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873809,,BAO_0000218,1969.0,
7770,5979,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620501,,BAO_0000218,,
7771,4689,Terminal half life after intravenous administration (1 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620502,,BAO_0000218,,
7772,4689,Terminal half life in Rat at a oral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620503,,BAO_0000218,,
7773,2463,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620504,,BAO_0000218,,
7774,4883,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876605,,BAO_0000218,,
7775,4883,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620505,,BAO_0000218,,
7776,15662,plasma half life was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873811,,BAO_0000218,1969.0,
7777,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL624016,,BAO_0000218,,
7778,4576,Half life of compound determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624017,,BAO_0000218,,
7779,4576,Mean residence time determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624018,,BAO_0000218,,
7780,4576,Plasma half life determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624019,,BAO_0000218,,
7781,4910,Compound was evaluated for Tmax in brain after intravenous administration in male rats,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624020,,BAO_0000218,955.0,
7782,4891,Compound was evaluated for pharmacokinetic parameter maximum time period,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624201,,BAO_0000218,,
7783,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL872528,,BAO_0000218,,
7784,5974,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624202,,BAO_0000218,,
7785,5974,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624203,,BAO_0000218,,
7786,5974,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624350,,BAO_0000218,,
7787,5974,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621320,,BAO_0000218,,
7788,17582,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621321,,BAO_0000218,,
7789,4026,Maximum time (Tmax) required to reach Cmax in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621322,,BAO_0000218,,
7790,4890,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621323,,BAO_0000218,,
7791,6571,Maximum time of clearance of compound in rats after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621324,,BAO_0000218,,
7792,4727,Maximum time at the dose of 2 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621325,,BAO_0000218,,
7793,17651,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL875837,,BAO_0000218,1969.0,
7794,17651,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621326,,BAO_0000218,1969.0,
7795,14465,Tmax in Guinea pig (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621327,,BAO_0000218,,
7796,14941,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621328,,BAO_0000218,,
7797,5960,Pharmacokinetic parameter (Tmax) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621329,,BAO_0000218,,
7798,5022,Pharmacokinetic parameter (Tmax) was estimated,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621330,,BAO_0000218,,
7799,4408,Pharmacokinetic property (Tmax) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621331,,BAO_0000218,,
7800,5983,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621332,,BAO_0000218,,
7801,4689,T max in Rat at a oral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621333,,BAO_0000218,,
7802,2792,T max was determined at 10 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621334,,BAO_0000218,,
7803,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621335,,BAO_0000218,,
7804,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621336,,BAO_0000218,,
7805,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621337,,BAO_0000218,,
7806,14599,Area under curve was measured after i.v. administration into Beagle dog.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621338,,BAO_0000218,,
7807,14599,Area under curve was measured after iv administration into Beagle dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875838,,BAO_0000218,,
7808,14599,Area under curve was measured after po administration into Beagle dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621339,,BAO_0000218,,
7809,14599,Area under curve was measured after po administration into Beagle dog.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621340,,BAO_0000218,,
7810,15675,Area under curve was measured at peroral dose of 3 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621341,,BAO_0000218,,
7811,12706,Area under curve was measured by using concentration Vs time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621342,,BAO_0000019,,
7812,12706,Area under curve was measured by using concentration Vs time; not tested,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621343,,BAO_0000019,,
7813,9750,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621344,,BAO_0000218,,
7814,9750,Area under curve(AUC) was measured in mice after oral administration.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621345,,BAO_0000218,,
7815,14691,Area under curve(AUC) value of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621346,,BAO_0000019,,
7816,14691,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL621347,,BAO_0000218,,
7817,14691,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621348,,BAO_0000218,,
7818,2939,Area under curve(carotid artery) was determined by the availability in blood,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL621349,,BAO_0000019,178.0,
7819,2939,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL621350,,BAO_0000019,178.0,
7820,2939,Area under curve(carotid artery) was determined by the availability in blood; No data,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL875839,,BAO_0000019,178.0,
7821,2939,Area under curve(portal vein) was determined by the availability in blood,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL620211,,BAO_0000019,178.0,
7822,2939,Area under curve(portal vein) was determined by the availability in blood; ND means no data,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL620212,,BAO_0000019,178.0,
7823,2939,Area under curve(portal vein) was determined by the availability in blood; No data,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL620213,,BAO_0000019,178.0,
7824,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",A,,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL620214,,BAO_0000218,1969.0,
7825,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",A,,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL620215,,BAO_0000218,1969.0,
7826,9552,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,A,,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL620216,,BAO_0000218,1969.0,
7827,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620888,,BAO_0000218,1969.0,
7828,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL620889,,BAO_0000218,1969.0,
7829,9552,Area under plasma concentration vs time curve observed in rats for 0-3 h,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL620890,,BAO_0000019,1969.0,
7830,11911,Area under plasma time curve determined in male rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL620891,,BAO_0000218,1969.0,
7831,16618,Area under the MAP curve measured over 5 min.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL620892,,BAO_0000019,,
7832,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621079,,BAO_0000218,,
7833,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL621080,,BAO_0000218,,
7834,12836,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621081,,BAO_0000218,,
7835,12836,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,A,,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL621082,,BAO_0000218,,
7836,12836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621083,,BAO_0000218,,
7837,14339,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621084,,BAO_0000218,,
7838,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621085,,BAO_0000218,,
7839,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621086,,BAO_0000218,,
7840,10524,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621087,,BAO_0000218,,
7841,9994,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622607,,BAO_0000218,,
7842,11325,Serum AUC in marmosets (IV dose),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622608,,BAO_0000218,,
7843,12536,Area under the curve after intravenous administration at a dose of 10 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624481,,BAO_0000019,,
7844,12536,Area under the curve after intravenous administration at a dose of 2 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624482,,BAO_0000019,,
7845,12536,Area under the curve after intravenous administration at a dose of 4 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624483,,BAO_0000019,,
7846,12536,Area under the curve after intravenous administration at a dose of 40 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624484,,BAO_0000019,,
7847,12536,Area under the curve after intravenous administration at a dose of 5 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624485,,BAO_0000019,,
7848,15556,Area under the curve for fumarate salt was evaluated in F344 Rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624486,,BAO_0000218,,
7849,2809,Area under the curve for the compound was calculated.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624487,,BAO_0000019,,
7850,9511,Area under the curve in concentration/ time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624488,,BAO_0000019,,
7851,12818,Area under the curve administered intraintestinal in rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624489,,BAO_0000218,,
7852,12818,Area under the curve administered intravenously in rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625184,,BAO_0000218,,
7853,15118,Area under the curve during intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625185,,BAO_0000019,,
7854,15118,Area under the curve during intravenous administration; Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875954,,BAO_0000019,,
7855,15118,Area under the curve during systemic administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625186,,BAO_0000019,,
7856,15118,Area under the curve during systemic administration; Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625187,,BAO_0000019,,
7857,2632,Area under the curve was calculated for the compound.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625188,,BAO_0000019,,
7858,14346,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625189,,BAO_0000218,,
7859,14346,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625190,,BAO_0000218,,
7860,14346,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621733,,BAO_0000218,,
7861,14346,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621734,,BAO_0000218,,
7862,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621735,,BAO_0000218,,
7863,17796,Clearance of the drug was measured in the plasma of rat; No data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621736,,BAO_0000218,1969.0,
7864,5247,The pharmacokinetic parameter plasma clearance in vivo in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621737,,BAO_0000218,1969.0,
7865,4727,Plasma clearance at the dose of 2 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621738,,BAO_0000218,,
7866,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622806,,BAO_0000218,,
7867,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623519,,BAO_0000218,,
7868,17260,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623520,,BAO_0000218,,
7869,17065,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623521,,BAO_0000218,,
7870,17671,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623522,,BAO_0000218,,
7871,6672,Clearance rate in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623523,,BAO_0000218,,
7872,6673,Clearance rate in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623690,,BAO_0000218,,
7873,5978,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623691,,BAO_0000218,,
7874,5978,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623692,,BAO_0000218,,
7875,5978,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623693,,BAO_0000218,,
7876,5978,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623694,,BAO_0000218,,
7877,4413,Clearance of compound after iv administration of 20 mg/kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623695,,BAO_0000218,,
7878,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623696,,BAO_0000218,,
7879,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623697,,BAO_0000218,,
7880,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL623698,,BAO_0000218,1969.0,
7881,5005,Compound was tested for its plasma clearance rate in Sprague Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL623699,,BAO_0000218,1969.0,
7882,15765,Mean (%CV) PK parameters for CL(mL/min/kg).,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623700,,BAO_0000218,,
7883,3747,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623701,,BAO_0000218,,
7884,16366,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623702,,BAO_0000218,1969.0,
7885,4199,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623703,,BAO_0000218,,
7886,17267,Plasma clearance in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623704,,BAO_0000218,,
7887,6535,Plasma clearance in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623705,,BAO_0000218,,
7888,6535,Plasma clearance in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623706,,BAO_0000218,,
7889,5041,Plasma clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623707,,BAO_0000218,,
7890,5960,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623708,,BAO_0000218,,
7891,5937,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623709,,BAO_0000218,,
7892,5871,Plasma clearance in rat by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623710,,BAO_0000218,,
7893,5874,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623711,,BAO_0000218,,
7894,6504,Plasma clearance in rat p.o.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623712,,BAO_0000218,,
7895,6803,Plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623713,,BAO_0000218,,
7896,5041,Plasma clearance was determined; ND denotes no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623714,,BAO_0000218,,
7897,5041,Plasma clearance was determined; ND denotes not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623715,,BAO_0000218,,
7898,1916,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623716,,BAO_0000218,,
7899,5199,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622980,,BAO_0000218,,
7900,16367,Plasma administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622981,,BAO_0000218,,
7901,6362,Plasma clearance of the compound in female Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622982,,BAO_0000218,,
7902,15662,Plasma clearance was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622983,,BAO_0000218,,
7903,6215,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622984,,BAO_0000218,,
7904,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622985,,BAO_0000218,,
7905,15662,plasma clearance was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623631,,BAO_0000218,1969.0,
7906,4723,In vivo CL/F determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623632,,BAO_0000218,,
7907,2792,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623633,,BAO_0000218,1969.0,
7908,2792,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623634,,BAO_0000218,1969.0,
7909,5213,Compound was tested for the lower blood clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623635,,BAO_0000218,,
7910,4687,Evaluated for the low clearance in rat (in vivo),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621195,,BAO_0000218,,
7911,3371,Pharmacokinetic property (CLb)of the compound was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621196,,BAO_0000218,,
7912,4690,Rapid clearance after intravenous administration in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875287,,BAO_0000218,,
7913,5702,Clearance measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621197,,BAO_0000218,,
7914,740,Compound was evaluated for plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621198,,BAO_0000218,1969.0,
7915,4853,Low plasma clearance was calculated in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621199,,BAO_0000218,1969.0,
7916,5789,Pharmacokinetic property (Clp) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621200,,BAO_0000218,,
7917,4527,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621201,,BAO_0000218,,
7918,4527,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621202,,BAO_0000218,,
7919,6518,Plasma clearance after IV dosing at 0.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621203,,BAO_0000218,,
7920,6518,Plasma clearance after IV dosing at 1 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621204,,BAO_0000218,,
7921,9866,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621205,,BAO_0000218,948.0,
7922,9866,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621206,,BAO_0000218,948.0,
7923,9866,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621207,,BAO_0000218,948.0,
7924,9866,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621208,,BAO_0000218,948.0,
7925,9866,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621209,,BAO_0000218,948.0,
7926,9866,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL876484,,BAO_0000218,948.0,
7927,9866,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621210,,BAO_0000218,948.0,
7928,9866,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621211,,BAO_0000218,948.0,
7929,9866,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621212,,BAO_0000218,948.0,
7930,9866,Biodistribution in rat heart in the presence of GdDTPA at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621213,,BAO_0000218,948.0,
7931,9866,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621214,,BAO_0000218,948.0,
7932,9866,Biodistribution in rat heart in the presence of GdDTPA at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621215,,BAO_0000218,948.0,
7933,9866,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621216,,BAO_0000218,948.0,
7934,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621217,,BAO_0000218,948.0,
7935,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621218,,BAO_0000218,948.0,
7936,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621219,,BAO_0000218,948.0,
7937,9866,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621220,,BAO_0000218,948.0,
7938,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621221,,BAO_0000218,948.0,
7939,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621222,,BAO_0000218,948.0,
7940,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621223,,BAO_0000218,948.0,
7941,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL876485,,BAO_0000218,948.0,
7942,9866,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621224,,BAO_0000218,948.0,
7943,9866,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621225,,BAO_0000218,948.0,
7944,9866,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621226,,BAO_0000218,948.0,
7945,9866,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621227,,BAO_0000218,2113.0,
7946,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621228,,BAO_0000218,2113.0,
7947,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621229,,BAO_0000218,2113.0,
7948,9866,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621230,,BAO_0000218,2113.0,
7949,9866,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621231,,BAO_0000218,2113.0,
7950,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621232,,BAO_0000218,2113.0,
7951,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621233,,BAO_0000218,2113.0,
7952,9866,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621234,,BAO_0000218,2113.0,
7953,9866,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621235,,BAO_0000218,2113.0,
7954,9866,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621236,,BAO_0000218,2113.0,
7955,9866,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621237,,BAO_0000218,2113.0,
7956,9866,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL876486,,BAO_0000218,2113.0,
7957,9866,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622436,,BAO_0000218,160.0,
7958,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622437,,BAO_0000218,160.0,
7959,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622438,,BAO_0000218,160.0,
7960,9866,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622439,,BAO_0000218,2107.0,
7961,9866,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622440,,BAO_0000218,2107.0,
7962,9866,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622441,,BAO_0000218,2107.0,
7963,9866,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622442,,BAO_0000218,2107.0,
7964,9866,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622443,,BAO_0000218,2107.0,
7965,9866,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622444,,BAO_0000218,2107.0,
7966,9866,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622445,,BAO_0000218,2107.0,
7967,9866,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622446,,BAO_0000218,2107.0,
7968,9866,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622447,,BAO_0000218,2107.0,
7969,9866,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622448,,BAO_0000218,2107.0,
7970,9866,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622449,,BAO_0000218,2107.0,
7971,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622450,,BAO_0000218,2107.0,
7972,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622451,,BAO_0000218,2107.0,
7973,9866,Biodistribution in rat liver in the presence of GdDTPA at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622452,,BAO_0000218,2107.0,
7974,9866,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622453,,BAO_0000218,2107.0,
7975,9866,Biodistribution in rat liver in the presence of GdDTPA at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622454,,BAO_0000218,2107.0,
7976,9866,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622455,,BAO_0000218,2107.0,
7977,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL876024,,BAO_0000218,2107.0,
7978,2792,T max was determined at 3 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622456,,BAO_0000218,,
7979,15078,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622457,,BAO_0000218,,
7980,15078,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622458,,BAO_0000218,,
7981,15022,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622459,,BAO_0000218,,
7982,15022,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873343,,BAO_0000218,,
7983,15022,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622460,,BAO_0000218,,
7984,4576,Time for maximum plasma concentration determined in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622461,,BAO_0000218,1969.0,
7985,6681,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622462,,BAO_0000218,1969.0,
7986,16365,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622463,,BAO_0000218,,
7987,16365,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622464,,BAO_0000218,,
7988,16365,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622465,,BAO_0000218,,
7989,16365,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622466,,BAO_0000218,,
7990,16365,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622467,,BAO_0000218,,
7991,6824,Time of maximum plasma concentration in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622468,,BAO_0000218,1969.0,
7992,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876025,,BAO_0000218,1969.0,
7993,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622469,,BAO_0000218,1969.0,
7994,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622470,,BAO_0000218,1969.0,
7995,15662,Time required to reach maximum concentration (Cmax) after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622471,,BAO_0000218,,
7996,1742,Time required to reach maximum concentration in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622472,,BAO_0000218,1969.0,
7997,2774,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622473,,BAO_0000218,1969.0,
7998,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624282,,BAO_0000218,1969.0,
7999,12873,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624283,,BAO_0000218,1969.0,
8000,12873,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624284,,BAO_0000218,1969.0,
8001,1916,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624285,,BAO_0000218,1969.0,
8002,16367,Time to reach Cmax after oral administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624286,,BAO_0000218,,
8003,16366,Time to reach Cmax when a dose of 1 mg/kg is administered orally,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624287,,BAO_0000218,,
8004,216,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624288,,BAO_0000218,,
8005,6410,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624289,,BAO_0000218,1969.0,
8006,6410,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873344,,BAO_0000218,1969.0,
8007,6215,Tmax after peroral administration (10 mg/kg) was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619623,,BAO_0000218,,
8008,3598,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL621399,,BAO_0000218,,
8009,4527,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621400,,BAO_0000218,,
8010,17670,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621401,,BAO_0000218,,
8011,1465,Tmax was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621402,,BAO_0000218,,
8012,2552,Tmax was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621403,,BAO_0000218,,
8013,5656,Tmax after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621121,,BAO_0000218,,
8014,17764,Tmax after peroral administration in rats at 2.4 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL872525,,BAO_0000218,,
8015,5610,Tmax in male rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621122,,BAO_0000218,,
8016,6046,Tmax in rat at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621123,,BAO_0000218,,
8017,5874,Tmax in rat by po administration at a dose of 40 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621124,,BAO_0000218,,
8018,17596,Tmax in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621125,,BAO_0000218,,
8019,17804,Tmax was measured in rats after peroral administration at 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621126,,BAO_0000218,,
8020,1908,Tmax value after oral dose at a dose of 10 mg/kg in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621127,,BAO_0000218,,
8021,2959,Tmax value after administration of 20 mg/Kg oral dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621128,,BAO_0000218,,
8022,6757,Tmax value at a dose of 10 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618263,,BAO_0000218,,
8023,6757,Tmax value at a dose of 100 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618264,,BAO_0000218,,
8024,6757,Tmax value at a dose of 50 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618265,,BAO_0000218,,
8025,4186,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618266,,BAO_0000218,1969.0,
8026,15662,time required to reach maximum concentration (Cmax) after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618267,,BAO_0000218,,
8027,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL618450,,BAO_0000218,1088.0,
8028,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL618451,,BAO_0000218,1088.0,
8029,5546,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618452,,BAO_0000218,,
8030,3173,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL618453,,BAO_0000218,1088.0,
8031,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL618454,,BAO_0000218,1088.0,
8032,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL618455,,BAO_0000218,1088.0,
8033,4257,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618456,,BAO_0000218,,
8034,6011,Compound distribution in rat tissues was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618457,,BAO_0000218,,
8035,5472,Volume of distribution was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618458,,BAO_0000218,,
8036,14346,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618459,,BAO_0000218,,
8037,14346,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876733,,BAO_0000218,,
8038,14346,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL618460,,BAO_0000218,,
8039,14346,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618461,,BAO_0000218,,
8040,15469,Area under the curve was determined after oral administration (300 uM/Kg),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL618462,,BAO_0000019,,
8041,14346,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618463,,BAO_0000218,,
8042,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618464,,BAO_0000218,,
8043,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618465,,BAO_0000218,,
8044,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618466,,BAO_0000218,,
8045,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618467,,BAO_0000218,,
8046,15372,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618468,,BAO_0000218,,
8047,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618469,,BAO_0000218,1969.0,
8048,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL618470,,BAO_0000218,1969.0,
8049,14813,Plasma drug AUC in rat (PO dose),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL618471,,BAO_0000218,,
8050,15792,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618472,,BAO_0000218,,
8051,3579,Area under was determined at a dose of 30 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL618473,,BAO_0000218,,
8052,12487,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL621699,,BAO_0000218,,
8053,12487,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621700,,BAO_0000218,,
8054,12487,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621701,,BAO_0000218,,
8055,12487,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL621702,,BAO_0000218,,
8056,12487,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621703,,BAO_0000218,,
8057,12487,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL621704,,BAO_0000218,,
8058,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624259,,BAO_0000218,,
8059,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624260,,BAO_0000218,,
8060,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624430,,BAO_0000218,,
8061,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624431,,BAO_0000218,,
8062,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624432,,BAO_0000218,,
8063,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624433,,BAO_0000218,,
8064,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624434,,BAO_0000218,,
8065,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624435,,BAO_0000218,,
8066,12745,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618570,,BAO_0000218,,
8067,12745,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618571,,BAO_0000218,,
8068,12745,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618572,,BAO_0000218,,
8069,12745,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618573,,BAO_0000218,,
8070,12745,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619267,,BAO_0000218,,
8071,12745,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619431,,BAO_0000218,,
8072,12745,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619432,,BAO_0000218,,
8073,12745,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619433,,BAO_0000218,,
8074,13298,AUC in mice after oral dose (50 mg/kg),A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619434,,BAO_0000218,1969.0,
8075,12226,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,A,,,Mus musculus,10090.0,,Serum,,,50594,N,1,Intermediate,1,,CHEMBL619435,,BAO_0000218,1977.0,
8076,12634,AUC (0-4 hr) ug/ml/h,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL619436,,BAO_0000019,1969.0,
8077,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619437,,BAO_0000218,,
8078,13889,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619438,,BAO_0000218,,
8079,10018,Compound was evaluated for Area under curve in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619439,,BAO_0000218,,
8080,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619440,,BAO_0000218,,
8081,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619441,,BAO_0000218,,
8082,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619442,,BAO_0000218,,
8083,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875156,,BAO_0000019,,
8084,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619443,,BAO_0000019,,
8085,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL619444,,BAO_0000019,,
8086,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623464,,BAO_0000019,,
8087,15115,Compound was evaluated for area under curve when administered through oral route in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623465,,BAO_0000218,,
8088,6518,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623466,,BAO_0000218,,
8089,6518,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623467,,BAO_0000218,,
8090,6249,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623468,,BAO_0000218,,
8091,2463,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622660,,BAO_0000218,,
8092,4969,Plasma clearance rate in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622661,,BAO_0000218,,
8093,17720,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622662,,BAO_0000218,,
8094,3457,Pharmacokinetic property (total body clearance) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622663,,BAO_0000218,,
8095,5983,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622664,,BAO_0000218,,
8096,6295,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622665,,BAO_0000218,,
8097,6296,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622666,,BAO_0000218,,
8098,17686,Cl in rat i.v. at 2 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621615,,BAO_0000218,,
8099,17764,Clearance of compound after intravenous administration in rats at 24 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621616,,BAO_0000218,,
8100,5503,Clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621617,,BAO_0000218,,
8101,4368,Clearance by intravenous administration of 3.4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621618,,BAO_0000218,,
8102,6005,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621619,,BAO_0000218,,
8103,5031,Clearance rate after i.v. administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621620,,BAO_0000218,,
8104,4890,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621786,,BAO_0000218,,
8105,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621787,,BAO_0000218,,
8106,5979,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621788,,BAO_0000218,,
8107,5656,Clearance (Cl) after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621789,,BAO_0000218,,
8108,17804,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621790,,BAO_0000218,,
8109,4839,Compound was tested for plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621791,,BAO_0000218,1969.0,
8110,5041,In vitro microsome metabolism clearance in rat was determined,A,In vitro,,Rattus norvegicus,10116.0,,,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL621792,,BAO_0000218,,
8111,5041,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,A,In vitro,,Rattus norvegicus,10116.0,,,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL621793,,BAO_0000218,,
8112,5974,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621794,,BAO_0000218,,
8113,5496,In vivo plasma clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621795,,BAO_0000218,1969.0,
8114,5739,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621796,,BAO_0000218,,
8115,5676,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,Hepatocyte,,50597,N,1,Intermediate,1,,CHEMBL621797,401.0,BAO_0000218,2107.0,
8116,4239,Pharmacokinetic property (Plasma clearance) was measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621798,,BAO_0000218,,
8117,5676,Pharmacokinetic property (clearance) in rat i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621799,,BAO_0000218,,
8118,1918,"Plasma Clearance was evaluated in rats, iv",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621800,,BAO_0000218,,
8119,17800,Plasma clearance (in vivo) in rats was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621801,,BAO_0000218,,
8120,6056,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621802,,BAO_0000218,,
8121,5496,Plasma clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618596,,BAO_0000218,,
8122,5939,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618597,,BAO_0000218,,
8123,5939,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618598,,BAO_0000218,,
8124,17752,Plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618599,,BAO_0000218,,
8125,4576,Plasma clearance rate determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618600,,BAO_0000218,,
8126,6011,Plasma clearance was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618601,,BAO_0000218,,
8127,5510,Plasma clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618602,,BAO_0000218,,
8128,5948,Plasma clearance value in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618603,,BAO_0000218,,
8129,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,A,Ex vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL618604,,BAO_0000218,2107.0,
8130,4839,Clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618605,,BAO_0000218,,
8131,17686,Total body clearance in rat i.v. at 2 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618606,,BAO_0000218,,
8132,6571,Clearance of compound in rats after intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618607,,BAO_0000218,,
8133,3364,Clearance after iv administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618608,,BAO_0000218,,
8134,13569,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618609,,BAO_0000218,,
8135,13569,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618610,,BAO_0000218,,
8136,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618611,,BAO_0000218,,
8137,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618612,,BAO_0000218,,
8138,13569,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618613,,BAO_0000218,,
8139,13569,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621076,,BAO_0000218,,
8140,13569,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621077,,BAO_0000218,,
8141,17670,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621078,,BAO_0000218,,
8142,5970,Clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621251,,BAO_0000218,,
8143,6495,Clearance in rat after oral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621252,,BAO_0000218,,
8144,4590,Clearance in rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621253,,BAO_0000218,,
8145,6193,Clearance rate following an oral dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621254,,BAO_0000218,,
8146,2832,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621255,,BAO_0000218,,
8147,1052,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621256,,BAO_0000218,1969.0,
8148,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621257,,BAO_0000218,2107.0,
8149,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621258,,BAO_0000218,2107.0,
8150,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621259,,BAO_0000218,2107.0,
8151,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621260,,BAO_0000218,2107.0,
8152,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL876494,,BAO_0000218,2107.0,
8153,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621261,,BAO_0000218,2107.0,
8154,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621262,,BAO_0000218,2107.0,
8155,9866,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621263,,BAO_0000218,2107.0,
8156,9866,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621264,,BAO_0000218,2107.0,
8157,9866,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621265,,BAO_0000218,2385.0,
8158,9866,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621266,,BAO_0000218,2385.0,
8159,9866,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621267,,BAO_0000218,2385.0,
8160,9866,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621268,,BAO_0000218,2385.0,
8161,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621269,,BAO_0000218,2385.0,
8162,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621270,,BAO_0000218,2385.0,
8163,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621271,,BAO_0000218,2385.0,
8164,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621272,,BAO_0000218,2385.0,
8165,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621273,,BAO_0000218,2385.0,
8166,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621274,,BAO_0000218,2385.0,
8167,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL876495,,BAO_0000218,2385.0,
8168,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621275,,BAO_0000218,2385.0,
8169,9866,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621276,,BAO_0000218,2385.0,
8170,9866,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621277,,BAO_0000218,2385.0,
8171,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621278,,BAO_0000218,160.0,
8172,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621279,,BAO_0000218,160.0,
8173,9866,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621280,,BAO_0000218,160.0,
8174,9866,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621281,,BAO_0000218,2106.0,
8175,9866,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621282,,BAO_0000218,2106.0,
8176,9866,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621283,,BAO_0000218,2106.0,
8177,9866,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621284,,BAO_0000218,2106.0,
8178,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621285,,BAO_0000218,2106.0,
8179,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621286,,BAO_0000218,2106.0,
8180,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL623220,,BAO_0000218,2106.0,
8181,9866,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL623221,,BAO_0000218,2106.0,
8182,9866,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL876029,,BAO_0000218,2106.0,
8183,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL623222,,BAO_0000218,945.0,
8184,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL623223,,BAO_0000218,945.0,
8185,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL621445,,BAO_0000218,945.0,
8186,13950,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621446,,BAO_0000218,178.0,
8187,13950,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621447,,BAO_0000218,178.0,
8188,13950,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL619681,,BAO_0000218,178.0,
8189,13950,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL619682,,BAO_0000218,178.0,
8190,13950,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL619683,,BAO_0000218,178.0,
8191,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619684,,BAO_0000218,955.0,
8192,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619685,,BAO_0000218,955.0,
8193,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619686,,BAO_0000218,955.0,
8194,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619687,,BAO_0000218,955.0,
8195,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619688,,BAO_0000218,955.0,
8196,13950,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL619689,,BAO_0000218,948.0,
8197,13950,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL619690,,BAO_0000218,948.0,
8198,13950,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL619691,,BAO_0000218,948.0,
8199,6062,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619692,,BAO_0000218,,
8200,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL619693,,BAO_0000218,,
8201,1908,Vc value after IV dose at a dose of 5 mg/kg in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619694,,BAO_0000218,,
8202,17596,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619695,,BAO_0000218,,
8203,4891,Compound was evaluated for pharmacokinetic parameter volume of distribution,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619696,,BAO_0000218,,
8204,740,Compound was evaluated for volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619697,,BAO_0000218,,
8205,16366,Steady state volume distribution was determined; steady state(ss),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619698,,BAO_0000218,,
8206,3364,Steady state volume of distribution after iv administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619699,,BAO_0000218,,
8207,2552,Steady state volume of distribution dosing at 3 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619700,,BAO_0000218,,
8208,406,The compound was evaluated for volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619701,,BAO_0000218,,
8209,12500,The compound was tested for volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL619702,,BAO_0000218,,
8210,12500,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620335,,BAO_0000218,,
8211,5656,Volume distribution (VD) after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620336,,BAO_0000218,,
8212,17671,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620337,,BAO_0000218,,
8213,1094,Volume distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620520,,BAO_0000218,,
8214,5833,Volume distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620521,,BAO_0000218,,
8215,5939,Volume distribution in rat after peroral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875825,,BAO_0000218,,
8216,5939,Volume distribution in rat after peroral administration at 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620522,,BAO_0000218,,
8217,6005,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620523,,BAO_0000218,,
8218,1696,Volume of distribution in rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620524,,BAO_0000218,,
8219,6672,Volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620525,,BAO_0000218,,
8220,6673,Volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620526,,BAO_0000218,,
8221,5871,Volume of distribution in rat by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620527,,BAO_0000218,,
8222,6803,Volume of distribution in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620528,,BAO_0000218,,
8223,5199,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620529,,BAO_0000218,,
8224,4727,Volume distribution at the dose of 2 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620530,,BAO_0000218,,
8225,16367,Steady state volume of distribution was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620531,,BAO_0000218,,
8226,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Intermediate,1,,CHEMBL620532,,BAO_0000218,,
8227,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL620533,,BAO_0000218,,
8228,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL620534,,BAO_0000218,,
8229,15765,Mean (%CV) PK parameters for Vdss(mL/kg).,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620535,,BAO_0000218,,
8230,2792,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875826,,BAO_0000218,,
8231,2792,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620536,,BAO_0000218,,
8232,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620537,,BAO_0000218,,
8233,5334,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618526,,BAO_0000218,,
8234,5739,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618527,,BAO_0000218,,
8235,5789,Pharmacokinetic property (Vdss) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618528,,BAO_0000218,,
8236,4239,Pharmacokinetic property (vdss) was measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618529,,BAO_0000218,,
8237,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618530,,BAO_0000218,,
8238,6642,Volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618531,,BAO_0000218,,
8239,5247,The pharmacokinetic parameter volume of distribution in vivo in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618532,,BAO_0000218,,
8240,17720,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,F,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618533,,BAO_0000218,,
8241,17686,Vdss in rat i.v. at 2 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618534,,BAO_0000218,,
8242,4689,Volume distribution after intravenous administration (1 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618535,,BAO_0000218,,
8243,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618536,,BAO_0000218,,
8244,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618537,,BAO_0000218,,
8245,4527,Volume distribution at a dose of 10 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618538,,BAO_0000218,,
8246,4521,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618539,,BAO_0000218,,
8247,6057,Volume distribution was calculated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618540,,BAO_0000218,,
8248,5510,Volume distribution was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618541,,BAO_0000218,,
8249,2938,Volume of distribution after intravenous administration was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618542,,BAO_0000218,,
8250,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622544,,BAO_0000218,,
8251,6685,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622545,,BAO_0000218,,
8252,6685,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622546,,BAO_0000218,,
8253,6685,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622547,,BAO_0000218,,
8254,5145,Volume of distribution in steady state was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622548,,BAO_0000218,,
8255,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622549,,BAO_0000218,,
8256,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622550,,BAO_0000218,,
8257,15115,Compound was evaluated for area under curve when administered through oral route to mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622551,,BAO_0000218,,
8258,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622552,,BAO_0000218,,
8259,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622553,,BAO_0000218,,
8260,8267,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,F,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622554,,BAO_0000218,,
8261,8267,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622555,,BAO_0000218,,
8262,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622556,,BAO_0000218,,
8263,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622557,,BAO_0000218,,
8264,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622558,,BAO_0000218,178.0,
8265,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622559,,BAO_0000218,178.0,
8266,10754,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622560,,BAO_0000218,,
8267,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622561,,BAO_0000218,,
8268,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622562,,BAO_0000218,,
8269,14681,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622563,,BAO_0000218,,
8270,13118,Concentration of compound in Central nervous system,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622564,,BAO_0000019,,
8271,13118,Concentration of compound in Central nervous system; Not detectable,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622565,,BAO_0000019,,
8272,13318,"Concentration of diester in the blood, following oral administration in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622566,,BAO_0000218,,
8273,13318,"Concentration of monoester in the blood, following oral administration in mice",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624515,,BAO_0000218,,
8274,13318,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624516,,BAO_0000218,,
8275,15692,Evaluated for Pharmacokinetic property: Area under the curve,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624517,,BAO_0000019,,
8276,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624518,,BAO_0000218,,
8277,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624519,,BAO_0000218,,
8278,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624520,,BAO_0000218,,
8279,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624521,,BAO_0000218,,
8280,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624522,,BAO_0000218,,
8281,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624523,,BAO_0000218,,
8282,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624409,,BAO_0000218,,
8283,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624410,,BAO_0000218,,
8284,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL624411,,BAO_0000218,,
8285,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623531,,BAO_0000218,,
8286,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623532,,BAO_0000218,,
8287,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623533,,BAO_0000218,,
8288,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623534,,BAO_0000218,,
8289,14839,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623535,,BAO_0000218,,
8290,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623536,,BAO_0000218,,
8291,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623537,,BAO_0000218,,
8292,14839,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623538,,BAO_0000218,,
8293,14839,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623539,,BAO_0000218,,
8294,14839,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623540,,BAO_0000218,,
8295,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623541,,BAO_0000218,,
8296,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623542,,BAO_0000218,,
8297,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623543,,BAO_0000218,,
8298,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623544,,BAO_0000218,,
8299,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623545,,BAO_0000218,,
8300,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623546,,BAO_0000218,,
8301,5408,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623547,,BAO_0000218,1969.0,
8302,6827,High i.v. clearance in Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623548,,BAO_0000218,,
8303,17538,In vitro clearance in rat liver microsomes,A,In vitro,,Rattus norvegicus,10116.0,,Liver,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL623549,,BAO_0000218,2107.0,
8304,6331,Intrinsic clearance in rat liver microsomes was determined,A,In vitro,,Rattus norvegicus,10116.0,,Liver,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL623550,,BAO_0000218,2107.0,
8305,5948,Intrinsic clearance in rat hepatocytes was determined,A,In vitro,,Rattus norvegicus,10116.0,,Liver,Hepatocyte,,50597,N,1,Intermediate,1,,CHEMBL875276,401.0,BAO_0000218,2107.0,
8306,4026,Plasma Clearance was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621872,,BAO_0000218,,
8307,6647,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621873,,BAO_0000218,,
8308,1696,Plasma clearance in rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621874,,BAO_0000218,,
8309,6597,Plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621875,,BAO_0000218,,
8310,347,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621876,,BAO_0000218,,
8311,16423,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621877,,BAO_0000218,,
8312,2879,Plasma clearance was measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621878,,BAO_0000218,,
8313,4883,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621879,,BAO_0000218,,
8314,5328,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621880,,BAO_0000218,1969.0,
8315,5160,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621881,,BAO_0000218,,
8316,17582,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621882,,BAO_0000218,,
8317,17651,Total clearance at 1 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875283,,BAO_0000218,,
8318,17651,Total clearance at 10 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621883,,BAO_0000218,,
8319,6596,Clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621884,,BAO_0000218,,
8320,4796,Plasma clearance rate determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621885,,BAO_0000218,,
8321,6850,Clearance of compound in rat was evaluated,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621886,,BAO_0000218,,
8322,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621887,,BAO_0000218,1969.0,
8323,3371,Pharmacokinetic property (blood clearance) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621888,,BAO_0000218,,
8324,2083,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621889,,BAO_0000218,,
8325,4942,Plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621890,,BAO_0000218,,
8326,6838,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,A,In vitro,,Rattus norvegicus,10116.0,,Liver,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL621891,,BAO_0000218,2107.0,
8327,5353,Clearance in Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621892,,BAO_0000218,,
8328,6641,Clearance rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621893,,BAO_0000218,,
8329,6641,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621894,,BAO_0000218,,
8330,6641,Clearance rat; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621895,,BAO_0000218,,
8331,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875284,,BAO_0000218,,
8332,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618699,,BAO_0000218,,
8333,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618700,,BAO_0000218,,
8334,6211,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618701,,BAO_0000218,,
8335,12873,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876600,,BAO_0000218,1969.0,
8336,6570,Clearance of compound in rat after 1 mg/kg i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618702,,BAO_0000218,,
8337,3341,Compound was evaluated for Hepatic clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618703,,BAO_0000218,,
8338,4891,In vivo clearance after 5 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618704,,BAO_0000218,,
8339,1094,Compound was tested for plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618705,,BAO_0000218,1969.0,
8340,2938,Hepatic clearance after intravenous administration was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618706,,BAO_0000218,,
8341,17853,Lower clearance in rat (i.v.) at 0.5 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618707,,BAO_0000218,,
8342,6049,Pharmacokinetic parameter expressed as plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618708,,BAO_0000218,1969.0,
8343,5789,Pharmacokinetic property (Clp) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618709,,BAO_0000218,,
8344,4514,Plasma clearance in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618710,,BAO_0000218,,
8345,6448,Plasma clearance (Clp) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618711,,BAO_0000218,,
8346,6062,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618712,,BAO_0000218,,
8347,5710,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618713,,BAO_0000218,,
8348,4709,Plasma clearance after intravenous administration of 1 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618714,,BAO_0000218,,
8349,4521,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618715,,BAO_0000218,,
8350,1742,Plasma clearance in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618716,,BAO_0000218,,
8351,6057,Plasma clearance measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876601,,BAO_0000218,,
8352,6057,Plasma clearance was calculated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618717,,BAO_0000218,,
8353,5145,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618718,,BAO_0000218,,
8354,5833,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618719,,BAO_0000218,,
8355,6453,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618720,,BAO_0000218,,
8356,6640,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618721,,BAO_0000218,,
8357,6305,Plasma clearance in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621477,,BAO_0000218,,
8358,6642,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621478,,BAO_0000218,,
8359,5472,Plasma clearance was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621479,,BAO_0000218,,
8360,5472,Plasma clearance was evaluated in rat; Not tested,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621480,,BAO_0000218,,
8361,5144,Plasma clearance rate was determined for the compound in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621481,,BAO_0000218,,
8362,6685,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621482,,BAO_0000218,,
8363,6685,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621483,,BAO_0000218,,
8364,6685,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621484,,BAO_0000218,,
8365,13950,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621485,,BAO_0000218,948.0,
8366,13950,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL621486,,BAO_0000218,948.0,
8367,13950,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621487,,BAO_0000218,160.0,
8368,13950,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621488,,BAO_0000218,160.0,
8369,13950,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621489,,BAO_0000218,160.0,
8370,13950,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621490,,BAO_0000218,160.0,
8371,13950,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL621491,,BAO_0000218,160.0,
8372,13950,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621492,,BAO_0000218,2113.0,
8373,13950,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621493,,BAO_0000218,2113.0,
8374,13950,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621494,,BAO_0000218,2113.0,
8375,13950,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621495,,BAO_0000218,2113.0,
8376,13950,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621496,,BAO_0000218,2113.0,
8377,13950,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621497,,BAO_0000218,2107.0,
8378,13950,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621498,,BAO_0000218,2107.0,
8379,13950,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621499,,BAO_0000218,2107.0,
8380,13950,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL618634,,BAO_0000218,2107.0,
8381,13950,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL618635,,BAO_0000218,2107.0,
8382,13950,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL618636,,BAO_0000218,2048.0,
8383,13950,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL619737,,BAO_0000218,2048.0,
8384,13950,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL619738,,BAO_0000218,2048.0,
8385,13950,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624329,,BAO_0000218,2048.0,
8386,13950,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624330,,BAO_0000218,2048.0,
8387,13950,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624331,,BAO_0000218,2385.0,
8388,13950,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624332,,BAO_0000218,2385.0,
8389,13950,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624333,,BAO_0000218,2385.0,
8390,13950,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624334,,BAO_0000218,2385.0,
8391,13950,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624335,,BAO_0000218,2385.0,
8392,13950,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL620016,,BAO_0000218,2106.0,
8393,13950,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL620169,,BAO_0000218,2106.0,
8394,13950,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL620170,,BAO_0000218,2106.0,
8395,13950,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL620171,,BAO_0000218,2106.0,
8396,13950,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL620172,,BAO_0000218,2106.0,
8397,13950,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL620173,,BAO_0000218,945.0,
8398,13950,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL620174,,BAO_0000218,945.0,
8399,13950,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL620175,,BAO_0000218,945.0,
8400,13950,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL620176,,BAO_0000218,945.0,
8401,13950,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL620177,,BAO_0000218,945.0,
8402,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL620178,,BAO_0000218,2037.0,
8403,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL620179,,BAO_0000218,2037.0,
8404,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620180,,BAO_0000218,,
8405,6570,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620181,,BAO_0000218,,
8406,6571,Volume of distribution of compound in rats after intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620182,,BAO_0000218,,
8407,6453,Volume of distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620183,,BAO_0000218,,
8408,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620184,,BAO_0000218,,
8409,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620185,,BAO_0000218,,
8410,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620186,,BAO_0000218,,
8411,5353,Volume of distribution was determined in Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620187,,BAO_0000218,,
8412,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620188,,BAO_0000218,,
8413,5334,Volume of distribution was reported in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620189,,BAO_0000218,,
8414,6641,Volumes of distribution in rat after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620190,,BAO_0000218,,
8415,6641,Volumes of distribution in rat after po administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620191,,BAO_0000218,,
8416,6641,Volumes of distribution in rat after po administration; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620192,,BAO_0000218,,
8417,5676,Pharmacokinetic property (Volume) in rat i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620193,,BAO_0000218,,
8418,6410,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620194,,BAO_0000218,,
8419,17670,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876730,,BAO_0000218,,
8420,6495,Volume distribution in rat after oral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620195,,BAO_0000218,,
8421,5408,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620196,,BAO_0000218,,
8422,4883,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620197,,BAO_0000218,,
8423,6647,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620198,,BAO_0000218,,
8424,6495,Volume of distribution in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620199,,BAO_0000218,,
8425,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620200,,BAO_0000218,,
8426,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620201,,BAO_0000218,,
8427,5974,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620202,,BAO_0000218,,
8428,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620203,,BAO_0000218,,
8429,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620204,,BAO_0000218,,
8430,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620205,,BAO_0000218,,
8431,5960,Pharmacokinetic parameter (Vss) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624664,,BAO_0000218,,
8432,5676,Pharmacokinetic property (Volume) in rat i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624665,,BAO_0000218,,
8433,5948,Pharmacokinetic property (Vss) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624666,,BAO_0000218,,
8434,5979,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624667,,BAO_0000218,,
8435,5978,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624668,,BAO_0000218,,
8436,5978,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624669,,BAO_0000218,,
8437,5978,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624670,,BAO_0000218,,
8438,5978,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624671,,BAO_0000218,,
8439,6448,Steady state volume distribution in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624672,,BAO_0000218,,
8440,12873,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624673,,BAO_0000218,1969.0,
8441,4576,Steady state volume of distribution determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624674,,BAO_0000218,,
8442,17582,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624675,,BAO_0000218,,
8443,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621728,,BAO_0000218,,
8444,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621729,,BAO_0000218,,
8445,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621730,,BAO_0000218,,
8446,6535,Volume distribution in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621731,,BAO_0000218,,
8447,6535,Volume distribution in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621732,,BAO_0000218,,
8448,5041,Volume in steady state distribution value was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621908,,BAO_0000218,,
8449,5041,Volume in steady state distribution value was determined; ND denotes no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875347,,BAO_0000218,,
8450,5041,Volume in steady state distribution value was determined; ND denotes not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621909,,BAO_0000218,,
8451,17065,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621910,,BAO_0000218,,
8452,6597,Volume of distribution at steady state was evaluated in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621911,,BAO_0000218,,
8453,15662,Volume of distribution at steady state was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621912,,BAO_0000218,,
8454,6485,Volume of distribution in steady state was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621913,,BAO_0000218,,
8455,17655,Volume of distribution in steady state was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621914,,BAO_0000218,,
8456,6616,Volume of distribution after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621915,,BAO_0000218,,
8457,1916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621916,,BAO_0000218,,
8458,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621917,,BAO_0000218,2107.0,
8459,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL621918,,BAO_0000218,2107.0,
8460,16438,Biodistribution of compound (oxidized form) in spleen tissue,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL621919,,BAO_0000218,2106.0,
8461,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL621920,,BAO_0000218,2106.0,
8462,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL621921,,BAO_0000218,2106.0,
8463,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622401,,BAO_0000218,2106.0,
8464,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL875348,,BAO_0000218,2106.0,
8465,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL622402,,BAO_0000218,2106.0,
8466,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622403,,BAO_0000218,178.0,
8467,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL622404,,BAO_0000218,178.0,
8468,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622405,,BAO_0000218,955.0,
8469,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622406,,BAO_0000218,955.0,
8470,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622407,,BAO_0000218,955.0,
8471,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622408,,BAO_0000218,948.0,
8472,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622409,,BAO_0000218,948.0,
8473,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL622410,,BAO_0000218,948.0,
8474,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL622411,,BAO_0000218,2113.0,
8475,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL627864,,BAO_0000218,2113.0,
8476,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL627865,,BAO_0000218,2113.0,
8477,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627866,,BAO_0000218,2107.0,
8478,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627751,,BAO_0000218,2107.0,
8479,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL627752,,BAO_0000218,2106.0,
8480,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL627753,,BAO_0000218,2106.0,
8481,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL627754,,BAO_0000218,2106.0,
8482,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627755,,BAO_0000218,,
8483,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627756,,BAO_0000218,955.0,
8484,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627757,,BAO_0000218,955.0,
8485,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627758,,BAO_0000218,955.0,
8486,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627759,,BAO_0000218,955.0,
8487,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627760,,BAO_0000218,955.0,
8488,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627761,,BAO_0000218,955.0,
8489,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL876811,,BAO_0000218,948.0,
8490,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL627762,,BAO_0000218,948.0,
8491,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL627763,,BAO_0000218,948.0,
8492,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL627764,,BAO_0000218,948.0,
8493,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL627765,,BAO_0000218,948.0,
8494,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL627766,,BAO_0000218,948.0,
8495,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL627767,,BAO_0000218,2113.0,
8496,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL627768,,BAO_0000218,2113.0,
8497,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL628422,,BAO_0000218,2113.0,
8498,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL628423,,BAO_0000218,2113.0,
8499,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628424,,BAO_0000218,,
8500,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628425,,BAO_0000218,,
8501,4257,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628426,,BAO_0000218,,
8502,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628427,,BAO_0000218,,
8503,5546,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626938,,BAO_0000218,,
8504,6141,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626939,,BAO_0000218,,
8505,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626940,,BAO_0000218,,
8506,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626941,,BAO_0000218,,
8507,5334,Plasma clearance was reported in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626942,,BAO_0000218,,
8508,4689,Plasma clearance after intravenous administration (1 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876812,,BAO_0000218,,
8509,6848,Plasma clearance of compound in rats was evaluated,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626943,,BAO_0000218,,
8510,6848,Plasma clearance of compound in rats was evaluated; ND indicates not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626944,,BAO_0000218,,
8511,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626945,,BAO_0000218,,
8512,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626946,,BAO_0000218,,
8513,4956,Plasma clearance rate in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626856,,BAO_0000218,,
8514,5529,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626857,,BAO_0000218,,
8515,406,The compound was evaluated for plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626858,,BAO_0000218,1969.0,
8516,17655,Total plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627018,,BAO_0000218,1969.0,
8517,3293,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625331,,BAO_0000218,178.0,
8518,4075,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625332,,BAO_0000218,178.0,
8519,2792,C max was determined at 10 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877590,,BAO_0000218,,
8520,2792,C max was determined at 3 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625333,,BAO_0000218,,
8521,17594,Cmax after repeated oral dose of compound at 1 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625334,,BAO_0000218,,
8522,17594,Cmax after single intravenous bolus of 1 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625335,,BAO_0000218,,
8523,4762,Cmax of compound at 5 mg/kg after po administration was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625336,,BAO_0000218,,
8524,17509,Cmax 24 hr after 10 mg/kg oral administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625337,,BAO_0000218,,
8525,17509,Cmax 24 hr after 2 mg/kg oral administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625338,,BAO_0000218,,
8526,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625339,,BAO_0000218,1969.0,
8527,6535,Cmax in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625340,,BAO_0000218,,
8528,6535,Cmax in rat after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625341,,BAO_0000218,,
8529,3169,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622687,,BAO_0000218,,
8530,6515,Cmax wa determined in rat plasma at 30 mg/kg after po administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622688,,BAO_0000218,1969.0,
8531,11149,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622689,,BAO_0000218,178.0,
8532,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL620295,,BAO_0000218,178.0,
8533,17858,Cmax after 10 mg/kg oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620296,,BAO_0000218,,
8534,6518,Cmax after IV dosing at 0.5 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620297,,BAO_0000218,,
8535,6518,Cmax after IV dosing at 1 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620298,,BAO_0000218,,
8536,4426,Cmax after oral administration at 20 mpk in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620299,,BAO_0000218,,
8537,4426,Cmax after oral administration at 20 mpk in rats; Not performed.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620300,,BAO_0000218,,
8538,4426,Cmax after oral administration at 20 mpk in rats d; Not performed.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620301,,BAO_0000218,,
8539,5656,Cmax after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620302,,BAO_0000218,,
8540,6518,Cmax after oral administration at a dose of 2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620303,,BAO_0000218,,
8541,6518,Cmax after oral administration at a dose of 4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620304,,BAO_0000218,,
8542,6113,Cmax in rats after 20 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620305,,BAO_0000218,,
8543,17764,Cmax after peroral administration in rats at 2.4 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620306,,BAO_0000218,,
8544,4756,Cmax at the dose of 2 mg/Kg administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620307,,BAO_0000218,,
8545,4756,Cmax at the dose of 5 mg/Kg administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620308,,BAO_0000218,,
8546,6402,Cmax by administering at 20 mg/kg p.o. in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620309,,BAO_0000218,,
8547,5610,Cmax in male rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620310,,BAO_0000218,,
8548,5207,Cmax in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620311,,BAO_0000218,,
8549,6011,Cmax in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620312,,BAO_0000218,,
8550,6504,Cmax in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620313,,BAO_0000218,,
8551,6046,Cmax in rat at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620314,,BAO_0000218,,
8552,6504,Cmax in rat at the dose of 1 mg/kg i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620315,,BAO_0000218,,
8553,5874,Cmax in rat by po administration at a dose of 40 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620316,,BAO_0000218,,
8554,17686,Cmax in rat p.o. at 20 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620317,,BAO_0000218,,
8555,5836,Cmax in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620318,,BAO_0000218,,
8556,17596,Cmax in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620319,,BAO_0000218,,
8557,16423,Cmax was evaluated after 20 uM/kg of peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620320,,BAO_0000218,,
8558,17804,Cmax was measured in rats after peroral administration at 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620321,,BAO_0000218,,
8559,1908,Cmax value after oral dose at a dose of 10 mg/kg in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620322,,BAO_0000218,,
8560,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620323,,BAO_0000218,,
8561,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Frontal cortex,,,50597,N,1,Intermediate,1,,CHEMBL620324,,BAO_0000218,1870.0,
8562,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Frontal cortex,,,50597,N,1,Intermediate,1,,CHEMBL620325,,BAO_0000218,1870.0,
8563,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL620326,,BAO_0000218,10000000.0,
8564,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL620327,,BAO_0000218,10000000.0,
8565,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620328,,BAO_0000218,,
8566,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620329,,BAO_0000218,,
8567,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Midbrain,,,50597,N,1,Intermediate,1,,CHEMBL620330,,BAO_0000218,1891.0,
8568,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Midbrain,,,50597,N,1,Intermediate,1,,CHEMBL875286,,BAO_0000218,1891.0,
8569,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620331,,BAO_0000218,,
8570,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620332,,BAO_0000218,,
8571,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL620333,,BAO_0000218,2435.0,
8572,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL620334,,BAO_0000218,2435.0,
8573,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621015,,BAO_0000218,178.0,
8574,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621016,,BAO_0000218,178.0,
8575,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621191,,BAO_0000218,178.0,
8576,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621192,,BAO_0000218,178.0,
8577,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621193,,BAO_0000218,178.0,
8578,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621194,,BAO_0000218,178.0,
8579,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624204,,BAO_0000218,178.0,
8580,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624205,,BAO_0000218,178.0,
8581,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624206,,BAO_0000218,178.0,
8582,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624207,,BAO_0000218,178.0,
8583,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624208,,BAO_0000218,178.0,
8584,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624209,,BAO_0000218,178.0,
8585,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624210,,BAO_0000218,178.0,
8586,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624211,,BAO_0000218,178.0,
8587,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624212,,BAO_0000218,178.0,
8588,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624213,,BAO_0000218,178.0,
8589,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL876611,,BAO_0000218,178.0,
8590,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624214,,BAO_0000218,178.0,
8591,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624215,,BAO_0000218,178.0,
8592,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624216,,BAO_0000218,178.0,
8593,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624217,,BAO_0000218,178.0,
8594,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624218,,BAO_0000218,178.0,
8595,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624219,,BAO_0000218,178.0,
8596,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624220,,BAO_0000218,178.0,
8597,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624221,,BAO_0000218,178.0,
8598,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624222,,BAO_0000218,,
8599,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624223,,BAO_0000218,,
8600,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624224,,BAO_0000218,,
8601,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624225,,BAO_0000218,,
8602,17764,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622420,,BAO_0000218,,
8603,5031,Volume of steady state distribution after i.v. administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622421,,BAO_0000218,,
8604,6215,Vss after intravenous administration (5.0 mg/kg) was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622422,,BAO_0000218,,
8605,17671,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622423,,BAO_0000218,,
8606,17752,Vss was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622424,,BAO_0000218,,
8607,6596,Vss in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622425,,BAO_0000218,,
8608,16423,Vss was evaluated after 10 uM/kg of intra arterial administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876612,,BAO_0000218,,
8609,15662,volume of distribution at steady state was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622426,,BAO_0000218,,
8610,6062,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622427,,BAO_0000218,,
8611,5874,Pharmacokinetic (PK) parameter Vz in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622428,,BAO_0000218,,
8612,4942,Volume distribution in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622429,,BAO_0000218,,
8613,17796,Volume of distribution in rat; No data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622430,,BAO_0000218,,
8614,4890,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622431,,BAO_0000218,,
8615,15765,% absorption predicted from in vitro rat ileum transport studies,A,,,Rattus norvegicus,10116.0,,Ileum,,,50597,N,1,Intermediate,1,,CHEMBL622432,,BAO_0000218,2116.0,
8616,13569,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622433,,BAO_0000218,,
8617,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622434,,BAO_0000218,,
8618,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622435,,BAO_0000218,,
8619,13569,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618748,,BAO_0000218,,
8620,13569,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618749,,BAO_0000218,,
8621,13569,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618750,,BAO_0000218,,
8622,13569,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618751,,BAO_0000218,,
8623,13569,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618752,,BAO_0000218,,
8624,4576,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618753,,BAO_0000218,,
8625,750,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL618754,,BAO_0000218,1969.0,
8626,750,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618755,,BAO_0000218,,
8627,4590,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618756,,BAO_0000218,,
8628,1716,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618757,,BAO_0000218,,
8629,1974,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618758,,BAO_0000218,,
8630,4502,Oral bioavailability in rat (dose 30 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621088,,BAO_0000218,,
8631,3371,Pharmacokinetic property (cLogP) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621089,,BAO_0000218,,
8632,9099,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,F,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621090,,BAO_0000218,178.0,
8633,9099,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,F,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621091,,BAO_0000218,178.0,
8634,4590,Clearance in rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876731,,BAO_0000218,,
8635,3184,Compound was evaluated for its clearance when administered intravenously in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621092,,BAO_0000218,,
8636,16456,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621093,,BAO_0000218,,
8637,4199,Blood: Brain distribution ratio is determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621094,,BAO_0000218,,
8638,4199,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621095,,BAO_0000218,,
8639,4199,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621096,,BAO_0000218,,
8640,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621097,,BAO_0000218,2113.0,
8641,7449,Percent dose excreted in 0-48 hours administered ip to male rat,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621098,,BAO_0000218,,
8642,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL621099,,BAO_0000218,2037.0,
8643,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL621100,,BAO_0000218,2037.0,
8644,11977,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL621101,,BAO_0000218,2037.0,
8645,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL621102,,BAO_0000218,2037.0,
8646,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL876732,,BAO_0000218,2037.0,
8647,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621103,,BAO_0000218,,
8648,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621104,,BAO_0000218,,
8649,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621105,,BAO_0000218,,
8650,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621106,,BAO_0000218,,
8651,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621107,,BAO_0000218,,
8652,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621108,,BAO_0000218,,
8653,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621109,,BAO_0000218,,
8654,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621110,,BAO_0000218,2113.0,
8655,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL621111,,BAO_0000218,2113.0,
8656,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622541,,BAO_0000218,2107.0,
8657,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622542,,BAO_0000218,2107.0,
8658,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL622543,,BAO_0000218,2107.0,
8659,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624412,,BAO_0000218,2107.0,
8660,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624413,,BAO_0000218,2107.0,
8661,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL624414,,BAO_0000218,2107.0,
8662,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624415,,BAO_0000218,2048.0,
8663,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624416,,BAO_0000218,2048.0,
8664,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624417,,BAO_0000218,2048.0,
8665,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624418,,BAO_0000218,2048.0,
8666,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624419,,BAO_0000218,2048.0,
8667,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL624420,,BAO_0000218,2048.0,
8668,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL624421,,BAO_0000218,2385.0,
8669,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL624422,,BAO_0000218,2385.0,
8670,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL624423,,BAO_0000218,2385.0,
8671,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL625123,,BAO_0000218,2385.0,
8672,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL625124,,BAO_0000218,2385.0,
8673,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL625125,,BAO_0000218,2385.0,
8674,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL625126,,BAO_0000218,14.0,
8675,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL626947,,BAO_0000218,14.0,
8676,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL626948,,BAO_0000218,14.0,
8677,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL626949,,BAO_0000218,14.0,
8678,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL626950,,BAO_0000218,14.0,
8679,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL626951,,BAO_0000218,14.0,
8680,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626952,,BAO_0000218,2106.0,
8681,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626953,,BAO_0000218,2106.0,
8682,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626954,,BAO_0000218,2106.0,
8683,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626955,,BAO_0000218,2106.0,
8684,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626956,,BAO_0000218,2106.0,
8685,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL626957,,BAO_0000218,2106.0,
8686,17208,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626958,,BAO_0000218,178.0,
8687,17208,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626959,,BAO_0000218,178.0,
8688,17208,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626960,,BAO_0000218,178.0,
8689,17208,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626961,,BAO_0000218,178.0,
8690,17208,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL627589,,BAO_0000218,178.0,
8691,17208,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL627590,,BAO_0000218,178.0,
8692,3132,Time taken for EC90 was determined when tested in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627591,,BAO_0000218,,
8693,3132,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627592,,BAO_0000218,,
8694,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627593,,BAO_0000218,,
8695,5727,Half life in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627594,,BAO_0000218,,
8696,5302,Half life period in mouse after 10 mg/Kg dose,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876813,,BAO_0000218,,
8697,5302,Half life period in mouse after 10 mg/kg dose,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627595,,BAO_0000218,,
8698,6348,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627596,,BAO_0000218,,
8699,5964,Cmax value at 5 mg/kg po was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627597,,BAO_0000218,,
8700,6078,Cmax value evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627598,,BAO_0000218,,
8701,5206,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627599,,BAO_0000218,955.0,
8702,2959,Cmax value after administration of 20 mg/Kg oral dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627600,,BAO_0000218,,
8703,5964,Cmax value at 1 mg/kg po in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627601,,BAO_0000218,,
8704,5964,Cmax value at 5 mg/kg po in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627776,,BAO_0000218,,
8705,6757,Cmax value at a dose of 10 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627777,,BAO_0000218,,
8706,6757,Cmax value at a dose of 100 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627778,,BAO_0000218,,
8707,6757,Cmax value at a dose of 50 mg/kg in male SD rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627779,,BAO_0000218,,
8708,17617,Cmax value in rats at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876814,,BAO_0000218,,
8709,1445,Cmax value was evaluated in rats at a dose of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627780,,BAO_0000218,,
8710,6082,Cmax value was determined after peroral administration of 20 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627781,,BAO_0000218,,
8711,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627782,,BAO_0000218,,
8712,5407,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627783,,BAO_0000218,1969.0,
8713,2690,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627784,,BAO_0000218,1969.0,
8714,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627785,,BAO_0000218,,
8715,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627786,,BAO_0000218,,
8716,4891,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627787,,BAO_0000218,1969.0,
8717,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627788,,BAO_0000218,1969.0,
8718,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626579,,BAO_0000218,1969.0,
8719,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626580,,BAO_0000218,1969.0,
8720,3634,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876815,,BAO_0000218,,
8721,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626581,,BAO_0000218,1969.0,
8722,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626582,,BAO_0000218,1969.0,
8723,429,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626583,,BAO_0000218,,
8724,5974,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626205,,BAO_0000218,,
8725,5974,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626206,,BAO_0000218,,
8726,5974,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626207,,BAO_0000218,,
8727,5974,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623882,,BAO_0000218,,
8728,17582,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623883,,BAO_0000218,,
8729,17582,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623884,,BAO_0000218,,
8730,3032,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623885,,BAO_0000218,1969.0,
8731,6295,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623886,,BAO_0000218,1969.0,
8732,6619,Maximal concentration in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623887,,BAO_0000218,,
8733,6616,Maximal concentration after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623888,,BAO_0000218,,
8734,3249,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623889,,BAO_0000218,1969.0,
8735,17791,Maximal plasma concentration in rat after oral administration at 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623890,,BAO_0000218,1969.0,
8736,17791,Cmax in rat plasma after oral dose (50 mg/Kg),A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623891,,BAO_0000218,1969.0,
8737,1360,Maximal plasma concentration was determined.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623892,,BAO_0000218,1969.0,
8738,2552,Maximal plasma drug concentration was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623893,,BAO_0000218,1969.0,
8739,6571,Maximal concentration in rats after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877616,,BAO_0000218,,
8740,6570,Maximum concentration in rat after 2 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623894,,BAO_0000218,,
8741,6567,Maximum concentration in rat plasma after 5 mg/kg oral gavage,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623895,,BAO_0000218,1969.0,
8742,3031,Maximum concentration of compound in rat was evaluated.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623896,,BAO_0000218,,
8743,3436,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623897,,BAO_0000218,,
8744,3436,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623898,,BAO_0000218,,
8745,2083,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623899,,BAO_0000218,,
8746,3436,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623900,,BAO_0000218,,
8747,4527,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623901,,BAO_0000218,,
8748,1974,Maximum concentration was evaluated in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623902,,BAO_0000218,,
8749,3307,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,Cerebrospinal fluid,,,50597,N,1,Intermediate,1,,CHEMBL623903,,BAO_0000218,1359.0,
8750,3307,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623904,,BAO_0000218,1969.0,
8751,1916,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL877617,,BAO_0000218,1969.0,
8752,1500,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623905,,BAO_0000218,,
8753,1500,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623906,,BAO_0000218,,
8754,4186,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623907,,BAO_0000218,1969.0,
8755,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623908,,BAO_0000218,,
8756,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623909,,BAO_0000218,,
8757,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623910,,BAO_0000218,,
8758,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623911,,BAO_0000218,,
8759,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623912,,BAO_0000218,,
8760,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624616,,BAO_0000218,,
8761,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624617,,BAO_0000218,,
8762,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624618,,BAO_0000218,,
8763,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624619,,BAO_0000218,,
8764,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624794,,BAO_0000218,,
8765,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624795,,BAO_0000218,,
8766,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623921,,BAO_0000218,,
8767,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623922,,BAO_0000218,,
8768,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623923,,BAO_0000218,,
8769,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623924,,BAO_0000218,,
8770,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623925,,BAO_0000218,,
8771,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623926,,BAO_0000218,,
8772,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623927,,BAO_0000218,,
8773,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623928,,BAO_0000218,,
8774,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623929,,BAO_0000218,,
8775,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623930,,BAO_0000218,,
8776,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623931,,BAO_0000218,955.0,
8777,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622165,,BAO_0000218,955.0,
8778,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621249,,BAO_0000218,955.0,
8779,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621250,,BAO_0000218,955.0,
8780,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621448,,BAO_0000218,955.0,
8781,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621449,,BAO_0000218,955.0,
8782,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621450,,BAO_0000218,955.0,
8783,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621451,,BAO_0000218,955.0,
8784,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621452,,BAO_0000218,955.0,
8785,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621453,,BAO_0000218,955.0,
8786,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621454,,BAO_0000218,955.0,
8787,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621455,,BAO_0000218,955.0,
8788,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621456,,BAO_0000218,955.0,
8789,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625145,,BAO_0000218,955.0,
8790,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL875847,,BAO_0000218,955.0,
8791,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625146,,BAO_0000218,955.0,
8792,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625147,,BAO_0000218,955.0,
8793,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625148,,BAO_0000218,955.0,
8794,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625149,,BAO_0000218,955.0,
8795,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625150,,BAO_0000218,955.0,
8796,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625151,,BAO_0000218,955.0,
8797,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625152,,BAO_0000218,955.0,
8798,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625153,,BAO_0000218,955.0,
8799,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625154,,BAO_0000218,955.0,
8800,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625155,,BAO_0000218,955.0,
8801,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625156,,BAO_0000218,,
8802,11977,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624354,,BAO_0000218,,
8803,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL624355,,BAO_0000218,10000000.0,
8804,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL624356,,BAO_0000218,10000000.0,
8805,11977,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL624357,,BAO_0000218,10000000.0,
8806,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL624358,,BAO_0000218,10000000.0,
8807,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL624359,,BAO_0000218,2435.0,
8808,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL624360,,BAO_0000218,2435.0,
8809,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL624361,,BAO_0000218,2435.0,
8810,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL624362,,BAO_0000218,2435.0,
8811,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL624363,,BAO_0000218,2435.0,
8812,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624364,,BAO_0000218,178.0,
8813,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624365,,BAO_0000218,178.0,
8814,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624366,,BAO_0000218,178.0,
8815,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624367,,BAO_0000218,178.0,
8816,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624368,,BAO_0000218,955.0,
8817,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624369,,BAO_0000218,955.0,
8818,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624370,,BAO_0000218,955.0,
8819,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625069,,BAO_0000218,955.0,
8820,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625070,,BAO_0000218,955.0,
8821,11977,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626051,,BAO_0000218,948.0,
8822,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626052,,BAO_0000218,948.0,
8823,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626053,,BAO_0000218,948.0,
8824,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626054,,BAO_0000218,948.0,
8825,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626055,,BAO_0000218,948.0,
8826,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626056,,BAO_0000218,2113.0,
8827,11977,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626057,,BAO_0000218,2113.0,
8828,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625193,,BAO_0000218,2113.0,
8829,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625194,,BAO_0000218,2113.0,
8830,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625195,,BAO_0000218,2107.0,
8831,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625196,,BAO_0000218,2107.0,
8832,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625197,,BAO_0000218,2107.0,
8833,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625198,,BAO_0000218,2107.0,
8834,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627929,,BAO_0000218,2107.0,
8835,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627074,,BAO_0000218,2048.0,
8836,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627075,,BAO_0000218,2048.0,
8837,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627076,,BAO_0000218,2048.0,
8838,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627077,,BAO_0000218,2048.0,
8839,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627078,,BAO_0000218,2048.0,
8840,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627079,,BAO_0000218,2385.0,
8841,4573,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL873824,,BAO_0000218,,
8842,3132,Half life in mouse plasma was determined at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627080,,BAO_0000218,1969.0,
8843,17718,Half life was determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627081,,BAO_0000218,,
8844,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627082,,BAO_0000218,,
8845,5961,Half-life in male mice after 1 mg/kg intravenous dose,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627083,,BAO_0000218,,
8847,17731,Half life in mice plasma,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627085,,BAO_0000218,1969.0,
8848,17592,Half life in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627086,,BAO_0000218,,
8849,3132,Half life in mouse plasma at dose 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627087,,BAO_0000218,1969.0,
8850,17729,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627088,,BAO_0000218,,
8851,17729,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627089,,BAO_0000218,,
8852,17729,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627090,,BAO_0000218,,
8853,3277,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627091,,BAO_0000218,,
8854,3760,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627092,,BAO_0000218,,
8855,3760,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876785,,BAO_0000218,,
8856,2862,Half-life by iv administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627093,,BAO_0000218,,
8857,2862,Half-life by oral administration in mouse,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627094,,BAO_0000218,,
8858,5980,Half-life in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627095,,BAO_0000218,,
8859,6159,Half-life using mouse brain homogenate,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627096,,BAO_0000218,955.0,
8860,6254,Half-life was measured in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627097,,BAO_0000218,,
8861,6062,Half-life was measured in mouse after an iv dose of 1 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627098,,BAO_0000218,,
8862,1574,Half-life period was determined in mouse blood,A,,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL627099,,BAO_0000218,178.0,
8863,56,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL627100,,BAO_0000218,955.0,
8864,993,Plasma half life in mouse,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627101,,BAO_0000218,1969.0,
8865,6652,Stability of the peptide in the presence of mouse serum,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627102,,BAO_0000218,,
8866,17852,Terminal half life of compound was determined in mouse,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627103,,BAO_0000218,,
8867,2675,Terminal half life was evaluated in mice after intravenous administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627104,,BAO_0000218,,
8868,2675,Terminal half life was evaluated in mice after oral administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627105,,BAO_0000218,,
8869,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876786,,BAO_0000218,,
8870,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL873825,,BAO_0000218,,
8871,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627106,,BAO_0000218,,
8872,14239,half life period is evaluated by administering intravenously at 25 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626336,,BAO_0000218,,
8873,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL877462,,BAO_0000218,,
8874,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626337,,BAO_0000218,,
8875,17734,Half life after intraperitoneal administration of 100 mg/kg in mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626338,,BAO_0000218,,
8876,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626339,,BAO_0000218,,
8877,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626340,,BAO_0000218,,
8878,17728,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625377,,BAO_0000218,,
8879,17728,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625378,,BAO_0000218,,
8880,17728,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625379,,BAO_0000218,,
8881,14294,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),A,,,Sus scrofa,9823.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL625380,,BAO_0000251,,
8882,14294,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),A,,,Sus scrofa,9823.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL625381,,BAO_0000251,,
8883,6056,Stability to porcine renal DHP-I,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625382,,BAO_0000019,,
8884,1317,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,A,In vivo,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL873828,,BAO_0000218,,
8885,1317,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,A,In vivo,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625383,,BAO_0000218,,
8886,5229,Half-life of the parent prodrug in porcine esterase solution,A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625384,,BAO_0000019,,
8887,4231,"First order rate constant, k was determined in in pig liver Esterase",A,,,Sus scrofa,9823.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625385,,BAO_0000019,,
8888,4231,Half life of the in pig liver Esterase,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL625386,,BAO_0000221,2107.0,
8889,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623571,,BAO_0000221,2107.0,
8890,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623572,,BAO_0000221,2107.0,
8891,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623573,,BAO_0000221,2107.0,
8892,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623574,,BAO_0000221,2107.0,
8893,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623575,,BAO_0000221,2107.0,
8894,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated.,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623749,,BAO_0000221,2107.0,
8895,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623750,,BAO_0000221,2107.0,
8896,889,Half-life in vitro in pig liver,A,In vitro,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623751,,BAO_0000221,2107.0,
8897,1904,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,A,,,Sus scrofa,9823.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL623752,,BAO_0000221,2107.0,
8898,4186,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623753,,BAO_0000218,1969.0,
8899,2774,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623754,,BAO_0000218,1969.0,
8900,1742,Maximum concentration in rat plasma was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623755,,BAO_0000218,1969.0,
8901,3169,Maximum concentration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623756,,BAO_0000218,,
8902,3169,Maximum concentration in rats at 1-2 hours,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623757,,BAO_0000218,,
8903,2081,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623758,,BAO_0000218,,
8904,3307,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623759,,BAO_0000218,955.0,
8905,4727,Maximum concentration at the dose of 2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623760,,BAO_0000218,,
8906,6597,Maximum concentration was evaluated in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623761,,BAO_0000218,,
8907,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623762,,BAO_0000218,1969.0,
8908,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL877594,,BAO_0000218,1969.0,
8909,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623763,,BAO_0000218,1969.0,
8910,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623764,,BAO_0000218,1969.0,
8911,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623765,,BAO_0000218,1969.0,
8912,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623766,,BAO_0000218,178.0,
8913,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623767,,BAO_0000218,178.0,
8914,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623768,,BAO_0000218,178.0,
8915,5978,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623769,,BAO_0000218,1969.0,
8916,5978,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623770,,BAO_0000218,1969.0,
8917,5978,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623771,,BAO_0000218,1969.0,
8918,5978,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623772,,BAO_0000218,1969.0,
8919,5978,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623773,,BAO_0000218,1969.0,
8920,5978,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623774,,BAO_0000218,1969.0,
8921,5978,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623775,,BAO_0000218,1969.0,
8922,14465,Cmax in rat (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623776,,BAO_0000218,,
8923,4723,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622191,,BAO_0000218,1969.0,
8924,4723,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622192,,BAO_0000218,1969.0,
8925,4576,Maximum plasma concentration determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622193,,BAO_0000218,1969.0,
8926,12873,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622194,,BAO_0000218,1969.0,
8927,12873,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622195,,BAO_0000218,1969.0,
8928,6824,Maximum plasma concentration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622196,,BAO_0000218,1969.0,
8929,17065,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622197,,BAO_0000218,1969.0,
8930,2932,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622198,,BAO_0000218,1969.0,
8931,2932,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622199,,BAO_0000218,1969.0,
8932,2879,Maximum plasma concentration of compound was measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622200,,BAO_0000218,1969.0,
8933,2864,Maximum plasma concentration after 20 mg/kg oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622201,,BAO_0000218,1969.0,
8934,16367,Maximum plasma concentration after oral administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623990,,BAO_0000218,1969.0,
8935,17717,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623991,,BAO_0000218,1969.0,
8936,17717,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623992,,BAO_0000218,1969.0,
8937,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623993,,BAO_0000218,1969.0,
8938,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623994,,BAO_0000218,1969.0,
8939,17720,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,F,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623995,,BAO_0000218,1969.0,
8940,17720,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,F,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623996,,BAO_0000218,1969.0,
8941,17720,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,F,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623997,,BAO_0000218,1969.0,
8942,4516,Maximum plasma concentration dosed orally in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623998,,BAO_0000218,1969.0,
8943,4516,Maximum plasma concentration dosed orally in rats after 6 hours,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623999,,BAO_0000218,1969.0,
8944,4516,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624000,,BAO_0000218,1969.0,
8945,5199,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624001,,BAO_0000218,1969.0,
8946,17538,Maximum plasma concentration in rat after po administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624002,,BAO_0000218,1969.0,
8947,6685,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624003,,BAO_0000218,1969.0,
8948,6685,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624004,,BAO_0000218,1969.0,
8949,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624005,,BAO_0000218,948.0,
8950,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624006,,BAO_0000218,948.0,
8951,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624007,,BAO_0000218,948.0,
8952,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624008,,BAO_0000218,948.0,
8953,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624009,,BAO_0000218,948.0,
8954,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL874387,,BAO_0000218,948.0,
8955,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624010,,BAO_0000218,948.0,
8956,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624011,,BAO_0000218,948.0,
8957,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624012,,BAO_0000218,948.0,
8958,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624013,,BAO_0000218,948.0,
8959,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624736,,BAO_0000218,948.0,
8960,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624737,,BAO_0000218,948.0,
8961,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624738,,BAO_0000218,948.0,
8962,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624739,,BAO_0000218,948.0,
8963,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624740,,BAO_0000218,948.0,
8964,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624896,,BAO_0000218,948.0,
8965,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624897,,BAO_0000218,948.0,
8966,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624108,,BAO_0000218,948.0,
8967,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624109,,BAO_0000218,948.0,
8968,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624110,,BAO_0000218,948.0,
8969,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624111,,BAO_0000218,948.0,
8970,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624112,,BAO_0000218,948.0,
8971,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624113,,BAO_0000218,948.0,
8972,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL619709,,BAO_0000218,948.0,
8973,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL619710,,BAO_0000218,948.0,
8974,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619711,,BAO_0000218,2113.0,
8975,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619712,,BAO_0000218,2113.0,
8976,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619713,,BAO_0000218,2113.0,
8977,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619714,,BAO_0000218,2113.0,
8978,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619715,,BAO_0000218,2113.0,
8979,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619716,,BAO_0000218,2113.0,
8980,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619717,,BAO_0000218,2113.0,
8981,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619718,,BAO_0000218,2113.0,
8982,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619719,,BAO_0000218,2113.0,
8983,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL875329,,BAO_0000218,2113.0,
8984,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619720,,BAO_0000218,2113.0,
8985,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619721,,BAO_0000218,2113.0,
8986,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619722,,BAO_0000218,2113.0,
8987,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619723,,BAO_0000218,2113.0,
8988,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619724,,BAO_0000218,2113.0,
8989,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619725,,BAO_0000218,2113.0,
8990,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619726,,BAO_0000218,2113.0,
8991,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619727,,BAO_0000218,2113.0,
8992,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619728,,BAO_0000218,2113.0,
8993,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL619729,,BAO_0000218,2113.0,
8994,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL619730,,BAO_0000218,2385.0,
8995,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL619731,,BAO_0000218,2385.0,
8996,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL619732,,BAO_0000218,2385.0,
8997,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL619733,,BAO_0000218,2385.0,
8998,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL619734,,BAO_0000218,2385.0,
8999,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL619735,,BAO_0000218,14.0,
9000,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL875330,,BAO_0000218,14.0,
9001,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL628465,,BAO_0000218,14.0,
9002,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL628466,,BAO_0000218,14.0,
9003,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL628467,,BAO_0000218,14.0,
9004,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628468,,BAO_0000218,2106.0,
9005,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628469,,BAO_0000218,2106.0,
9006,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628470,,BAO_0000218,2106.0,
9007,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628471,,BAO_0000218,2106.0,
9008,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628472,,BAO_0000218,2106.0,
9009,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL625191,,BAO_0000218,2046.0,
9010,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL625192,,BAO_0000218,2046.0,
9011,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL875337,,BAO_0000218,2046.0,
9012,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626341,,BAO_0000218,2046.0,
9013,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626342,,BAO_0000218,2046.0,
9014,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621943,,BAO_0000218,2107.0,
9015,3748,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621944,,BAO_0000218,,
9016,15765,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621945,,BAO_0000218,,
9017,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621946,,BAO_0000218,,
9018,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621947,,BAO_0000218,,
9019,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621948,,BAO_0000218,,
9020,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621949,,BAO_0000218,,
9021,5413,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621950,,BAO_0000218,,
9022,5413,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621951,,BAO_0000218,,
9023,15272,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621952,,BAO_0000218,178.0,
9024,4689,Stability (%) in rat liver microsomes,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621953,,BAO_0000218,2107.0,
9025,6057,Area under curve was calculated after intravenous administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621954,,BAO_0000218,,
9026,6057,Area under the curve was calculated after iv administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621955,,BAO_0000218,,
9027,6057,Area under the curve was calculated in rat after peroral administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621956,,BAO_0000218,,
9028,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621957,,BAO_0000218,,
9029,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621958,,BAO_0000218,,
9030,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621959,,BAO_0000218,,
9031,17853,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621960,,BAO_0000218,,
9032,17853,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621961,,BAO_0000218,,
9033,15765,p value of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621962,,BAO_0000218,,
9034,15765,p value of the compound,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876787,,BAO_0000218,,
9035,15765,p value of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621963,,BAO_0000218,,
9036,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622637,,BAO_0000218,945.0,
9037,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622638,,BAO_0000218,945.0,
9038,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL626561,,BAO_0000218,945.0,
9039,7991,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),F,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626562,,BAO_0000019,,
9040,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626563,,BAO_0000218,,
9041,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626564,,BAO_0000218,,
9042,6253,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626565,,BAO_0000218,,
9043,6253,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626566,,BAO_0000218,,
9044,3615,Clearance rate in rabbits,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626567,,BAO_0000218,,
9045,4059,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626568,,BAO_0000218,,
9046,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626569,,BAO_0000218,,
9047,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626570,,BAO_0000218,,
9048,5124,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626571,,BAO_0000218,,
9049,429,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626572,,BAO_0000218,,
9050,4059,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626573,,BAO_0000218,1969.0,
9051,9659,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,A,,,Oryctolagus cuniculus,9986.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL626574,,BAO_0000251,2107.0,
9052,9659,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,A,,,Oryctolagus cuniculus,9986.0,,Liver,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL626575,,BAO_0000251,2107.0,
9053,3639,Dose at which bioavailability of intravenously administered compound was tested in rabbit,A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626576,,BAO_0000218,,
9054,3639,Dose at which bioavailability of perorally administered compound was tested in rabbit,A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626577,,BAO_0000218,,
9055,3639,The compound was tested for its bioavailability in rabbit (by oral dosage).,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626578,,BAO_0000218,,
9056,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625263,,BAO_0000218,,
9057,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625264,,BAO_0000218,,
9058,5124,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625265,,BAO_0000218,,
9059,14294,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),A,,,Oryctolagus cuniculus,9986.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL625266,,BAO_0000251,,
9060,14294,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),A,,,Oryctolagus cuniculus,9986.0,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL876796,,BAO_0000251,,
9061,429,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625267,,BAO_0000218,,
9062,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL625268,,BAO_0000218,1969.0,
9063,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL625269,,BAO_0000218,1969.0,
9064,5124,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624689,,BAO_0000218,1969.0,
9065,429,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624690,,BAO_0000218,,
9066,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),A,,,Oryctolagus cuniculus,9986.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL624691,,BAO_0000218,1088.0,
9067,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),A,,,Oryctolagus cuniculus,9986.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL624692,,BAO_0000218,1088.0,
9068,4059,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624693,,BAO_0000218,,
9069,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624694,,BAO_0000218,,
9070,11672,In vitro Biological half-life in crude homogenate of rabbit renal cortex,A,In vitro,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL877596,,BAO_0000221,,
9071,12886,Time within which only 10% of the drug was degraded,A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624695,,BAO_0000019,,
9072,3853,Half life period in rabbit liver homogenate,A,,,Oryctolagus cuniculus,9986.0,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL624696,,BAO_0000221,2107.0,
9073,3615,Half life value in rabbits,A,,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624697,,BAO_0000019,,
9074,6253,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,A,In vivo,,Oryctolagus cuniculus,9986.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624698,,BAO_0000218,178.0,
9075,6253,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,A,In vivo,,Oryctolagus cuniculus,9986.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624699,,BAO_0000218,178.0,
9076,6077,Half-life period in rabbits following intravenous administration at 2 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624700,,BAO_0000218,,
9077,17617,AUC 0-8 hr value in rats at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622903,,BAO_0000218,1969.0,
9078,17594,AUC after administration at 2000 mg/kg/day in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622904,,BAO_0000218,1969.0,
9079,6149,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622905,,BAO_0000218,1969.0,
9080,17260,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622906,,BAO_0000218,1969.0,
9081,17260,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622907,,BAO_0000218,1969.0,
9082,6644,AUC in rat after oral administration at 10.5 mg/kg dose,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622908,,BAO_0000218,1969.0,
9083,6644,AUC in rat after oral administration at 11.2 mg/kg dose,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622909,,BAO_0000218,1969.0,
9084,6644,AUC in rat after oral administration at 9.7 mg/kg dose,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622910,,BAO_0000218,1969.0,
9085,6495,AUC in rat brain after oral administration at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622911,,BAO_0000218,955.0,
9086,6504,AUC in rat p.o.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622912,,BAO_0000218,1969.0,
9087,17686,AUC in rat p.o. at 20 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622913,,BAO_0000218,1969.0,
9088,6495,AUC in rat plasma after oral administration at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622914,,BAO_0000218,1969.0,
9089,216,AUC in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622915,,BAO_0000218,1969.0,
9090,1908,AUC value after IV dose at a dose of 5 mg/kg in rats.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622916,,BAO_0000218,1969.0,
9091,1908,AUC value after oral dose at a dose of 10 mg/kg in rats.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622917,,BAO_0000218,1969.0,
9092,6685,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622918,,BAO_0000218,1969.0,
9093,216,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622919,,BAO_0000218,1969.0,
9094,6049,Maximum plasma concentration was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622920,,BAO_0000218,1969.0,
9095,2463,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622921,,BAO_0000218,1969.0,
9096,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622922,,BAO_0000218,1969.0,
9097,6681,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622923,,BAO_0000218,1969.0,
9098,4890,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL877604,,BAO_0000218,1969.0,
9099,6410,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622924,,BAO_0000218,1969.0,
9100,6410,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622925,,BAO_0000218,1969.0,
9101,16366,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622926,,BAO_0000218,1969.0,
9102,6227,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623625,,BAO_0000218,1969.0,
9103,3598,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Expert,1,,CHEMBL623626,,BAO_0000218,1969.0,
9104,1465,Maximum plasma drug concentration was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623627,,BAO_0000218,1969.0,
9105,4368,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623628,,BAO_0000218,,
9106,15662,Mean peak plasma concentration was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623629,,BAO_0000218,1969.0,
9107,15662,Mean peak plasma concentration was observed after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623630,,BAO_0000218,1969.0,
9108,5355,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623804,,BAO_0000218,,
9109,5355,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623805,,BAO_0000218,,
9110,1567,Peak oral plasma concentration was determined in rats by oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623806,,BAO_0000218,1969.0,
9111,4026,Peak plasma concentration (Cmax) was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623807,,BAO_0000218,1969.0,
9112,6193,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623808,,BAO_0000218,1969.0,
9113,4026,Peak plasma concentration (Cmax) in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623809,,BAO_0000218,1969.0,
9114,6485,Peak plasma concentration at 1 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623810,,BAO_0000218,1969.0,
9115,17655,Peak plasma concentration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623811,,BAO_0000218,1969.0,
9116,14941,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623812,,BAO_0000218,1969.0,
9117,5394,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877605,,BAO_0000218,,
9118,4408,Pharmacokinetic property (Cmax) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623813,,BAO_0000218,,
9119,5983,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623814,,BAO_0000218,,
9120,4878,Cmax in rat after 3mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623815,,BAO_0000218,,
9121,5862,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,Sprague-Dawley,,,,50597,N,1,Intermediate,1,,CHEMBL623816,,BAO_0000218,,
9122,4517,Cmax in rats after 20 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623145,,BAO_0000218,,
9123,5932,Cmax in rat plasma after 30mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623146,,BAO_0000218,1969.0,
9124,5436,Plasma concentration after oral administration of 100 mg/kg to rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623147,,BAO_0000218,1969.0,
9125,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623042,,BAO_0000218,955.0,
9126,4950,Tested for the Cmax in rat at 10 mg/kg per orally,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623043,,BAO_0000218,,
9127,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623044,,BAO_0000218,,
9128,15078,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623045,,BAO_0000218,,
9129,3360,Bioavailability as oral Cmax in rats at 30 mins,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623046,,BAO_0000218,,
9130,3360,Bioavailability as oral Cmax in rats at 6hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623226,,BAO_0000218,,
9131,15022,The maximum concentration of compound was measured at the dose of 100 umol/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623227,,BAO_0000218,,
9132,15022,The maximum concentration of compound was measured at the dose of 300 umol/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623228,,BAO_0000218,,
9133,15022,The maximum concentration of compound was measured at the dose of 30 umol/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623229,,BAO_0000218,,
9134,5160,The maximum plasma levels for the compounds were determined by LC-MS.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623230,,BAO_0000218,1969.0,
9135,15662,mean peak plasma concentration was observed after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623231,,BAO_0000218,1969.0,
9136,15662,mean peak plasma concentration was observed after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623232,,BAO_0000218,1969.0,
9137,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623233,,BAO_0000218,,
9138,3535,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623234,,BAO_0000218,,
9139,3535,Concentration in plasma (portal) following oral dose in rats at 1 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623235,,BAO_0000218,,
9140,3535,Concentration in plasma (portal) following oral dose in rats at 2 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623236,,BAO_0000218,,
9141,3535,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623237,,BAO_0000218,,
9142,3535,Concentration in plasma (systemic) following oral dose in rats at 1 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623238,,BAO_0000218,,
9143,3535,Concentration in plasma (systemic) following oral dose in rats at 2 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623239,,BAO_0000218,,
9144,5005,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL623240,,BAO_0000218,1969.0,
9145,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",A,,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL623241,,BAO_0000218,1898.0,
9146,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",A,,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL623242,,BAO_0000218,1898.0,
9147,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874394,,BAO_0000218,,
9148,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623243,,BAO_0000218,,
9149,17411,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623244,,BAO_0000218,,
9150,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623245,,BAO_0000218,2113.0,
9151,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623246,,BAO_0000218,2113.0,
9152,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623247,,BAO_0000218,2113.0,
9153,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623248,,BAO_0000218,2113.0,
9154,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623249,,BAO_0000218,2113.0,
9155,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625072,,BAO_0000218,2107.0,
9156,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625073,,BAO_0000218,2107.0,
9157,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625074,,BAO_0000218,2107.0,
9158,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625075,,BAO_0000218,2107.0,
9159,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625076,,BAO_0000218,2107.0,
9160,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625077,,BAO_0000218,2107.0,
9161,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625078,,BAO_0000218,2107.0,
9162,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL874395,,BAO_0000218,2107.0,
9163,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625079,,BAO_0000218,2107.0,
9164,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625080,,BAO_0000218,2107.0,
9165,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625081,,BAO_0000218,2107.0,
9166,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625082,,BAO_0000218,2107.0,
9167,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625083,,BAO_0000218,2107.0,
9168,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625084,,BAO_0000218,2107.0,
9169,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625085,,BAO_0000218,2107.0,
9170,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625086,,BAO_0000218,2107.0,
9171,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625087,,BAO_0000218,2107.0,
9172,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625088,,BAO_0000218,2107.0,
9173,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622205,,BAO_0000218,2107.0,
9174,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622206,,BAO_0000218,2107.0,
9175,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622207,,BAO_0000218,2107.0,
9176,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622366,,BAO_0000218,2107.0,
9177,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622367,,BAO_0000218,2107.0,
9178,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL875331,,BAO_0000218,2107.0,
9179,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622368,,BAO_0000218,2107.0,
9180,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622369,,BAO_0000218,2048.0,
9181,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622370,,BAO_0000218,2048.0,
9182,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622371,,BAO_0000218,2048.0,
9183,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622372,,BAO_0000218,2048.0,
9184,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622373,,BAO_0000218,2048.0,
9185,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622374,,BAO_0000218,2048.0,
9186,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622375,,BAO_0000218,2048.0,
9187,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622376,,BAO_0000218,2048.0,
9188,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622377,,BAO_0000218,2048.0,
9189,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622378,,BAO_0000218,2048.0,
9190,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622379,,BAO_0000218,2048.0,
9191,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622380,,BAO_0000218,2048.0,
9192,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622381,,BAO_0000218,2048.0,
9193,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622382,,BAO_0000218,2048.0,
9194,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622383,,BAO_0000218,2048.0,
9195,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL875332,,BAO_0000218,945.0,
9196,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622384,,BAO_0000218,945.0,
9197,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622385,,BAO_0000218,945.0,
9198,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),A,,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622386,,BAO_0000218,945.0,
9199,10839,The compound was tested for the plasma binding in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622387,,BAO_0000218,,
9200,16459,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622388,,BAO_0000218,,
9201,16459,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622389,,BAO_0000218,,
9202,16459,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622390,,BAO_0000218,,
9203,16459,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622391,,BAO_0000218,,
9204,16459,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622392,,BAO_0000218,,
9205,16459,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622393,,BAO_0000218,,
9206,3278,Plasma level at 2 hr after administration of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622394,,BAO_0000218,,
9207,3278,plasma level at 2 hr after administration of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622395,,BAO_0000218,,
9208,4684,Stability in rat serum measured as % recovery at 1 min,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL622396,,BAO_0000218,1977.0,
9209,4684,Stability in rat serum measured as % recovery at 10 min,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624894,,BAO_0000218,1977.0,
9210,4684,Stability in rat serum measured as % recovery at 10 mins,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624895,,BAO_0000218,1977.0,
9211,4684,Stability in rat serum measured as % recovery at 2 hr,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624058,,BAO_0000218,1977.0,
9212,4684,Stability in rat serum measured as % recovery at 3 min,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624059,,BAO_0000218,1977.0,
9213,4684,Stability in rat serum measured as % recovery at 3 mins,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624060,,BAO_0000218,1977.0,
9214,4684,Stability in rat serum measured as % recovery at 5 min,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624061,,BAO_0000218,1977.0,
9215,4684,Stability in rat serum measured as % recovery at 5 mins,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL624062,,BAO_0000218,1977.0,
9216,16456,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624063,,BAO_0000218,,
9217,16456,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624064,,BAO_0000218,,
9218,723,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624065,,BAO_0000218,1969.0,
9219,723,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624066,,BAO_0000218,1969.0,
9220,5160,Half life tested in mature male rat at a dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877490,,BAO_0000218,,
9221,4709,Half life after intravenous administration of 1 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874442,,BAO_0000218,,
9222,5633,Half life period after administration (30 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626890,,BAO_0000218,,
9223,5302,Half life period in rat after 5 mg/Kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626891,,BAO_0000218,,
9224,5302,Half life period in rat after 5 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626892,,BAO_0000218,,
9225,17791,Half life period was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626893,,BAO_0000218,,
9226,17791,Half life period was evaluated in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626894,,BAO_0000218,,
9227,17791,Half life period was evaluated in rat; 0.5-1.0,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626895,,BAO_0000218,,
9228,17791,Half life period was evaluated in rat; 5.9-7.5,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626896,,BAO_0000218,,
9229,14512,Half-life in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626897,,BAO_0000218,1969.0,
9230,6230,Half-life time in rat was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626898,,BAO_0000218,,
9231,3364,Terminal half-life after iv administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626899,,BAO_0000218,,
9232,6874,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626900,,BAO_0000218,,
9233,857,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626901,,BAO_0000218,,
9234,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626902,,BAO_0000218,,
9235,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626903,,BAO_0000218,,
9236,5355,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874443,,BAO_0000218,,
9237,5355,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626904,,BAO_0000218,,
9238,6305,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626905,,BAO_0000218,,
9239,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873830,,BAO_0000218,1969.0,
9240,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626906,,BAO_0000218,,
9241,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631076,,BAO_0000218,1969.0,
9242,2932,Biological half-life was measured in plasma of rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631077,,BAO_0000218,1969.0,
9243,17065,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631078,,BAO_0000218,,
9244,15765,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631079,,BAO_0000218,,
9245,2713,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631080,,BAO_0000218,,
9246,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631081,,BAO_0000218,,
9247,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631239,,BAO_0000218,,
9248,740,Compound was evaluated for plasma half life in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631240,,BAO_0000218,1969.0,
9249,6597,AUC value at a dose of 5 mg/kg (p.o.) in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631241,,BAO_0000218,1969.0,
9250,2959,AUC value after administration of 20 mg/Kg oral dose in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631242,,BAO_0000218,1969.0,
9251,17594,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631243,,BAO_0000218,1969.0,
9252,17596,AUC0-96 after administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL874444,,BAO_0000218,1969.0,
9253,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631244,,BAO_0000218,1969.0,
9254,3293,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631245,,BAO_0000218,,
9255,6757,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627162,,BAO_0000218,,
9256,6757,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627163,,BAO_0000218,,
9257,6757,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627164,,BAO_0000218,,
9258,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627165,,BAO_0000218,2113.0,
9259,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627166,,BAO_0000218,,
9260,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627167,,BAO_0000218,,
9261,4026,Area under curve (AUC) at a dose of 30 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627822,,BAO_0000218,,
9262,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627823,,BAO_0000218,,
9263,5355,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627824,,BAO_0000218,,
9264,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627825,,BAO_0000218,,
9265,5633,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627826,,BAO_0000218,,
9266,1716,Area under curve (Pharmacokinetic property) was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627827,,BAO_0000218,,
9267,1716,Area under curve (Pharmacokinetic property) of the compound; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627828,,BAO_0000218,,
9268,4689,Area under curve after intravenous administration (1 mg/kg) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627829,,BAO_0000218,,
9269,4527,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627830,,BAO_0000218,,
9270,4527,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627831,,BAO_0000218,,
9271,15662,Area under curve in male SD rats was observed after oral administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627832,,BAO_0000218,,
9272,4413,Area under curve of compound after iv administration of 20 mg/kg dose in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627833,,BAO_0000218,,
9273,3598,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL627834,,BAO_0000218,,
9274,3598,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL628004,,BAO_0000218,,
9275,5964,Area under curve at 5 mg/kg po was determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628005,,BAO_0000218,,
9276,4689,Area under curve in Rat at a oral dose of 5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628006,,BAO_0000218,,
9277,4186,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628007,,BAO_0000218,,
9278,5510,Area under curve was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625676,,BAO_0000218,,
9279,17858,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631309,,BAO_0000218,,
9280,17804,Area under curve after intravenous administration at 3 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631310,,BAO_0000218,,
9281,6106,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631311,,BAO_0000218,,
9282,5964,Area under curve at 4 hr in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631312,,BAO_0000218,,
9283,4026,Area under curve at a dose of 30 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631313,,BAO_0000218,,
9284,4756,Area under curve at the dose of 2 mg/Kg administered perorally in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631314,,BAO_0000218,,
9285,4756,Area under curve at the dose of 5 mg/Kg administered perorally in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631315,,BAO_0000218,,
9286,5862,Area under curve for a 2-mpk po dose in SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631316,,BAO_0000218,,
9287,5862,Area under curve in SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631317,,BAO_0000218,,
9288,6644,Area under curve in rat after oral administration at 13 mg/kg dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874471,,BAO_0000218,,
9289,5871,Area under curve in rat by po administration at 0-24 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631318,,BAO_0000218,,
9290,5919,Area under curve in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631319,,BAO_0000218,1969.0,
9291,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631320,,BAO_0000218,,
9292,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631321,,BAO_0000218,,
9293,10,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631322,,BAO_0000218,,
9294,11149,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631323,,BAO_0000218,,
9295,5302,Area under curve value in rat at a dose of 5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631324,,BAO_0000218,,
9296,17796,Area under curve was determined after oral administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631325,,BAO_0000218,,
9297,4890,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631326,,BAO_0000218,,
9298,6011,Area under curve was determined after peroral administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631327,,BAO_0000218,,
9299,5375,Area under curve was determined at a dose 30 mpk administered orally.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631328,,BAO_0000218,,
9300,17764,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631329,,BAO_0000218,,
9301,4368,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627217,,BAO_0000218,,
9302,5610,Area under curve was determined in male rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626352,,BAO_0000218,,
9303,5833,Area under curve was determined in rat after PO administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626353,,BAO_0000218,,
9304,4257,Area under curve was determined in rat after a 3 mg/kg of oral dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626354,,BAO_0000218,,
9305,5937,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626355,,BAO_0000218,,
9306,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626356,,BAO_0000218,,
9307,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626357,,BAO_0000218,,
9308,17411,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626358,,BAO_0000218,,
9309,17411,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626359,,BAO_0000218,,
9310,17771,Peak plasma concentration in rat at a dose of 3 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626360,,BAO_0000218,1969.0,
9311,1628,Plasma concentration at 2 hr in rats was evaluated.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626361,,BAO_0000218,,
9312,1628,Plasma concentration at 2 hr in rats was evaluated; Not available,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626362,,BAO_0000218,,
9313,17411,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626363,,BAO_0000218,,
9314,4910,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626970,,BAO_0000218,,
9315,4910,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626971,,BAO_0000218,,
9316,4910,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626972,,BAO_0000218,1969.0,
9317,4910,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626973,,BAO_0000218,1969.0,
9318,4910,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626974,,BAO_0000218,1969.0,
9319,4910,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL874592,,BAO_0000218,1969.0,
9320,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626975,,BAO_0000218,,
9321,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626976,,BAO_0000218,,
9322,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626977,,BAO_0000218,,
9323,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626978,,BAO_0000218,,
9324,16427,PK study was carried to determine the relative absorption ranking in rat.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626979,,BAO_0000218,,
9325,4689,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626980,,BAO_0000218,1969.0,
9326,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626981,,BAO_0000218,178.0,
9327,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626982,,BAO_0000218,178.0,
9328,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626983,,BAO_0000218,178.0,
9329,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622522,,BAO_0000218,178.0,
9330,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622523,,BAO_0000218,178.0,
9331,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622524,,BAO_0000218,178.0,
9332,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622525,,BAO_0000218,955.0,
9333,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622526,,BAO_0000218,955.0,
9334,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619849,,BAO_0000218,955.0,
9335,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL619850,,BAO_0000218,955.0,
9336,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623864,,BAO_0000218,955.0,
9337,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623865,,BAO_0000218,955.0,
9338,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623866,,BAO_0000218,948.0,
9339,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623867,,BAO_0000218,948.0,
9340,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL877615,,BAO_0000218,948.0,
9341,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623868,,BAO_0000218,948.0,
9342,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623869,,BAO_0000218,948.0,
9343,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623870,,BAO_0000218,948.0,
9344,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL623871,,BAO_0000218,2048.0,
9345,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL623872,,BAO_0000218,2048.0,
9346,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622129,,BAO_0000218,2048.0,
9347,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622130,,BAO_0000218,2048.0,
9348,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622131,,BAO_0000218,2048.0,
9349,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622132,,BAO_0000218,2048.0,
9350,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622133,,BAO_0000218,2048.0,
9351,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622134,,BAO_0000218,2048.0,
9352,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622135,,BAO_0000218,2048.0,
9353,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622136,,BAO_0000218,2048.0,
9354,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622137,,BAO_0000218,2385.0,
9355,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622138,,BAO_0000218,2385.0,
9356,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623017,,BAO_0000218,2385.0,
9357,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623018,,BAO_0000218,2385.0,
9358,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623019,,BAO_0000218,2385.0,
9359,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623020,,BAO_0000218,2385.0,
9360,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623021,,BAO_0000218,2385.0,
9361,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623022,,BAO_0000218,2385.0,
9362,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623023,,BAO_0000218,2385.0,
9363,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623024,,BAO_0000218,2385.0,
9364,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623025,,BAO_0000218,2385.0,
9365,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620545,,BAO_0000218,2385.0,
9366,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620546,,BAO_0000218,2385.0,
9367,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620547,,BAO_0000218,2385.0,
9368,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620548,,BAO_0000218,2385.0,
9369,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620549,,BAO_0000218,2385.0,
9370,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620550,,BAO_0000218,2385.0,
9371,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620551,,BAO_0000218,2385.0,
9372,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620552,,BAO_0000218,2385.0,
9373,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620553,,BAO_0000218,2385.0,
9374,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620554,,BAO_0000218,2385.0,
9375,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL875845,,BAO_0000218,2385.0,
9376,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620555,,BAO_0000218,2385.0,
9377,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620556,,BAO_0000218,2385.0,
9378,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620557,,BAO_0000218,2385.0,
9379,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620558,,BAO_0000218,,
9380,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620559,,BAO_0000218,,
9381,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622939,,BAO_0000218,,
9382,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622940,,BAO_0000218,,
9383,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622941,,BAO_0000218,,
9384,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622942,,BAO_0000218,,
9385,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622943,,BAO_0000218,,
9386,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622944,,BAO_0000218,,
9387,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622945,,BAO_0000218,,
9388,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622946,,BAO_0000218,,
9389,3341,Compound was evaluated for terminal half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622947,,BAO_0000218,,
9390,3634,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622948,,BAO_0000218,1969.0,
9391,3634,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622949,,BAO_0000218,1969.0,
9392,4839,Compound was tested for its half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622950,,BAO_0000218,,
9393,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL622951,,BAO_0000218,1969.0,
9394,5005,Compound was tested for its plasma half life in Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL622952,,BAO_0000366,1969.0,
9395,5005,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Intermediate,1,,CHEMBL622953,,BAO_0000366,1969.0,
9396,1094,Compound was tested for plasma half-life period in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873818,,BAO_0000218,1969.0,
9397,5031,Elimination half life after i.v. administration of compound in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622954,,BAO_0000218,,
9398,6518,Elimination half-life after IV dosing at 0.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622955,,BAO_0000218,,
9399,6518,Elimination half-life after IV dosing at 1 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875229,,BAO_0000218,,
9400,6518,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622956,,BAO_0000218,,
9401,6518,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622957,,BAO_0000218,,
9402,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622958,,BAO_0000218,955.0,
9403,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622959,,BAO_0000218,1969.0,
9404,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622960,,BAO_0000218,955.0,
9405,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622961,,BAO_0000218,1969.0,
9406,4687,Evaluated for the half life in rat (in vivo),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622962,,BAO_0000218,,
9407,6640,Hafl life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622963,,BAO_0000218,,
9408,6640,Hafl life rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622964,,BAO_0000218,,
9409,6641,Hafl life rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622965,,BAO_0000218,,
9410,6640,Hafl life rat; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622966,,BAO_0000218,,
9411,6641,Hafl life rat; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622967,,BAO_0000218,,
9412,17411,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622968,,BAO_0000218,2113.0,
9413,17411,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622969,,BAO_0000218,2107.0,
9414,17411,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL875327,,BAO_0000218,2048.0,
9415,6570,Half life in rat after 1 mg/kg i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628638,,BAO_0000218,,
9416,6570,Half life in rat after 2 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628639,,BAO_0000218,,
9417,17411,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625840,,BAO_0000218,,
9418,4722,Half life of 10 mg/kg oral dose determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625841,,BAO_0000218,,
9419,5978,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625842,,BAO_0000218,,
9420,5978,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625843,,BAO_0000218,,
9421,5978,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625844,,BAO_0000218,,
9422,5978,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873822,,BAO_0000218,,
9423,5978,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625845,,BAO_0000218,,
9424,5978,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627059,,BAO_0000218,,
9425,5978,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627060,,BAO_0000218,,
9426,5978,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627061,,BAO_0000218,,
9427,4762,Half life of compound at 5 mg/kg after po administration was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627709,,BAO_0000218,,
9428,5327,Half life of compound determined after intravenous administration to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627710,,BAO_0000218,,
9429,4847,Half life of compound was determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627711,,BAO_0000218,,
9430,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627712,,BAO_0000218,1969.0,
9431,4723,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627713,,BAO_0000218,,
9432,4723,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627714,,BAO_0000218,,
9433,4256,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627889,,BAO_0000218,,
9434,4256,Half life determined in rat by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627890,,BAO_0000218,,
9435,4722,Half life determined in rats after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627891,,BAO_0000218,,
9436,6535,Half life in rat plasma after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627892,,BAO_0000218,1969.0,
9437,6535,Half life in rat plasma after administration of 2 mg/kg iv,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627893,,BAO_0000218,1969.0,
9438,1435,Half life in rat plasma was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627894,,BAO_0000218,1969.0,
9439,1435,Half life in rat plasma was determined; NA means not applicable,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627895,,BAO_0000218,1969.0,
9440,5206,Half life in rat was tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627896,,BAO_0000218,,
9441,6080,Half life measured in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627897,,BAO_0000218,1969.0,
9442,4449,Half life recorded in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627898,,BAO_0000218,,
9443,6057,Half life was calculated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627899,,BAO_0000218,,
9444,6057,Half life was calculated in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873823,,BAO_0000218,,
9445,3747,Half life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627900,,BAO_0000218,,
9446,17858,Half life after 10 mg/kg oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627901,,BAO_0000218,,
9447,16365,Half life after administering orally a dose of 10 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627902,,BAO_0000218,,
9448,16365,Half life after administering orally a dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627903,,BAO_0000218,,
9449,5031,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627904,,BAO_0000218,,
9450,4722,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627905,,BAO_0000218,,
9451,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627906,,BAO_0000218,,
9452,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627907,,BAO_0000218,,
9453,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876783,,BAO_0000218,,
9454,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627908,,BAO_0000218,,
9455,17065,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627909,,BAO_0000218,,
9456,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627910,,BAO_0000218,,
9457,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627911,,BAO_0000218,,
9458,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627912,,BAO_0000218,,
9459,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627913,,BAO_0000218,,
9460,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627914,,BAO_0000218,,
9461,16423,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627915,,BAO_0000218,,
9462,16423,Area under the curve was evaluated after 20 uM/kg of peroral administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627916,,BAO_0000218,,
9463,6062,Area under the curve was measured in rat after an iv dose of 1 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627917,,BAO_0000218,,
9464,6056,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627918,,BAO_0000218,,
9465,5182,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627919,,BAO_0000218,,
9466,6410,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627920,,BAO_0000218,,
9467,6410,Area under the curve was evaluated at an oral dose of 30 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627921,,BAO_0000218,,
9468,4723,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627922,,BAO_0000218,,
9469,4723,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876784,,BAO_0000218,,
9470,4723,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627923,,BAO_0000218,,
9471,4723,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626208,,BAO_0000218,,
9472,4723,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626209,,BAO_0000218,,
9473,4723,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626210,,BAO_0000218,,
9474,2463,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627994,,BAO_0000218,1969.0,
9475,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627995,,BAO_0000218,,
9476,4075,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627996,,BAO_0000218,,
9477,5394,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627997,,BAO_0000218,,
9478,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627998,,BAO_0000218,,
9479,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628640,,BAO_0000218,,
9480,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628641,,BAO_0000218,,
9481,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628642,,BAO_0000218,,
9482,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628643,,BAO_0000218,,
9483,2591,Compound was tested for area under curve in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628644,,BAO_0000218,,
9484,6567,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628645,,BAO_0000218,,
9485,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628646,,BAO_0000218,,
9486,5529,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628647,,BAO_0000218,,
9487,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628648,,BAO_0000218,,
9488,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625358,,BAO_0000218,,
9489,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625359,,BAO_0000218,,
9490,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625360,,BAO_0000218,,
9491,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625361,,BAO_0000218,,
9492,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625362,,BAO_0000218,,
9493,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625363,,BAO_0000218,,
9494,4796,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625364,,BAO_0000218,,
9495,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625365,,BAO_0000218,,
9496,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625366,,BAO_0000218,,
9497,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625367,,BAO_0000218,,
9498,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625368,,BAO_0000218,2113.0,
9499,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625369,,BAO_0000218,2113.0,
9500,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625370,,BAO_0000218,2113.0,
9501,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625371,,BAO_0000218,2113.0,
9502,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625372,,BAO_0000218,2113.0,
9503,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625373,,BAO_0000218,2113.0,
9504,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625374,,BAO_0000218,2107.0,
9505,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL877593,,BAO_0000218,2107.0,
9506,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625375,,BAO_0000218,2107.0,
9507,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625376,,BAO_0000218,2107.0,
9508,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621973,,BAO_0000218,2107.0,
9509,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621974,,BAO_0000218,2107.0,
9510,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL621975,,BAO_0000218,2048.0,
9511,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622166,,BAO_0000218,2048.0,
9512,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622167,,BAO_0000218,2048.0,
9513,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622168,,BAO_0000218,2048.0,
9514,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622169,,BAO_0000218,2048.0,
9515,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622170,,BAO_0000218,2048.0,
9516,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622171,,BAO_0000218,2046.0,
9517,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622172,,BAO_0000218,2046.0,
9518,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622173,,BAO_0000218,2046.0,
9519,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622174,,BAO_0000218,2046.0,
9520,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622175,,BAO_0000218,2046.0,
9521,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622176,,BAO_0000218,2046.0,
9522,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622177,,BAO_0000218,2046.0,
9523,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622178,,BAO_0000218,2046.0,
9524,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622179,,BAO_0000218,2046.0,
9525,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622180,,BAO_0000218,2046.0,
9526,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622181,,BAO_0000218,,
9527,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622182,,BAO_0000218,,
9528,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622183,,BAO_0000218,,
9529,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622184,,BAO_0000218,,
9530,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622185,,BAO_0000218,,
9531,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622186,,BAO_0000218,,
9532,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622187,,BAO_0000218,,
9533,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625002,,BAO_0000218,,
9534,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622090,,BAO_0000218,,
9535,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622091,,BAO_0000218,,
9536,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622092,,BAO_0000218,,
9537,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622093,,BAO_0000218,,
9538,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622094,,BAO_0000218,,
9539,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622095,,BAO_0000218,,
9540,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622264,,BAO_0000218,,
9541,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622265,,BAO_0000218,2106.0,
9542,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622266,,BAO_0000218,2106.0,
9543,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622267,,BAO_0000218,2106.0,
9544,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622268,,BAO_0000218,2106.0,
9545,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622269,,BAO_0000218,2106.0,
9546,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625071,,BAO_0000218,2106.0,
9547,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621621,,BAO_0000218,2106.0,
9548,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621622,,BAO_0000218,2106.0,
9549,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621623,,BAO_0000218,2106.0,
9550,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621624,,BAO_0000218,2106.0,
9551,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621625,,BAO_0000218,2106.0,
9552,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621626,,BAO_0000218,2106.0,
9553,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621627,,BAO_0000218,2106.0,
9554,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621628,,BAO_0000218,2106.0,
9555,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL875328,,BAO_0000218,2106.0,
9556,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621629,,BAO_0000218,2106.0,
9557,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621630,,BAO_0000218,2106.0,
9558,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621631,,BAO_0000218,2106.0,
9559,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621632,,BAO_0000218,2106.0,
9560,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621633,,BAO_0000218,2106.0,
9561,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621634,,BAO_0000218,2106.0,
9562,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621635,,BAO_0000218,2106.0,
9563,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621636,,BAO_0000218,2106.0,
9564,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621637,,BAO_0000218,2106.0,
9565,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL621638,,BAO_0000218,2106.0,
9566,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618883,,BAO_0000218,,
9567,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618884,,BAO_0000218,,
9568,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628627,,BAO_0000218,,
9569,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628628,,BAO_0000218,,
9570,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628629,,BAO_0000218,,
9571,16365,Half life after administering orally a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628630,,BAO_0000218,,
9572,16365,Half life after administering orally a dose of 3 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628631,,BAO_0000218,,
9573,16365,Half life after administering intravenously a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628632,,BAO_0000218,,
9574,526,Half life after oral dosing in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628633,,BAO_0000218,,
9575,16365,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628634,,BAO_0000218,,
9576,4368,Half life by intravenous administration of 3.4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627789,,BAO_0000218,,
9577,3371,Half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627790,,BAO_0000218,,
9578,6448,Half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627791,,BAO_0000218,,
9579,6453,Half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627792,,BAO_0000218,,
9580,4353,Half life in rat after intravenous administration of the compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627793,,BAO_0000218,,
9581,4353,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627794,,BAO_0000218,1969.0,
9582,4353,Half life in rat after po administration of the compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627795,,BAO_0000218,,
9583,4353,Half life in rat after po administration of the compound; ND means Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627796,,BAO_0000218,,
9584,4353,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL875335,,BAO_0000218,1969.0,
9585,4353,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627797,,BAO_0000218,1969.0,
9586,5789,Half life in rat i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627798,,BAO_0000218,,
9587,17686,Half life in rat i.v. at 2 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627799,,BAO_0000218,,
9588,6495,Half life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627800,,BAO_0000218,,
9589,484,Half life in rats after intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627801,,BAO_0000218,,
9590,6467,Half life in rats at the dose of 1.0 mpk by i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627802,,BAO_0000218,,
9591,6642,Half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL627803,,BAO_0000218,,
9592,16367,Half life was evaluated after intravenous administration to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873820,,BAO_0000218,,
9593,1369,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627804,,BAO_0000218,,
9594,5472,Half life was evaluated in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627805,,BAO_0000218,,
9595,6049,Half life was evaluated in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627806,,BAO_0000218,,
9596,5472,Half life was evaluated in rat; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627107,,BAO_0000218,,
9597,16366,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627108,,BAO_0000218,,
9598,11149,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627109,,BAO_0000218,,
9599,11149,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627110,,BAO_0000218,178.0,
9600,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,A,In vivo,,Primates,9443.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627111,,BAO_0000218,,
9601,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,A,In vivo,,Primates,9443.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627112,,BAO_0000218,,
9602,2891,Half life was measured in rat at dose of 30 mg/kg by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627113,,BAO_0000218,,
9603,2891,Half life was measured in rat at dose of 30 mg/kg by po administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL627114,,BAO_0000218,,
9604,4026,Half life (t1/2) was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627115,,BAO_0000218,,
9605,4527,Half life period at a dose of 10 uM/kg in rat was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627116,,BAO_0000218,,
9606,4527,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627117,,BAO_0000218,,
9607,5503,Half life period was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627118,,BAO_0000218,,
9608,4426,Half life period after intravenous administration at 20 mpk in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627119,,BAO_0000218,,
9609,4426,Half life period after intravenous administration at 20 mpk in rats; Not performed.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627120,,BAO_0000218,,
9610,6109,Half life period after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626922,,BAO_0000218,,
9611,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626923,,BAO_0000218,,
9612,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626924,,BAO_0000218,,
9613,4755,Half life period in 80% rat plasma at 37 degree Centigrade,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626925,,BAO_0000218,1969.0,
9614,5862,Half life period in SD rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626926,,BAO_0000218,,
9615,1515,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626927,,BAO_0000218,1969.0,
9616,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626928,,BAO_0000218,1969.0,
9617,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626929,,BAO_0000218,1969.0,
9618,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626930,,BAO_0000218,1969.0,
9619,5960,Half life period in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626931,,BAO_0000218,,
9620,6103,Half life period in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626932,,BAO_0000218,,
9621,6317,Half life period in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626933,,BAO_0000218,,
9622,6644,Half life period in rat after oral administration at 10.5 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873826,,BAO_0000218,,
9623,6644,Half life period in rat after oral administration at 11.2 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626934,,BAO_0000218,,
9624,6644,Half life period in rat after oral administration at 13 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626935,,BAO_0000218,,
9625,6644,Half life period in rat after oral administration at 9.7 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626936,,BAO_0000218,,
9626,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626937,,BAO_0000218,,
9627,6295,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625906,,BAO_0000218,,
9628,6296,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625907,,BAO_0000218,,
9629,16427,PK study was carried to determine AUC (area under curve) value in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625908,,BAO_0000218,,
9630,16367,Pharmacokinetic parameter AUC after intravenous administration to rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625909,,BAO_0000218,,
9631,16367,Pharmacokinetic parameter AUC after oral administration to rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625910,,BAO_0000218,,
9632,16365,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625911,,BAO_0000218,,
9633,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625912,,BAO_0000218,,
9634,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626538,,BAO_0000218,,
9635,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876794,,BAO_0000218,,
9636,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626539,,BAO_0000218,,
9637,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626540,,BAO_0000218,,
9638,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626541,,BAO_0000218,,
9639,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626542,,BAO_0000218,,
9640,2792,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626543,,BAO_0000218,,
9641,2792,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626544,,BAO_0000218,,
9642,2792,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626545,,BAO_0000218,,
9643,2792,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626546,,BAO_0000218,,
9644,5334,Pharmacokinetic parameter area under curve was reported,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626547,,BAO_0000218,,
9645,4408,Pharmacokinetic property (AUC) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626548,,BAO_0000218,,
9646,5983,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626549,,BAO_0000218,,
9647,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626550,,BAO_0000218,,
9648,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626551,,BAO_0000218,,
9649,5491,Pharmacokinetic property was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623777,,BAO_0000218,,
9650,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623778,,BAO_0000218,,
9651,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623779,,BAO_0000218,,
9652,4199,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623780,,BAO_0000218,1969.0,
9653,4199,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622015,,BAO_0000218,1969.0,
9654,4199,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622016,,BAO_0000218,1969.0,
9655,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622017,,BAO_0000218,,
9656,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622018,,BAO_0000218,,
9657,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622019,,BAO_0000218,,
9658,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622020,,BAO_0000218,,
9659,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622021,,BAO_0000218,,
9660,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622022,,BAO_0000218,,
9661,5327,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622023,,BAO_0000218,,
9662,6681,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622024,,BAO_0000218,,
9663,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622693,,BAO_0000218,,
9664,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622694,,BAO_0000218,,
9665,6685,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622695,,BAO_0000218,,
9666,6685,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622696,,BAO_0000218,,
9667,6685,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622697,,BAO_0000218,,
9668,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622874,,BAO_0000218,,
9669,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622875,,BAO_0000218,,
9670,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622876,,BAO_0000218,,
9671,4796,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622877,,BAO_0000218,,
9672,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622878,,BAO_0000218,,
9673,4910,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622879,,BAO_0000218,1969.0,
9674,4839,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877602,,BAO_0000218,,
9675,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622880,,BAO_0000218,,
9676,15078,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622881,,BAO_0000218,,
9677,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622882,,BAO_0000218,,
9678,15078,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622883,,BAO_0000218,,
9679,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622884,,BAO_0000218,2046.0,
9680,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622885,,BAO_0000218,2046.0,
9681,8151,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622886,,BAO_0000218,,
9682,8151,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622887,,BAO_0000218,,
9683,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622888,,BAO_0000218,1088.0,
9684,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622889,,BAO_0000218,178.0,
9685,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622890,,BAO_0000218,178.0,
9686,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622891,,BAO_0000218,178.0,
9687,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL877603,,BAO_0000218,178.0,
9688,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622892,,BAO_0000218,955.0,
9689,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622893,,BAO_0000218,955.0,
9690,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622894,,BAO_0000218,955.0,
9691,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622895,,BAO_0000218,955.0,
9692,8677,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622896,,BAO_0000218,955.0,
9693,8677,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622897,,BAO_0000218,948.0,
9694,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622898,,BAO_0000218,948.0,
9695,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622899,,BAO_0000218,948.0,
9696,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622900,,BAO_0000218,2113.0,
9697,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624114,,BAO_0000218,2113.0,
9698,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624115,,BAO_0000218,2113.0,
9699,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624116,,BAO_0000218,2113.0,
9700,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624117,,BAO_0000218,2107.0,
9701,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624118,,BAO_0000218,2107.0,
9702,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624119,,BAO_0000218,2107.0,
9703,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624120,,BAO_0000218,2107.0,
9704,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624121,,BAO_0000218,2048.0,
9705,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624122,,BAO_0000218,2048.0,
9706,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624123,,BAO_0000218,2048.0,
9707,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624124,,BAO_0000218,2048.0,
9708,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624125,,BAO_0000218,2385.0,
9709,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624126,,BAO_0000218,2385.0,
9710,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624127,,BAO_0000218,2385.0,
9711,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624128,,BAO_0000218,2385.0,
9712,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL624129,,BAO_0000218,14.0,
9713,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL624130,,BAO_0000218,14.0,
9714,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL622340,,BAO_0000218,14.0,
9715,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL622341,,BAO_0000218,14.0,
9716,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622342,,BAO_0000218,160.0,
9717,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622343,,BAO_0000218,160.0,
9718,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622344,,BAO_0000218,160.0,
9719,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622345,,BAO_0000218,160.0,
9720,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622346,,BAO_0000218,2106.0,
9721,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622347,,BAO_0000218,2106.0,
9722,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622348,,BAO_0000218,2106.0,
9723,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622349,,BAO_0000218,2106.0,
9724,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622350,,BAO_0000218,,
9725,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622351,,BAO_0000218,,
9726,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622352,,BAO_0000218,,
9727,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622353,,BAO_0000218,,
9728,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622354,,BAO_0000218,,
9729,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622355,,BAO_0000218,,
9730,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622356,,BAO_0000218,,
9731,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622357,,BAO_0000218,,
9732,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622358,,BAO_0000218,,
9733,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622359,,BAO_0000218,,
9734,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874393,,BAO_0000218,,
9735,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622872,,BAO_0000218,,
9736,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622873,,BAO_0000218,,
9737,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623047,,BAO_0000218,,
9738,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623048,,BAO_0000218,,
9739,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623049,,BAO_0000218,,
9740,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623050,,BAO_0000218,,
9741,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623051,,BAO_0000218,,
9742,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623052,,BAO_0000218,,
9743,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626343,,BAO_0000218,,
9744,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626344,,BAO_0000218,,
9745,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626345,,BAO_0000218,,
9746,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626346,,BAO_0000218,,
9747,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626347,,BAO_0000218,,
9748,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626348,,BAO_0000218,,
9749,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626349,,BAO_0000218,,
9750,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626350,,BAO_0000218,,
9751,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626351,,BAO_0000218,,
9752,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627650,,BAO_0000218,,
9753,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627651,,BAO_0000218,,
9754,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627652,,BAO_0000218,,
9755,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627653,,BAO_0000218,,
9756,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627654,,BAO_0000218,,
9757,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627835,,BAO_0000218,,
9758,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627836,,BAO_0000218,,
9759,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627837,,BAO_0000218,,
9760,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627838,,BAO_0000218,,
9761,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875338,,BAO_0000218,,
9762,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627839,,BAO_0000218,,
9763,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627840,,BAO_0000218,,
9764,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627841,,BAO_0000218,,
9765,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627842,,BAO_0000218,,
9766,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627843,,BAO_0000218,,
9767,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627844,,BAO_0000218,,
9768,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627845,,BAO_0000218,,
9769,5874,Half life period in rat by iv administration at a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627846,,BAO_0000218,,
9770,1515,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627847,,BAO_0000218,1969.0,
9771,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873821,,BAO_0000218,1969.0,
9772,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626079,,BAO_0000218,1969.0,
9773,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626080,,BAO_0000218,1969.0,
9774,5491,Half life period was evaluated in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626081,,BAO_0000218,1969.0,
9775,5491,Half life period was evaluated in rat plasma; Not tested,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL875344,,BAO_0000218,1969.0,
9776,1918,Half life period was evaluated in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626082,,BAO_0000218,,
9777,1918,"Half life period was evaluated in rats, iv",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626250,,BAO_0000218,,
9778,6113,Half life period after intravenous administration at 5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626251,,BAO_0000218,,
9779,5546,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626252,,BAO_0000218,,
9780,5553,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626253,,BAO_0000218,,
9781,4188,Half life stability of compound was evaluated in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626254,,BAO_0000218,1969.0,
9782,6215,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626255,,BAO_0000218,,
9783,6141,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626256,,BAO_0000218,,
9784,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626257,,BAO_0000218,,
9785,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626258,,BAO_0000218,,
9786,5710,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626259,,BAO_0000218,,
9787,5789,Half in rat i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626260,,BAO_0000218,,
9788,6011,Half period in rat after intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875345,,BAO_0000218,,
9789,17594,Half-life after repeated oral dose of compound at 1 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626261,,BAO_0000218,,
9790,12357,Half-life measured in in vitro Cathepsin B assay in rat liver,A,In vitro,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626262,,BAO_0000218,2107.0,
9791,5210,Half-life of compound was determined in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626263,,BAO_0000218,,
9792,17596,Half-life at 10 mg/kg in rat upon intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625270,,BAO_0000218,,
9793,6672,Half-life determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625271,,BAO_0000218,,
9794,6673,Half-life determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625272,,BAO_0000218,,
9795,4910,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625273,,BAO_0000218,955.0,
9796,3741,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625274,,BAO_0000218,1969.0,
9797,17671,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625275,,BAO_0000218,,
9798,4910,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625276,,BAO_0000218,1969.0,
9799,17537,Half-life in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625277,,BAO_0000218,1969.0,
9800,4965,Half-life in rat plasma was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625278,,BAO_0000218,1969.0,
9801,17537,Half-life in rat plasma; Not tested,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625279,,BAO_0000218,1969.0,
9802,6124,Half-life in rat serum,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL625280,,BAO_0000218,1977.0,
9803,6124,Half-life in rat serum; na is not available,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL876797,,BAO_0000218,1977.0,
9804,6078,Half-life was calculated in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625281,,BAO_0000218,,
9805,17668,Half-life was calculated in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL873827,,BAO_0000218,1969.0,
9806,3185,Half-life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625282,,BAO_0000218,,
9807,4883,Half-life was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625283,,BAO_0000218,,
9808,2959,Half-life after administration of 20 mg/Kg oral dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625284,,BAO_0000218,,
9809,4029,Half-life after administration of 3.2 mg/kg intravenously in male rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625285,,BAO_0000218,,
9810,4029,Half-life after intravenous administration in female rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625286,,BAO_0000218,,
9811,4029,Half-life after intravenous administration in male rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625287,,BAO_0000218,,
9812,6180,Half-life after intravenous dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625288,,BAO_0000218,,
9813,1557,Half-life in a rat liver homogenate preparation,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625289,,BAO_0000218,2107.0,
9814,12500,Half-life in plasma of rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625290,,BAO_0000218,1969.0,
9815,12500,Half-life in plasma of rat at dose of 3-10 mgkg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876798,,BAO_0000218,1969.0,
9816,5064,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625291,,BAO_0000218,,
9817,5145,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625292,,BAO_0000218,,
9818,5147,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625293,,BAO_0000218,,
9819,5833,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622832,,BAO_0000218,,
9820,6596,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622833,,BAO_0000218,,
9821,17655,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622834,,BAO_0000218,,
9822,6495,Half-life in rat after oral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622835,,BAO_0000218,,
9823,17538,Half-life in rat after po administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622836,,BAO_0000218,,
9824,17538,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622837,,BAO_0000218,,
9825,10,Half-life in rat at 3 mg/kg dose administered intravenously,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622838,,BAO_0000218,,
9826,17669,Half-life in rat brain homogenate,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622839,,BAO_0000218,955.0,
9827,17065,Half-life in rat plasma,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622840,,BAO_0000218,1969.0,
9828,4333,Half-life in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622841,,BAO_0000218,,
9829,6827,Half-life in Dawley rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622842,,BAO_0000218,,
9830,889,Half-life in vitro in rat plasma,A,In vitro,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622843,,BAO_0000218,1969.0,
9831,889,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,A,In vitro,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622844,,BAO_0000218,1969.0,
9832,3747,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622845,,BAO_0000218,,
9833,15022,The area under the curve of compound was measured at the dose of 100 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622846,,BAO_0000218,,
9834,15022,The area under the curve of compound was measured at the dose of 300 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622847,,BAO_0000218,,
9835,15022,The area under the curve of compound was measured at the dose of 30 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622848,,BAO_0000218,,
9836,3360,Bioavailability as oral AUC in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622849,,BAO_0000218,,
9837,5334,The plasma concentration versus time curve (AUC) was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622850,,BAO_0000218,1969.0,
9838,17411,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876807,,BAO_0000218,,
9839,17411,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622851,,BAO_0000218,,
9840,17411,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622852,,BAO_0000218,,
9841,6570,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622853,,BAO_0000218,,
9842,6570,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622854,,BAO_0000218,,
9843,17411,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622855,,BAO_0000218,,
9844,14941,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622856,,BAO_0000218,1969.0,
9845,14941,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622857,,BAO_0000218,1969.0,
9846,17538,AUC in rat after po administration at a dose of 10 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622858,,BAO_0000218,1969.0,
9847,17752,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622859,,BAO_0000218,1969.0,
9848,17509,Area under curve value 24 hr after 10 mg/kg iv administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622860,,BAO_0000218,,
9849,17509,Area under curve value 24 hr after 10 mg/kg oral administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622861,,BAO_0000218,,
9850,17509,Area under curve value 24 hr after 2 mg/kg iv administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622862,,BAO_0000218,,
9851,17509,Area under curve value 24 hr after 2 mg/kg oral administration in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622863,,BAO_0000218,,
9852,17509,Area under curve value 6 hr after po administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623817,,BAO_0000218,,
9853,17717,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623818,,BAO_0000218,,
9854,17717,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623819,,BAO_0000218,,
9855,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623820,,BAO_0000218,,
9856,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623821,,BAO_0000218,,
9857,6642,AUC normalized for dose (AUCN) in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623822,,BAO_0000218,1969.0,
9858,6640,Area under curve in rat after p.o. administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623823,,BAO_0000218,,
9859,6641,Area under curve in rat after p.o. administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623824,,BAO_0000218,,
9860,6641,Area under curve in rat after p.o. administration; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623825,,BAO_0000218,,
9861,6641,Area under curve in rat after peroral administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622070,,BAO_0000218,,
9862,3603,Area under curve (carotid artery) value of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622071,,BAO_0000218,,
9863,3550,Bioavailability expressed as the area under curve of rat carotid artery,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622072,,BAO_0000218,,
9864,15662,Area under curve in male SD rats was observed after intravenous administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622073,,BAO_0000218,,
9865,17720,Area under curve of the compound was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622074,,BAO_0000218,,
9866,5407,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622075,,BAO_0000218,,
9867,17752,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622076,,BAO_0000218,1969.0,
9868,17752,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622077,,BAO_0000218,1969.0,
9869,3603,Area under curve (portal vein) value of the compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622078,,BAO_0000218,,
9870,3550,Bioavailability expressed as the area under curve of rat portal vein,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622079,,BAO_0000218,,
9871,17655,Area Under plasma concentration time curve in rat upon peroral administration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622080,,BAO_0000218,1969.0,
9872,17582,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877612,,BAO_0000218,,
9873,17582,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622081,,BAO_0000218,,
9874,17791,Compound was evaluated for oral bioavailability in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622082,,BAO_0000218,,
9875,17791,Compound was evaluated for oral bioavailability in rats after iv administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622083,,BAO_0000218,,
9876,17791,Compound was evaluated for oral bioavailability in rats; 30-80,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622084,,BAO_0000218,,
9877,17791,Compound was evaluated for oral bioavailability in rats; 50-60,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622085,,BAO_0000218,,
9878,17791,Compound was evaluated for oral bioavailability in rats; no data,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622086,,BAO_0000218,,
9879,17791,Compound was evaluated for oral bioavailability in rats; peptide,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622087,,BAO_0000218,,
9880,7768,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622088,,BAO_0000218,178.0,
9881,7768,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622089,,BAO_0000218,178.0,
9882,7768,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623685,,BAO_0000218,178.0,
9883,7768,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623686,,BAO_0000218,178.0,
9884,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL623687,,BAO_0000218,945.0,
9885,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL623688,,BAO_0000218,945.0,
9886,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL623689,,BAO_0000218,945.0,
9887,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Stomach,,,50597,N,1,Intermediate,1,,CHEMBL622485,,BAO_0000218,945.0,
9888,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622486,,BAO_0000218,2046.0,
9889,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL877613,,BAO_0000218,2046.0,
9890,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622487,,BAO_0000218,2046.0,
9891,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622488,,BAO_0000218,2046.0,
9892,8677,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622489,,BAO_0000218,948.0,
9893,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622490,,BAO_0000218,1088.0,
9894,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622491,,BAO_0000218,1088.0,
9895,6899,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622492,,BAO_0000218,2107.0,
9896,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622493,,BAO_0000218,1088.0,
9897,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622494,,BAO_0000218,1088.0,
9898,8677,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622495,,BAO_0000218,2385.0,
9899,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622496,,BAO_0000218,,
9900,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622497,,BAO_0000218,1088.0,
9901,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622498,,BAO_0000218,,
9902,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624918,,BAO_0000218,1088.0,
9903,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624919,,BAO_0000218,1088.0,
9904,10839,Biodistribution of compound in rat blood after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624920,,BAO_0000218,178.0,
9905,10839,Biodistribution of compound in rat blood after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624921,,BAO_0000218,178.0,
9906,10839,Biodistribution of compound in rat brain after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624922,,BAO_0000218,955.0,
9907,10839,Biodistribution of compound in rat heart after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624923,,BAO_0000218,948.0,
9908,10839,Biodistribution of compound in rat heart after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624924,,BAO_0000218,948.0,
9909,10839,Biodistribution of compound in rat kidney after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624925,,BAO_0000218,2113.0,
9910,10839,Biodistribution of compound in rat kidney after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624926,,BAO_0000218,2113.0,
9911,10839,Biodistribution of compound in rat liver after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624927,,BAO_0000218,2107.0,
9912,10839,Biodistribution of compound in rat liver after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL874402,,BAO_0000218,2107.0,
9913,10839,Biodistribution of compound in rat lung after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624928,,BAO_0000218,2048.0,
9914,10839,Biodistribution of compound in rat lung after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624929,,BAO_0000218,2048.0,
9915,10839,Biodistribution of compound in rat muscle after 5 min of administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624930,,BAO_0000218,2385.0,
9916,10839,Biodistribution of compound in rat muscle after 5 min of administration.,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624931,,BAO_0000218,2385.0,
9917,4043,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624932,,BAO_0000218,948.0,
9918,4043,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624933,,BAO_0000218,948.0,
9919,4043,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624934,,BAO_0000218,2107.0,
9920,4043,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624935,,BAO_0000218,2107.0,
9921,4043,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624936,,BAO_0000218,,
9922,4043,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624937,,BAO_0000218,,
9923,4043,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL624938,,BAO_0000218,2106.0,
9924,4043,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL624939,,BAO_0000218,2106.0,
9925,4043,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624940,,BAO_0000218,,
9926,4043,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874403,,BAO_0000218,,
9927,1446,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624941,,BAO_0000218,,
9928,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624942,,BAO_0000218,1088.0,
9929,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624943,,BAO_0000218,1088.0,
9930,5765,% Bioavailability after 1 day of the drug administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624944,,BAO_0000218,,
9931,5765,% Bioavailability after 4 day of the drug administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624945,,BAO_0000218,,
9932,4257,Absolute bioavailability was evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624946,,BAO_0000218,,
9933,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624947,,BAO_0000218,,
9934,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624948,,BAO_0000218,,
9935,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624949,,BAO_0000218,,
9936,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622025,,BAO_0000218,2113.0,
9937,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622026,,BAO_0000218,2113.0,
9938,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622027,,BAO_0000218,2113.0,
9939,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622028,,BAO_0000218,2113.0,
9940,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622029,,BAO_0000218,2107.0,
9941,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622208,,BAO_0000218,2107.0,
9942,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622209,,BAO_0000218,2107.0,
9943,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622210,,BAO_0000218,2107.0,
9944,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622211,,BAO_0000218,,
9945,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622212,,BAO_0000218,,
9946,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622213,,BAO_0000218,,
9947,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874404,,BAO_0000218,,
9948,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620452,,BAO_0000218,2385.0,
9949,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620453,,BAO_0000218,2385.0,
9950,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL620454,,BAO_0000218,2385.0,
9951,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624067,,BAO_0000218,2385.0,
9952,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624068,,BAO_0000218,,
9953,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL624069,,BAO_0000218,992.0,
9954,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL624070,,BAO_0000218,992.0,
9955,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL624071,,BAO_0000218,992.0,
9956,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL624072,,BAO_0000218,995.0,
9957,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL624073,,BAO_0000218,995.0,
9958,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL624788,,BAO_0000218,995.0,
9959,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL624789,,BAO_0000218,995.0,
9960,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624790,,BAO_0000218,,
9961,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624791,,BAO_0000218,,
9962,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624792,,BAO_0000218,,
9963,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624793,,BAO_0000218,,
9964,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL877491,,BAO_0000218,2385.0,
9965,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624957,,BAO_0000218,2385.0,
9966,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624958,,BAO_0000218,2385.0,
9967,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624959,,BAO_0000218,2385.0,
9968,11977,Dissociation constant was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624960,,BAO_0000218,,
9969,14941,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624961,,BAO_0000218,,
9970,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624962,,BAO_0000218,,
9971,15078,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624963,,BAO_0000218,,
9972,4755,Observed rate constant in 80% rat plasma at 37 degree Centigrade,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624964,,BAO_0000218,,
9973,589,LogP value was evaluated in the in situ rat gut perfusion assay,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624965,,BAO_0000218,,
9974,17582,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624966,,BAO_0000218,,
9975,5031,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624967,,BAO_0000218,,
9976,17764,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624968,,BAO_0000218,,
9977,17720,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624969,,BAO_0000218,,
9978,2862,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL624970,,BAO_0000218,,
9979,16423,Half-life was evaluated after 10 uM/kg of intra arterial administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624971,,BAO_0000218,,
9980,16423,Half-life was evaluated after 20 uM/kg of peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624972,,BAO_0000218,,
9981,6005,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624973,,BAO_0000218,,
9982,2938,Half-life was evaluated in plasma of rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL624974,,BAO_0000218,1969.0,
9983,6410,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624975,,BAO_0000218,,
9984,6410,Half-life was evaluated in rats at an oral dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877492,,BAO_0000218,,
9985,6062,Half-life was measured in rat after an iv dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624976,,BAO_0000218,,
9986,6571,Half-life period of compound in rats after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624977,,BAO_0000218,,
9987,3136,Half-life period of compound was measured in rat plasma.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626848,,BAO_0000218,1969.0,
9988,3136,Half-life period of compound was measured in rat plasma; ND is not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626849,,BAO_0000218,1969.0,
9989,3136,Half-life period of compound was measured in rat plasma; not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626850,,BAO_0000218,1969.0,
9990,4521,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626851,,BAO_0000218,,
9991,5871,Half-life period in rat by iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626852,,BAO_0000218,,
9992,6077,Half-life period in rats following intravenous administration at 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626853,,BAO_0000218,,
9993,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626854,,BAO_0000218,,
9994,5144,Half-life period was determined for the compound in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627486,,BAO_0000218,,
9995,4498,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627487,,BAO_0000218,,
9996,4498,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627488,,BAO_0000218,,
9997,1908,Half-life value after IV dose at a dose of 5 mg/kg in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627489,,BAO_0000218,,
9998,6211,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627490,,BAO_0000218,,
9999,5529,Half-life was determined in rat after intravenous administration (0.5 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873829,,BAO_0000218,,
10000,6444,Half-life was determined in rat at a dose of 1 mpk i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627655,,BAO_0000218,,
10001,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625994,,BAO_0000218,,
10002,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625995,,BAO_0000218,,
10003,5207,Half-life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625996,,BAO_0000218,,
10004,530,In vitro half life in rat plasma,A,In vitro,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625850,,BAO_0000218,1969.0,
10005,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",A,In vitro,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625851,,BAO_0000218,1969.0,
10006,3219,In vitro half life in rat,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625852,,BAO_0000218,,
10007,6109,In vivo half life period after intravenous administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625853,,BAO_0000218,,
10008,17582,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625854,,BAO_0000218,,
10009,17582,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874450,,BAO_0000218,,
10010,5974,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625855,,BAO_0000218,,
10011,5974,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625856,,BAO_0000218,,
10012,5974,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625857,,BAO_0000218,,
10013,5974,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873831,,BAO_0000218,,
10014,17853,Longer half-life in rat (i.v.) at 0.5 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625858,,BAO_0000218,,
10015,17853,Longer half-life in rat (p.o.) at 2.0 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625859,,BAO_0000218,,
10016,3457,Pharmacokinetic property (half life) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625860,,BAO_0000218,,
10017,2792,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625861,,BAO_0000218,,
10018,2792,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625862,,BAO_0000218,,
10019,2792,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625863,,BAO_0000218,,
10020,2792,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625864,,BAO_0000218,,
10021,5739,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625865,,BAO_0000218,,
10022,15765,Pharmacokinetic half time was determined intravenously in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625866,,BAO_0000218,,
10023,6567,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625867,,BAO_0000218,1969.0,
10024,2448,Plasma half life of hydrolysis of the compound,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625868,,BAO_0000218,1969.0,
10025,5423,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625869,,BAO_0000218,1969.0,
10026,4853,Plasma half life period was calculated in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL874451,,BAO_0000218,1969.0,
10027,4514,Plasma half-life in Sprague-Dawley rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625870,,BAO_0000218,1969.0,
10028,4514,Plasma half-life in Sprague-Dawley rats; Not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625871,,BAO_0000218,1969.0,
10029,1500,Plasma half-life in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625872,,BAO_0000218,1969.0,
10030,1500,Plasma half-life in rats; <MQL,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625873,,BAO_0000218,1969.0,
10031,5334,Plasma half-life period (0-8 h) was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625874,,BAO_0000218,1969.0,
10032,5334,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625875,,BAO_0000218,1969.0,
10033,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625876,,BAO_0000218,1969.0,
10034,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631258,,BAO_0000218,1969.0,
10035,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631259,,BAO_0000218,1969.0,
10036,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631260,,BAO_0000218,1969.0,
10037,7768,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631261,,BAO_0000218,178.0,
10038,7768,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631262,,BAO_0000218,178.0,
10039,7768,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631263,,BAO_0000218,178.0,
10040,7768,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631264,,BAO_0000218,,
10041,7768,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631265,,BAO_0000218,,
10042,7768,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631266,,BAO_0000218,,
10043,7768,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631267,,BAO_0000218,,
10044,7768,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631268,,BAO_0000218,,
10045,7768,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631269,,BAO_0000218,,
10046,7768,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631270,,BAO_0000218,,
10047,7768,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631271,,BAO_0000218,948.0,
10048,7768,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631272,,BAO_0000218,948.0,
10049,7768,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631273,,BAO_0000218,948.0,
10050,7768,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631274,,BAO_0000218,948.0,
10051,7768,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631275,,BAO_0000218,948.0,
10052,7768,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626984,,BAO_0000218,948.0,
10053,7768,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626985,,BAO_0000218,948.0,
10054,7768,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626986,,BAO_0000218,2107.0,
10055,7768,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626987,,BAO_0000218,2107.0,
10056,7768,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626988,,BAO_0000218,2107.0,
10057,7768,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626989,,BAO_0000218,2107.0,
10058,7768,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626990,,BAO_0000218,2107.0,
10059,7768,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626991,,BAO_0000218,2107.0,
10060,7768,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626992,,BAO_0000218,2107.0,
10061,7768,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626993,,BAO_0000218,2048.0,
10062,7768,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL874593,,BAO_0000218,2048.0,
10063,7768,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626994,,BAO_0000218,2048.0,
10064,7768,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626995,,BAO_0000218,2048.0,
10065,7768,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626190,,BAO_0000218,2048.0,
10066,7768,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626191,,BAO_0000218,2048.0,
10067,7768,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626364,,BAO_0000218,2048.0,
10068,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626365,,BAO_0000218,2046.0,
10069,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626366,,BAO_0000218,2046.0,
10070,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626367,,BAO_0000218,2046.0,
10071,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626368,,BAO_0000218,2046.0,
10072,7768,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626369,,BAO_0000218,2046.0,
10073,7768,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626370,,BAO_0000218,2046.0,
10074,4498,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626371,,BAO_0000218,,
10075,4498,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626372,,BAO_0000218,,
10076,3603,Bioavailability after a dose of 10 mg/kg p.o.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626373,,BAO_0000218,,
10077,6215,Bioavailability after peroral administration (10 mg/kg) was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626374,,BAO_0000218,,
10078,5710,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626375,,BAO_0000218,,
10079,5710,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626376,,BAO_0000218,,
10080,5676,Bioavailability in rat po was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626377,,BAO_0000218,,
10081,17667,Bioavailability of compound at 10 mg/kg in rat after oral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626378,,BAO_0000218,,
10082,17667,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626379,,BAO_0000218,,
10083,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626380,,BAO_0000218,,
10084,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626381,,BAO_0000218,,
10085,17267,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626382,,BAO_0000218,,
10086,6362,Bioavailability in rat (Sprague-Dawley) (female),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626383,,BAO_0000218,,
10087,17671,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874652,,BAO_0000218,,
10088,17671,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626384,,BAO_0000218,,
10089,4333,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626385,,BAO_0000218,,
10090,6077,Bioavailability in rat at an oral dose of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626386,,BAO_0000218,,
10091,3278,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626387,,BAO_0000218,,
10092,5964,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626388,,BAO_0000218,,
10093,4884,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626389,,BAO_0000218,,
10094,4905,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626390,,BAO_0000218,,
10095,4884,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626391,,BAO_0000218,,
10096,6850,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626392,,BAO_0000218,,
10097,2864,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626393,,BAO_0000218,,
10098,5780,Bioavailability was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623026,,BAO_0000218,,
10099,1465,Bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623027,,BAO_0000218,,
10100,5199,Bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623028,,BAO_0000218,,
10101,5765,Bioavailability in rat after 1 day dosing,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623029,,BAO_0000218,,
10102,5765,Bioavailability in rat after 4 day dosing,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623030,,BAO_0000218,,
10103,6518,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623031,,BAO_0000218,,
10104,6518,Bioavailability after IV dosing at 1 mg/kg in rat; no data,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623032,,BAO_0000218,,
10105,6518,Bioavailability after oral administration at a dose of 2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623033,,BAO_0000218,,
10106,6518,Bioavailability after oral administration at a dose of 4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623034,,BAO_0000218,,
10107,2083,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623035,,BAO_0000218,,
10108,17260,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623036,,BAO_0000218,,
10109,4956,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623037,,BAO_0000218,,
10110,4368,Bioavailability by intravenous administration of 3.4 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623038,,BAO_0000218,,
10111,17752,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL874385,,BAO_0000218,1969.0,
10112,1446,Bioavailability in rat (Fisher) (fasted),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623039,,BAO_0000218,,
10113,2891,Bioavailability in monkey after po administration of 10 mg/kg dose,A,In vivo,,Primates,9443.0,,,,,22224,U,0,Intermediate,1,,CHEMBL623040,,BAO_0000218,,
10114,2891,Oral bioavailability in monkey (dose 10 mg/kg),A,In vivo,,Primates,9443.0,,,,,22224,U,0,Intermediate,1,,CHEMBL623041,,BAO_0000218,,
10115,6672,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623741,,BAO_0000218,,
10116,6673,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623742,,BAO_0000218,,
10117,17655,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623743,,BAO_0000218,,
10118,17796,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623744,,BAO_0000218,,
10119,17853,Bioavailability in rat (dose 2.0 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623745,,BAO_0000218,,
10120,4521,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623746,,BAO_0000218,,
10121,4940,Oral bioavailability in rat (dose 5 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623747,,BAO_0000218,,
10122,2891,Bioavailability in rat after po administration of 30 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL623748,,BAO_0000218,,
10123,2891,Bioavailability in rat after po administration of 30 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL623916,,BAO_0000218,,
10124,4521,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623917,,BAO_0000218,,
10125,17686,Bioavailability in rat (dose 2 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623918,,BAO_0000218,,
10126,17796,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874386,,BAO_0000218,,
10127,17796,Bioavailability in rat; Only traces detected in rat plasma,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623919,,BAO_0000218,1969.0,
10128,5064,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623920,,BAO_0000218,,
10129,5147,Bioavailability upon oral administration of compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623148,,BAO_0000218,,
10130,1916,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623149,,BAO_0000218,,
10131,6049,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623150,,BAO_0000218,,
10132,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623151,,BAO_0000218,,
10133,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623152,,BAO_0000218,,
10134,2862,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL623153,,BAO_0000218,,
10135,2862,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL623154,,BAO_0000218,,
10136,4194,In vitro and metabolic stability was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623155,,BAO_0000218,,
10137,4194,In vitro metabolic stability in rat hepatocytes,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623156,,BAO_0000218,,
10138,5486,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623157,,BAO_0000218,,
10139,17582,Metabolic rate for compound was observed in rat hepatocytes,A,In vitro,,Rattus norvegicus,10116.0,,Liver,Hepatocyte,,50597,N,1,Intermediate,1,,CHEMBL623158,401.0,BAO_0000218,2107.0,
10140,5600,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623159,,BAO_0000218,,
10141,14294,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874390,,BAO_0000218,,
10142,14294,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623160,,BAO_0000218,,
10143,14294,Metabolism of compound in rat S9 microsomes; Trace,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623161,,BAO_0000218,,
10144,17847,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623162,,BAO_0000218,,
10145,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623163,,BAO_0000218,,
10146,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623164,,BAO_0000218,,
10147,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623165,,BAO_0000218,,
10148,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623166,,BAO_0000218,,
10149,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624983,,BAO_0000218,,
10150,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624984,,BAO_0000218,,
10151,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624985,,BAO_0000218,,
10152,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622970,,BAO_0000218,,
10153,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622971,,BAO_0000218,,
10154,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622972,,BAO_0000218,,
10155,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622973,,BAO_0000218,,
10156,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622974,,BAO_0000218,,
10157,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622975,,BAO_0000218,,
10158,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622976,,BAO_0000218,,
10159,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622977,,BAO_0000218,,
10160,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624351,,BAO_0000218,,
10161,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624352,,BAO_0000218,,
10162,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624353,,BAO_0000218,,
10163,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622397,,BAO_0000218,,
10164,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622398,,BAO_0000218,,
10165,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622399,,BAO_0000218,,
10166,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622400,,BAO_0000218,,
10167,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628428,,BAO_0000218,,
10168,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628590,,BAO_0000218,,
10169,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628591,,BAO_0000218,,
10170,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628592,,BAO_0000218,,
10171,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628593,,BAO_0000218,,
10172,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875333,,BAO_0000218,,
10173,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628594,,BAO_0000218,,
10174,4969,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628595,,BAO_0000218,1969.0,
10175,6737,Stability in rat plasma was determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628596,,BAO_0000218,1969.0,
10176,6737,Stability in rat plasma was determined; ND= no data,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628597,,BAO_0000218,1969.0,
10177,5089,Tested for plasma half life period in rat (0-8 hr),A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628598,,BAO_0000218,1969.0,
10178,5089,Tested for plasma half life period in rat (0-8 hr); Not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628599,,BAO_0000218,1969.0,
10179,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628600,,BAO_0000218,,
10180,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628601,,BAO_0000218,,
10181,4950,Tested for the half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628602,,BAO_0000218,,
10182,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628603,,BAO_0000218,,
10183,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628604,,BAO_0000218,,
10184,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628605,,BAO_0000218,,
10185,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628606,,BAO_0000218,,
10186,2412,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,A,In vitro,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628607,,BAO_0000218,,
10187,15022,The biological half life the compound was measured at the dose of 100 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628608,,BAO_0000218,,
10188,15022,The biological half life the compound was measured at the dose of 30 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628609,,BAO_0000218,,
10189,406,The compound was evaluated for plasma half life period in rat,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628610,,BAO_0000218,1969.0,
10190,15078,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL873819,,BAO_0000218,,
10191,15078,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628611,,BAO_0000218,,
10192,5247,The pharmacokinetic parameter half-life period in vivo in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628612,,BAO_0000218,,
10193,5041,"The pharmacokinetic property, Half-life was determined",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628613,,BAO_0000218,,
10194,5041,"The pharmacokinetic property, Half-life in rat in vivo",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628614,,BAO_0000218,,
10195,5041,"The pharmacokinetic property, Half-life was determined; ND denotes no data",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628615,,BAO_0000218,,
10196,5041,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628616,,BAO_0000218,,
10197,3918,The plasma half life period in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627924,,BAO_0000218,1969.0,
10198,2906,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627925,,BAO_0000218,2107.0,
10199,6467,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627926,,BAO_0000218,,
10200,5510,t1/2 (apparent elimination)of the compound was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627927,,BAO_0000218,,
10201,3788,t1/2 value in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627928,,BAO_0000218,,
10202,17796,Half life in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627539,,BAO_0000218,,
10203,12873,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876790,,BAO_0000218,1969.0,
10204,5983,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL858186,,BAO_0000218,,
10205,15765,Half-life period in fasted rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627540,,BAO_0000218,,
10206,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627541,,BAO_0000218,,
10207,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627715,,BAO_0000218,,
10208,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627716,,BAO_0000218,,
10209,17655,Maximum time required to achieve Cmax was determined in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627717,,BAO_0000218,,
10210,17717,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627718,,BAO_0000218,,
10211,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627719,,BAO_0000218,,
10212,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627720,,BAO_0000218,,
10213,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627721,,BAO_0000218,,
10214,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627722,,BAO_0000218,,
10215,5978,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627723,,BAO_0000218,,
10216,5978,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626058,,BAO_0000218,,
10217,5978,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626059,,BAO_0000218,,
10218,5978,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626060,,BAO_0000218,,
10219,17720,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626061,,BAO_0000218,1969.0,
10220,4723,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876791,,BAO_0000218,,
10221,4723,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626062,,BAO_0000218,,
10222,4756,Tmax at the dose of 2 mg/Kg administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626063,,BAO_0000218,,
10223,4756,Tmax at the dose of 5 mg/Kg administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626064,,BAO_0000218,,
10224,17720,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626065,,BAO_0000218,1969.0,
10225,17720,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626066,,BAO_0000218,1969.0,
10226,1466,tmax upon peroral administration of 10.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626067,,BAO_0000218,,
10227,7449,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626068,,BAO_0000218,,
10228,7449,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626069,,BAO_0000218,,
10229,7449,Percent total excretion of 3-methoxyacetaminophen glucuronide,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626070,,BAO_0000218,,
10230,7449,Percent total excretion of N-methoxyacetaminophen glucuronide,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626071,,BAO_0000218,,
10231,7449,Percent total excretion of N-methoxyacetaminophen sulfate,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626072,,BAO_0000218,,
10232,7449,Percent total excretion of acetaminophen,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626073,,BAO_0000218,,
10233,7768,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626741,,BAO_0000218,2046.0,
10234,17655,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626742,,BAO_0000218,,
10235,17735,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626743,,BAO_0000218,,
10236,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876792,,BAO_0000218,,
10237,17735,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626744,,BAO_0000218,,
10238,7116,Compound was tested for antidiuretic activity in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626745,,BAO_0000218,,
10239,4878,AUC in rat after 3mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626746,,BAO_0000218,1969.0,
10240,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626747,,BAO_0000218,,
10241,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626748,,BAO_0000218,,
10242,16367,Bioavailability administered orally at a dose of 10 mg/kg to rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626749,,BAO_0000218,,
10243,16366,Oral Bioavailability was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626750,,BAO_0000218,,
10244,4426,Oral bioavailability in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626751,,BAO_0000218,,
10245,4426,Oral bioavailability in rat; Not performed.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626913,,BAO_0000218,,
10246,5041,Bioavailability,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626914,,BAO_0000218,,
10247,5041,Bioavailability was determined; ND denotes no data,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626915,,BAO_0000218,,
10248,1500,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626916,,BAO_0000218,,
10249,1500,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626917,,BAO_0000218,,
10250,17409,Binding towards rat plasma protein at 10 uM,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626918,,BAO_0000218,,
10251,17409,Binding towards rat plasma protein at 100 uM,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626919,,BAO_0000218,,
10252,2959,Bioavailability in rat (dose 20 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626920,,BAO_0000218,,
10253,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621976,,BAO_0000218,,
10254,6567,Bioavailability in rat after 5 mg/kg oral gavage,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877599,,BAO_0000218,,
10255,6571,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621977,,BAO_0000218,,
10256,6715,Bioavailability in rat (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621978,,BAO_0000218,,
10257,6715,Bioavailability in rat (dose 3 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621979,,BAO_0000218,,
10258,2932,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621980,,BAO_0000218,,
10259,4171,Bioavailability of the compound in rats after administration of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621981,,BAO_0000218,,
10260,17509,Bioavailability after administration of 10 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621982,,BAO_0000218,,
10261,17509,Bioavailability after administration of 2 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL882953,,BAO_0000218,,
10262,4527,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621983,,BAO_0000218,,
10263,4026,Bioavailability in dogs was determined; high,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621984,,BAO_0000218,,
10264,6659,Bioavailability in monkey after intravenous administration at 1 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621985,,BAO_0000218,,
10265,6659,Bioavailability in monkey after peroral administration at 10 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621986,,BAO_0000218,,
10266,6659,Bioavailability in rat after intravenous administration at 1 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621987,,BAO_0000218,,
10267,6659,Bioavailability in rat after intravenous administration at 2 mpk,F,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877600,,BAO_0000218,,
10268,6659,Bioavailability in rat after peroral administration at 30 mpk,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621988,,BAO_0000218,,
10269,6659,Bioavailability in rat after peroral administration at at 100 mpk,F,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621989,,BAO_0000218,,
10270,6597,Bioavailability in rats was evaluated,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621990,,BAO_0000218,,
10271,1202,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621991,,BAO_0000218,,
10272,1202,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621992,,BAO_0000218,,
10273,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621993,,BAO_0000218,,
10274,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621994,,BAO_0000218,,
10275,5207,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621995,,BAO_0000218,,
10276,5970,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621996,,BAO_0000218,,
10277,17538,Oral bioavailability in rat (dose 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621997,,BAO_0000218,,
10278,17538,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621998,,BAO_0000218,,
10279,1466,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621999,,BAO_0000218,,
10280,2879,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622000,,BAO_0000218,,
10281,2879,Bioavailability was measured in rat after oral administration; 2-4,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622001,,BAO_0000218,,
10282,2879,Bioavailability was measured in rat after oral administration; 3-7,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622002,,BAO_0000218,,
10283,3777,Bioavailability in rat (intraduodenal administration),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622003,,BAO_0000218,,
10284,3777,Bioavailability in rat (intraduodenal administration),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877601,,BAO_0000218,,
10285,3777,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624871,,BAO_0000218,,
10286,3777,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622004,,BAO_0000218,,
10287,5423,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL882954,,BAO_0000218,,
10288,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622005,,BAO_0000218,,
10289,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622006,,BAO_0000218,,
10290,4239,Bioavailability was measured in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622007,,BAO_0000218,,
10291,5438,Bioavailability was reported,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622008,,BAO_0000218,,
10292,5334,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622009,,BAO_0000218,,
10293,5334,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622010,,BAO_0000218,,
10294,4199,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622011,,BAO_0000218,,
10295,4199,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622012,,BAO_0000218,,
10296,4199,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622013,,BAO_0000218,,
10297,4890,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622014,,BAO_0000218,,
10298,2792,Bioavailability was determined at 3 mg/kg po dose in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624749,,BAO_0000218,,
10299,5529,Oral bioavailability in rat (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624750,,BAO_0000218,,
10300,6685,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624751,,BAO_0000218,,
10301,6685,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624752,,BAO_0000218,,
10302,6685,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624753,,BAO_0000218,,
10303,6005,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624754,,BAO_0000218,,
10304,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624755,,BAO_0000218,,
10305,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624756,,BAO_0000218,,
10306,6103,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624757,,BAO_0000218,,
10307,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624758,,BAO_0000218,,
10308,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622270,,BAO_0000218,,
10309,5353,Bioavailability in rat (Sprague-Dawley),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622271,,BAO_0000218,,
10310,4727,Bioavailability in rat at the dose of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622272,,BAO_0000218,,
10311,17804,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622273,,BAO_0000218,,
10312,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622274,,BAO_0000218,,
10313,17804,Bioavailability value of compound in rats was determined after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622275,,BAO_0000218,,
10314,3634,Oral bioavailability in rat (dose 20 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622276,,BAO_0000218,,
10315,3341,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622277,,BAO_0000218,,
10316,2690,Oral bioavailability in rat (dose 5 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622278,,BAO_0000218,,
10317,3184,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622279,,BAO_0000218,,
10318,740,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622280,,BAO_0000218,,
10319,1806,Compound was evaluated for oral bioavailability in rats; 15-27 %,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624083,,BAO_0000218,,
10320,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624084,,BAO_0000218,,
10321,3634,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624085,,BAO_0000218,,
10322,64,Compound was tested for bioavailability in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624086,,BAO_0000218,,
10323,4839,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624087,,BAO_0000218,,
10324,1094,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624088,,BAO_0000218,,
10325,5005,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Intermediate,1,,CHEMBL624089,,BAO_0000218,,
10326,5005,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Intermediate,1,,CHEMBL624090,,BAO_0000218,,
10327,4687,Evaluated for the bioavailability in rat (in vivo),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624091,,BAO_0000218,,
10328,17804,F value of compound in rats was determined after peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624092,,BAO_0000218,,
10329,5974,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624093,,BAO_0000218,,
10330,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624094,,BAO_0000218,,
10331,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624095,,BAO_0000218,,
10332,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624096,,BAO_0000218,,
10333,1088,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624097,,BAO_0000218,,
10334,1742,Maximum fall in carotid flow in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624098,,BAO_0000218,,
10335,4689,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874392,,BAO_0000218,,
10336,2463,Oral bioavailability in rat (dose 5 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624099,,BAO_0000218,,
10337,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624100,,BAO_0000218,,
10338,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624101,,BAO_0000218,,
10339,6874,Oral bioavailability in rat (male Wistar),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624102,,BAO_0000218,,
10340,5633,Oral bioavailability after administration (30 mg/kg) in rat; good,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624103,,BAO_0000218,,
10341,5496,Oral bioavailability at the dose of 2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624104,,BAO_0000218,,
10342,2358,Oral bioavailability determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624105,,BAO_0000218,,
10343,16456,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624106,,BAO_0000218,,
10344,5302,Oral bioavailability in rat (dose single 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624107,,BAO_0000218,,
10345,5302,Oral bioavailability in rat (dose single 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623943,,BAO_0000218,,
10346,5302,Oral bioavailability in rat (dose 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623944,,BAO_0000218,,
10347,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623945,,BAO_0000218,,
10348,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623946,,BAO_0000218,,
10349,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623947,,BAO_0000218,,
10350,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623948,,BAO_0000218,,
10351,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623949,,BAO_0000218,,
10352,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623950,,BAO_0000218,,
10353,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874398,,BAO_0000218,,
10354,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623951,,BAO_0000218,,
10355,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623952,,BAO_0000218,,
10356,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623953,,BAO_0000218,,
10357,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623954,,BAO_0000218,,
10358,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623955,,BAO_0000218,,
10359,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623956,,BAO_0000218,,
10360,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627807,,BAO_0000218,,
10361,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627808,,BAO_0000218,,
10362,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627809,,BAO_0000218,,
10363,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627810,,BAO_0000218,,
10364,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627811,,BAO_0000218,,
10365,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627812,,BAO_0000218,,
10366,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627813,,BAO_0000218,,
10367,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627814,,BAO_0000218,,
10368,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875336,,BAO_0000218,,
10369,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627815,,BAO_0000218,,
10370,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627816,,BAO_0000218,,
10371,11020,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627817,,BAO_0000218,,
10372,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627818,,BAO_0000218,,
10373,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627819,,BAO_0000218,,
10374,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627820,,BAO_0000218,,
10375,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627821,,BAO_0000218,,
10376,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628464,,BAO_0000218,,
10377,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626239,,BAO_0000218,,
10378,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626240,,BAO_0000218,,
10379,11020,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626241,,BAO_0000218,,
10380,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626242,,BAO_0000218,,
10381,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626243,,BAO_0000218,,
10382,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626244,,BAO_0000218,,
10383,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626907,,BAO_0000218,,
10384,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626908,,BAO_0000218,,
10385,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626909,,BAO_0000218,,
10386,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626910,,BAO_0000218,,
10387,7449,Percent total excretion of acetaminophen cysteine conjugate,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875342,,BAO_0000218,,
10388,7449,Percent total excretion of acetaminophen glucuronide,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626911,,BAO_0000218,,
10389,7449,Percent total excretion of acetaminophen sulfate,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626912,,BAO_0000218,,
10390,7449,Percent total excretion of acetaminophen-mercapturic acid,F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627065,,BAO_0000218,,
10391,3172,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627066,,BAO_0000218,1088.0,
10392,16456,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627067,,BAO_0000218,,
10393,10839,Biodistribution of compound in rat muscle after 5 min of administration,A,In vivo,,ratrat,8656.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627068,,BAO_0000218,2385.0,
10394,10839,Biodistribution of compound in rat muscle after 5 min of administration.,A,In vivo,,ratrat,8656.0,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627069,,BAO_0000218,2385.0,
10395,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627070,,BAO_0000218,,
10396,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627071,,BAO_0000218,,
10397,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627072,,BAO_0000218,,
10398,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627073,,BAO_0000218,,
10399,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625387,,BAO_0000218,,
10400,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625388,,BAO_0000218,,
10401,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL625389,,BAO_0000218,1969.0,
10402,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),A,In vivo,,Ovis aries,9940.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL875343,,BAO_0000218,1969.0,
10403,1735,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),A,,,Serpentes,8570.0,,,,,50497,N,1,Intermediate,1,,CHEMBL876795,,BAO_0000218,,
10404,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,A,,,Serpentes,8570.0,,,,,50497,N,1,Intermediate,1,,CHEMBL626552,,BAO_0000218,,
10405,1336,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,A,,,Serpentes,8570.0,,,,,50497,N,1,Intermediate,1,,CHEMBL626553,,BAO_0000218,,
10406,12403,The human biological plasma half life of the compound,A,,,Homo sapiens,9606.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626554,,BAO_0000366,1969.0,
10407,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626555,,BAO_0000218,1088.0,
10408,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626556,,BAO_0000218,,
10409,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626557,,BAO_0000218,,
10410,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626558,,BAO_0000218,,
10411,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626559,,BAO_0000218,,
10412,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626560,,BAO_0000218,,
10413,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876803,,BAO_0000218,,
10414,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627964,,BAO_0000218,,
10415,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627965,,BAO_0000218,,
10416,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627966,,BAO_0000218,,
10417,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627967,,BAO_0000218,,
10418,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627968,,BAO_0000218,,
10419,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627969,,BAO_0000218,,
10420,8004,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627970,,BAO_0000218,,
10421,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627971,,BAO_0000218,178.0,
10422,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627972,,BAO_0000218,178.0,
10423,15917,Dissociation constant against binding to human cyclophilin A,B,,,Homo sapiens,9606.0,,,,,180,D,9,Expert,1,,CHEMBL856029,,BAO_0000357,,
10424,12396,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,B,,,Bos taurus,9913.0,,,,,11591,H,8,Expert,1,,CHEMBL627973,,BAO_0000019,,
10425,7065,-Log C was determined by performing the electroshock minimum test,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627974,,BAO_0000019,,
10426,7065,-Log C was determined by performing the foot shock test,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627975,,BAO_0000019,,
10427,7065,-Log C was determined by performing the incl screen test,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627976,,BAO_0000019,,
10428,7065,-Log C was determined by performing the maximum electroshock test,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627977,,BAO_0000019,,
10429,7065,-Log C was determined by performing the pentylenetetrazole test,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627978,,BAO_0000019,,
10430,12415,Tested for experimental arotinoid inhibitory dose,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627979,,BAO_0000019,,
10431,10256,Negative log transformed activity,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL876804,,BAO_0000019,,
10432,7991,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627980,,BAO_0000019,,
10433,14342,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,A,,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL627981,,BAO_0000218,,
10434,14342,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,A,,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL627982,,BAO_0000218,,
10435,14342,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,A,,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL627983,,BAO_0000218,,
10436,14342,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,A,,,Cavia porcellus,10141.0,,Ileum,,,50512,N,1,Intermediate,1,,CHEMBL627984,,BAO_0000218,2116.0,
10437,6047,Solubility in water was determined; values expressed as -log,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL627985,,BAO_0000100,,
10438,17269,Ratio of Kcat to that of Km was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627986,,BAO_0000019,,
10439,10026,Observed first order rate constant,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627987,,BAO_0000019,,
10440,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627988,,BAO_0000019,,
10441,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627989,,BAO_0000218,,
10442,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627990,,BAO_0000218,,
10443,4029,Oral Bioavailability after administration of 10 mg/kg in male rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876805,,BAO_0000218,,
10444,17735,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627991,,BAO_0000218,,
10445,4576,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627992,,BAO_0000218,,
10446,17582,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627993,,BAO_0000218,,
10447,17651,Oral bioavailability at 1 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622817,,BAO_0000218,,
10448,17651,Oral bioavailability at 10 mg/kg was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622818,,BAO_0000218,,
10449,17670,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622819,,BAO_0000218,,
10450,5045,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL872267,,BAO_0000218,,
10451,1696,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622820,,BAO_0000218,,
10452,17764,Oral bioavailability after intravenous administration in rats at 24 uM/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622821,,BAO_0000218,,
10453,6448,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622822,,BAO_0000218,,
10454,6596,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622823,,BAO_0000218,,
10455,17547,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622824,,BAO_0000218,,
10456,17771,Oral bioavailability in rat at a dose of 3 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622825,,BAO_0000218,,
10457,6495,Oral bioavailability in rat after oral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622901,,BAO_0000218,,
10458,4558,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622902,,BAO_0000218,,
10459,17596,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621844,,BAO_0000218,,
10460,6827,Oral bioavailability in Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621845,,BAO_0000218,,
10461,4026,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621846,,BAO_0000218,,
10462,10,Oral bioavailability in rat (dose 30 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621847,,BAO_0000218,,
10463,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877609,,BAO_0000218,,
10464,17717,Bioavailability in rat (dose 3 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621848,,BAO_0000218,,
10465,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621849,,BAO_0000218,,
10466,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622030,,BAO_0000218,,
10467,4796,Percent oral bioavailability determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622031,,BAO_0000218,,
10468,4883,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622032,,BAO_0000218,,
10469,2137,The compound was evaluated for bioavailability in rats; 32-51,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622033,,BAO_0000218,,
10470,2959,Bioavailability in rat (dose 20 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622034,,BAO_0000218,,
10471,1361,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622035,,BAO_0000218,,
10472,4727,Bioavailability percent in rat at the dose of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL882966,,BAO_0000218,,
10473,16423,Bioavailability was evaluated after 20 uM/kg of peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622036,,BAO_0000218,,
10474,5206,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622037,,BAO_0000218,,
10475,6448,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622038,,BAO_0000218,,
10476,17723,Bioavailability in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622039,,BAO_0000218,,
10477,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622040,,BAO_0000218,178.0,
10478,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622041,,BAO_0000218,178.0,
10479,17738,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622042,,BAO_0000218,178.0,
10480,17738,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622043,,BAO_0000218,178.0,
10481,17738,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622044,,BAO_0000218,178.0,
10482,17738,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL622045,,BAO_0000218,10000001.0,
10483,17738,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL622046,,BAO_0000218,10000001.0,
10484,17738,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL622047,,BAO_0000218,10000001.0,
10485,17738,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL877610,,BAO_0000218,10000001.0,
10486,17738,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622048,,BAO_0000218,955.0,
10487,17738,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622049,,BAO_0000218,955.0,
10488,17738,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622050,,BAO_0000218,955.0,
10489,17738,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622051,,BAO_0000218,955.0,
10490,17738,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622052,,BAO_0000218,,
10491,17738,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622053,,BAO_0000218,,
10492,17738,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622054,,BAO_0000218,,
10493,17738,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622055,,BAO_0000218,,
10494,5237,Oral bioavailability in rats was determined; High,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622056,,BAO_0000218,,
10495,5503,Oral bioavailability in the rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622057,,BAO_0000218,,
10496,15765,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628008,,BAO_0000218,,
10497,15660,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622058,,BAO_0000218,,
10498,5978,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622059,,BAO_0000218,,
10499,5978,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622060,,BAO_0000218,,
10500,5978,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622061,,BAO_0000218,,
10501,5978,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622062,,BAO_0000218,,
10502,5656,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622063,,BAO_0000218,,
10503,3598,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL877611,,BAO_0000218,,
10504,4216,Oral bioavailability of compound in Sprague Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622064,,BAO_0000218,,
10505,17839,Oral bioavailability of compound in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622065,,BAO_0000218,,
10506,6570,Oral bioavailability in rat (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622066,,BAO_0000218,,
10507,5334,Oral bioavailability of compound in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622067,,BAO_0000218,,
10508,6886,Oral bioavailability of compound in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622068,,BAO_0000218,,
10509,5210,Oral bioavailability of compound was determined in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622069,,BAO_0000218,,
10510,4170,Oral bioavailability at a dose of 30 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624796,,BAO_0000218,,
10511,6028,Oral bioavailability in rat (dose 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624797,,BAO_0000218,,
10512,6028,Oral bioavailability in rat (dose 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623053,,BAO_0000218,,
10513,6078,Oral bioavailability evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623054,,BAO_0000218,,
10514,6168,Oral bioavailability in fasted rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623055,,BAO_0000218,,
10515,6168,Oral bioavailability in fed rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623056,,BAO_0000218,,
10516,5160,Oral bioavailability in rat (mature male) (dose 30 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623057,,BAO_0000218,,
10517,6057,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623058,,BAO_0000218,,
10518,6535,Oral bioavailability in rat (dose 10 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623059,,BAO_0000218,,
10519,6535,Oral bioavailability in rat after administration of 10 mg/kg po,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623060,,BAO_0000218,,
10520,4194,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623061,,BAO_0000218,,
10521,6230,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623062,,BAO_0000218,,
10522,6619,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623063,,BAO_0000218,,
10523,17607,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623064,,BAO_0000218,,
10524,4942,Oral bioavailability in ratrs,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623065,,BAO_0000218,,
10525,4942,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623066,,BAO_0000218,,
10526,6646,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623067,,BAO_0000218,,
10527,5237,Oral bioavailability in rats was determined; High,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623068,,BAO_0000218,,
10528,6646,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623069,,BAO_0000218,,
10529,4449,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623070,,BAO_0000218,,
10530,6057,Oral bioavailability was calculated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623071,,BAO_0000218,,
10531,2552,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623072,,BAO_0000218,,
10532,5496,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623073,,BAO_0000218,,
10533,6484,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623074,,BAO_0000218,,
10534,6485,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623075,,BAO_0000218,,
10535,6616,Oral bioavailability after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623076,,BAO_0000218,,
10536,4969,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623077,,BAO_0000218,,
10537,5862,Oral bioavailability in rat (Sprague-Dawley),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623078,,BAO_0000218,,
10538,4514,Oral bioavailability in Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623079,,BAO_0000218,,
10539,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623080,,BAO_0000218,,
10540,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623081,,BAO_0000218,,
10541,5546,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623082,,BAO_0000218,,
10542,6168,Oral bioavailability in fasted rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874400,,BAO_0000218,,
10543,6168,Oral bioavailability in fed rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623083,,BAO_0000218,,
10544,3624,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623084,,BAO_0000218,,
10545,5213,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623085,,BAO_0000218,,
10546,5496,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623086,,BAO_0000218,,
10547,5553,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623087,,BAO_0000218,,
10548,5833,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623088,,BAO_0000218,,
10549,5836,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623089,,BAO_0000218,,
10550,5865,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623090,,BAO_0000218,,
10551,5960,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623091,,BAO_0000218,,
10552,6249,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623092,,BAO_0000218,,
10553,6448,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623093,,BAO_0000218,,
10554,6453,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874401,,BAO_0000218,,
10555,6640,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623094,,BAO_0000218,,
10556,17607,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623095,,BAO_0000218,,
10557,5939,Oral bioavailability in rat after peroral administration at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623096,,BAO_0000218,,
10558,5939,Oral bioavailability in rat after peroral administration at 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624913,,BAO_0000218,,
10559,6281,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624914,,BAO_0000218,,
10560,5874,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624915,,BAO_0000218,,
10561,5213,Oral bioavailability in rat; Not measured,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624916,,BAO_0000218,,
10562,4964,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624917,,BAO_0000218,,
10563,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625157,,BAO_0000218,,
10564,6251,In vitro metabolic potential in rat liver microsomes,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625158,,BAO_0000218,2107.0,
10565,1568,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625159,,BAO_0000218,,
10566,3032,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625160,,BAO_0000218,,
10567,3748,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625161,,BAO_0000218,,
10568,401,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625162,,BAO_0000218,,
10569,6512,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625163,,BAO_0000218,,
10570,17617,Oral bioavailability in rats at 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625164,,BAO_0000218,,
10571,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625165,,BAO_0000218,,
10572,6742,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625166,,BAO_0000218,,
10573,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625167,,BAO_0000218,,
10574,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625168,,BAO_0000218,,
10575,3185,Plasma clearance of the compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625169,,BAO_0000218,,
10576,17596,Plasma clearance at 10 mg/kg in rat upon intravenous administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626264,,BAO_0000218,,
10577,2713,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626265,,BAO_0000218,,
10578,12500,The compound was tested for plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626266,,BAO_0000218,1969.0,
10579,12500,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626267,,BAO_0000218,1969.0,
10580,2713,Plasma concentration upon oral administration of 1 mg/Kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626268,,BAO_0000218,,
10581,1446,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626269,,BAO_0000218,,
10582,6227,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626270,,BAO_0000218,,
10583,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626271,,BAO_0000218,,
10584,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626272,,BAO_0000218,,
10585,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626273,,BAO_0000218,,
10586,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875346,,BAO_0000218,,
10587,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626274,,BAO_0000218,,
10588,4514,Compound was tested for protein binding in rat plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626275,,BAO_0000218,,
10589,2713,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624646,,BAO_0000218,,
10590,2713,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624647,,BAO_0000218,,
10591,5340,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624648,,BAO_0000218,2107.0,
10592,12058,Area under curve ratio was determined (po/iv) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624649,,BAO_0000218,,
10593,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624650,,BAO_0000218,,
10594,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624651,,BAO_0000218,,
10595,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624652,,BAO_0000218,,
10596,6495,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624653,,BAO_0000218,,
10597,6078,Ratio of AUCbrain to AUCplasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624654,,BAO_0000218,,
10598,5656,Ratio of brain to plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624655,,BAO_0000218,,
10599,4910,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624656,,BAO_0000218,,
10600,4910,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624657,,BAO_0000218,,
10601,4910,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624658,,BAO_0000218,,
10602,10130,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624659,,BAO_0000218,,
10603,10130,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624660,,BAO_0000218,,
10604,10130,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624661,,BAO_0000218,,
10605,5213,Steady state brain :blood ratio was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624662,,BAO_0000218,,
10606,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625199,,BAO_0000218,,
10607,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625200,,BAO_0000218,,
10608,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625201,,BAO_0000218,,
10609,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625202,,BAO_0000218,,
10610,2083,Percentage recovery after 3h incubation with rat hapatocytes was determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625203,,BAO_0000218,,
10611,2082,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625204,,BAO_0000218,,
10612,2082,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625205,,BAO_0000218,,
10613,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625206,,BAO_0000218,,
10614,14583,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625207,,BAO_0000019,,
10615,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625208,,BAO_0000019,,
10616,4608,In vivo absorption in Caco-2 cell line monolayers was determined,A,,,Homo sapiens,9606.0,,,Caco-2,,50587,N,1,Intermediate,1,,CHEMBL625209,495.0,BAO_0000218,,
10617,13668,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625210,,BAO_0000100,,
10618,5669,Area under curve was determine after peroral administration at 10 mpk in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625211,,BAO_0000218,,
10619,5669,Area under curve was determine after peroral administration at 10 mpk in Rhesus,A,,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL625212,,BAO_0000218,,
10620,5669,Area under curve was determine after peroral administration at 160 mpk in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625213,,BAO_0000218,,
10621,5669,Area under curve was determine after peroral administration at 20 mpk in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625214,,BAO_0000218,,
10622,5669,Area under curve was determine after peroral administration at 50 mpk in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874542,,BAO_0000218,,
10623,6472,Calculated partition coefficient (clogP) (AlogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625215,,BAO_0000100,,
10624,15106,Activated partial thromboplastin time measured,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625216,,BAO_0000019,,
10625,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625217,,BAO_0000100,,
10626,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625218,,BAO_0000100,,
10627,13941,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622864,,BAO_0000218,1969.0,
10628,13941,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622865,,BAO_0000218,1969.0,
10629,13941,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622866,,BAO_0000218,1969.0,
10630,13941,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622867,,BAO_0000218,1969.0,
10631,15240,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,A,,,Cavia porcellus,10141.0,,Plasma,,,50512,N,1,Intermediate,1,,CHEMBL876808,,BAO_0000218,1969.0,
10632,10655,AUC in brain,A,,,,,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL627725,,BAO_0000019,955.0,
10633,10655,AUC in serum,A,,,,,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL627726,,BAO_0000019,1977.0,
10634,6504,AUC was determined,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627727,,BAO_0000019,1969.0,
10635,10615,AUC of the compound.,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627728,,BAO_0000019,1969.0,
10636,10353,AUC value (0-4 hr),A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627729,,BAO_0000019,1969.0,
10637,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627730,,BAO_0000019,1969.0,
10638,14907,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627731,,BAO_0000019,1969.0,
10639,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627732,,BAO_0000019,1969.0,
10640,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627733,,BAO_0000019,1969.0,
10641,16359,AUC(area under curve) was determined after intravenous administration in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627734,,BAO_0000218,1969.0,
10642,16359,AUC(area under curve) was determined after oral administration in rats,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627735,,BAO_0000218,1969.0,
10643,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,A,,,Cavia porcellus,10141.0,,Plasma,,,50512,N,1,Intermediate,1,,CHEMBL627736,,BAO_0000218,1969.0,
10644,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876809,,BAO_0000218,1969.0,
10645,15469,Area Under Curve after oral dosing of 100 uM/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627737,,BAO_0000019,,
10646,15469,Area Under Curve after oral dosing of 30 uM/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627738,,BAO_0000019,,
10647,13520,Area Under Curve was measured by ploting the graph between concentration verses time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627739,,BAO_0000019,,
10648,17025,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626143,,BAO_0000218,,
10649,17025,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626144,,BAO_0000218,,
10650,17025,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL626145,,BAO_0000218,,
10651,17025,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626146,,BAO_0000218,,
10652,12032,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626147,,BAO_0000218,178.0,
10653,10291,Area under curve (AUC) was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626148,,BAO_0000019,,
10654,5767,Area under curve (AUC) following ip administration at 1 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626149,,BAO_0000218,,
10655,1434,Area under curve (AUC) was determined; ND is Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626150,,BAO_0000019,,
10656,14925,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626151,,BAO_0000218,,
10657,14925,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626152,,BAO_0000218,,
10658,14925,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626153,,BAO_0000218,,
10659,1434,Area under curve (AUR) was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626154,,BAO_0000019,,
10660,11883,Area under curve at 1 uM/dg administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626155,,BAO_0000019,,
10661,11883,Area under curve at 10 uM/dg administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626156,,BAO_0000019,,
10662,11883,Area under curve at 2 uM/dg administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626157,,BAO_0000019,,
10663,11883,Area under curve at 20 uM/dg administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626158,,BAO_0000019,,
10664,15233,Area under curve at a peroral dose of 3 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626159,,BAO_0000218,,
10665,15233,Area under curve at a peroral dose of 3 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626160,,BAO_0000218,,
10666,15233,Area under curve at an iv dose of 1 mg/kg in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626161,,BAO_0000218,,
10667,15233,Area under curve at an iv dose of 1 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626162,,BAO_0000218,,
10668,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626163,,BAO_0000019,,
10669,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626164,,BAO_0000019,,
10670,11355,Area under curve measured as conc vs time after intravenous administration to mice.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626165,,BAO_0000218,,
10671,11355,Area under curve measured as conc vs time after peroral administration to mice.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626166,,BAO_0000218,,
10672,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626167,,BAO_0000218,,
10673,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626168,,BAO_0000218,,
10674,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL877463,,BAO_0000218,,
10675,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626169,,BAO_0000218,,
10676,17738,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626170,,BAO_0000218,948.0,
10677,17738,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626171,,BAO_0000218,948.0,
10678,17738,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626172,,BAO_0000218,948.0,
10679,17738,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626173,,BAO_0000218,948.0,
10680,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626174,,BAO_0000218,2113.0,
10681,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626175,,BAO_0000218,2113.0,
10682,17738,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626176,,BAO_0000218,2113.0,
10683,17738,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626177,,BAO_0000218,2113.0,
10684,17738,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622499,,BAO_0000218,2113.0,
10685,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622500,,BAO_0000218,2107.0,
10686,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622501,,BAO_0000218,2107.0,
10687,17738,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622502,,BAO_0000218,2107.0,
10688,17738,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622503,,BAO_0000218,2107.0,
10689,17738,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL877614,,BAO_0000218,2107.0,
10690,17738,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624839,,BAO_0000218,2048.0,
10691,17738,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624840,,BAO_0000218,2048.0,
10692,17738,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624841,,BAO_0000218,2048.0,
10693,17738,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624842,,BAO_0000218,2048.0,
10694,17738,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624843,,BAO_0000218,2385.0,
10695,17738,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624844,,BAO_0000218,2385.0,
10696,17738,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624845,,BAO_0000218,2385.0,
10697,17738,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL621904,,BAO_0000218,2385.0,
10698,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621905,,BAO_0000218,178.0,
10699,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL874382,,BAO_0000218,178.0,
10700,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL621906,,BAO_0000218,178.0,
10701,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL621907,,BAO_0000218,955.0,
10702,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622096,,BAO_0000218,955.0,
10703,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622097,,BAO_0000218,955.0,
10704,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622098,,BAO_0000218,948.0,
10705,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622099,,BAO_0000218,948.0,
10706,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622100,,BAO_0000218,948.0,
10707,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622101,,BAO_0000218,2113.0,
10708,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622102,,BAO_0000218,2113.0,
10709,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622103,,BAO_0000218,2113.0,
10710,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622104,,BAO_0000218,2107.0,
10711,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622105,,BAO_0000218,2107.0,
10712,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622106,,BAO_0000218,2107.0,
10713,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622107,,BAO_0000218,2048.0,
10714,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622108,,BAO_0000218,2048.0,
10715,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622109,,BAO_0000218,2048.0,
10716,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622110,,BAO_0000218,2385.0,
10717,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622111,,BAO_0000218,2385.0,
10718,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL874383,,BAO_0000218,2385.0,
10719,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL622112,,BAO_0000218,14.0,
10720,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL622113,,BAO_0000218,14.0,
10721,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL622114,,BAO_0000218,14.0,
10722,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622115,,BAO_0000218,2106.0,
10723,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622116,,BAO_0000218,2106.0,
10724,6193,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622117,,BAO_0000218,,
10725,6803,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622118,,BAO_0000218,,
10726,6647,Oral bioavailability in rats at 6 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622119,,BAO_0000218,,
10727,6647,Oral bioavailability in rat (dose 6 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622120,,BAO_0000218,,
10728,6647,Oral bioavailability in rats at 6 mg/kg dose; Not tested,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622121,,BAO_0000218,,
10729,6640,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622122,,BAO_0000218,,
10730,6641,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622123,,BAO_0000218,,
10731,6641,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622124,,BAO_0000218,,
10732,6642,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622125,,BAO_0000218,,
10733,5472,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622126,,BAO_0000218,,
10734,6141,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620455,,BAO_0000218,,
10735,4390,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620456,,BAO_0000218,,
10736,5472,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620457,,BAO_0000218,,
10737,5472,Oral bioavailability was evaluated; Not tested,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620458,,BAO_0000218,,
10738,5438,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620459,,BAO_0000218,,
10739,4883,Oral bioavailability in rat by oral dosing,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620460,,BAO_0000218,,
10740,1908,Oral bioavailability in rat (dose 10 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620461,,BAO_0000218,,
10741,4853,Oral bioavailability in rat (Sprague-Dawley),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620462,,BAO_0000218,,
10742,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620463,,BAO_0000218,,
10743,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620464,,BAO_0000218,,
10744,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620465,,BAO_0000218,,
10745,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620466,,BAO_0000218,,
10746,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620467,,BAO_0000218,,
10747,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620468,,BAO_0000218,,
10748,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620469,,BAO_0000218,,
10749,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620470,,BAO_0000218,,
10750,3169,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620471,,BAO_0000218,,
10751,6305,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620472,,BAO_0000218,,
10752,4762,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620473,,BAO_0000218,,
10753,17847,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620474,,BAO_0000218,,
10754,6211,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620475,,BAO_0000218,,
10755,6011,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620476,,BAO_0000218,,
10756,6317,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620477,,BAO_0000218,,
10757,6644,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620478,,BAO_0000218,,
10758,6644,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618768,,BAO_0000218,,
10759,6644,Oral bioavailability in rat after oral administration at 13 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618769,,BAO_0000218,,
10760,6644,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618770,,BAO_0000218,,
10761,6113,Oral bioavailability (dose 20 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618771,,BAO_0000218,,
10762,5937,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618772,,BAO_0000218,,
10763,5711,Oral bioavailability in rat at 10 mg/kg of the compound,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618773,,BAO_0000218,,
10764,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875842,,BAO_0000218,,
10765,17717,Bioavailability in rat (dose 3 mg/kg i.v.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618774,,BAO_0000218,,
10766,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618775,,BAO_0000218,,
10767,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618776,,BAO_0000218,,
10768,4722,Percent bioavailability (F) in rats after iv administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618777,,BAO_0000218,,
10769,4722,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618778,,BAO_0000218,,
10770,4353,Bioavailability in rat (dose 5 uM/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618779,,BAO_0000218,,
10771,15662,Oral bioavailability,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618780,,BAO_0000218,,
10772,4756,Bioavailability in rat (dose 2 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618781,,BAO_0000218,,
10773,4756,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618782,,BAO_0000218,,
10774,3436,Oral bioavailability in rat (dose 20 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618783,,BAO_0000218,,
10775,17800,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618784,,BAO_0000218,,
10776,15762,Percent oral bioavailability evaluated in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618785,,BAO_0000218,,
10777,5089,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618786,,BAO_0000218,,
10778,5089,Percent oral bioavailability in rat; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618787,,BAO_0000218,,
10779,3185,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618788,,BAO_0000218,,
10780,5145,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618789,,BAO_0000218,,
10781,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618790,,BAO_0000218,,
10782,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618791,,BAO_0000218,,
10783,5983,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875843,,BAO_0000218,,
10784,5739,Oral bioavailability in rat (dose 20 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL618792,,BAO_0000218,,
10785,3579,Cmax at a dose of 30 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623395,,BAO_0000218,,
10786,17788,Cmax in monkeys at a dose of 1 mg/kg,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623396,,BAO_0000218,,
10787,14956,Cmax in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623397,,BAO_0000218,,
10788,17788,Cmax in rats at a dose of 1 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623398,,BAO_0000218,,
10789,9750,Cmax was measured in mice after an oral dose of 50 mg/kg.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623399,,BAO_0000218,,
10790,12767,"Cmax value at a dose of 12.7 uM/kg, po",A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623400,,BAO_0000218,,
10791,12767,"Cmax value at a dose of 6.3 uM/kg, iv",A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623401,,BAO_0000218,,
10792,12767,"Cmax value at a dose of 7.1 uM/kg, iv",A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623402,,BAO_0000218,,
10793,12703,Cmax value of compound was determined after 1 hr,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623403,,BAO_0000218,,
10794,15778,Cmax value of the compound,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623404,,BAO_0000218,,
10795,12818,Cmax value administered intraintestinal in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625997,,BAO_0000218,,
10796,14964,Cmax value administered perorally was determined in rat; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625998,,BAO_0000218,,
10797,15808,Cmax value at the dose of 2.3 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625999,,BAO_0000218,,
10798,15808,Cmax value at the dose of 5 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626000,,BAO_0000218,,
10799,15778,Cmax value in the period of 8 hr after dosing. ,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626001,,BAO_0000218,,
10800,3715,Cmax value at a oral dose of 20 mg/kg; Not tested,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626002,,BAO_0000218,,
10801,3715,Cmax value at a oral dose of 20 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626003,,BAO_0000218,,
10802,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626004,,BAO_0000218,,
10803,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL626005,,BAO_0000218,,
10804,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626006,,BAO_0000218,,
10805,14810,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626007,,BAO_0000218,1969.0,
10806,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL626008,,BAO_0000218,1969.0,
10807,12555,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,A,In vivo,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL626009,,BAO_0000218,2107.0,
10808,10754,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626010,,BAO_0000218,,
10809,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626011,,BAO_0000218,178.0,
10810,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626012,,BAO_0000218,178.0,
10811,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626013,,BAO_0000218,178.0,
10812,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL626014,,BAO_0000218,178.0,
10813,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL877496,,BAO_0000218,178.0,
10814,14600,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,F,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626015,,BAO_0000218,,
10815,14600,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,F,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626016,,BAO_0000218,,
10816,14600,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,F,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626017,,BAO_0000218,,
10817,13543,Bioavailability as maximal plasma concentration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626018,,BAO_0000218,1969.0,
10818,13543,Bioavailability as maximal plasma concentration in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626692,,BAO_0000218,1969.0,
10819,13543,Bioavailability as maximal plasma concentration in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626693,,BAO_0000218,1969.0,
10820,13543,Bioavailability as maximal plasma concentration in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626694,,BAO_0000218,1969.0,
10821,14600,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626695,,BAO_0000218,178.0,
10822,14600,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626696,,BAO_0000218,178.0,
10823,14600,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626697,,BAO_0000218,178.0,
10824,14600,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626859,,BAO_0000218,178.0,
10825,14600,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626860,,BAO_0000218,178.0,
10826,14600,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,A,In vivo,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL626861,,BAO_0000218,178.0,
10827,14681,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626296,,BAO_0000218,,
10828,15905,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626297,,BAO_0000218,,
10829,15905,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626298,,BAO_0000218,1969.0,
10830,13304,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626299,,BAO_0000218,1969.0,
10831,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626300,,BAO_0000218,1969.0,
10832,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626301,,BAO_0000218,1969.0,
10833,15137,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626962,,BAO_0000218,1969.0,
10834,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626963,,BAO_0000218,1969.0,
10835,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626964,,BAO_0000218,1969.0,
10836,14839,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,A,In vivo,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL626965,,BAO_0000218,1969.0,
10837,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL626966,,BAO_0000218,1969.0,
10838,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL626967,,BAO_0000218,1969.0,
10839,14839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,A,In vivo,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL626968,,BAO_0000218,1969.0,
10840,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626969,,BAO_0000218,948.0,
10841,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627126,,BAO_0000218,948.0,
10842,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631276,,BAO_0000218,948.0,
10843,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631277,,BAO_0000218,948.0,
10844,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631278,,BAO_0000218,948.0,
10845,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL874457,,BAO_0000218,948.0,
10846,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631279,,BAO_0000218,948.0,
10847,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631280,,BAO_0000218,948.0,
10848,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631281,,BAO_0000218,948.0,
10849,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631968,,BAO_0000218,948.0,
10850,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631969,,BAO_0000218,948.0,
10851,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631970,,BAO_0000218,948.0,
10852,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631971,,BAO_0000218,948.0,
10853,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL631972,,BAO_0000218,948.0,
10854,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630435,,BAO_0000218,948.0,
10855,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630436,,BAO_0000218,948.0,
10856,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630437,,BAO_0000218,948.0,
10857,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630438,,BAO_0000218,948.0,
10858,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630439,,BAO_0000218,948.0,
10859,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630440,,BAO_0000218,2113.0,
10860,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630441,,BAO_0000218,2113.0,
10861,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630442,,BAO_0000218,2113.0,
10862,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625234,,BAO_0000218,2113.0,
10863,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625235,,BAO_0000218,2113.0,
10864,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625236,,BAO_0000218,2113.0,
10865,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625237,,BAO_0000218,2113.0,
10866,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626125,,BAO_0000218,2113.0,
10867,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626126,,BAO_0000218,2113.0,
10868,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626127,,BAO_0000218,2113.0,
10869,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626128,,BAO_0000218,2113.0,
10870,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626129,,BAO_0000218,2113.0,
10871,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626130,,BAO_0000218,2113.0,
10872,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626131,,BAO_0000218,2113.0,
10873,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626132,,BAO_0000218,2113.0,
10874,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626752,,BAO_0000218,2113.0,
10875,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626753,,BAO_0000218,2113.0,
10876,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626754,,BAO_0000218,2113.0,
10877,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626755,,BAO_0000218,2113.0,
10878,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626756,,BAO_0000218,2107.0,
10879,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626757,,BAO_0000218,2107.0,
10880,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626758,,BAO_0000218,2107.0,
10881,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626759,,BAO_0000218,2107.0,
10882,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626760,,BAO_0000218,2107.0,
10883,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626394,,BAO_0000218,,
10884,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626395,,BAO_0000218,,
10885,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626396,,BAO_0000218,,
10886,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626397,,BAO_0000218,,
10887,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626398,,BAO_0000218,,
10888,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626399,,BAO_0000218,,
10889,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874653,,BAO_0000218,,
10890,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626400,,BAO_0000218,,
10891,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626401,,BAO_0000218,,
10892,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626402,,BAO_0000218,,
10893,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626403,,BAO_0000218,,
10894,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626404,,BAO_0000218,,
10895,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626405,,BAO_0000218,,
10896,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625529,,BAO_0000218,,
10897,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625530,,BAO_0000218,,
10898,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625531,,BAO_0000218,,
10899,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625532,,BAO_0000218,,
10900,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625533,,BAO_0000218,,
10901,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875474,,BAO_0000218,,
10902,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625534,,BAO_0000218,,
10903,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625535,,BAO_0000218,,
10904,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625536,,BAO_0000218,,
10905,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625537,,BAO_0000218,,
10906,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625538,,BAO_0000218,,
10907,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625539,,BAO_0000218,,
10908,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625540,,BAO_0000218,,
10909,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625541,,BAO_0000218,,
10910,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625542,,BAO_0000218,,
10911,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625543,,BAO_0000218,,
10912,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625544,,BAO_0000218,,
10913,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625545,,BAO_0000218,,
10914,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625546,,BAO_0000218,,
10915,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625547,,BAO_0000218,,
10916,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625548,,BAO_0000218,,
10917,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625549,,BAO_0000218,,
10918,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625550,,BAO_0000218,,
10919,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625551,,BAO_0000218,,
10920,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875475,,BAO_0000218,,
10921,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625552,,BAO_0000218,,
10922,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625553,,BAO_0000218,,
10923,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625554,,BAO_0000218,,
10924,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625555,,BAO_0000218,,
10925,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625556,,BAO_0000218,,
10926,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624986,,BAO_0000218,,
10927,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624987,,BAO_0000218,,
10928,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624988,,BAO_0000218,,
10929,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624989,,BAO_0000218,1637.0,
10930,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624990,,BAO_0000218,1637.0,
10931,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL874391,,BAO_0000218,1637.0,
10932,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624991,,BAO_0000218,1637.0,
10933,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624992,,BAO_0000218,1637.0,
10934,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624993,,BAO_0000218,1637.0,
10935,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624994,,BAO_0000218,1637.0,
10936,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624995,,BAO_0000218,1637.0,
10937,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624996,,BAO_0000218,1637.0,
10938,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624997,,BAO_0000218,1637.0,
10939,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624998,,BAO_0000218,1637.0,
10940,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624999,,BAO_0000218,1637.0,
10941,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL882955,,BAO_0000218,1637.0,
10942,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625000,,BAO_0000218,1637.0,
10943,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625001,,BAO_0000218,1637.0,
10944,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625089,,BAO_0000218,1637.0,
10945,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625090,,BAO_0000218,1637.0,
10946,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625091,,BAO_0000218,1637.0,
10947,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625092,,BAO_0000218,1637.0,
10948,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625093,,BAO_0000218,1637.0,
10949,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625094,,BAO_0000218,1637.0,
10950,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL625095,,BAO_0000218,1637.0,
10951,2249,Compound was evaluated for its bioavailability in the dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625096,,BAO_0000218,,
10952,2249,Compound was evaluated for its bioavailability in the rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625097,,BAO_0000218,,
10953,17515,Compound was evaluated for oral bioavailability,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL882956,,BAO_0000218,,
10954,14541,Compound was evaluated for percentage of Oral bioavailability in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625098,,BAO_0000218,,
10955,12797,Bioavailability in guinea pig,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625099,,BAO_0000218,,
10956,12797,Compound was evaluated for the oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625100,,BAO_0000218,,
10957,12797,Compound was evaluated for the oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625101,,BAO_0000218,,
10958,12797,Compound was evaluated for the oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874396,,BAO_0000218,,
10959,11727,Bioavailability in dog (dosed i.v.),F,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625102,,BAO_0000218,,
10960,13249,Compound was tested for in vivo bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625103,,BAO_0000218,,
10961,13249,Compound was tested for in vivo bioavailability in hamsters,A,In vivo,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL625104,,BAO_0000218,,
10962,13249,Compound was tested for in vivo bioavailability in monkey,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625105,,BAO_0000218,,
10963,13249,Compound was tested for in vivo bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625106,,BAO_0000218,,
10964,9552,Oral bioavailability in mouse,A,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625107,,BAO_0000218,,
10965,9552,Compound was tested for percent of oral bioavailability in mice; 56-74,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625108,,BAO_0000218,,
10966,14839,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625109,,BAO_0000218,,
10967,14839,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625110,,BAO_0000218,,
10968,14839,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625111,,BAO_0000218,,
10969,14839,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625112,,BAO_0000218,,
10970,14839,Oral bioavailability in nude mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875334,,BAO_0000218,,
10971,11219,Bioavailability in monkey (i.d. dosing),A,In vivo,,Primates,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628617,,BAO_0000218,,
10972,9552,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628618,,BAO_0000218,,
10973,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628619,,BAO_0000218,,
10974,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628620,,BAO_0000218,,
10975,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL628621,,BAO_0000218,,
10976,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL628622,,BAO_0000218,,
10977,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL628623,,BAO_0000218,,
10978,14839,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,A,In vivo,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL628624,,BAO_0000218,1969.0,
10979,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL628625,,BAO_0000218,1969.0,
10980,14839,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,A,In vivo,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL628626,,BAO_0000218,1969.0,
10981,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627041,,BAO_0000218,1969.0,
10982,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627042,,BAO_0000218,1969.0,
10983,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627043,,BAO_0000218,1969.0,
10984,13932,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627044,,BAO_0000218,1969.0,
10985,11637,Cmax in mouse plasma,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL627045,,BAO_0000218,1969.0,
10986,11637,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL627046,,BAO_0000218,1969.0,
10987,13960,Maximal plasma concentration in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627047,,BAO_0000218,1969.0,
10988,15905,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627048,,BAO_0000218,1969.0,
10989,14062,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627049,,BAO_0000218,,
10990,14062,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627050,,BAO_0000218,,
10991,14062,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627051,,BAO_0000218,,
10992,14062,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627052,,BAO_0000218,,
10993,14062,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627053,,BAO_0000218,,
10994,14062,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627054,,BAO_0000218,,
10995,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627055,,BAO_0000218,,
10996,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627056,,BAO_0000218,,
10997,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627057,,BAO_0000218,,
10998,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627058,,BAO_0000218,,
10999,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626211,,BAO_0000218,,
11000,10291,Maximum Concentration of the compound.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626212,,BAO_0000218,,
11001,14599,Maximum Concentration was measured after iv administration into Beagle dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626213,,BAO_0000218,,
11002,14599,Maximum Concentration was measured after iv administration into Beagle dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626214,,BAO_0000218,,
11003,14599,Maximum Concentration was measured after po administration into Beagle dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626215,,BAO_0000218,,
11004,14599,Maximum Concentration was measured after po administration into Beagle dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626216,,BAO_0000218,,
11005,12767,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626217,,BAO_0000218,178.0,
11006,12767,Maximum blood level reached after an iv dose of 12.2 uM/kg,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626218,,BAO_0000218,178.0,
11007,12767,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626219,,BAO_0000218,178.0,
11008,12767,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626220,,BAO_0000218,178.0,
11009,12767,Maximum blood level reached after an oral dose of 5.0 mg/kg,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626221,,BAO_0000218,178.0,
11010,12767,Maximum blood level reached at dose of 10.6 uM/kg orally,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626222,,BAO_0000218,178.0,
11011,14706,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL626223,,BAO_0000218,,
11012,14706,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL626224,,BAO_0000218,,
11013,14793,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL626225,,BAO_0000218,955.0,
11014,14793,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL626226,,BAO_0000218,955.0,
11015,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL626227,,BAO_0000218,955.0,
11016,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL626228,,BAO_0000218,955.0,
11017,14793,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626229,,BAO_0000218,,
11018,14793,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626921,,BAO_0000218,,
11019,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876793,,BAO_0000218,,
11020,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625309,,BAO_0000218,,
11021,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),A,In vivo,,Bacillus subtilis,1423.0,,,,,50278,N,1,Intermediate,1,,CHEMBL625310,,BAO_0000218,,
11022,11871,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625311,,BAO_0000218,,
11023,11871,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625312,,BAO_0000218,,
11024,3437,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625313,,BAO_0000218,,
11025,12038,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625314,,BAO_0000218,,
11026,12038,Maximum concentration in male rats after iv administration of 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625315,,BAO_0000218,,
11027,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625316,,BAO_0000218,2107.0,
11028,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625317,,BAO_0000218,2107.0,
11029,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625318,,BAO_0000218,2107.0,
11030,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625319,,BAO_0000218,2107.0,
11031,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625320,,BAO_0000218,2107.0,
11032,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625321,,BAO_0000218,2107.0,
11033,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625322,,BAO_0000218,2107.0,
11034,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL876801,,BAO_0000218,2107.0,
11035,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625323,,BAO_0000218,2107.0,
11036,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625324,,BAO_0000218,2107.0,
11037,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625325,,BAO_0000218,2107.0,
11038,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625326,,BAO_0000218,2107.0,
11039,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625327,,BAO_0000218,2107.0,
11040,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625328,,BAO_0000218,2107.0,
11041,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625329,,BAO_0000218,2048.0,
11042,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625330,,BAO_0000218,2048.0,
11043,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627774,,BAO_0000218,2048.0,
11044,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627775,,BAO_0000218,2048.0,
11045,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627949,,BAO_0000218,2048.0,
11046,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627950,,BAO_0000218,2048.0,
11047,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627951,,BAO_0000218,2048.0,
11048,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627952,,BAO_0000218,2048.0,
11049,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627953,,BAO_0000218,2048.0,
11050,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627954,,BAO_0000218,2048.0,
11051,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627955,,BAO_0000218,2048.0,
11052,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627956,,BAO_0000218,2048.0,
11053,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL876802,,BAO_0000218,2048.0,
11054,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627957,,BAO_0000218,2048.0,
11055,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627958,,BAO_0000218,2048.0,
11056,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627959,,BAO_0000218,2048.0,
11057,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627960,,BAO_0000218,2048.0,
11058,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627961,,BAO_0000218,2048.0,
11059,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627962,,BAO_0000218,2048.0,
11060,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627963,,BAO_0000218,,
11061,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624759,,BAO_0000218,,
11062,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624760,,BAO_0000218,,
11063,9796,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624761,,BAO_0000218,,
11064,9796,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877607,,BAO_0000218,,
11065,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624762,,BAO_0000218,2107.0,
11066,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624763,,BAO_0000218,2107.0,
11067,9796,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624764,,BAO_0000218,2107.0,
11068,9796,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624765,,BAO_0000218,2107.0,
11069,9796,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624766,,BAO_0000218,2107.0,
11070,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624767,,BAO_0000218,,
11071,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624768,,BAO_0000218,,
11072,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624769,,BAO_0000218,,
11073,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624770,,BAO_0000218,,
11074,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624771,,BAO_0000218,,
11075,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624772,,BAO_0000218,,
11076,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624773,,BAO_0000218,,
11077,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624774,,BAO_0000218,,
11078,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624775,,BAO_0000218,,
11079,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624776,,BAO_0000218,,
11080,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624777,,BAO_0000218,,
11081,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624778,,BAO_0000218,,
11082,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624779,,BAO_0000218,,
11083,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624780,,BAO_0000218,,
11084,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624781,,BAO_0000218,,
11085,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877608,,BAO_0000218,,
11086,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624782,,BAO_0000218,,
11087,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624783,,BAO_0000218,,
11088,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624784,,BAO_0000218,,
11089,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624785,,BAO_0000218,,
11090,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624786,,BAO_0000218,,
11091,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624787,,BAO_0000218,,
11092,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628676,,BAO_0000218,,
11093,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621842,,BAO_0000218,,
11094,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL621843,,BAO_0000218,,
11095,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623873,,BAO_0000218,,
11096,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623874,,BAO_0000218,,
11097,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623875,,BAO_0000218,,
11098,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623876,,BAO_0000218,,
11099,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623877,,BAO_0000218,,
11100,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623878,,BAO_0000218,,
11101,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623879,,BAO_0000218,,
11102,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623880,,BAO_0000218,,
11103,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623881,,BAO_0000218,,
11104,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623957,,BAO_0000218,,
11105,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623958,,BAO_0000218,,
11106,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623959,,BAO_0000218,,
11107,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623960,,BAO_0000218,,
11108,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623961,,BAO_0000218,,
11109,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623962,,BAO_0000218,,
11110,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624676,,BAO_0000218,,
11111,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624677,,BAO_0000218,,
11112,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624678,,BAO_0000218,,
11113,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624679,,BAO_0000218,,
11114,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624680,,BAO_0000218,,
11115,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624849,,BAO_0000218,,
11116,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624850,,BAO_0000218,,
11117,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874399,,BAO_0000218,,
11118,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624851,,BAO_0000218,,
11119,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624852,,BAO_0000218,,
11120,13359,Oral bioavailability in rat (dose 10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624853,,BAO_0000218,,
11121,16618,Oral bioavailability in rat (Sprague-Dawley),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624854,,BAO_0000218,,
11122,13960,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624855,,BAO_0000218,,
11123,13917,Oral bioavailability in rats was determined in vivo,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624856,,BAO_0000218,,
11124,14266,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL882957,,BAO_0000218,,
11125,12359,Oral bioavailability of compound in monkey,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624857,,BAO_0000218,,
11126,12359,Oral bioavailability of compound in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622202,,BAO_0000218,,
11127,12359,Bioavailability in rat of PMEA prodrug,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622203,,BAO_0000218,,
11128,12359,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625522,,BAO_0000218,,
11129,10791,Serum conc at 3 hours following 25 mg/kg dose,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622868,,BAO_0000218,,
11130,10791,Urine conc 0-5 hours following 25 mg/kg dose,A,In vivo,,Macaca mulatta,9544.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL622869,,BAO_0000218,1088.0,
11131,10791,Urine conc 0-24 hours following 25 mg/kg dose,A,In vivo,,Macaca mulatta,9544.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL622870,,BAO_0000218,1088.0,
11132,138,Oral bioavailability in African green monkeys; 20-25,A,In vivo,,Chlorocebus aethiops,9534.0,,,,,22224,U,0,Autocuration,1,,CHEMBL622871,,BAO_0000218,,
11133,14521,Oral bioavailability in cynomolgus monkey.,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL620560,,BAO_0000218,,
11134,13953,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620561,,BAO_0000218,,
11135,12836,Oral bioavailability in dog at 10 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620562,,BAO_0000218,,
11136,12836,Oral bioavailability in hamster at 10 mg/kg oral dose,A,In vivo,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL620563,,BAO_0000218,,
11137,12836,Oral bioavailability in rat at 10 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL620564,,BAO_0000218,,
11138,14521,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL872265,,BAO_0000218,,
11139,13953,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620565,,BAO_0000218,,
11140,6799,Oral bioavailability,A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620566,,BAO_0000218,,
11141,11311,Oral bioavailability was determined; range 49-102%,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL620567,,BAO_0000218,,
11142,4013,Oral bioavailability was determined in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL620568,,BAO_0000218,,
11143,4013,Oral bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620569,,BAO_0000218,,
11144,17591,Oral bioavailability,A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620570,,BAO_0000218,,
11145,17591,Oral bioavailability was determined; Not orally available,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL620571,,BAO_0000218,,
11146,15011,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620572,,BAO_0000218,,
11147,15011,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620573,,BAO_0000218,,
11148,15011,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,A,In vivo,,Mus musculus,10090.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620574,,BAO_0000218,,
11149,9552,Oral bioavailability in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620575,,BAO_0000218,,
11150,9552,Oral bioavailability in dog (female mongrel),A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620576,,BAO_0000218,,
11151,3639,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875846,,BAO_0000218,,
11152,13397,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620577,,BAO_0000218,,
11153,3031,Percentage Bioavailability was evaluated.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL620578,,BAO_0000218,,
11154,12818,Bioavailability in rat administered i.d.,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL620579,,BAO_0000218,,
11155,4847,Bioavailability,A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL621248,,BAO_0000218,,
11156,12421,Bioavailability in dog (male Beagle) i.v. administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625390,,BAO_0000218,,
11157,11966,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625391,,BAO_0000218,,
11158,11218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),A,In vivo,,Primates,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL872266,,BAO_0000218,,
11159,13129,Oral bioavailability in rat (Sprague-Dawley) (male),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625392,,BAO_0000218,,
11160,12350,The oral bioavailability was measured on rats after oral administration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625393,,BAO_0000218,,
11161,2231,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625394,,BAO_0000218,,
11162,2231,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,A,In vivo,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL625395,,BAO_0000218,,
11163,12187,Bioavailability in rat (dose 10 mg/kg i.d.),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625396,,BAO_0000218,,
11164,12421,Bioavailability in dog (male Beagle) i.v. administration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625397,,BAO_0000218,,
11165,13256,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625398,,BAO_0000218,,
11166,13256,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625399,,BAO_0000218,178.0,
11167,13256,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Cerebellum,,,50594,N,1,Intermediate,1,,CHEMBL626074,,BAO_0000218,2037.0,
11168,13256,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626075,,BAO_0000218,,
11169,2231,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626076,,BAO_0000218,1969.0,
11170,2231,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL626077,,BAO_0000218,1969.0,
11171,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626078,,BAO_0000218,178.0,
11172,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL625846,,BAO_0000218,178.0,
11173,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL625847,,BAO_0000218,178.0,
11174,15633,Maximum concentration observed in rats at an oral dose of 50 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL625848,,BAO_0000218,,
11175,14258,Maximum concentration of compound in plasma administered orally to rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625849,,BAO_0000218,1969.0,
11176,14224,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626023,,BAO_0000218,1969.0,
11177,14224,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626024,,BAO_0000218,1969.0,
11178,14224,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626025,,BAO_0000218,1969.0,
11179,5566,Maximum concentration after 10 mg/kg by oral administration,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626026,,BAO_0000218,,
11180,16935,Maximum concentration at a dose of 1.5 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626027,,BAO_0000218,,
11181,16935,Maximum concentration at a dose of 2.0 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626028,,BAO_0000218,,
11182,14224,Maximum concentration in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626029,,BAO_0000218,1969.0,
11183,12536,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626030,,BAO_0000218,1969.0,
11184,12536,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626031,,BAO_0000218,1969.0,
11185,12536,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626032,,BAO_0000218,1969.0,
11186,12536,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626033,,BAO_0000218,1969.0,
11187,12536,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626034,,BAO_0000218,1969.0,
11188,9994,Maximum concentration in plasma after oral administration in dog (25 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626035,,BAO_0000218,1969.0,
11189,1434,Maximum concentration in plasma at Tmax,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626036,,BAO_0000218,1969.0,
11190,12836,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Expert,1,,CHEMBL626037,,BAO_0000218,1969.0,
11191,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,A,In vivo,,Cricetinae,10026.0,,Plasma,,,100712,N,1,Intermediate,1,,CHEMBL626038,,BAO_0000218,1969.0,
11192,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626039,,BAO_0000218,1969.0,
11193,12545,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626040,,BAO_0000218,1969.0,
11194,13856,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,50592,N,1,Intermediate,1,,CHEMBL626041,,BAO_0000218,1969.0,
11195,3550,Maximum concentration was calculated,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626042,,BAO_0000218,,
11196,2632,Maximum concentration was calculated.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626043,,BAO_0000218,,
11197,5566,Maximum concentration at a peroral dose of 10 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626044,,BAO_0000218,,
11198,11883,Maximum concentration of the drug at 10 uM/dg administered perorally,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626045,,BAO_0000218,,
11199,11883,Maximum concentration of the drug at 2 uM/dg administered intravenously,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626046,,BAO_0000218,,
11200,14122,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626047,,BAO_0000218,1969.0,
11201,14122,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",A,In vivo,,Cricetinae,10026.0,,Plasma,,,100712,N,1,Intermediate,1,,CHEMBL626048,,BAO_0000218,1969.0,
11202,14122,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626049,,BAO_0000218,1969.0,
11203,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626050,,BAO_0000218,1969.0,
11204,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL874541,,BAO_0000218,1969.0,
11205,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,A,In vivo,,Cricetinae,10026.0,,Plasma,,,100712,N,1,Intermediate,1,,CHEMBL622826,,BAO_0000218,1969.0,
11206,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,A,In vivo,,Cricetinae,10026.0,,Plasma,,,100712,N,1,Intermediate,1,,CHEMBL622827,,BAO_0000218,1969.0,
11207,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622828,,BAO_0000218,1969.0,
11208,14080,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622829,,BAO_0000218,1969.0,
11209,11911,Maximum concentration reached following intravenous administration in male rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876806,,BAO_0000218,,
11210,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622830,,BAO_0000218,,
11211,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622831,,BAO_0000218,,
11212,14346,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626794,,BAO_0000218,,
11213,14346,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626795,,BAO_0000218,,
11214,14346,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626796,,BAO_0000218,,
11215,14346,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626797,,BAO_0000218,,
11216,14127,Maximum drug concentration is determined after oral dosing in rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626798,,BAO_0000218,,
11217,14339,Maximum observed concentration in oral (5 mg/kg) fasted dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626799,,BAO_0000218,,
11218,14339,Maximum observed concentration in oral (5 mg/kg) fed dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626800,,BAO_0000218,,
11219,13494,Maximum plasma concentration,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626801,,BAO_0000218,1969.0,
11220,14925,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876816,,BAO_0000218,1969.0,
11221,14474,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626802,,BAO_0000218,1969.0,
11222,14474,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626803,,BAO_0000218,1969.0,
11223,13917,Maximum plasma concentration following oral administration of 30 umol/kg,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626804,,BAO_0000218,1969.0,
11224,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626805,,BAO_0000218,1969.0,
11225,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626309,,BAO_0000218,1969.0,
11226,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626310,,BAO_0000218,1969.0,
11227,9796,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626311,,BAO_0000218,1969.0,
11228,9796,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626312,,BAO_0000218,1969.0,
11229,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626313,,BAO_0000218,995.0,
11230,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626314,,BAO_0000218,995.0,
11231,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626315,,BAO_0000218,995.0,
11232,9796,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626316,,BAO_0000218,995.0,
11233,9796,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626317,,BAO_0000218,995.0,
11234,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626318,,BAO_0000218,,
11235,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626319,,BAO_0000218,,
11236,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626320,,BAO_0000218,,
11237,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875053,,BAO_0000218,,
11238,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626321,,BAO_0000218,,
11239,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626322,,BAO_0000218,,
11240,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626323,,BAO_0000218,,
11241,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626324,,BAO_0000218,,
11242,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626325,,BAO_0000218,,
11243,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626326,,BAO_0000218,,
11244,8363,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626327,,BAO_0000218,,
11245,8363,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626328,,BAO_0000218,,
11246,8684,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626329,,BAO_0000218,178.0,
11247,8684,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626330,,BAO_0000218,178.0,
11248,8684,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626331,,BAO_0000218,178.0,
11249,8684,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626332,,BAO_0000218,178.0,
11250,8684,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626333,,BAO_0000218,178.0,
11251,8684,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626334,,BAO_0000218,178.0,
11252,8684,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626335,,BAO_0000218,178.0,
11253,8684,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624798,,BAO_0000218,178.0,
11254,8684,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624799,,BAO_0000218,955.0,
11255,8684,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624800,,BAO_0000218,955.0,
11256,8684,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624801,,BAO_0000218,955.0,
11257,8684,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624802,,BAO_0000218,955.0,
11258,8684,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624803,,BAO_0000218,955.0,
11259,8684,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624804,,BAO_0000218,955.0,
11260,8684,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624805,,BAO_0000218,955.0,
11261,8684,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL624806,,BAO_0000218,955.0,
11262,8684,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624807,,BAO_0000218,,
11263,8684,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624808,,BAO_0000218,,
11264,8684,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624809,,BAO_0000218,,
11265,8684,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624810,,BAO_0000218,,
11266,8684,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877618,,BAO_0000218,,
11267,8684,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624811,,BAO_0000218,,
11268,8684,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624812,,BAO_0000218,,
11269,8684,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624813,,BAO_0000218,,
11270,8684,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624814,,BAO_0000218,,
11271,8684,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624815,,BAO_0000218,,
11272,8684,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624816,,BAO_0000218,,
11273,8684,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624817,,BAO_0000218,,
11274,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624818,,BAO_0000218,,
11275,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624819,,BAO_0000218,,
11276,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624820,,BAO_0000218,,
11277,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624821,,BAO_0000218,,
11278,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624822,,BAO_0000218,,
11279,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624823,,BAO_0000218,,
11280,15599,Observed diffusion coefficient in organic solvent for Escherichia coli,A,,,Escherichia coli,562.0,,,,,50212,N,1,Intermediate,1,,CHEMBL624824,,BAO_0000218,,
11281,9614,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624825,,BAO_0000218,178.0,
11282,9614,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624826,,BAO_0000218,178.0,
11283,9614,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,Cardiac atrium,,,50597,N,1,Intermediate,1,,CHEMBL876817,,BAO_0000218,2081.0,
11284,9614,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,Cardiac atrium,,,50597,N,1,Intermediate,1,,CHEMBL624827,,BAO_0000218,2081.0,
11285,9614,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624828,,BAO_0000218,,
11286,9614,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624829,,BAO_0000218,,
11287,9614,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624830,,BAO_0000218,2107.0,
11288,9614,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624831,,BAO_0000218,2107.0,
11289,9614,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,Cardiac atrium,,,50597,N,1,Intermediate,1,,CHEMBL624832,,BAO_0000218,2081.0,
11290,9614,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,Cardiac atrium,,,50597,N,1,Intermediate,1,,CHEMBL624833,,BAO_0000218,2081.0,
11291,9614,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624834,,BAO_0000218,,
11292,9614,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624835,,BAO_0000218,,
11293,9614,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL624836,,BAO_0000218,2106.0,
11294,9614,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL624837,,BAO_0000218,2106.0,
11295,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624838,,BAO_0000218,178.0,
11296,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622188,,BAO_0000218,178.0,
11297,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622189,,BAO_0000218,948.0,
11298,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622190,,BAO_0000218,948.0,
11299,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625170,,BAO_0000218,948.0,
11300,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625171,,BAO_0000218,2113.0,
11301,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625172,,BAO_0000218,2113.0,
11302,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625173,,BAO_0000218,2113.0,
11303,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625174,,BAO_0000218,2107.0,
11304,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625175,,BAO_0000218,2107.0,
11305,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625176,,BAO_0000218,2107.0,
11306,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625177,,BAO_0000218,2048.0,
11307,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625178,,BAO_0000218,2048.0,
11308,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625179,,BAO_0000218,2048.0,
11309,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625180,,BAO_0000218,2048.0,
11310,10677,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625181,,BAO_0000218,,
11311,9750,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL625182,,BAO_0000218,1088.0,
11312,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625183,,BAO_0000218,,
11313,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875848,,BAO_0000218,,
11314,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622260,,BAO_0000218,,
11315,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622261,,BAO_0000218,,
11316,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622262,,BAO_0000218,,
11317,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622263,,BAO_0000218,2113.0,
11318,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622418,,BAO_0000218,2113.0,
11319,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622419,,BAO_0000218,2107.0,
11320,13256,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623388,,BAO_0000218,,
11321,13256,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL623389,,BAO_0000218,2107.0,
11322,13256,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623390,,BAO_0000218,,
11323,13256,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623391,,BAO_0000218,,
11324,13256,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623392,,BAO_0000218,178.0,
11325,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Cerebellum,,,50594,N,1,Intermediate,1,,CHEMBL623393,,BAO_0000218,2037.0,
11326,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623394,,BAO_0000218,,
11327,13256,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618885,,BAO_0000218,,
11328,13256,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618886,,BAO_0000218,2107.0,
11329,13256,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618887,,BAO_0000218,,
11330,13256,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619535,,BAO_0000218,,
11331,13256,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL619536,,BAO_0000218,178.0,
11332,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Cerebellum,,,50594,N,1,Intermediate,1,,CHEMBL619537,,BAO_0000218,2037.0,
11333,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619705,,BAO_0000218,,
11334,13256,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619706,,BAO_0000218,,
11335,13256,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL619707,,BAO_0000218,2107.0,
11336,13256,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL619708,,BAO_0000218,,
11337,13256,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625219,,BAO_0000218,,
11338,13256,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL625220,,BAO_0000218,178.0,
11339,13256,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Cerebellum,,,50594,N,1,Intermediate,1,,CHEMBL625221,,BAO_0000218,2037.0,
11340,13256,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625222,,BAO_0000218,,
11341,13256,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625223,,BAO_0000218,,
11342,13256,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL625224,,BAO_0000218,2107.0,
11343,13256,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625225,,BAO_0000218,,
11344,8829,Biodistribution in Rat blood after 24 hours of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625226,,BAO_0000218,178.0,
11345,8829,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625227,,BAO_0000218,178.0,
11346,8829,Biodistribution in Rat blood after 30 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625228,,BAO_0000218,178.0,
11347,8829,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875354,,BAO_0000218,178.0,
11348,8829,Biodistribution in Rat blood after 5 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625229,,BAO_0000218,178.0,
11349,8829,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625230,,BAO_0000218,178.0,
11350,8829,Biodistribution in Rat heart after 24 hours of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625231,,BAO_0000218,948.0,
11351,8829,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625900,,BAO_0000218,948.0,
11352,8829,Biodistribution in Rat heart after 30 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625901,,BAO_0000218,948.0,
11353,8829,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625902,,BAO_0000218,948.0,
11354,8829,Biodistribution in Rat heart after 5 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625903,,BAO_0000218,948.0,
11355,8829,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625904,,BAO_0000218,948.0,
11356,8829,Biodistribution in Rat liver after 24 hours of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625905,,BAO_0000218,2107.0,
11357,8829,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627861,,BAO_0000218,2107.0,
11358,8829,Biodistribution in Rat liver after 30 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627862,,BAO_0000218,2107.0,
11359,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627863,,BAO_0000218,2107.0,
11360,8829,Biodistribution in Rat liver after 30 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627769,,BAO_0000218,2107.0,
11361,13249,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL627770,,BAO_0000218,1969.0,
11362,13622,Cmax in cynomolgus monkey (PO dose),A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL627771,,BAO_0000218,,
11363,13622,Cmax in rat (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627772,,BAO_0000218,,
11364,13622,Cmax in rat (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627773,,BAO_0000218,,
11365,13494,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621922,,BAO_0000218,1969.0,
11366,12170,Cmax in rat plasma after oral dose (10 mg/kg),A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621923,,BAO_0000218,1969.0,
11367,12170,Cmax in plasma after oral dose (10 mg/kg),A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621924,,BAO_0000218,1969.0,
11368,17025,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621925,,BAO_0000218,1969.0,
11369,17025,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621926,,BAO_0000218,1969.0,
11370,17025,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,A,In vivo,,Oryctolagus cuniculus,9986.0,,Plasma,,,50592,N,1,Intermediate,1,,CHEMBL621927,,BAO_0000218,1969.0,
11371,17025,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621928,,BAO_0000218,1969.0,
11372,14187,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621929,,BAO_0000218,1969.0,
11373,14816,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL621930,,BAO_0000218,1969.0,
11374,17820,Maximum plasma concentration after oral dosing in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621931,,BAO_0000218,1969.0,
11375,14380,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621932,,BAO_0000218,1969.0,
11376,14380,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621933,,BAO_0000218,1969.0,
11377,14691,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621934,,BAO_0000218,1969.0,
11378,14691,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL621935,,BAO_0000218,1969.0,
11379,13375,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL621936,,BAO_0000218,1969.0,
11380,6236,Maximum plasma concentration was determined,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621937,,BAO_0000218,1969.0,
11381,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621938,,BAO_0000218,1969.0,
11382,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621939,,BAO_0000218,1969.0,
11383,14380,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621940,,BAO_0000218,1969.0,
11384,14380,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621941,,BAO_0000218,1969.0,
11385,14380,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL621942,,BAO_0000218,1969.0,
11386,14380,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626178,,BAO_0000218,1969.0,
11387,14380,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626179,,BAO_0000218,1969.0,
11388,14380,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626180,,BAO_0000218,1969.0,
11389,13622,Plasma Cmax in rat (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626181,,BAO_0000218,1969.0,
11390,15372,Maximum serum concentration after po dose of 5.22 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626182,,BAO_0000218,,
11391,15372,Maximum serum concentration after po dose of 5.46 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626183,,BAO_0000218,,
11392,15372,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626184,,BAO_0000218,,
11393,15372,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626185,,BAO_0000218,,
11394,14925,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626186,,BAO_0000218,1969.0,
11395,14925,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL877589,,BAO_0000218,1969.0,
11396,11883,Maximum concentration of the drug at 1 uM/dg administered intravenously,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626187,,BAO_0000218,,
11397,11883,Maximum concentration of the drug at 20 uM/dg administered perorally,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626188,,BAO_0000218,,
11398,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626189,,BAO_0000218,,
11399,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL626855,,BAO_0000218,178.0,
11400,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL623781,,BAO_0000218,178.0,
11401,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL623782,,BAO_0000218,178.0,
11402,16360,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623783,,BAO_0000218,1969.0,
11403,3673,Cmax in dog plasma after 1mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623784,,BAO_0000218,1969.0,
11404,14431,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623785,,BAO_0000218,1969.0,
11405,14431,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623786,,BAO_0000218,1969.0,
11406,14964,Oral maximum concentration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623787,,BAO_0000218,,
11407,14964,Oral maximum concentration in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623788,,BAO_0000218,,
11408,14209,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623789,,BAO_0000218,1969.0,
11409,11355,Peak concentration in blood after intravenous administration to mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623790,,BAO_0000218,178.0,
11410,11355,Peak concentration in blood after peroral administration to mice,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL623791,,BAO_0000218,178.0,
11411,11966,Peak concentration in rat plasma was determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623792,,BAO_0000218,1969.0,
11412,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623793,,BAO_0000218,1969.0,
11413,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623794,,BAO_0000218,1969.0,
11414,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623795,,BAO_0000218,1969.0,
11415,8684,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623796,,BAO_0000218,,
11416,8684,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623797,,BAO_0000218,,
11417,8684,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623798,,BAO_0000218,,
11418,8684,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623799,,BAO_0000218,,
11419,8684,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624490,,BAO_0000218,160.0,
11420,8684,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624491,,BAO_0000218,160.0,
11421,8684,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624492,,BAO_0000218,160.0,
11422,8684,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624493,,BAO_0000218,160.0,
11423,8684,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL877595,,BAO_0000218,160.0,
11424,8684,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624494,,BAO_0000218,160.0,
11425,8684,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624495,,BAO_0000218,160.0,
11426,8684,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL624681,,BAO_0000218,160.0,
11427,8684,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624682,,BAO_0000218,,
11428,8684,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624683,,BAO_0000218,,
11429,8684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624684,,BAO_0000218,,
11430,8684,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624685,,BAO_0000218,,
11431,8684,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624686,,BAO_0000218,,
11432,8684,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624687,,BAO_0000218,,
11433,8684,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624688,,BAO_0000218,,
11434,8684,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627161,,BAO_0000218,,
11435,8684,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622127,,BAO_0000218,,
11436,8684,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622128,,BAO_0000218,,
11437,8684,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874384,,BAO_0000218,,
11438,8684,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624898,,BAO_0000218,,
11439,8684,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624899,,BAO_0000218,,
11440,8684,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624900,,BAO_0000218,,
11441,8684,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624901,,BAO_0000218,,
11442,8684,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624902,,BAO_0000218,,
11443,8684,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624903,,BAO_0000218,,
11444,8684,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624904,,BAO_0000218,,
11445,8684,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624905,,BAO_0000218,,
11446,8684,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624906,,BAO_0000218,,
11447,8684,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624907,,BAO_0000218,,
11448,8684,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624908,,BAO_0000218,,
11449,8684,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624909,,BAO_0000218,,
11450,8684,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624910,,BAO_0000218,,
11451,8684,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624911,,BAO_0000218,2385.0,
11452,8684,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL874388,,BAO_0000218,2385.0,
11453,8684,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL624912,,BAO_0000218,2385.0,
11454,8684,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622930,,BAO_0000218,2385.0,
11455,8684,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623121,,BAO_0000218,2385.0,
11456,8684,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623122,,BAO_0000218,2385.0,
11457,8684,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623123,,BAO_0000218,2385.0,
11458,8684,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623124,,BAO_0000218,2385.0,
11459,8684,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623125,,BAO_0000218,,
11460,8684,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623126,,BAO_0000218,,
11461,8684,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623127,,BAO_0000218,,
11462,8684,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623128,,BAO_0000218,,
11463,8684,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623129,,BAO_0000218,,
11464,8684,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623130,,BAO_0000218,,
11465,8684,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623131,,BAO_0000218,,
11466,8684,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623132,,BAO_0000218,,
11467,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623133,,BAO_0000218,2107.0,
11468,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623134,,BAO_0000218,,
11469,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874389,,BAO_0000218,,
11470,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623135,,BAO_0000218,,
11471,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623136,,BAO_0000218,,
11472,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623137,,BAO_0000218,,
11473,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623138,,BAO_0000218,,
11474,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623139,,BAO_0000218,2113.0,
11475,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623140,,BAO_0000218,2113.0,
11476,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623141,,BAO_0000218,2107.0,
11477,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623142,,BAO_0000218,2107.0,
11478,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623143,,BAO_0000218,,
11479,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL623144,,BAO_0000218,1088.0,
11480,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623405,,BAO_0000218,1088.0,
11481,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624074,,BAO_0000218,,
11482,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624075,,BAO_0000218,,
11483,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624076,,BAO_0000218,,
11484,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624077,,BAO_0000218,,
11485,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624078,,BAO_0000218,,
11486,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624079,,BAO_0000218,2113.0,
11487,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624261,,BAO_0000218,2113.0,
11488,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624262,,BAO_0000218,,
11489,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624263,,BAO_0000218,,
11490,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624264,,BAO_0000218,,
11491,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624265,,BAO_0000218,,
11492,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624266,,BAO_0000218,,
11493,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624267,,BAO_0000218,,
11494,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624268,,BAO_0000218,,
11495,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875227,,BAO_0000218,,
11496,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624269,,BAO_0000218,2113.0,
11497,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624270,,BAO_0000218,2113.0,
11498,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624271,,BAO_0000218,,
11499,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624272,,BAO_0000218,,
11500,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624273,,BAO_0000218,,
11501,12064,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624274,,BAO_0000218,1088.0,
11502,12064,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624275,,BAO_0000218,1088.0,
11503,12064,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624276,,BAO_0000218,1088.0,
11504,12038,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624277,,BAO_0000218,1088.0,
11505,14314,% dose converted to 2-amino-5-chlorophenyl sulfate,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624278,,BAO_0000019,,
11506,14314,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624279,,BAO_0000019,,
11507,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL624280,,BAO_0000218,1988.0,
11508,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL624281,,BAO_0000218,1988.0,
11509,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL622933,,BAO_0000218,1988.0,
11510,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL622934,,BAO_0000218,1988.0,
11511,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622935,,BAO_0000218,2107.0,
11512,8829,Biodistribution in Rat liver after 5 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622936,,BAO_0000218,2107.0,
11513,8829,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL875228,,BAO_0000218,2107.0,
11514,8829,Biodistribution in Rat lung after 24 hours of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622937,,BAO_0000218,2048.0,
11515,8829,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622938,,BAO_0000218,2048.0,
11516,8829,Biodistribution in Rat lung after 30 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL619736,,BAO_0000218,2048.0,
11517,8829,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625117,,BAO_0000218,2048.0,
11518,8829,Biodistribution in Rat lung after 5 minutes of iv administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625118,,BAO_0000218,2048.0,
11519,8829,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625119,,BAO_0000218,2048.0,
11520,14972,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL625120,,BAO_0000218,2037.0,
11521,14972,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625121,,BAO_0000218,,
11522,14972,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",A,In vivo,,Rattus norvegicus,10116.0,,Thalamus,,,50597,N,1,Intermediate,1,,CHEMBL625122,,BAO_0000218,10000006.0,
11523,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL622204,,BAO_0000218,178.0,
11524,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL877503,,BAO_0000218,178.0,
11525,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627127,,BAO_0000218,178.0,
11526,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,,,,Hippocampus,,,22224,U,0,Autocuration,1,,CHEMBL627128,,BAO_0000218,10000000.0,
11527,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,,,,Hippocampus,,,22224,U,0,Autocuration,1,,CHEMBL627129,,BAO_0000218,10000000.0,
11528,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,,,,Hippocampus,,,22224,U,0,Autocuration,1,,CHEMBL627130,,BAO_0000218,10000000.0,
11529,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627131,,BAO_0000218,955.0,
11530,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627132,,BAO_0000218,955.0,
11531,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL627133,,BAO_0000218,955.0,
11532,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL627134,,BAO_0000218,2037.0,
11533,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL627135,,BAO_0000218,2037.0,
11534,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL627136,,BAO_0000218,2037.0,
11535,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628435,,BAO_0000218,,
11536,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628436,,BAO_0000218,,
11537,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628437,,BAO_0000218,,
11538,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL628438,,BAO_0000218,948.0,
11539,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL628439,,BAO_0000218,948.0,
11540,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL628440,,BAO_0000218,948.0,
11541,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628441,,BAO_0000218,10000000.0,
11542,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628442,,BAO_0000218,10000000.0,
11543,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628443,,BAO_0000218,10000000.0,
11544,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628444,,BAO_0000218,2113.0,
11545,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628445,,BAO_0000218,2113.0,
11546,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL877504,,BAO_0000218,2113.0,
11547,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628446,,BAO_0000218,2107.0,
11548,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626874,,BAO_0000218,2107.0,
11549,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626875,,BAO_0000218,2107.0,
11550,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626876,,BAO_0000218,2048.0,
11551,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626877,,BAO_0000218,2048.0,
11552,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626878,,BAO_0000218,2048.0,
11553,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL626879,,BAO_0000218,2385.0,
11554,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626880,,BAO_0000218,1969.0,
11555,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL626881,,BAO_0000218,1969.0,
11556,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626882,,BAO_0000218,1969.0,
11557,14470,Peak plasma concentration was measured in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626883,,BAO_0000218,1969.0,
11558,14393,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626884,,BAO_0000218,,
11559,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626885,,BAO_0000218,,
11560,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626886,,BAO_0000218,,
11561,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626887,,BAO_0000218,,
11562,14393,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626888,,BAO_0000218,,
11563,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626889,,BAO_0000218,,
11564,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626761,,BAO_0000218,,
11565,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626762,,BAO_0000218,,
11566,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626763,,BAO_0000218,,
11567,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626764,,BAO_0000218,,
11568,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626765,,BAO_0000218,,
11569,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626766,,BAO_0000218,,
11570,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626767,,BAO_0000218,,
11571,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626768,,BAO_0000218,,
11572,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626769,,BAO_0000218,,
11573,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL874463,,BAO_0000218,,
11574,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626770,,BAO_0000218,,
11575,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626771,,BAO_0000218,,
11576,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626772,,BAO_0000218,,
11577,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL626773,,BAO_0000218,,
11578,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626774,,BAO_0000218,,
11579,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626775,,BAO_0000218,,
11580,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626776,,BAO_0000218,,
11581,14443,Maximum concentration (Cmax) in rat when administered orally,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626777,,BAO_0000218,,
11582,13465,Maximal concentration in monkey plasma after 25 mg/kg oral dose,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626778,,BAO_0000218,1969.0,
11583,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626779,,BAO_0000218,,
11584,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626780,,BAO_0000218,,
11585,15618,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626781,,BAO_0000218,1969.0,
11586,14554,Pharmacokinetic profile Cmax was evaluated in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632164,,BAO_0000218,,
11587,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL632165,,BAO_0000218,,
11588,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL632166,,BAO_0000218,,
11589,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL632167,,BAO_0000218,,
11590,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL632168,,BAO_0000218,,
11591,2021,Cmax in rat plasma,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL632169,,BAO_0000218,1969.0,
11592,5932,Cmax in dog plasma after 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL632170,,BAO_0000218,1969.0,
11593,5932,Cmax in rat plasma after 30mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632171,,BAO_0000218,1969.0,
11594,17320,Plasma level in rats at 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632172,,BAO_0000218,1969.0,
11595,15831,Tested for maximum plasma concentration in mice,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL632173,,BAO_0000218,1969.0,
11596,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632174,,BAO_0000218,,
11597,14941,The Cmax values in female wistar rats.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632175,,BAO_0000218,,
11598,15343,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL632176,,BAO_0000218,1969.0,
11599,15343,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632177,,BAO_0000218,1969.0,
11600,14856,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632178,,BAO_0000218,1969.0,
11601,13129,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632179,,BAO_0000218,,
11602,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632180,,BAO_0000218,178.0,
11603,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632181,,BAO_0000218,178.0,
11604,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632182,,BAO_0000218,178.0,
11605,15478,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,A,In vivo,,Mus musculus,10090.0,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL632183,,BAO_0000218,178.0,
11606,15341,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL632184,,BAO_0000218,,
11607,15341,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874470,,BAO_0000218,,
11608,8684,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631302,,BAO_0000218,,
11609,8684,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631303,,BAO_0000218,,
11610,8684,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631304,,BAO_0000218,,
11611,8684,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631305,,BAO_0000218,,
11612,8684,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631306,,BAO_0000218,,
11613,8684,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631307,,BAO_0000218,,
11614,8684,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631308,,BAO_0000218,,
11615,8684,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625557,,BAO_0000218,,
11616,8684,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625558,,BAO_0000218,2106.0,
11617,8684,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625559,,BAO_0000218,2106.0,
11618,8684,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625560,,BAO_0000218,2106.0,
11619,8684,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625561,,BAO_0000218,2106.0,
11620,8684,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625562,,BAO_0000218,2106.0,
11621,8684,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL875320,,BAO_0000218,2106.0,
11622,8684,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625563,,BAO_0000218,2106.0,
11623,8684,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625564,,BAO_0000218,2106.0,
11624,8684,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL625565,,BAO_0000218,995.0,
11625,8684,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL625566,,BAO_0000218,995.0,
11626,8684,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL625567,,BAO_0000218,995.0,
11627,8684,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL625568,,BAO_0000218,995.0,
11628,8684,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL628217,,BAO_0000218,995.0,
11629,8684,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL628218,,BAO_0000218,995.0,
11630,8684,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL628219,,BAO_0000218,995.0,
11631,8684,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL628220,,BAO_0000218,995.0,
11632,8926,Distribution in the blood after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628221,,BAO_0000019,,
11633,8926,Distribution in the blood after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628222,,BAO_0000019,,
11634,8926,Distribution in the blood after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628223,,BAO_0000019,,
11635,8926,Distribution in the blood after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628224,,BAO_0000019,,
11636,8926,Distribution in the blood after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628225,,BAO_0000019,,
11637,8926,Distribution in the blood after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628226,,BAO_0000019,,
11638,8926,Distribution in the bone after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628227,,BAO_0000019,,
11639,8926,Distribution in the bone after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875481,,BAO_0000019,,
11640,8926,Distribution in the bone after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628228,,BAO_0000019,,
11641,8926,Distribution in the bone after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628229,,BAO_0000019,,
11642,8926,Distribution in the bone after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628230,,BAO_0000019,,
11643,8926,Distribution in the bone after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628231,,BAO_0000019,,
11644,8926,Distribution in the heart after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628232,,BAO_0000019,,
11645,8926,Distribution in the heart after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628233,,BAO_0000019,,
11646,8926,Distribution in the heart after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628234,,BAO_0000019,,
11647,8926,Distribution in the heart after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628235,,BAO_0000019,,
11648,8926,Distribution in the heart after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628236,,BAO_0000019,,
11649,8926,Distribution in the heart after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628237,,BAO_0000019,,
11650,8926,Distribution in the kidneys after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628238,,BAO_0000019,,
11651,8926,Distribution in the kidneys after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628239,,BAO_0000019,,
11652,8926,Distribution in the kidneys after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628240,,BAO_0000019,,
11653,8926,Distribution in the kidneys after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628241,,BAO_0000019,,
11654,8926,Distribution in the kidneys after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628242,,BAO_0000019,,
11655,8926,Distribution in the kidneys after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875482,,BAO_0000019,,
11656,8926,Distribution in the liver after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628243,,BAO_0000019,,
11657,8926,Distribution in the liver after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628244,,BAO_0000019,,
11658,8926,Distribution in the liver after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628245,,BAO_0000019,,
11659,8926,Distribution in the liver after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628246,,BAO_0000019,,
11660,8926,Distribution in the liver after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628247,,BAO_0000019,,
11661,8926,Distribution in the liver after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628248,,BAO_0000019,,
11662,8926,Distribution in the lung after 120 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628249,,BAO_0000019,,
11663,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625452,,BAO_0000218,,
11664,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625453,,BAO_0000218,,
11665,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625454,,BAO_0000218,,
11666,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623844,,BAO_0000218,,
11667,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623845,,BAO_0000218,,
11668,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623846,,BAO_0000218,,
11669,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623847,,BAO_0000218,,
11670,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623848,,BAO_0000218,,
11671,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623849,,BAO_0000218,,
11672,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623850,,BAO_0000218,,
11673,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623851,,BAO_0000218,,
11674,12187,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623852,,BAO_0000218,,
11675,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL624551,,BAO_0000218,,
11676,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL624552,,BAO_0000218,,
11677,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624553,,BAO_0000218,,
11678,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624554,,BAO_0000218,,
11679,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624555,,BAO_0000218,,
11680,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624741,,BAO_0000218,,
11681,14122,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624742,,BAO_0000218,,
11682,14122,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",A,,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL624743,,BAO_0000218,,
11683,14122,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877606,,BAO_0000218,,
11684,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624744,,BAO_0000218,,
11685,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624745,,BAO_0000218,178.0,
11686,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624746,,BAO_0000218,178.0,
11687,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL624747,,BAO_0000218,178.0,
11688,16360,Oral absorption expressed as Area under curve was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624748,,BAO_0000019,,
11689,3673,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622504,,BAO_0000218,,
11690,14122,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622505,,BAO_0000218,,
11691,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",A,,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL622506,,BAO_0000218,,
11692,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",A,,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL622507,,BAO_0000218,,
11693,14122,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622508,,BAO_0000218,,
11694,13889,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622509,,BAO_0000019,,
11695,14393,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622510,,BAO_0000218,,
11696,17279,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622511,,BAO_0000218,,
11697,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL622512,,BAO_0000218,,
11698,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL622513,,BAO_0000218,,
11699,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL622514,,BAO_0000218,,
11700,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622515,,BAO_0000218,,
11701,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622516,,BAO_0000218,,
11702,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622517,,BAO_0000218,,
11703,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622518,,BAO_0000218,,
11704,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622519,,BAO_0000218,,
11705,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622520,,BAO_0000218,2385.0,
11706,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622521,,BAO_0000218,2385.0,
11707,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL625113,,BAO_0000218,14.0,
11708,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL625114,,BAO_0000218,14.0,
11709,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL874397,,BAO_0000218,14.0,
11710,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625115,,BAO_0000218,2106.0,
11711,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625116,,BAO_0000218,2106.0,
11712,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL623932,,BAO_0000218,2106.0,
11713,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL623933,,BAO_0000218,2435.0,
11714,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL623934,,BAO_0000218,2435.0,
11715,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL623935,,BAO_0000218,2435.0,
11716,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL623936,,BAO_0000218,2046.0,
11717,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL623937,,BAO_0000218,2046.0,
11718,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL623938,,BAO_0000218,2046.0,
11719,15383,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623939,,BAO_0000218,,
11720,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623940,,BAO_0000218,,
11721,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623941,,BAO_0000218,,
11722,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627216,,BAO_0000218,,
11723,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623942,,BAO_0000218,,
11724,15383,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618793,,BAO_0000218,955.0,
11725,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618794,,BAO_0000218,955.0,
11726,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL618795,,BAO_0000218,955.0,
11727,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618796,,BAO_0000218,,
11728,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618797,,BAO_0000218,,
11729,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618798,,BAO_0000218,2113.0,
11730,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618799,,BAO_0000218,2113.0,
11731,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618800,,BAO_0000218,2113.0,
11732,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618801,,BAO_0000218,2113.0,
11733,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618802,,BAO_0000218,2113.0,
11734,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL618803,,BAO_0000218,2113.0,
11735,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618804,,BAO_0000218,2107.0,
11736,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618805,,BAO_0000218,2107.0,
11737,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618806,,BAO_0000218,2107.0,
11738,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618807,,BAO_0000218,2107.0,
11739,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618808,,BAO_0000218,2107.0,
11740,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL618809,,BAO_0000218,2107.0,
11741,15383,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618810,,BAO_0000218,2385.0,
11742,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618811,,BAO_0000218,2385.0,
11743,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL875844,,BAO_0000218,2385.0,
11744,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618812,,BAO_0000218,2385.0,
11745,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL618813,,BAO_0000218,2385.0,
11746,15383,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618814,,BAO_0000218,,
11747,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618815,,BAO_0000218,,
11748,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618816,,BAO_0000218,,
11749,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL618817,,BAO_0000218,,
11750,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL620544,,BAO_0000218,,
11751,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626230,,BAO_0000218,,
11752,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626231,,BAO_0000218,,
11753,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626232,,BAO_0000218,,
11754,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626233,,BAO_0000218,1969.0,
11755,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626234,,BAO_0000218,1969.0,
11756,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL875341,,BAO_0000218,1969.0,
11757,14215,The maximum plasma concentration (100 mg/kg) administered orally in human,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL626235,,BAO_0000218,1969.0,
11758,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,A,In vivo,,Callithrix,9481.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626236,,BAO_0000218,1969.0,
11759,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626237,,BAO_0000218,1969.0,
11760,14215,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626238,,BAO_0000218,1969.0,
11761,14215,The maximum plasma concentration (200 mg/kg) administered orally in human,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL622412,,BAO_0000218,1969.0,
11762,14215,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623114,,BAO_0000218,1969.0,
11763,14215,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,A,In vivo,,Callithrix,9481.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623115,,BAO_0000218,1969.0,
11764,14215,The maximum plasma concentration (25 mg/kg) administered orally in monkey,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623116,,BAO_0000218,1969.0,
11765,14215,The maximum plasma concentration (30 mg/kg) administered orally in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623117,,BAO_0000218,1969.0,
11766,14215,The maximum plasma concentration (400 mg/kg) administered orally in human,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL623118,,BAO_0000218,1969.0,
11767,14215,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623119,,BAO_0000218,1969.0,
11768,14215,The maximum plasma concentration (50 mg/kg) administered orally in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623120,,BAO_0000218,1969.0,
11769,14215,The maximum plasma concentration (800 mg/kg) administered orally in human,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL623286,,BAO_0000218,1969.0,
11770,14067,The maximum plasma concentration was measured on rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623287,,BAO_0000218,1969.0,
11771,12350,The maximum plasma concentration was measured on rats after oral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623288,,BAO_0000218,1969.0,
11772,14813,Plasma drug Cmax in rat (PO dose),A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623289,,BAO_0000218,1969.0,
11773,12536,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623290,,BAO_0000218,,
11774,14169,maximum Plasma concentration in Dog was determined after Peroral administration,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623291,,BAO_0000218,1969.0,
11775,14169,maximum Plasma concentration in Rats was determined after Peroral administration,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623292,,BAO_0000218,1969.0,
11776,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL623293,,BAO_0000218,1969.0,
11777,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623294,,BAO_0000218,1969.0,
11778,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623295,,BAO_0000218,1969.0,
11779,14387,maximum concentration was measured when administered through oral route in mice,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623296,,BAO_0000218,,
11780,15115,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875349,,BAO_0000218,,
11781,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623297,,BAO_0000019,,
11782,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623298,,BAO_0000019,,
11783,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL623299,,BAO_0000019,,
11784,16359,Pharmacokinetic parameter was evaluated in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623300,,BAO_0000218,,
11785,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623301,,BAO_0000218,,
11786,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623302,,BAO_0000218,,
11787,12829,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623303,,BAO_0000218,,
11788,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623304,,BAO_0000218,,
11789,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623305,,BAO_0000218,,
11790,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623306,,BAO_0000218,1969.0,
11791,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623307,,BAO_0000218,1969.0,
11792,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL623308,,BAO_0000218,1969.0,
11793,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,A,,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL623309,,BAO_0000218,1969.0,
11794,13509,Plasma Concentration after 120 min of oral administration to mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623310,,BAO_0000218,,
11795,13509,Plasma Concentration after 30 min of oral administration to mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623311,,BAO_0000218,,
11796,13509,Plasma Concentration after 60 min of oral administration to mice,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL623312,,BAO_0000218,,
11797,13509,Plasma Concentration after 60 min of oral administration to mice; Not determined,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL875350,,BAO_0000218,,
11798,13509,Plasma Concentration after 90 min of oral administration to mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628635,,BAO_0000218,,
11799,12064,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628636,,BAO_0000218,,
11800,12064,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628637,,BAO_0000218,,
11801,12064,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628058,,BAO_0000218,,
11802,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628059,,BAO_0000218,,
11803,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628060,,BAO_0000218,,
11804,8926,Distribution in the lung after 15 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628061,,BAO_0000019,,
11805,8926,Distribution in the lung after 30 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628062,,BAO_0000019,,
11806,8926,Distribution in the lung after 5 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628063,,BAO_0000019,,
11807,8926,Distribution in the lung after 60 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628064,,BAO_0000019,,
11808,8926,Distribution in the lung after 90 min of intravenous administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628065,,BAO_0000019,,
11809,8926,Distribution in the muscle after 120 min of intravenous administration,A,,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL628066,,BAO_0000019,2385.0,
11810,8926,Distribution in the muscle after 15 min of intravenous administration,A,,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL628067,,BAO_0000019,2385.0,
11811,8926,Distribution in the muscle after 30 min of intravenous administration,A,,,Mus musculus,10090.0,,Muscle tissue,,,50594,N,1,Intermediate,1,,CHEMBL874646,,BAO_0000218,2385.0,
11812,8926,Distribution in the muscle after 5 min of intravenous administration,A,,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL628068,,BAO_0000019,2385.0,
11813,8926,Distribution in the muscle after 60 min of intravenous administration,A,,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL628069,,BAO_0000019,2385.0,
11814,8926,Distribution in the muscle after 90 min of intravenous administration,A,,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL628070,,BAO_0000019,2385.0,
11815,8926,Distribution in the spleen after 120 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628071,,BAO_0000019,2106.0,
11816,8926,Distribution in the spleen after 15 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628072,,BAO_0000019,2106.0,
11817,8926,Distribution in the spleen after 30 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628073,,BAO_0000019,2106.0,
11818,8926,Distribution in the spleen after 5 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628074,,BAO_0000019,2106.0,
11819,8926,Distribution in the spleen after 60 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628075,,BAO_0000019,2106.0,
11820,8926,Distribution in the spleen after 90 min of intravenous administration,A,,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL628076,,BAO_0000019,2106.0,
11821,7570,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Adrenal cortex,,,50597,N,1,Intermediate,1,,CHEMBL628077,,BAO_0000218,1235.0,
11822,7570,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628078,,BAO_0000218,178.0,
11823,7570,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628079,,BAO_0000218,2107.0,
11824,7570,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL628080,,BAO_0000218,992.0,
11825,7570,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628081,,BAO_0000218,2046.0,
11826,7570,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Adrenal cortex,,,50597,N,1,Intermediate,1,,CHEMBL628082,,BAO_0000218,1235.0,
11827,7570,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL874647,,BAO_0000218,178.0,
11828,7570,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626406,,BAO_0000218,2107.0,
11829,7570,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL626407,,BAO_0000218,992.0,
11830,7570,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626408,,BAO_0000218,2046.0,
11831,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626409,,BAO_0000218,178.0,
11832,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626410,,BAO_0000218,178.0,
11833,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626411,,BAO_0000218,178.0,
11834,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626412,,BAO_0000218,178.0,
11835,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626413,,BAO_0000218,178.0,
11836,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626414,,BAO_0000218,178.0,
11837,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626415,,BAO_0000218,178.0,
11838,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626416,,BAO_0000218,178.0,
11839,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627062,,BAO_0000218,178.0,
11840,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627063,,BAO_0000218,178.0,
11841,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627064,,BAO_0000218,178.0,
11842,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627227,,BAO_0000218,178.0,
11843,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627228,,BAO_0000218,178.0,
11844,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627229,,BAO_0000218,178.0,
11845,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625792,,BAO_0000218,178.0,
11846,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625793,,BAO_0000218,178.0,
11847,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625794,,BAO_0000218,178.0,
11848,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625795,,BAO_0000218,178.0,
11849,13792,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625796,,BAO_0000218,,
11850,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625797,,BAO_0000218,,
11851,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625798,,BAO_0000218,,
11852,14380,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875613,,BAO_0000218,,
11853,14380,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625799,,BAO_0000218,,
11854,14380,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625800,,BAO_0000218,,
11855,14380,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625801,,BAO_0000218,,
11856,14380,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625802,,BAO_0000218,,
11857,14380,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625803,,BAO_0000218,,
11858,14380,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625804,,BAO_0000019,,
11859,14380,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622530,,BAO_0000218,,
11860,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622531,,BAO_0000218,,
11861,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622532,,BAO_0000218,,
11862,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623176,,BAO_0000218,,
11863,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623177,,BAO_0000218,,
11864,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623178,,BAO_0000218,,
11865,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623179,,BAO_0000218,,
11866,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623180,,BAO_0000218,,
11867,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623181,,BAO_0000218,,
11868,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624131,,BAO_0000218,,
11869,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624132,,BAO_0000218,,
11870,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624133,,BAO_0000218,,
11871,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624846,,BAO_0000218,,
11872,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624847,,BAO_0000218,,
11873,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL624848,,BAO_0000218,,
11874,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625012,,BAO_0000218,,
11875,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625013,,BAO_0000218,,
11876,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625014,,BAO_0000218,,
11877,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625015,,BAO_0000218,,
11878,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625016,,BAO_0000218,,
11879,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625017,,BAO_0000218,,
11880,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625018,,BAO_0000218,,
11881,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625019,,BAO_0000218,,
11882,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625020,,BAO_0000218,,
11883,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625021,,BAO_0000218,,
11884,14393,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625022,,BAO_0000218,,
11885,14731,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625023,,BAO_0000218,,
11886,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL625024,,BAO_0000218,,
11887,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL627626,,BAO_0000218,,
11888,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,A,,,,,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL627627,,BAO_0000218,955.0,
11889,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,A,,,,,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL627628,,BAO_0000218,1977.0,
11890,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,A,,,,,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL627629,,BAO_0000218,955.0,
11891,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,A,,,,,,Serum,,,22224,U,0,Autocuration,1,,CHEMBL627630,,BAO_0000218,1977.0,
11892,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627631,,BAO_0000019,,
11893,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629515,,BAO_0000218,,
11894,15383,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL629516,,BAO_0000218,2106.0,
11895,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL629517,,BAO_0000218,2106.0,
11896,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL629518,,BAO_0000218,2106.0,
11897,15383,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL877499,,BAO_0000218,,
11898,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629519,,BAO_0000218,,
11899,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629520,,BAO_0000218,,
11900,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629521,,BAO_0000218,,
11901,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629522,,BAO_0000218,,
11902,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629523,,BAO_0000218,,
11903,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629524,,BAO_0000218,,
11904,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629525,,BAO_0000218,,
11905,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629526,,BAO_0000218,,
11906,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629527,,BAO_0000218,,
11907,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629528,,BAO_0000218,,
11908,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629529,,BAO_0000218,,
11909,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629530,,BAO_0000218,,
11910,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629531,,BAO_0000218,,
11911,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628656,,BAO_0000218,,
11912,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628657,,BAO_0000218,,
11913,13751,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628658,,BAO_0000218,,
11914,13751,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628659,,BAO_0000218,,
11915,13751,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877500,,BAO_0000218,,
11916,13751,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628660,,BAO_0000218,,
11917,13751,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628661,,BAO_0000218,,
11918,13751,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628662,,BAO_0000218,,
11919,13751,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628663,,BAO_0000218,,
11920,13751,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628664,,BAO_0000218,,
11921,13751,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628665,,BAO_0000218,178.0,
11922,13751,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628666,,BAO_0000218,178.0,
11923,13751,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628667,,BAO_0000218,178.0,
11924,13751,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628668,,BAO_0000218,178.0,
11925,13751,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628669,,BAO_0000218,178.0,
11926,13751,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628670,,BAO_0000218,178.0,
11927,13751,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628671,,BAO_0000218,178.0,
11928,13751,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL628672,,BAO_0000218,10000001.0,
11929,13751,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL630300,,BAO_0000218,10000001.0,
11930,13751,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL629787,,BAO_0000218,10000001.0,
11931,13751,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL629788,,BAO_0000218,10000001.0,
11932,13751,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629789,,BAO_0000218,955.0,
11933,13751,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629790,,BAO_0000218,955.0,
11934,13751,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629791,,BAO_0000218,955.0,
11935,13751,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629792,,BAO_0000218,955.0,
11936,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629793,,BAO_0000218,955.0,
11937,13751,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629794,,BAO_0000218,955.0,
11938,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874459,,BAO_0000218,,
11939,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629795,,BAO_0000218,,
11940,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629796,,BAO_0000218,,
11941,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629797,,BAO_0000218,,
11942,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629798,,BAO_0000218,,
11943,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Adrenal gland,,,50597,N,1,Intermediate,1,,CHEMBL629799,,BAO_0000218,2369.0,
11944,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Adrenal gland,,,50597,N,1,Intermediate,1,,CHEMBL629800,,BAO_0000218,2369.0,
11945,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Adrenal gland,,,50597,N,1,Intermediate,1,,CHEMBL629801,,BAO_0000218,2369.0,
11946,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,A,In vivo,,Rattus norvegicus,10116.0,,Adrenal gland,,,50597,N,1,Intermediate,1,,CHEMBL629802,,BAO_0000218,2369.0,
11947,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Adrenal gland,,,50597,N,1,Intermediate,1,,CHEMBL629803,,BAO_0000218,2369.0,
11948,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629804,,BAO_0000218,178.0,
11949,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629805,,BAO_0000218,178.0,
11950,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629806,,BAO_0000218,178.0,
11951,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629807,,BAO_0000218,178.0,
11952,10911,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629808,,BAO_0000218,178.0,
11953,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629809,,BAO_0000218,955.0,
11954,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629810,,BAO_0000218,955.0,
11955,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629811,,BAO_0000218,955.0,
11956,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629812,,BAO_0000218,955.0,
11957,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629813,,BAO_0000218,955.0,
11958,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL874460,,BAO_0000218,955.0,
11959,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629814,,BAO_0000218,,
11960,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629815,,BAO_0000218,,
11961,10911,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629816,,BAO_0000218,,
11962,10911,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629817,,BAO_0000218,,
11963,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626643,,BAO_0000218,2113.0,
11964,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626644,,BAO_0000218,2113.0,
11965,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626806,,BAO_0000218,2113.0,
11966,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626807,,BAO_0000218,2113.0,
11967,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627261,,BAO_0000218,2107.0,
11968,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627262,,BAO_0000218,2107.0,
11969,10911,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627263,,BAO_0000218,2107.0,
11970,10911,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627264,,BAO_0000218,2107.0,
11971,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627265,,BAO_0000218,2048.0,
11972,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627266,,BAO_0000218,2048.0,
11973,10911,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627267,,BAO_0000218,2048.0,
11974,10911,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627268,,BAO_0000218,2048.0,
11975,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627269,,BAO_0000218,2385.0,
11976,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627270,,BAO_0000218,2385.0,
11977,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627271,,BAO_0000218,,
11978,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627946,,BAO_0000218,,
11979,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875472,,BAO_0000218,,
11980,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627947,,BAO_0000218,,
11981,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627948,,BAO_0000218,,
11982,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628113,,BAO_0000218,,
11983,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628114,,BAO_0000218,,
11984,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628115,,BAO_0000218,,
11985,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628116,,BAO_0000218,,
11986,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628117,,BAO_0000218,,
11987,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628118,,BAO_0000218,,
11988,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628119,,BAO_0000218,,
11989,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628120,,BAO_0000218,,
11990,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628121,,BAO_0000218,,
11991,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628122,,BAO_0000218,,
11992,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627297,,BAO_0000218,,
11993,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627298,,BAO_0000218,,
11994,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627299,,BAO_0000218,,
11995,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627300,,BAO_0000218,,
11996,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627301,,BAO_0000218,,
11997,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627302,,BAO_0000218,,
11998,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627303,,BAO_0000218,,
11999,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627304,,BAO_0000218,,
12000,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627305,,BAO_0000218,,
12001,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627306,,BAO_0000218,,
12002,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623982,,BAO_0000218,,
12003,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623983,,BAO_0000218,,
12004,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623984,,BAO_0000218,,
12005,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623985,,BAO_0000218,,
12006,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623986,,BAO_0000218,,
12007,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623987,,BAO_0000218,,
12008,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623988,,BAO_0000218,,
12009,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623989,,BAO_0000218,,
12010,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622215,,BAO_0000218,,
12011,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622216,,BAO_0000218,,
12012,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877481,,BAO_0000218,,
12013,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622217,,BAO_0000218,,
12014,13701,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622218,,BAO_0000218,,
12015,14554,Pharmacokinetic profile AUC was evaluated in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622219,,BAO_0000218,,
12016,6241,Pharmacokinetic property (Area under curve),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622220,,BAO_0000019,,
12017,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622221,,BAO_0000218,,
12018,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622222,,BAO_0000218,,
12019,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL622223,,BAO_0000218,,
12020,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622224,,BAO_0000218,,
12021,13118,Plasma concentration (AUC) was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622225,,BAO_0000019,,
12022,13118,Plasma concentration (AUC) was determined; Not detectable,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622226,,BAO_0000019,,
12023,9562,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),A,,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL624154,,BAO_0000218,,
12024,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624155,,BAO_0000218,,
12025,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624156,,BAO_0000218,,
12026,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624157,,BAO_0000218,,
12027,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624158,,BAO_0000218,,
12028,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624159,,BAO_0000218,,
12029,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624160,,BAO_0000218,,
12030,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624161,,BAO_0000218,,
12031,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624162,,BAO_0000218,,
12032,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624163,,BAO_0000218,,
12033,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624164,,BAO_0000218,,
12034,14941,The AUC(0-infinity) values in female wistar rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624165,,BAO_0000218,,
12035,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624166,,BAO_0000218,,
12036,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624167,,BAO_0000218,,
12037,14941,The AUC(0-t)values in female wistar rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624168,,BAO_0000218,,
12038,14067,The Area under the concentration time curve of compound was measured on rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624169,,BAO_0000218,,
12039,14215,The area under curve (100 mg/kg) administered orally in humans,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL624170,,BAO_0000218,,
12040,14215,The area under curve (12.5 mg/kg) administered intravenously in marmoset,A,,,Callithrix,9481.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624171,,BAO_0000218,,
12041,14215,The area under curve (12.5 mg/kg) administered intravenously in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624172,,BAO_0000218,,
12042,14215,The area under curve (15 mg/kg) administered intravenously in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624173,,BAO_0000218,,
12043,14215,The area under curve (200 mg/kg) administered orally in humans,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL877488,,BAO_0000218,,
12044,14215,The area under curve (25 mg/kg) administered intravenously in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624174,,BAO_0000218,,
12045,14215,The area under curve (25 mg/kg) administered orally in marmoset,A,,,Callithrix,9481.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624175,,BAO_0000218,,
12046,14215,The area under curve (25 mg/kg) administered orally in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL624176,,BAO_0000218,,
12047,14215,The area under curve (30 mg/kg) administered orally in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624177,,BAO_0000218,,
12048,14215,The area under curve (400 mg/kg) administered orally in humans,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL624178,,BAO_0000218,,
12049,14215,The area under curve (50 mg/kg) administered orally in fasted rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624179,,BAO_0000218,,
12050,14215,The area under curve (50 mg/kg) administered orally in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627689,,BAO_0000218,,
12051,14215,The area under curve (800 mg/kg) administered orally in humans,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL627690,,BAO_0000218,,
12052,11324,The compound was evaluated for area under the curve,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627691,,BAO_0000019,,
12053,11324,The compound was evaluated for area under the curve in marmosets,A,,,Callithrix,9481.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627692,,BAO_0000019,,
12054,11324,The compound was evaluated for area under the curve in marmosets,A,,,Callithrix,9481.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627693,,BAO_0000019,,
12055,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627694,,BAO_0000218,,
12056,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627695,,BAO_0000218,,
12057,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627696,,BAO_0000218,,
12058,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627697,,BAO_0000218,,
12059,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627698,,BAO_0000218,,
12060,13875,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627699,,BAO_0000218,,
12061,13807,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627700,,BAO_0000218,,
12062,14127,Total drug exposure is determined after oral dosing in rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627701,,BAO_0000218,,
12063,15116,Total drug exposure (5 mg/kg) when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627702,,BAO_0000218,,
12064,15116,Total drug exposure (5 mg/kg) when administered orally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627703,,BAO_0000218,,
12065,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626873,,BAO_0000218,,
12066,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629583,,BAO_0000218,,
12067,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629584,,BAO_0000218,,
12068,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629585,,BAO_0000218,,
12069,13751,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629586,,BAO_0000218,955.0,
12070,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL629587,,BAO_0000218,955.0,
12071,13751,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629588,,BAO_0000218,,
12072,13751,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629589,,BAO_0000218,,
12073,13751,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629590,,BAO_0000218,,
12074,13751,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629591,,BAO_0000218,,
12075,13751,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629592,,BAO_0000218,,
12076,13751,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629593,,BAO_0000218,,
12077,13751,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629594,,BAO_0000218,,
12078,13751,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL629595,,BAO_0000218,948.0,
12079,13751,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630290,,BAO_0000218,948.0,
12080,13751,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627137,,BAO_0000218,948.0,
12081,13751,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627138,,BAO_0000218,948.0,
12082,13751,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627139,,BAO_0000218,948.0,
12083,13751,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627140,,BAO_0000218,948.0,
12084,13751,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627141,,BAO_0000218,948.0,
12085,13751,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627142,,BAO_0000218,2113.0,
12086,13751,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627143,,BAO_0000218,2113.0,
12087,13751,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL874449,,BAO_0000218,2113.0,
12088,13751,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627144,,BAO_0000218,2113.0,
12089,13751,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627145,,BAO_0000218,2113.0,
12090,13751,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627146,,BAO_0000218,2113.0,
12091,13751,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627147,,BAO_0000218,2113.0,
12092,13751,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627148,,BAO_0000218,2107.0,
12093,13751,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627149,,BAO_0000218,2048.0,
12094,13751,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL632160,,BAO_0000218,2048.0,
12095,13751,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL632161,,BAO_0000218,2048.0,
12096,13751,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL632162,,BAO_0000218,2048.0,
12097,13751,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL632163,,BAO_0000218,2048.0,
12098,13751,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL874469,,BAO_0000218,2048.0,
12099,13751,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627182,,BAO_0000218,2048.0,
12100,13751,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627183,,BAO_0000218,2385.0,
12101,13751,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627184,,BAO_0000218,2385.0,
12102,13751,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627185,,BAO_0000218,2385.0,
12103,13751,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627186,,BAO_0000218,2385.0,
12104,13751,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627187,,BAO_0000218,2385.0,
12105,13751,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627188,,BAO_0000218,2385.0,
12106,13751,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627189,,BAO_0000218,2385.0,
12107,13751,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627190,,BAO_0000218,,
12108,13751,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627191,,BAO_0000218,2107.0,
12109,13751,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627192,,BAO_0000218,2107.0,
12110,13751,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627193,,BAO_0000218,2107.0,
12111,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL874590,,BAO_0000218,2385.0,
12112,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627194,,BAO_0000218,2385.0,
12113,10911,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627195,,BAO_0000218,2385.0,
12114,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL627196,,BAO_0000218,992.0,
12115,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL627197,,BAO_0000218,992.0,
12116,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL627198,,BAO_0000218,992.0,
12117,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,A,In vivo,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL627199,,BAO_0000218,992.0,
12118,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Female gonad,,,50597,N,1,Intermediate,1,,CHEMBL627200,,BAO_0000218,992.0,
12119,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627201,,BAO_0000218,1969.0,
12120,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627202,,BAO_0000218,1969.0,
12121,10911,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627203,,BAO_0000218,1969.0,
12122,10911,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627204,,BAO_0000218,1969.0,
12123,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627205,,BAO_0000218,2106.0,
12124,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627206,,BAO_0000218,2106.0,
12125,10911,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627207,,BAO_0000218,2106.0,
12126,10911,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627208,,BAO_0000218,2106.0,
12127,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627209,,BAO_0000218,2046.0,
12128,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627210,,BAO_0000218,2046.0,
12129,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627211,,BAO_0000218,2046.0,
12130,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627212,,BAO_0000218,2046.0,
12131,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL627213,,BAO_0000218,995.0,
12132,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626599,,BAO_0000218,995.0,
12133,10911,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626600,,BAO_0000218,995.0,
12134,10911,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL626601,,BAO_0000218,995.0,
12135,8081,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627484,,BAO_0000019,,
12136,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),A,,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL627485,,BAO_0000218,1969.0,
12137,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,A,,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL628147,,BAO_0000218,1969.0,
12138,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,A,,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL628148,,BAO_0000218,1969.0,
12139,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628149,,BAO_0000218,1969.0,
12140,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628150,,BAO_0000218,1969.0,
12141,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628318,,BAO_0000218,1969.0,
12142,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628319,,BAO_0000218,1969.0,
12143,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875609,,BAO_0000218,,
12144,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628320,,BAO_0000019,,
12145,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628321,,BAO_0000019,,
12146,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628322,,BAO_0000019,,
12147,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628323,,BAO_0000019,,
12148,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628324,,BAO_0000019,,
12149,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628325,,BAO_0000019,,
12150,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628326,,BAO_0000019,,
12151,9614,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL628327,,BAO_0000218,1236.0,
12152,9614,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL628328,,BAO_0000218,1236.0,
12153,9614,"Concentration of compound in blood of dog 1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL628329,,BAO_0000218,178.0,
12154,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628330,,BAO_0000218,2107.0,
12155,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628331,,BAO_0000218,2107.0,
12156,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628332,,BAO_0000218,2107.0,
12157,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628333,,BAO_0000218,2107.0,
12158,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628334,,BAO_0000218,2107.0,
12159,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628335,,BAO_0000218,2107.0,
12160,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628336,,BAO_0000218,2107.0,
12161,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628337,,BAO_0000218,2107.0,
12162,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628338,,BAO_0000218,2107.0,
12163,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL875610,,BAO_0000218,2107.0,
12164,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628339,,BAO_0000218,2107.0,
12165,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628340,,BAO_0000218,2107.0,
12166,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628341,,BAO_0000218,2107.0,
12167,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622214,,BAO_0000218,2107.0,
12168,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623167,,BAO_0000218,2107.0,
12169,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623168,,BAO_0000218,2107.0,
12170,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623169,,BAO_0000218,2107.0,
12171,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623170,,BAO_0000218,2107.0,
12172,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627224,,BAO_0000218,2048.0,
12173,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL875634,,BAO_0000218,2048.0,
12174,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627225,,BAO_0000218,2048.0,
12175,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627226,,BAO_0000218,2048.0,
12176,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626083,,BAO_0000218,2048.0,
12177,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626084,,BAO_0000218,2048.0,
12178,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626085,,BAO_0000218,2048.0,
12179,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626086,,BAO_0000218,2048.0,
12180,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626087,,BAO_0000218,2048.0,
12181,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626088,,BAO_0000218,2048.0,
12182,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626089,,BAO_0000218,2048.0,
12183,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626090,,BAO_0000218,2048.0,
12184,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626091,,BAO_0000218,2048.0,
12185,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626092,,BAO_0000218,2048.0,
12186,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626093,,BAO_0000218,2048.0,
12187,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626094,,BAO_0000218,2048.0,
12188,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626095,,BAO_0000218,2048.0,
12189,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL626096,,BAO_0000218,2048.0,
12190,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626097,,BAO_0000218,,
12191,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626098,,BAO_0000218,,
12192,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626099,,BAO_0000218,1969.0,
12193,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL626100,,BAO_0000218,1969.0,
12194,17237,AUC 0-inf in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626101,,BAO_0000218,1969.0,
12195,17237,AUC 0-inf in guinea pig,A,,,Cavia porcellus,10141.0,,Plasma,,,50512,N,1,Intermediate,1,,CHEMBL626102,,BAO_0000218,1969.0,
12196,17237,AUC 0-t in dog,A,,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626103,,BAO_0000218,1969.0,
12197,17237,AUC 0-t in guinea pig,A,,,Cavia porcellus,10141.0,,Plasma,,,50512,N,1,Intermediate,1,,CHEMBL628391,,BAO_0000218,1969.0,
12198,15194,The compound was tested for brain to plasma partition in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628392,,BAO_0000218,,
12199,15194,The compound was tested for brain to plasma partition in rat.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628393,,BAO_0000218,,
12200,8787,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,A,,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL628394,,BAO_0000019,178.0,
12201,17025,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628395,,BAO_0000218,,
12202,17025,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628396,,BAO_0000218,,
12203,17025,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL628397,,BAO_0000218,,
12204,17025,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628398,,BAO_0000218,,
12205,4236,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,A,,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL628399,,BAO_0000218,,
12206,15343,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628400,,BAO_0000218,,
12207,15343,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874907,,BAO_0000218,,
12208,17720,Area under curve of the compound was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628401,,BAO_0000019,,
12209,17788,AUC in monkeys at a dose of 1 mg/kg,A,,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL628402,,BAO_0000218,1969.0,
12210,17788,AUC in rats at a dose of 1 mg/kg,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628403,,BAO_0000218,1969.0,
12211,8778,Compound was evaluated for the overall absorbance loss at pH of 2,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628404,,BAO_0000019,,
12212,8778,Compound was evaluated for the overall absorbance loss at pH of 4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628405,,BAO_0000019,,
12213,8778,Compound was evaluated for the overall absorbance loss at pH of 7,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628406,,BAO_0000019,,
12214,2249,Compound was evaluated for its absorption in the rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628407,,BAO_0000218,,
12215,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628408,,BAO_0000218,1088.0,
12216,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629171,,BAO_0000218,1088.0,
12217,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629172,,BAO_0000218,1088.0,
12218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629173,,BAO_0000218,1088.0,
12219,15286,In vitro percent permeability into rat ileum,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629174,,BAO_0000218,,
12220,15286,In vitro percent permeability into rat ileum; Range is 10-17,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629175,,BAO_0000218,,
12221,15286,In vitro percent permeability into rat ileum; Range is 10-18,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629176,,BAO_0000218,,
12222,15286,In vitro percent permeability into rat ileum; Range is 10-19,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629177,,BAO_0000218,,
12223,15286,In vitro percent permeability into rat ileum; Range is 12-15,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629178,,BAO_0000218,,
12224,15286,In vitro percent permeability into rat ileum; Range is 13-19,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631869,,BAO_0000218,,
12225,15286,In vitro percent permeability into rat ileum; Range is 14-17,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631870,,BAO_0000218,,
12226,15286,In vitro percent permeability into rat ileum; Range is 15-18,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631871,,BAO_0000218,,
12227,15286,In vitro percent permeability into rat ileum; Range is 2-5,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631872,,BAO_0000218,,
12228,15286,In vitro percent permeability into rat ileum; Range is 23-42,A,,,,,,Ileum,,,22224,U,0,Autocuration,1,,CHEMBL875775,,BAO_0000221,2116.0,
12229,15286,In vitro percent permeability into rat ileum; Range is 28-36,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631873,,BAO_0000218,,
12230,15286,In vitro percent permeability into rat ileum; Range is 29-35,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631874,,BAO_0000218,,
12231,15286,In vitro percent permeability into rat ileum; Range is 46-66,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631875,,BAO_0000218,,
12232,15286,In vitro percent permeability into rat ileum; Range is 50-68,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631876,,BAO_0000218,,
12233,15286,In vitro percent permeability into rat ileum; Range is 78-81,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631877,,BAO_0000218,,
12234,15286,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631878,,BAO_0000218,,
12235,15286,In vitro percent permeability into rat ileum; nd indicates not detected,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631879,,BAO_0000218,,
12236,15286,In vitro percent permeability into rat ileum; nt indicates not detected,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631880,,BAO_0000218,,
12237,15286,In vitro percent permeability into rat ileum; nt indicates not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631881,,BAO_0000218,,
12238,13770,Compound was tested for oral absorption in bile-duct cannulated rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631882,,BAO_0000218,,
12239,13770,Compound was tested for oral absorption in bile-duct cannulated rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630749,,BAO_0000218,,
12240,5202,Oral absorption using Caco-2 cell monolayers.,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL630750,,BAO_0000218,,
12241,14920,Percent of the drug absorbed after administration to humans was determined,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL630253,,BAO_0000218,,
12242,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL630254,,BAO_0000218,1969.0,
12243,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL630255,,BAO_0000218,1969.0,
12244,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL630256,,BAO_0000218,1969.0,
12245,13751,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL875781,,BAO_0000218,2107.0,
12246,13751,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL630257,,BAO_0000218,2107.0,
12247,13751,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL630258,,BAO_0000218,2107.0,
12248,15807,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630259,,BAO_0000218,,
12249,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL630260,,BAO_0000218,2435.0,
12250,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",A,,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL630261,,BAO_0000218,2435.0,
12251,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630262,,BAO_0000218,,
12252,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630263,,BAO_0000218,,
12253,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630264,,BAO_0000218,,
12254,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630265,,BAO_0000218,,
12255,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630266,,BAO_0000218,,
12256,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630267,,BAO_0000218,2113.0,
12257,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630268,,BAO_0000218,2113.0,
12258,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630269,,BAO_0000218,,
12259,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630270,,BAO_0000218,,
12260,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630141,,BAO_0000218,2048.0,
12261,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630142,,BAO_0000218,2048.0,
12262,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630143,,BAO_0000218,2385.0,
12263,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630144,,BAO_0000218,2385.0,
12264,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,A,,,Rattus norvegicus,10116.0,,Prostate gland,,,50597,N,1,Intermediate,1,,CHEMBL630145,,BAO_0000218,2367.0,
12265,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,A,,,Rattus norvegicus,10116.0,,Prostate gland,,,50597,N,1,Intermediate,1,,CHEMBL630146,,BAO_0000218,2367.0,
12266,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630147,,BAO_0000218,,
12267,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630148,,BAO_0000218,,
12268,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630149,,BAO_0000218,,
12269,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630150,,BAO_0000218,2106.0,
12270,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630151,,BAO_0000218,2106.0,
12271,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL632031,,BAO_0000218,2046.0,
12272,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL632032,,BAO_0000218,2046.0,
12273,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632033,,BAO_0000218,,
12274,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632034,,BAO_0000218,,
12275,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL632035,,BAO_0000218,2385.0,
12276,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632036,,BAO_0000218,,
12277,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL632037,,BAO_0000218,2046.0,
12278,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632038,,BAO_0000218,178.0,
12279,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632039,,BAO_0000218,178.0,
12280,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632040,,BAO_0000218,178.0,
12281,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL632041,,BAO_0000218,178.0,
12282,9614,"Concentration of compound in blood of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Blood,,,50588,N,1,Intermediate,1,,CHEMBL632042,,BAO_0000218,178.0,
12283,9614,"Concentration of compound in left ventricle of dog 1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL632043,,BAO_0000218,,
12284,9614,"Concentration of compound in left ventricle of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL632044,,BAO_0000218,,
12285,9614,"Concentration of compound in liver of dog 1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL632045,,BAO_0000218,2107.0,
12286,9614,"Concentration of compound in liver of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Liver,,,50588,N,1,Intermediate,1,,CHEMBL632046,,BAO_0000218,2107.0,
12287,9614,"Concentration of compound in lung of dog 1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Lung,,,50588,N,1,Intermediate,1,,CHEMBL632047,,BAO_0000218,2048.0,
12288,9614,"Concentration of compound in lung of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Lung,,,50588,N,1,Intermediate,1,,CHEMBL632048,,BAO_0000218,2048.0,
12289,9614,"Concentration of compound in muscle of dog 1, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Muscle tissue,,,50588,N,1,Intermediate,1,,CHEMBL632049,,BAO_0000218,2385.0,
12290,9614,"Concentration of compound in muscle of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Muscle tissue,,,50588,N,1,Intermediate,1,,CHEMBL876418,,BAO_0000218,2385.0,
12291,9614,"Concentration of compound in spleen of dog 1,after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL632050,,BAO_0000218,2106.0,
12292,9614,"Concentration of compound in spleen of dog 2, after administering intravenously",A,,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL632051,,BAO_0000218,2106.0,
12293,10353,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632052,,BAO_0000218,,
12294,10353,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632053,,BAO_0000218,,
12295,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632054,,BAO_0000218,,
12296,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632055,,BAO_0000218,,
12297,10353,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631181,,BAO_0000218,,
12298,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631182,,BAO_0000218,,
12299,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631183,,BAO_0000218,,
12300,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631184,,BAO_0000218,,
12301,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629774,,BAO_0000218,,
12302,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629775,,BAO_0000218,,
12303,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL876549,,BAO_0000218,,
12304,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628172,,BAO_0000218,,
12305,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628173,,BAO_0000218,,
12306,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628174,,BAO_0000218,,
12307,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628175,,BAO_0000218,,
12308,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628176,,BAO_0000218,,
12309,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628177,,BAO_0000218,,
12310,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628178,,BAO_0000218,,
12311,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628179,,BAO_0000218,,
12312,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628180,,BAO_0000218,,
12313,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628181,,BAO_0000218,,
12314,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628182,,BAO_0000218,,
12315,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628183,,BAO_0000218,,
12316,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628184,,BAO_0000218,,
12317,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628185,,BAO_0000218,,
12318,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875617,,BAO_0000218,,
12319,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628186,,BAO_0000218,,
12320,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628187,,BAO_0000218,,
12321,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628188,,BAO_0000218,,
12322,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628189,,BAO_0000218,,
12323,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628190,,BAO_0000218,,
12324,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628191,,BAO_0000218,,
12325,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626513,,BAO_0000218,,
12326,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626514,,BAO_0000218,2046.0,
12327,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626515,,BAO_0000218,2046.0,
12328,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626516,,BAO_0000218,2046.0,
12329,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626517,,BAO_0000218,2046.0,
12330,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626518,,BAO_0000218,2046.0,
12331,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626519,,BAO_0000218,2046.0,
12332,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626520,,BAO_0000218,2046.0,
12333,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626521,,BAO_0000218,2046.0,
12334,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626522,,BAO_0000218,2046.0,
12335,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626523,,BAO_0000218,2046.0,
12336,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626524,,BAO_0000218,2046.0,
12337,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626688,,BAO_0000218,2046.0,
12338,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626689,,BAO_0000218,2046.0,
12339,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626690,,BAO_0000218,2046.0,
12340,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626691,,BAO_0000218,2046.0,
12341,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL627319,,BAO_0000218,2046.0,
12342,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624052,,BAO_0000218,2046.0,
12343,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL624053,,BAO_0000218,2046.0,
12344,8085,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624054,,BAO_0000218,,
12345,8085,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624055,,BAO_0000218,,
12346,8085,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624056,,BAO_0000218,,
12347,8085,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL624057,,BAO_0000218,995.0,
12348,8085,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622281,,BAO_0000218,995.0,
12349,8085,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622282,,BAO_0000218,995.0,
12350,8085,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622283,,BAO_0000218,995.0,
12351,8085,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622284,,BAO_0000218,995.0,
12352,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622285,,BAO_0000218,995.0,
12353,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL622286,,BAO_0000218,995.0,
12354,7657,Distribution coefficient (D %) between octanol and buffer of pH 7.4,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622287,,BAO_0000100,,
12355,8935,Partition coefficient (logD7.4),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622288,,BAO_0000218,,
12356,13792,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622289,,BAO_0000218,,
12357,13792,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622290,,BAO_0000218,955.0,
12358,13792,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622291,,BAO_0000218,,
12359,13792,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622292,,BAO_0000218,955.0,
12360,13792,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622293,,BAO_0000218,,
12361,13792,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL622294,,BAO_0000218,955.0,
12362,13792,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL622295,,BAO_0000218,,
12363,13792,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,A,,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL622296,,BAO_0000218,955.0,
12364,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL874409,,BAO_0000218,1969.0,
12365,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622297,,BAO_0000218,1969.0,
12366,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622298,,BAO_0000218,1969.0,
12367,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622299,,BAO_0000218,1969.0,
12368,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622300,,BAO_0000218,1969.0,
12369,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622301,,BAO_0000218,1969.0,
12370,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622302,,BAO_0000218,1969.0,
12371,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622303,,BAO_0000218,1969.0,
12372,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622304,,BAO_0000218,1969.0,
12373,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622305,,BAO_0000218,1969.0,
12374,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622306,,BAO_0000218,1969.0,
12375,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626864,,BAO_0000218,1969.0,
12376,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626865,,BAO_0000218,1969.0,
12377,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626866,,BAO_0000218,1969.0,
12378,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626867,,BAO_0000218,1969.0,
12379,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626868,,BAO_0000218,1969.0,
12380,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626869,,BAO_0000218,1969.0,
12381,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626870,,BAO_0000218,1969.0,
12382,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626871,,BAO_0000218,1969.0,
12383,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626872,,BAO_0000218,1969.0,
12384,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632185,,BAO_0000218,1969.0,
12385,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL632186,,BAO_0000218,1969.0,
12386,12904,Amount of acetic acid produced by the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629310,,BAO_0000019,,
12387,12904,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629311,,BAO_0000019,,
12388,9663,Log of (Cbrain/Cblood) in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629312,,BAO_0000218,,
12389,7652,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629313,,BAO_0000221,,
12390,7652,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629314,,BAO_0000221,,
12391,7652,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629315,,BAO_0000221,,
12392,7652,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629316,,BAO_0000219,,
12393,7652,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629317,,BAO_0000221,,
12394,7652,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629318,,BAO_0000019,,
12395,7652,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877497,,BAO_0000019,,
12396,7652,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629319,,BAO_0000019,,
12397,7652,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629320,,BAO_0000019,,
12398,7652,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629496,,BAO_0000019,,
12399,7652,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629497,,BAO_0000019,,
12400,7652,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629498,,BAO_0000019,,
12401,7652,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629499,,BAO_0000019,,
12402,7652,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629500,,BAO_0000019,,
12403,7652,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629501,,BAO_0000019,,
12404,7652,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629502,,BAO_0000019,,
12405,8267,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,F,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629503,,BAO_0000218,,
12406,8267,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629504,,BAO_0000218,,
12407,14479,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629505,,BAO_0000019,,
12408,17515,Compound was evaluated for total body clearance,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629506,,BAO_0000019,,
12409,17515,Compound was evaluated for volume of distribution at steady state,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629507,,BAO_0000019,,
12410,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877498,,BAO_0000019,,
12411,14849,Percentage of the diamine which is monoprotonated at pH 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629508,,BAO_0000019,,
12412,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629509,,BAO_0000019,,
12413,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629510,,BAO_0000218,178.0,
12414,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629511,,BAO_0000218,178.0,
12415,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629512,,BAO_0000218,178.0,
12416,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629513,,BAO_0000218,178.0,
12417,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629514,,BAO_0000218,178.0,
12418,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628447,,BAO_0000218,178.0,
12419,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628448,,BAO_0000218,178.0,
12420,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628449,,BAO_0000218,178.0,
12421,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631119,,BAO_0000218,178.0,
12422,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631120,,BAO_0000218,178.0,
12423,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631121,,BAO_0000218,178.0,
12424,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL874458,,BAO_0000218,178.0,
12425,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631122,,BAO_0000218,178.0,
12426,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631123,,BAO_0000218,178.0,
12427,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631124,,BAO_0000218,178.0,
12428,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631125,,BAO_0000218,178.0,
12429,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631290,,BAO_0000218,178.0,
12430,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631291,,BAO_0000218,178.0,
12431,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631292,,BAO_0000218,178.0,
12432,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631293,,BAO_0000218,178.0,
12433,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631294,,BAO_0000218,178.0,
12434,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631295,,BAO_0000218,178.0,
12435,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631296,,BAO_0000218,178.0,
12436,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631297,,BAO_0000218,178.0,
12437,10263,Maximum biodistribution (Bmax) was determined.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631298,,BAO_0000218,,
12438,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631299,,BAO_0000218,,
12439,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631300,,BAO_0000218,,
12440,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631301,,BAO_0000218,,
12441,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630291,,BAO_0000218,,
12442,14793,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630292,,BAO_0000218,,
12443,14793,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630293,,BAO_0000218,,
12444,14793,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630294,,BAO_0000218,,
12445,14793,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630295,,BAO_0000218,,
12446,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630296,,BAO_0000218,,
12447,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626782,,BAO_0000218,,
12448,14793,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626783,,BAO_0000218,,
12449,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626784,,BAO_0000218,,
12450,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626785,,BAO_0000218,,
12451,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626786,,BAO_0000218,,
12452,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626787,,BAO_0000218,,
12453,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626788,,BAO_0000218,,
12454,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625927,,BAO_0000218,,
12455,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625928,,BAO_0000218,178.0,
12456,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625929,,BAO_0000218,178.0,
12457,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625930,,BAO_0000218,178.0,
12458,8374,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625931,,BAO_0000218,178.0,
12459,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627230,,BAO_0000218,178.0,
12460,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627231,,BAO_0000218,178.0,
12461,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627232,,BAO_0000218,178.0,
12462,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627233,,BAO_0000218,178.0,
12463,8374,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875470,,BAO_0000218,178.0,
12464,8374,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627234,,BAO_0000218,178.0,
12465,8374,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627235,,BAO_0000218,178.0,
12466,8374,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627236,,BAO_0000218,178.0,
12467,8374,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627237,,BAO_0000218,178.0,
12468,8374,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627238,,BAO_0000218,178.0,
12469,8374,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627239,,BAO_0000218,178.0,
12470,8374,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627240,,BAO_0000218,178.0,
12471,8374,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627241,,BAO_0000218,178.0,
12472,8374,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627242,,BAO_0000218,178.0,
12473,8374,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627243,,BAO_0000218,178.0,
12474,8374,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627244,,BAO_0000218,178.0,
12475,8374,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627245,,BAO_0000218,178.0,
12476,8374,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627246,,BAO_0000218,178.0,
12477,8374,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627247,,BAO_0000218,178.0,
12478,8374,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627248,,BAO_0000218,178.0,
12479,8374,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627249,,BAO_0000218,178.0,
12480,8374,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625569,,BAO_0000218,178.0,
12481,8374,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625570,,BAO_0000218,178.0,
12482,8374,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625571,,BAO_0000218,178.0,
12483,8374,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625572,,BAO_0000218,178.0,
12484,8374,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625573,,BAO_0000218,178.0,
12485,8374,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625574,,BAO_0000218,178.0,
12486,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626245,,BAO_0000218,178.0,
12487,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626246,,BAO_0000218,178.0,
12488,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626247,,BAO_0000218,,
12489,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626248,,BAO_0000218,,
12490,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626249,,BAO_0000218,,
12491,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626420,,BAO_0000218,,
12492,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626421,,BAO_0000218,,
12493,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626422,,BAO_0000218,,
12494,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626423,,BAO_0000218,,
12495,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626424,,BAO_0000218,,
12496,12023,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626425,,BAO_0000218,,
12497,12023,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875476,,BAO_0000218,,
12498,12023,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL626426,,BAO_0000218,,
12499,10580,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626427,,BAO_0000100,,
12500,10580,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626428,,BAO_0000100,,
12501,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626429,,BAO_0000019,,
12502,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL625025,,BAO_0000019,1088.0,
12503,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625026,,BAO_0000218,178.0,
12504,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625027,,BAO_0000218,178.0,
12505,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL874410,,BAO_0000218,178.0,
12506,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625028,,BAO_0000218,178.0,
12507,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625029,,BAO_0000218,178.0,
12508,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625030,,BAO_0000218,178.0,
12509,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625031,,BAO_0000218,178.0,
12510,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625032,,BAO_0000218,178.0,
12511,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625033,,BAO_0000218,178.0,
12512,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625034,,BAO_0000218,178.0,
12513,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624872,,BAO_0000218,948.0,
12514,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624873,,BAO_0000218,948.0,
12515,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624874,,BAO_0000218,948.0,
12516,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624875,,BAO_0000218,948.0,
12517,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624876,,BAO_0000218,948.0,
12518,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624877,,BAO_0000218,948.0,
12519,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624878,,BAO_0000218,948.0,
12520,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624879,,BAO_0000218,948.0,
12521,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624880,,BAO_0000218,948.0,
12522,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624881,,BAO_0000218,948.0,
12523,8594,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL624882,,BAO_0000218,948.0,
12524,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624883,,BAO_0000218,2113.0,
12525,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624884,,BAO_0000218,2113.0,
12526,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624885,,BAO_0000218,2113.0,
12527,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624886,,BAO_0000218,2113.0,
12528,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624887,,BAO_0000218,2113.0,
12529,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624888,,BAO_0000218,2113.0,
12530,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624889,,BAO_0000218,2113.0,
12531,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL624890,,BAO_0000218,2113.0,
12532,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621964,,BAO_0000218,2113.0,
12533,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL621965,,BAO_0000218,2113.0,
12534,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621966,,BAO_0000218,2107.0,
12535,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL621967,,BAO_0000218,2107.0,
12536,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL622164,,BAO_0000218,2107.0,
12537,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623097,,BAO_0000019,,
12538,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623098,,BAO_0000019,,
12539,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623099,,BAO_0000019,,
12540,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623100,,BAO_0000019,,
12541,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628673,,BAO_0000218,,
12542,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628674,,BAO_0000218,,
12543,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628675,,BAO_0000218,,
12544,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627644,,BAO_0000218,,
12545,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627645,,BAO_0000218,,
12546,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627646,,BAO_0000218,,
12547,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627647,,BAO_0000218,,
12548,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627648,,BAO_0000218,,
12549,12902,Free level in rat plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627649,,BAO_0000218,,
12550,6614,Level reaching in blood plasma of rat or human was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628313,,BAO_0000019,,
12551,9663,Log (Cbrain/Cblood) in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628314,,BAO_0000218,,
12552,17658,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628315,,BAO_0000019,,
12553,17658,Mean percentage of compound transport through membrane; expressed as membrane transport,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628316,,BAO_0000019,,
12554,14314,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628317,,BAO_0000218,,
12555,7385,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628473,,BAO_0000019,,
12556,7385,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628474,,BAO_0000019,,
12557,7385,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628475,,BAO_0000019,,
12558,1329,Net water uptake by a carrier mediated transport (%cm) mechanism,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628476,,BAO_0000019,,
12559,12187,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628477,,BAO_0000218,,
12560,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL628478,,BAO_0000218,,
12561,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL628479,,BAO_0000218,,
12562,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628480,,BAO_0000218,,
12563,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628481,,BAO_0000218,,
12564,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628482,,BAO_0000218,,
12565,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628483,,BAO_0000218,,
12566,9278,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628484,,BAO_0000218,1969.0,
12567,9278,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628485,,BAO_0000218,1969.0,
12568,9278,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",A,,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL628486,,BAO_0000218,1969.0,
12569,9278,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",A,,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL628487,,BAO_0000218,1969.0,
12570,9278,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628488,,BAO_0000218,1969.0,
12571,9278,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628489,,BAO_0000218,1969.0,
12572,9278,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628490,,BAO_0000218,1969.0,
12573,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL628491,,BAO_0000218,,
12574,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,A,,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL877507,,BAO_0000218,,
12575,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628492,,BAO_0000218,,
12576,12041,% metabolized in monkey S-9 after 2 hours (10 ug/mL),A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628493,,BAO_0000019,,
12577,12041,% metabolized in monkey S-9 after 2 hours (1 ug/ml),A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628494,,BAO_0000019,,
12578,12041,% metabolized in monkey S-9 after 2 hours (10 ug/ml),A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL628495,,BAO_0000019,,
12579,6737,Permeability in Caco-2 assay at 10E-6,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL628496,,BAO_0000218,,
12580,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,A,,,,,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL628497,,BAO_0000218,955.0,
12581,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,A,,,,,,Brain,,,22224,U,0,Autocuration,1,,CHEMBL628498,,BAO_0000218,955.0,
12582,5676,Plasma protein binding was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628499,,BAO_0000019,,
12583,14793,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627656,,BAO_0000218,,
12584,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627657,,BAO_0000218,,
12585,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626808,,BAO_0000218,,
12586,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626809,,BAO_0000218,,
12587,14793,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626810,,BAO_0000218,,
12588,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626811,,BAO_0000218,,
12589,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874465,,BAO_0000218,,
12590,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626812,,BAO_0000218,,
12591,14793,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626813,,BAO_0000218,,
12592,14793,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626814,,BAO_0000218,,
12593,14000,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626815,,BAO_0000019,,
12594,5948,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628566,,BAO_0000019,,
12595,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL628567,,BAO_0000100,,
12596,10778,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL628568,,BAO_0000100,,
12597,17237,C max in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628569,,BAO_0000218,,
12598,17237,C max in guinea pig,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL628570,,BAO_0000218,,
12599,2809,C max value was evaluated,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628571,,BAO_0000218,,
12600,11954,Cmax value after oral dose of 0.1 mg//kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628572,,BAO_0000218,,
12601,11954,Cmax value after oral dose of 0.3 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628573,,BAO_0000218,,
12602,11954,Cmax value after oral dose of 1 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628574,,BAO_0000218,,
12603,11954,Cmax value after oral dose of 10 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628575,,BAO_0000218,,
12604,11954,Cmax value after oral dose of 23.4 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628576,,BAO_0000218,,
12605,11954,Cmax value after oral dose of 3 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628577,,BAO_0000218,,
12606,11954,Cmax value after oral dose of 3.87 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628578,,BAO_0000218,,
12607,12768,Cmax value in female Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL874466,,BAO_0000218,,
12608,12768,Cmax value in male rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628579,,BAO_0000218,,
12609,12780,Cmax value in rat plasma when administered 20 mg/kg perorally,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628580,,BAO_0000218,1969.0,
12610,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628581,,BAO_0000218,1969.0,
12611,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL628582,,BAO_0000218,1969.0,
12612,17025,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628583,,BAO_0000218,,
12613,17025,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625782,,BAO_0000218,,
12614,17025,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL625783,,BAO_0000218,,
12615,17025,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625784,,BAO_0000218,,
12616,4236,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,A,,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL625785,,BAO_0000218,1969.0,
12617,15791,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625786,,BAO_0000218,,
12618,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874467,,BAO_0000019,,
12619,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625787,,BAO_0000218,,
12620,15778,cytotoxicity against HIV protease enzyme.,A,,,Human immunodeficiency virus,12721.0,,,,,50677,N,1,Intermediate,1,,CHEMBL625964,,BAO_0000218,,
12621,12745,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625965,,BAO_0000218,,
12622,12745,Apparent clearance in mice after oral administration of 100 mg/kg of dose,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625966,,BAO_0000218,,
12623,13941,The plasma clearance in dog.,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625967,,BAO_0000218,1969.0,
12624,13941,The plasma clearance in rat.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625968,,BAO_0000218,1969.0,
12625,16449,Clearance from plasma in male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625969,,BAO_0000218,1969.0,
12626,16449,Clearance from plasma in male cynomolgus monkeys,A,In vivo,,Macaca fascicularis,9541.0,,Plasma,,,100710,N,1,Intermediate,1,,CHEMBL625970,,BAO_0000218,1969.0,
12627,14224,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625971,,BAO_0000218,1969.0,
12628,14224,Clearance of compound in dog plasma,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625972,,BAO_0000218,1969.0,
12629,14224,Clearance of compound in human plasma,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL625973,,BAO_0000218,1969.0,
12630,14317,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625974,,BAO_0000218,,
12631,14317,Clearance of compound when administered intravenously as an individual dose to a single dog.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625975,,BAO_0000218,,
12632,14224,"Clearance (10 mg/kg, intravenously) in dog plasma",A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625976,,BAO_0000218,1969.0,
12633,17237,Clearance value in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625977,,BAO_0000218,,
12634,17237,Clearance value in guinea pig,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL625978,,BAO_0000218,,
12635,14187,Clearance values in rats after iv administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874468,,BAO_0000218,,
12636,4806,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL625421,,BAO_0000218,1969.0,
12637,15025,In vivo clearance (5 mg/kg) was determined in rabbits,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL625422,,BAO_0000218,,
12638,13197,Plasma Clearance rate was determined for the compound in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625423,,BAO_0000218,,
12639,13197,Plasma Clearance rate was determined for the compound in squirrel monkeys,A,In vivo,,Saimiri,9520.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625424,,BAO_0000218,,
12640,13960,Plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625425,,BAO_0000218,,
12641,17820,Plasma clearance of the compound,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625426,,BAO_0000218,,
12642,14706,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL625427,,BAO_0000218,,
12643,14706,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL625428,,BAO_0000218,,
12644,6504,Plasma clearance was determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625429,,BAO_0000218,,
12645,14925,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625430,,BAO_0000218,,
12646,13197,Plasma clearance rate was determined for the compound in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625431,,BAO_0000218,,
12647,13197,Plasma clearance rate was determined for the compound in squirrel monkeys,A,In vivo,,Saimiri,9520.0,,,,,22224,U,0,Autocuration,1,,CHEMBL627307,,BAO_0000218,,
12648,3437,Slow clearance (CL) was determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627308,,BAO_0000218,,
12649,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627309,,BAO_0000218,,
12650,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627310,,BAO_0000218,,
12651,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627311,,BAO_0000218,,
12652,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627312,,BAO_0000218,,
12653,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627313,,BAO_0000218,,
12654,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627314,,BAO_0000218,,
12655,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627315,,BAO_0000218,,
12656,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627316,,BAO_0000218,,
12657,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627317,,BAO_0000218,,
12658,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627318,,BAO_0000218,,
12659,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627999,,BAO_0000218,,
12660,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628000,,BAO_0000218,,
12661,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628001,,BAO_0000218,,
12662,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628002,,BAO_0000218,,
12663,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625610,,BAO_0000218,,
12664,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625611,,BAO_0000218,,
12665,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625612,,BAO_0000218,,
12666,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625613,,BAO_0000218,,
12667,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875479,,BAO_0000218,,
12668,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625614,,BAO_0000218,,
12669,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625615,,BAO_0000218,,
12670,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626302,,BAO_0000218,,
12671,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626303,,BAO_0000218,178.0,
12672,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627420,,BAO_0000218,178.0,
12673,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627421,,BAO_0000218,,
12674,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625695,,BAO_0000218,,
12675,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625696,,BAO_0000218,,
12676,10009,Distribution of compound in mice brain was measured after 1 hr,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL875606,,BAO_0000218,955.0,
12677,10009,Distribution of compound in mice brain was measured after 24 hr r,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625697,,BAO_0000218,955.0,
12678,10009,Distribution of compound in mice brain was measured after 2 hr,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625698,,BAO_0000218,955.0,
12679,10009,Distribution of compound in mice brain was measured after 3 hr,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625699,,BAO_0000218,955.0,
12680,10009,Distribution of compound in mice brain was measured after 6 hr,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL625700,,BAO_0000218,955.0,
12681,10009,Distribution of compound in mice liver was measured after 1 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625701,,BAO_0000218,,
12682,10009,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625702,,BAO_0000218,,
12683,10009,Distribution of compound in mice liver was measured after 2 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625703,,BAO_0000218,,
12684,10009,Distribution of compound in mice liver was measured after 3 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625704,,BAO_0000218,,
12685,10009,Distribution of compound in mice liver was measured after 6 hr,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625705,,BAO_0000218,,
12686,8170,Distribution in dog adrenal medulla 30 min after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL625706,,BAO_0000218,1236.0,
12687,8170,Distribution in dog adrenal medulla 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL625707,,BAO_0000218,1236.0,
12688,8170,Distribution in female dog Ovary 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625708,,BAO_0000218,,
12689,8170,Distribution in female dog Ovary 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625709,,BAO_0000218,,
12690,8170,Distribution in female dog adipose 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624180,,BAO_0000218,,
12691,8170,Distribution in female dog adipose 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624181,,BAO_0000218,,
12692,8170,Distribution in female dog adrenal cortex 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal cortex,,,50588,N,1,Intermediate,1,,CHEMBL624182,,BAO_0000218,1235.0,
12693,8170,Distribution in female dog adrenal cortex 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal cortex,,,50588,N,1,Intermediate,1,,CHEMBL624183,,BAO_0000218,1235.0,
12694,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624184,,BAO_0000218,2107.0,
12695,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL877489,,BAO_0000218,2107.0,
12696,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624185,,BAO_0000218,2107.0,
12697,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624186,,BAO_0000218,2107.0,
12698,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624187,,BAO_0000218,2107.0,
12699,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL624188,,BAO_0000218,2107.0,
12700,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624189,,BAO_0000218,2048.0,
12701,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624190,,BAO_0000218,2048.0,
12702,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624191,,BAO_0000218,2048.0,
12703,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624192,,BAO_0000218,2048.0,
12704,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624193,,BAO_0000218,2048.0,
12705,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624194,,BAO_0000218,2048.0,
12706,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624891,,BAO_0000218,2048.0,
12707,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624892,,BAO_0000218,2048.0,
12708,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL624893,,BAO_0000218,2048.0,
12709,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627632,,BAO_0000218,2048.0,
12710,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627633,,BAO_0000218,,
12711,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627634,,BAO_0000218,,
12712,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627635,,BAO_0000218,,
12713,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627636,,BAO_0000218,,
12714,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626816,,BAO_0000218,,
12715,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626817,,BAO_0000218,,
12716,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626818,,BAO_0000218,,
12717,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626819,,BAO_0000218,,
12718,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626820,,BAO_0000218,,
12719,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626821,,BAO_0000218,,
12720,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626822,,BAO_0000218,2046.0,
12721,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626823,,BAO_0000218,2046.0,
12722,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626824,,BAO_0000218,2046.0,
12723,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626825,,BAO_0000218,2046.0,
12724,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626826,,BAO_0000218,2046.0,
12725,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626827,,BAO_0000218,2046.0,
12726,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626828,,BAO_0000218,2046.0,
12727,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626829,,BAO_0000218,2046.0,
12728,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL626830,,BAO_0000218,2046.0,
12729,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627150,,BAO_0000218,,
12730,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627151,,BAO_0000218,,
12731,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627152,,BAO_0000218,,
12732,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627153,,BAO_0000218,,
12733,12904,Rate of acetate production by the compound was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627154,,BAO_0000019,,
12734,12904,Rate of acetate production by the compound was determined; Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627155,,BAO_0000019,,
12735,3730,Rate of hydrolysis of nitrocefin by compound was evaluated in water,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627156,,BAO_0000019,,
12736,3627,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627157,,BAO_0000019,,
12737,13799,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL627158,,BAO_0000218,,
12738,13799,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,A,,,Oryctolagus cuniculus,9986.0,,Plasma,,,50592,N,1,Intermediate,1,,CHEMBL627159,,BAO_0000218,1969.0,
12739,13799,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627160,,BAO_0000218,,
12740,13799,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628540,,BAO_0000218,,
12741,13799,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628541,,BAO_0000218,1969.0,
12742,13799,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628542,,BAO_0000218,1969.0,
12743,6629,Solubility after at a pH 1.2,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL628543,,BAO_0000100,,
12744,6629,Solubility after at pH 1.2,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL628544,,BAO_0000100,,
12745,6629,Solubility after injection of water,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL628545,,BAO_0000100,,
12746,14000,Statistical significance of IC 50 values; Expressed as R value,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628546,,BAO_0000019,,
12747,8267,Systemic availability with respect to methyldopa was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874455,,BAO_0000019,,
12748,13799,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628547,,BAO_0000218,,
12749,13799,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL628548,,BAO_0000218,1969.0,
12750,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628549,,BAO_0000218,1988.0,
12751,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628550,,BAO_0000218,1988.0,
12752,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628551,,BAO_0000218,1988.0,
12753,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628552,,BAO_0000218,1088.0,
12754,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628553,,BAO_0000218,1088.0,
12755,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628554,,BAO_0000218,1088.0,
12756,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628555,,BAO_0000218,1088.0,
12757,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628556,,BAO_0000218,1088.0,
12758,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Kidney,,,50592,N,1,Intermediate,1,,CHEMBL628557,,BAO_0000218,2113.0,
12759,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628558,,BAO_0000218,1988.0,
12760,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628559,,BAO_0000218,1988.0,
12761,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628560,,BAO_0000218,1988.0,
12762,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL874456,,BAO_0000218,1088.0,
12763,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628561,,BAO_0000218,1988.0,
12764,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL628562,,BAO_0000218,1988.0,
12765,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628563,,BAO_0000218,1088.0,
12766,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628564,,BAO_0000218,1088.0,
12767,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL628565,,BAO_0000218,1088.0,
12768,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL631248,,BAO_0000218,1088.0,
12769,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL631249,,BAO_0000218,1088.0,
12770,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Kidney,,,50592,N,1,Intermediate,1,,CHEMBL627214,,BAO_0000218,2113.0,
12771,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL874591,,BAO_0000218,1988.0,
12772,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL627215,,BAO_0000218,1988.0,
12773,7132,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL625471,,BAO_0000218,1988.0,
12774,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL625472,,BAO_0000218,,
12775,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL625473,,BAO_0000218,,
12776,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625474,,BAO_0000218,,
12777,15341,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625475,,BAO_0000218,,
12778,15341,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625476,,BAO_0000218,,
12779,15341,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625477,,BAO_0000218,,
12780,15341,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625478,,BAO_0000218,,
12781,12801,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,A,In vitro,,Rattus norvegicus,10116.0,,esophageal tunica muscularis mucosae,,,50597,N,1,Intermediate,1,,CHEMBL625479,,BAO_0000218,,
12782,12801,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,A,In vitro,,Rattus norvegicus,10116.0,,esophageal tunica muscularis mucosae,,,50597,N,1,Intermediate,1,,CHEMBL625480,,BAO_0000218,,
12783,14856,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625481,,BAO_0000218,1969.0,
12784,14062,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625482,,BAO_0000218,,
12785,14062,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625483,,BAO_0000218,,
12786,14062,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625484,,BAO_0000218,,
12787,14062,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625485,,BAO_0000218,,
12788,14346,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625486,,BAO_0000218,1969.0,
12789,14346,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625487,,BAO_0000218,1969.0,
12790,14346,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625488,,BAO_0000218,1969.0,
12791,14346,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625489,,BAO_0000218,1969.0,
12792,14346,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625490,,BAO_0000218,1969.0,
12793,14346,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL625491,,BAO_0000218,1969.0,
12794,14346,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625492,,BAO_0000218,1969.0,
12795,15711,plasma clearance in human,A,In vivo,,Homo sapiens,9606.0,,Plasma,,,50587,N,1,Intermediate,1,,CHEMBL625493,,BAO_0000218,1969.0,
12796,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625494,,BAO_0000218,,
12797,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625495,,BAO_0000218,,
12798,14886,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625496,,BAO_0000218,,
12799,4115,1-Octanol/water partition coefficient measured at 7.4,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625497,,BAO_0000100,,
12800,13733,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625498,,BAO_0000100,,
12801,12102,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625499,,BAO_0000019,,
12802,12676,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625500,,BAO_0000100,,
12803,13733,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625501,,BAO_0000100,,
12804,13740,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625502,,BAO_0000100,,
12805,12766,Calculated partition coefficient (clogP) (relative to BAY K 8644),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625503,,BAO_0000100,,
12806,2764,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625504,,BAO_0000100,,
12807,12355,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625505,,BAO_0000100,,
12808,11314,Calculated partition coefficient of the compound,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625506,,BAO_0000100,,
12809,12706,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625507,,BAO_0000019,,
12810,12645,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625508,,BAO_0000100,,
12811,13668,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625509,,BAO_0000100,,
12812,12819,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625510,,BAO_0000100,,
12813,13668,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL883125,,BAO_0000100,,
12814,13017,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625511,,BAO_0000100,,
12815,2448,Partition coefficient of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874650,,BAO_0000019,,
12816,11526,Partition coefficient of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625512,,BAO_0000019,,
12817,12426,Partition coefficient of compound was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625513,,BAO_0000019,,
12818,2448,Partition coefficient was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625514,,BAO_0000019,,
12819,12001,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625515,,BAO_0000100,,
12820,12426,partition coefficient of compound was determined,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625516,,BAO_0000100,,
12821,13204,The total body administered intravenously in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625517,,BAO_0000218,,
12822,13204,The total body administered intravenously in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625518,,BAO_0000218,,
12823,13889,Time taken for the administration to female NIH mice weighing 25-30 g.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625519,,BAO_0000218,,
12824,13889,Time taken for the administration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625520,,BAO_0000019,,
12825,17025,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL874651,,BAO_0000218,,
12826,17025,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625521,,BAO_0000218,,
12827,17025,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL623171,,BAO_0000218,,
12828,17025,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623853,,BAO_0000218,,
12829,15067,Plasma clearance for the compound was determined.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623854,,BAO_0000019,,
12830,3091,CLog P value of the compound,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874405,,BAO_0000100,,
12831,15592,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL623855,,BAO_0000100,,
12832,14738,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL623856,,BAO_0000100,,
12833,14738,ClogP value of the compound; nd ='no data',P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623857,,BAO_0000100,,
12834,14738,ClogP value of the compound; nd ='not determined',P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623858,,BAO_0000100,,
12835,6076,CLog P was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623859,,BAO_0000100,,
12836,17840,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL839829,,BAO_0000100,,
12837,13589,CLogP was calculated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623860,,BAO_0000019,,
12838,17655,CLogP value was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623861,,BAO_0000019,,
12839,5867,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623862,,BAO_0000019,,
12840,5867,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL874406,,BAO_0000100,,
12841,10783,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL623863,,BAO_0000100,,
12842,14849,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624021,,BAO_0000100,,
12843,8170,Distribution in female dog adrenal medulla 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL624022,,BAO_0000218,1236.0,
12844,8170,Distribution in female dog adrenal medulla 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Adrenal medulla,,,50588,N,1,Intermediate,1,,CHEMBL624023,,BAO_0000218,1236.0,
12845,8170,Distribution in female dog bile 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624024,,BAO_0000218,,
12846,8170,Distribution in female dog bile 72 hr after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624025,,BAO_0000218,,
12847,8170,Distribution in female dog blood 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624026,,BAO_0000218,,
12848,8170,Distribution in female dog blood 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624027,,BAO_0000218,,
12849,8170,Distribution in female dog heart 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624028,,BAO_0000218,,
12850,8170,Distribution in female dog heart 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624029,,BAO_0000218,,
12851,8170,Distribution in female dog kidney 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624030,,BAO_0000218,,
12852,8170,Distribution in female dog kidney 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624031,,BAO_0000218,,
12853,8170,Distribution in female dog large intestine 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Intestine,,,50588,N,1,Intermediate,1,,CHEMBL624032,,BAO_0000218,160.0,
12854,8170,Distribution in female dog large intestine 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Intestine,,,50588,N,1,Intermediate,1,,CHEMBL874407,,BAO_0000218,160.0,
12855,8170,Distribution in female dog liver 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624033,,BAO_0000218,,
12856,8170,Distribution in female dog liver 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624034,,BAO_0000218,,
12857,8170,Distribution in female dog lung 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624035,,BAO_0000218,,
12858,8170,Distribution in female dog lung 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624036,,BAO_0000218,,
12859,8170,Distribution in female dog muscle 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Muscle tissue,,,50588,N,1,Intermediate,1,,CHEMBL624037,,BAO_0000218,2385.0,
12860,8170,Distribution in female dog muscle 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Muscle tissue,,,50588,N,1,Intermediate,1,,CHEMBL624038,,BAO_0000218,2385.0,
12861,8170,Distribution in female dog pancreas 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624039,,BAO_0000218,,
12862,8170,Distribution in female dog pancreas 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624040,,BAO_0000218,,
12863,8170,Distribution in female dog small intestine 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Intestine,,,50588,N,1,Intermediate,1,,CHEMBL624041,,BAO_0000218,160.0,
12864,8170,Distribution in female dog small intestine 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Intestine,,,50588,N,1,Intermediate,1,,CHEMBL624042,,BAO_0000218,160.0,
12865,8170,Distribution in female dog spleen 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL624043,,BAO_0000218,2106.0,
12866,8170,Distribution in female dog spleen 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Spleen,,,50588,N,1,Intermediate,1,,CHEMBL624044,,BAO_0000218,2106.0,
12867,8170,Distribution in female dog stomach 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Stomach,,,50588,N,1,Intermediate,1,,CHEMBL624045,,BAO_0000218,945.0,
12868,8170,Distribution in female dog stomach 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Stomach,,,50588,N,1,Intermediate,1,,CHEMBL624046,,BAO_0000218,945.0,
12869,8170,Distribution in female dog thyroid 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Thyroid gland,,,50588,N,1,Intermediate,1,,CHEMBL624047,,BAO_0000218,2046.0,
12870,8170,Distribution in female dog thyroid 72 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Thyroid gland,,,50588,N,1,Intermediate,1,,CHEMBL624048,,BAO_0000218,2046.0,
12871,8170,Distribution in female dog urine 24 hours after administration.,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL874408,,BAO_0000218,1088.0,
12872,8170,Distribution in female dog urine 72 hr after administration.,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL624049,,BAO_0000218,1088.0,
12873,14283,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL624050,,BAO_0000218,1969.0,
12874,5623,Plasma concentration at 7 hr after intravenous dosing,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624051,,BAO_0000019,,
12875,13477,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623278,,BAO_0000218,,
12876,13477,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623279,,BAO_0000218,,
12877,13477,Plasma concentration of 3 mg/kg iv after 1 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623280,,BAO_0000218,,
12878,13477,Plasma concentration of 3 mg/kg iv after 2 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623963,,BAO_0000218,,
12879,13477,Plasma concentration of 3 mg/kg iv after 4 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623964,,BAO_0000218,,
12880,13477,Plasma concentration of 3 mg/kg iv after 6 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623965,,BAO_0000218,,
12881,13477,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623966,,BAO_0000218,,
12882,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874415,,BAO_0000218,,
12883,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623967,,BAO_0000218,,
12884,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623968,,BAO_0000218,,
12885,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623969,,BAO_0000218,,
12886,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628409,,BAO_0000218,,
12887,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628410,,BAO_0000218,,
12888,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628411,,BAO_0000218,,
12889,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628412,,BAO_0000218,,
12890,12553,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628413,,BAO_0000019,,
12891,14548,The concentration in plasmat; Not determined,A,,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL628414,,BAO_0000019,1969.0,
12892,14393,Tissue level at 10 mg/kg/po in wistar rats in blood,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628415,,BAO_0000218,,
12893,14393,Tissue level at 10 mg/kg/po in wistar rats in brown fat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628416,,BAO_0000218,,
12894,14393,Tissue level at 10 mg/kg/po in wistar rats in heart,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628417,,BAO_0000218,,
12895,14393,Tissue level at 10 mg/kg/po in wistar rats in liver,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL874908,,BAO_0000218,2107.0,
12896,14393,Tissue level at 10 mg/kg/po in wistar rats in plasma,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628418,,BAO_0000218,,
12897,14393,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL628419,,BAO_0000218,2385.0,
12898,14393,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628420,,BAO_0000218,,
12899,1629,Water solubility at 37 degree C.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628421,,BAO_0000019,,
12900,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626726,,BAO_0000100,,
12901,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626727,,BAO_0000100,,
12902,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626728,,BAO_0000218,178.0,
12903,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626729,,BAO_0000218,178.0,
12904,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626730,,BAO_0000218,178.0,
12905,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626731,,BAO_0000218,178.0,
12906,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL626732,,BAO_0000218,178.0,
12907,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626733,,BAO_0000218,948.0,
12908,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626734,,BAO_0000218,948.0,
12909,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626735,,BAO_0000218,948.0,
12910,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL874909,,BAO_0000218,948.0,
12911,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL626736,,BAO_0000218,948.0,
12912,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL626737,,BAO_0000218,2113.0,
12913,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630999,,BAO_0000218,2113.0,
12914,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631000,,BAO_0000218,2113.0,
12915,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631001,,BAO_0000218,2113.0,
12916,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631002,,BAO_0000218,2113.0,
12917,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631003,,BAO_0000218,2107.0,
12918,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631004,,BAO_0000218,2107.0,
12919,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631005,,BAO_0000218,2107.0,
12920,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631006,,BAO_0000218,2107.0,
12921,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631007,,BAO_0000218,2107.0,
12922,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL631008,,BAO_0000218,2048.0,
12923,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL631009,,BAO_0000218,2048.0,
12924,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL631010,,BAO_0000218,2048.0,
12925,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL631011,,BAO_0000218,2048.0,
12926,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL631012,,BAO_0000218,2048.0,
12927,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630271,,BAO_0000218,2046.0,
12928,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630272,,BAO_0000218,2046.0,
12929,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630273,,BAO_0000218,2046.0,
12930,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630274,,BAO_0000218,2046.0,
12931,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630275,,BAO_0000218,2046.0,
12932,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875782,,BAO_0000218,,
12933,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630276,,BAO_0000218,,
12934,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630277,,BAO_0000218,,
12935,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630278,,BAO_0000218,,
12936,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630279,,BAO_0000218,,
12937,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630280,,BAO_0000019,,
12938,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630281,,BAO_0000019,,
12939,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630282,,BAO_0000218,,
12940,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630283,,BAO_0000218,,
12941,5797,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630284,,BAO_0000019,,
12942,7849,Alkylating activity was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630285,,BAO_0000019,,
12943,14220,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),A,,,,,,,,Microsomes,22224,U,0,Autocuration,1,,CHEMBL630286,,BAO_0000251,,
12944,8650,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630069,,BAO_0000218,,
12945,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630070,,BAO_0000218,,
12946,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630071,,BAO_0000218,,
12947,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL630072,,BAO_0000218,,
12948,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL875110,,BAO_0000218,,
12949,7116,Compound was tested for antidiuretic activity in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630073,,BAO_0000218,,
12950,14131,Compound was tested for inactivation kinetic values,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630074,,BAO_0000019,,
12951,7415,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630075,,BAO_0000218,,
12952,13178,Dissociation rate calculated from the first-order equation using the t1/2 value,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630076,,BAO_0000019,,
12953,8815,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL630077,,BAO_0000100,,
12954,1450,Aqueous solubility was measured,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL630078,,BAO_0000100,,
12955,1450,Aqueous solubility was measured at a pH 4,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL630079,,BAO_0000100,,
12956,1450,Aqueous solubility (pH 7),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL630080,,BAO_0000100,,
12957,1450,Aqueous solubility was measured at a pH 9,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL630081,,BAO_0000100,,
12958,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630082,,BAO_0000019,,
12959,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630083,,BAO_0000019,,
12960,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630084,,BAO_0000019,,
12961,15032,Aqueous solubility of the compound,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL629198,,BAO_0000100,,
12962,9964,Aqueous solubility at 37 degree Celsius at pH 7.38,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL629199,,BAO_0000100,,
12963,14962,Aqueous solubility in pH 7.4 phosphate buffer,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL629200,,BAO_0000100,,
12964,12487,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629201,,BAO_0000218,,
12965,12487,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629202,,BAO_0000218,,
12966,10026,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL875111,,BAO_0000218,,
12967,10026,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL629203,,BAO_0000218,,
12968,10026,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL629204,,BAO_0000218,,
12969,10026,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL629205,,BAO_0000218,,
12970,10026,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL629206,,BAO_0000218,,
12971,10026,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631185,,BAO_0000019,,
12972,7415,Compound was evaluated for the average bile flow rat in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631186,,BAO_0000218,,
12973,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL631187,,BAO_0000218,,
12974,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",A,,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL631188,,BAO_0000218,,
12975,10184,Average half life period was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL876419,,BAO_0000019,,
12976,10184,Average half life period was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631189,,BAO_0000019,,
12977,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL631190,,BAO_0000218,,
12978,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL631191,,BAO_0000218,,
12979,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL631192,,BAO_0000218,,
12980,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632400,,BAO_0000218,,
12981,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL630564,,BAO_0000218,,
12982,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL630565,,BAO_0000218,,
12983,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL630566,,BAO_0000218,,
12984,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL631229,,BAO_0000218,,
12985,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL631230,,BAO_0000218,,
12986,6030,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL876428,,BAO_0000100,,
12987,6147,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631231,,BAO_0000100,,
12988,14556,Calculated partition coefficient (clogP) (MacLogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631232,,BAO_0000100,,
12989,768,Hydrophilicity was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631233,,BAO_0000019,,
12990,14452,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631234,,BAO_0000100,,
12991,5237,Increased absorption was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL883126,,BAO_0000019,,
12992,14378,Lipophilicity value was evaluated,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631235,,BAO_0000100,,
12993,14418,Log P value of the compound.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631236,,BAO_0000100,,
12994,5249,Partition coefficient of compound was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631237,,BAO_0000019,,
12995,14621,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631238,,BAO_0000100,,
12996,12542,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL876429,,BAO_0000100,,
12997,12542,Partition coefficient was measured by medchem software; Not calculated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631414,,BAO_0000019,,
12998,12542,Partition coefficient was measured by octanol-water using standard shake-flask method,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631415,,BAO_0000100,,
12999,15462,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631416,,BAO_0000100,,
13000,14884,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631417,,BAO_0000019,,
13001,16526,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631418,,BAO_0000100,,
13002,13693,The Octanol/Water partition coefficient CLogP,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631419,,BAO_0000100,,
13003,13693,The pharmacokinetic parameter C Log p was reported,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631420,,BAO_0000019,,
13004,13779,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631421,,BAO_0000100,,
13005,14772,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631422,,BAO_0000100,,
13006,14393,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL631423,,BAO_0000100,,
13007,14793,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL876430,,BAO_0000218,1969.0,
13008,14793,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL631424,,BAO_0000218,1969.0,
13009,13744,Compound was administered intravenously in dog to evaluate plasma clearance values,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL631425,,BAO_0000218,1969.0,
13010,13744,Compound was administered intravenously in monkey to evaluate plasma clearance values,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL631426,,BAO_0000218,1969.0,
13011,13744,Compound was administered intravenously in mouse to evaluate plasma clearance values,A,In vivo,,Mus musculus,10090.0,,Plasma,,,50594,N,1,Intermediate,1,,CHEMBL631427,,BAO_0000218,1969.0,
13012,13207,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL631428,,BAO_0000218,1969.0,
13013,5669,Intrinsic clearance in Rhesus liver microsome,A,In vitro,,Macaca mulatta,9544.0,,Liver,,Microsomes,50797,N,1,Intermediate,1,,CHEMBL631429,,BAO_0000218,2107.0,
13014,5669,Intrinsic clearance in dog liver microsome,A,In vitro,,Canis lupus familiaris,9615.0,,Liver,,Microsomes,50588,N,1,Intermediate,1,,CHEMBL631430,,BAO_0000218,2107.0,
13015,5669,Intrinsic clearance in rat liver microsome,A,In vitro,,Rattus norvegicus,10116.0,,Liver,,Microsomes,50597,N,1,Intermediate,1,,CHEMBL631431,,BAO_0000218,2107.0,
13016,4853,Low plasma clearance was calculated in rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,Plasma,,,50797,N,1,Intermediate,1,,CHEMBL631432,,BAO_0000218,1969.0,
13017,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631433,,BAO_0000218,,
13018,11954,Plasma clearance after intravenous dose of 0.3 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631434,,BAO_0000218,,
13019,11954,Plasma clearance after intravenous dose of 1 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631435,,BAO_0000218,,
13020,11954,Plasma clearance after intravenous dose of 3 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631436,,BAO_0000218,,
13021,11954,Plasma clearance after intravenous dose of 3.87 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631437,,BAO_0000218,,
13022,5669,Plasma clearance after peroral administration at 10 mpk in Rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631438,,BAO_0000218,,
13023,5669,Plasma clearance after peroral administration at 10 mpk in Rhesus,A,In vivo,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL876431,,BAO_0000218,,
13024,5669,Plasma clearance after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631439,,BAO_0000218,,
13025,13662,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631440,,BAO_0000218,,
13026,8272,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631441,,BAO_0000019,,
13027,13410,Critical Micellar concentration was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631442,,BAO_0000019,,
13028,13410,Critical Micellar concentration of the compound. was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626525,,BAO_0000019,,
13029,12628,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627168,,BAO_0000019,,
13030,9675,Critical micellar concentration was measured in water by the dye solubilization method,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875618,,BAO_0000019,,
13031,12628,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626612,,BAO_0000019,,
13032,12766,CMR value (relative to BAY K 8644),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626613,,BAO_0000019,,
13033,7849,Carbamoylating activity was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626614,,BAO_0000019,,
13034,12187,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,A,,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626615,,BAO_0000218,,
13035,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626616,,BAO_0000019,,
13036,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626617,,BAO_0000019,,
13037,14180,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626618,,BAO_0000218,1969.0,
13038,14180,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626619,,BAO_0000218,1969.0,
13039,14474,"Clearance rate at 0.46 mg/kg, iv, in dogs",A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626620,,BAO_0000218,,
13040,14474,"Clearance rate at 5.5 mg/kg, iv, in rat",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626621,,BAO_0000218,,
13041,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL626622,,BAO_0000218,,
13042,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL626623,,BAO_0000218,,
13043,14548,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626624,,BAO_0000218,,
13044,14548,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626625,,BAO_0000218,,
13045,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,A,Ex vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL626626,,BAO_0000218,2107.0,
13046,6874,Tested for the total clearance of the compound,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626627,,BAO_0000218,,
13047,15343,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626628,,BAO_0000218,,
13048,6236,Total body clearance was determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626629,,BAO_0000218,,
13049,11510,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626630,,BAO_0000218,,
13050,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626631,,BAO_0000218,,
13051,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626632,,BAO_0000100,,
13052,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626633,,BAO_0000100,,
13053,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626634,,BAO_0000100,,
13054,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626635,,BAO_0000100,,
13055,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626636,,BAO_0000100,,
13056,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626637,,BAO_0000100,,
13057,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL626638,,BAO_0000218,,
13058,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL626639,,BAO_0000218,,
13059,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL626640,,BAO_0000218,,
13060,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL626641,,BAO_0000218,,
13061,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL627272,,BAO_0000218,,
13062,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL627273,,BAO_0000218,,
13063,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL627441,,BAO_0000218,,
13064,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL628355,,BAO_0000218,,
13065,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL628356,,BAO_0000218,,
13066,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL628357,,BAO_0000218,,
13067,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL628358,,BAO_0000218,,
13068,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),A,,,Pneumocystis carinii,4754.0,,,,,50339,N,1,Intermediate,1,,CHEMBL622307,,BAO_0000218,,
13069,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622527,,BAO_0000019,,
13070,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622528,,BAO_0000019,,
13071,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622529,,BAO_0000019,,
13072,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622992,,BAO_0000019,,
13073,13118,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622993,,BAO_0000019,,
13074,13118,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622994,,BAO_0000019,,
13075,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622995,,BAO_0000218,,
13076,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622996,,BAO_0000218,,
13077,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622997,,BAO_0000218,,
13078,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622998,,BAO_0000218,,
13079,5767,Cp max following ip administration at 1 mg/kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622999,,BAO_0000218,,
13080,3302,Maximum concentration in plasma was reported at 0.5 hour,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623000,,BAO_0000218,1969.0,
13081,3302,Maximum concentration in plasma was reported at 2 hour,A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL623001,,BAO_0000218,1969.0,
13082,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL623002,,BAO_0000218,,
13083,11778,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL623003,,BAO_0000100,,
13084,4321,Steady state concentration was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623004,,BAO_0000019,,
13085,14884,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623005,,BAO_0000019,,
13086,15234,Partition coefficient (logD7.4),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623006,,BAO_0000019,,
13087,14198,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623007,,BAO_0000218,2107.0,
13088,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL623008,,BAO_0000218,10000001.0,
13089,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL876654,,BAO_0000218,2037.0,
13090,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623009,,BAO_0000218,,
13091,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623010,,BAO_0000218,,
13092,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623011,,BAO_0000218,948.0,
13093,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL623012,,BAO_0000218,160.0,
13094,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623013,,BAO_0000019,,
13095,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623014,,BAO_0000019,,
13096,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623015,,BAO_0000019,1088.0,
13097,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL623016,,BAO_0000019,1088.0,
13098,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL624858,,BAO_0000019,1088.0,
13099,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624859,,BAO_0000218,,
13100,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624860,,BAO_0000218,,
13101,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624861,,BAO_0000218,,
13102,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624862,,BAO_0000218,,
13103,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624863,,BAO_0000218,,
13104,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876655,,BAO_0000218,,
13105,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624864,,BAO_0000218,,
13106,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624865,,BAO_0000218,,
13107,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624866,,BAO_0000218,,
13108,6996,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,F,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Expert,1,,CHEMBL624867,,BAO_0000218,,
13109,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL624868,,BAO_0000218,,
13110,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628450,,BAO_0000218,,
13111,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628451,,BAO_0000218,,
13112,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628452,,BAO_0000218,,
13113,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628453,,BAO_0000218,,
13114,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628454,,BAO_0000218,,
13115,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628455,,BAO_0000218,,
13116,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628456,,BAO_0000218,,
13117,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628457,,BAO_0000218,,
13118,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL877505,,BAO_0000218,,
13119,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628458,,BAO_0000218,,
13120,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628459,,BAO_0000218,,
13121,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628460,,BAO_0000218,,
13122,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628461,,BAO_0000218,,
13123,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628462,,BAO_0000218,,
13124,6996,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628463,,BAO_0000218,,
13125,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",F,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL625666,,BAO_0000218,,
13126,6996,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625667,,BAO_0000218,,
13127,6996,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Expert,1,,CHEMBL625668,,BAO_0000218,,
13128,6996,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625669,,BAO_0000218,,
13129,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625670,,BAO_0000019,,
13130,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625671,,BAO_0000218,,
13131,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL625672,,BAO_0000218,,
13132,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL625673,,BAO_0000218,,
13133,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL625674,,BAO_0000218,,
13134,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL625675,,BAO_0000218,,
13135,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627637,,BAO_0000218,,
13136,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627638,,BAO_0000218,,
13137,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627639,,BAO_0000218,,
13138,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627640,,BAO_0000218,,
13139,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627641,,BAO_0000218,,
13140,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL627642,,BAO_0000218,,
13141,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL877506,,BAO_0000218,,
13142,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627275,,BAO_0000218,,
13143,11219,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL627643,,BAO_0000218,,
13144,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL631246,,BAO_0000218,,
13145,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL631247,,BAO_0000218,,
13146,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL629532,,BAO_0000218,,
13147,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL629533,,BAO_0000218,,
13148,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL629534,,BAO_0000218,,
13149,11219,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,A,,,Mustela putorius furo,9669.0,,,,,50506,N,1,Intermediate,1,,CHEMBL629535,,BAO_0000218,,
13150,14837,Pharmacokinetic parameter :drug bound to plasma was reported,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625932,,BAO_0000019,,
13151,14837,compound was evaluated for drug bound in plasma,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625933,,BAO_0000019,,
13152,15343,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625934,,BAO_0000218,,
13153,13761,Bioavailability,A,,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625935,,BAO_0000218,,
13154,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625936,,BAO_0000218,,
13155,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625937,,BAO_0000218,,
13156,13249,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625938,,BAO_0000218,,
13157,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL625939,,BAO_0000218,1970.0,
13158,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL625940,,BAO_0000218,1970.0,
13159,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL874464,,BAO_0000218,1970.0,
13160,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL625941,,BAO_0000218,1970.0,
13161,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL625942,,BAO_0000218,1970.0,
13162,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,A,,,Rattus norvegicus,10116.0,,Bile,,,50597,N,1,Intermediate,1,,CHEMBL625943,,BAO_0000218,1970.0,
13163,15549,In vitro protein binding in human serum at 5 ug/ml,A,,,Homo sapiens,9606.0,,Serum,,,50587,N,1,Intermediate,1,,CHEMBL625944,,BAO_0000218,1977.0,
13164,10929,Serum protein binding ability was measured,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625945,,BAO_0000019,,
13165,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625946,,BAO_0000019,,
13166,12860,Oral bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625947,,BAO_0000218,,
13167,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625948,,BAO_0000218,,
13168,15173,Absolute oral bioavailability at an iv dose of 14 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625949,,BAO_0000218,,
13169,15173,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625950,,BAO_0000218,,
13170,15173,Oral bioavailability (dose 15 mg/kg i.v.),A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625951,,BAO_0000218,,
13171,15173,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625952,,BAO_0000218,,
13172,15173,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625953,,BAO_0000218,,
13173,15173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625954,,BAO_0000218,,
13174,15173,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL882959,,BAO_0000218,,
13175,11767,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625955,,BAO_0000218,,
13176,11219,Bioavailability in ferret,A,In vivo,,Mustela putorius furo,9669.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625956,,BAO_0000218,,
13177,12186,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL625957,,BAO_0000218,,
13178,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625958,,BAO_0000218,,
13179,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625959,,BAO_0000218,,
13180,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626642,,BAO_0000218,,
13181,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631330,,BAO_0000218,,
13182,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631331,,BAO_0000218,,
13183,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631332,,BAO_0000218,,
13184,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631333,,BAO_0000218,,
13185,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632018,,BAO_0000218,,
13186,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632019,,BAO_0000218,,
13187,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632020,,BAO_0000218,,
13188,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632021,,BAO_0000218,,
13189,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632022,,BAO_0000218,,
13190,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632023,,BAO_0000218,,
13191,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632024,,BAO_0000218,,
13192,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874472,,BAO_0000218,,
13193,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632025,,BAO_0000218,,
13194,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632026,,BAO_0000218,,
13195,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632027,,BAO_0000218,,
13196,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632028,,BAO_0000218,,
13197,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626430,,BAO_0000218,,
13198,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626431,,BAO_0000218,,
13199,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626432,,BAO_0000218,,
13200,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626433,,BAO_0000218,,
13201,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626434,,BAO_0000218,,
13202,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627280,,BAO_0000218,,
13203,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627281,,BAO_0000218,,
13204,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627282,,BAO_0000218,,
13205,7199,Total body clearance was measured at given dose,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627283,,BAO_0000019,,
13206,7199,Total body clearance was measured at given dose.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627284,,BAO_0000218,,
13207,7095,Metabolic clearance from the body in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627285,,BAO_0000218,,
13208,7095,Renal clearance from the body,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627286,,BAO_0000218,,
13209,7095,Renal clearance from the body in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875477,,BAO_0000218,,
13210,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627287,,BAO_0000218,,
13211,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627288,,BAO_0000218,,
13212,7095,Total clearance from the body in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627289,,BAO_0000218,,
13213,14223,Clearance into cortex from rat plasma or PBS,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627290,,BAO_0000218,1969.0,
13214,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627291,,BAO_0000218,,
13215,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627292,,BAO_0000218,,
13216,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627293,,BAO_0000218,,
13217,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627294,,BAO_0000218,,
13218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875478,,BAO_0000218,,
13219,13979,Clearance was determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627295,,BAO_0000218,,
13220,14315,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627296,,BAO_0000218,,
13221,14315,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,A,In vivo,,Oryctolagus cuniculus,9986.0,,,,,50592,N,1,Intermediate,1,,CHEMBL626119,,BAO_0000218,,
13222,14315,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626120,,BAO_0000218,,
13223,12174,Clearance in rat after iv dose (100 ug/kg),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626121,,BAO_0000218,,
13224,12797,Clearance in guinea pig,A,In vivo,,Cavia porcellus,10141.0,,,,,22224,U,0,Autocuration,1,,CHEMBL626122,,BAO_0000218,,
13225,12797,Compound was evaluated for clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626123,,BAO_0000218,,
13226,12797,Compound was evaluated for the clearance in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL623456,,BAO_0000218,,
13227,12797,Compound was evaluated for the clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623457,,BAO_0000218,,
13228,11500,Compound was tested in vivo for clearance after iv administration in the rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623458,,BAO_0000218,,
13229,15173,IV clearance determined at an iv dose of 14 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623459,,BAO_0000218,,
13230,15173,IV clearance determined at an iv dose of 15.2 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875484,,BAO_0000218,,
13231,15173,IV clearance determined at an iv dose of 15 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623460,,BAO_0000218,,
13232,15173,IV clearance determined at an peroral dose of 30 mg/kg.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623461,,BAO_0000218,,
13233,15173,IV clearance determined at an peroral dose of 30.2 mg/kg.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623462,,BAO_0000218,,
13234,15173,IV clearance determined at an peroral dose of 30.3 mg/kg.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627386,,BAO_0000218,,
13235,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627387,,BAO_0000218,2113.0,
13236,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627388,,BAO_0000218,2107.0,
13237,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627389,,BAO_0000218,2048.0,
13238,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627390,,BAO_0000218,2385.0,
13239,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627391,,BAO_0000218,1969.0,
13240,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627392,,BAO_0000218,,
13241,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL627393,,BAO_0000218,2106.0,
13242,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Trachea,,,50597,N,1,Intermediate,1,,CHEMBL627394,,BAO_0000218,3126.0,
13243,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627395,,BAO_0000218,10000001.0,
13244,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL875485,,BAO_0000218,2037.0,
13245,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627396,,BAO_0000218,,
13246,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627397,,BAO_0000218,,
13247,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL627398,,BAO_0000218,948.0,
13248,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL627399,,BAO_0000218,10000001.0,
13249,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627400,,BAO_0000218,2113.0,
13250,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627401,,BAO_0000218,2107.0,
13251,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627402,,BAO_0000218,2048.0,
13252,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL627403,,BAO_0000218,2385.0,
13253,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL627404,,BAO_0000218,1969.0,
13254,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623101,,BAO_0000218,,
13255,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL877480,,BAO_0000218,2106.0,
13256,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Trachea,,,50597,N,1,Intermediate,1,,CHEMBL623102,,BAO_0000218,3126.0,
13257,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL623103,,BAO_0000218,10000001.0,
13258,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL623104,,BAO_0000218,2037.0,
13259,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623105,,BAO_0000218,,
13260,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623106,,BAO_0000218,,
13261,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL623107,,BAO_0000218,948.0,
13262,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL623108,,BAO_0000218,160.0,
13263,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL623109,,BAO_0000218,2113.0,
13264,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL623110,,BAO_0000218,2107.0,
13265,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL623111,,BAO_0000218,2048.0,
13266,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625060,,BAO_0000218,2385.0,
13267,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625061,,BAO_0000218,1969.0,
13268,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625062,,BAO_0000218,,
13269,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625063,,BAO_0000218,2106.0,
13270,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Trachea,,,50597,N,1,Intermediate,1,,CHEMBL625064,,BAO_0000218,3126.0,
13271,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Bone,,,50597,N,1,Intermediate,1,,CHEMBL625065,,BAO_0000218,10000001.0,
13272,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL625066,,BAO_0000218,2037.0,
13273,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625067,,BAO_0000218,,
13274,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625068,,BAO_0000218,,
13275,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL622159,,BAO_0000218,948.0,
13276,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Intestine,,,50597,N,1,Intermediate,1,,CHEMBL622160,,BAO_0000218,160.0,
13277,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL622161,,BAO_0000218,2113.0,
13278,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL622162,,BAO_0000218,2048.0,
13279,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL622163,,BAO_0000218,2385.0,
13280,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622313,,BAO_0000218,1969.0,
13281,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622314,,BAO_0000218,,
13282,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622315,,BAO_0000218,2106.0,
13283,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,A,In vivo,,Rattus norvegicus,10116.0,,Trachea,,,50597,N,1,Intermediate,1,,CHEMBL622316,,BAO_0000218,3126.0,
13284,15599,Normal diffusion coefficient in water for Escherichia coli,A,,,Escherichia coli,562.0,,,,,50212,N,1,Intermediate,1,,CHEMBL877486,,BAO_0000218,,
13285,8204,Average max percent decrease in RVR (renal vascular resistance) was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622317,,BAO_0000019,,
13286,8204,Average max percent decrease in RVR (renal vascular resistance) was determined.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622318,,BAO_0000019,,
13287,6154,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622319,,BAO_0000019,,
13288,6154,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622320,,BAO_0000019,,
13289,6154,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622321,,BAO_0000019,,
13290,6154,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622322,,BAO_0000019,,
13291,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622323,,BAO_0000019,,
13292,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622324,,BAO_0000218,,
13293,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622325,,BAO_0000218,1088.0,
13294,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622326,,BAO_0000218,1088.0,
13295,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL877487,,BAO_0000218,1088.0,
13296,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622327,,BAO_0000218,1088.0,
13297,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622328,,BAO_0000218,1088.0,
13298,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622329,,BAO_0000218,1088.0,
13299,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622330,,BAO_0000218,1088.0,
13300,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622331,,BAO_0000218,1088.0,
13301,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622332,,BAO_0000218,1088.0,
13302,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622333,,BAO_0000218,1088.0,
13303,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL627658,,BAO_0000218,1088.0,
13304,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630428,,BAO_0000218,1088.0,
13305,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630429,,BAO_0000218,1088.0,
13306,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630430,,BAO_0000218,1088.0,
13307,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630431,,BAO_0000218,1088.0,
13308,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL630432,,BAO_0000218,1088.0,
13309,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL630433,,BAO_0000218,1088.0,
13310,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL630434,,BAO_0000218,1088.0,
13311,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629372,,BAO_0000218,1088.0,
13312,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629553,,BAO_0000218,1088.0,
13313,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629554,,BAO_0000218,1088.0,
13314,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL874447,,BAO_0000218,1088.0,
13315,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629555,,BAO_0000218,1088.0,
13316,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629556,,BAO_0000218,1088.0,
13317,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629557,,BAO_0000218,1088.0,
13318,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629558,,BAO_0000218,1088.0,
13319,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629559,,BAO_0000218,1088.0,
13320,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629560,,BAO_0000218,1088.0,
13321,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629561,,BAO_0000218,1088.0,
13322,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629562,,BAO_0000218,1088.0,
13323,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629563,,BAO_0000218,1088.0,
13324,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629564,,BAO_0000218,1088.0,
13325,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629565,,BAO_0000218,1088.0,
13326,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629566,,BAO_0000218,1088.0,
13327,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629567,,BAO_0000218,1088.0,
13328,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629568,,BAO_0000218,1088.0,
13329,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629569,,BAO_0000218,1088.0,
13330,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL629570,,BAO_0000218,1088.0,
13331,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL629571,,BAO_0000218,1088.0,
13332,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629572,,BAO_0000218,,
13333,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629573,,BAO_0000218,,
13334,4985,Bioavailability (dose 20 mg/kg),A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629574,,BAO_0000218,,
13335,15145,Bioavailability in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629575,,BAO_0000218,,
13336,14080,Bioavailability in rat (Sprague-Dawley) (male),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL874448,,BAO_0000218,,
13337,11219,Bioavailability in monkey (dose 10 mg/kg i.d.),A,In vivo,,Primates,9443.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629576,,BAO_0000218,,
13338,15145,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629577,,BAO_0000218,,
13339,15145,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629578,,BAO_0000218,,
13340,1202,Bioavailability in dog (dose 3.0 mg/kg p.o.),A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629579,,BAO_0000218,,
13341,1202,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL882958,,BAO_0000218,,
13342,1202,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,A,In vivo,,Pan troglodytes,9598.0,,,,,50505,N,1,Intermediate,1,,CHEMBL629580,,BAO_0000218,,
13343,4026,Bioavailability,A,In vivo,,Eutheria,9347.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629581,,BAO_0000218,,
13344,1492,Bioavailability in squirrel monkey,A,In vivo,,Saimiri,9520.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629582,,BAO_0000218,,
13345,12793,Bioavailability was evaluated in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628522,,BAO_0000218,,
13346,12793,Bioavailability was evaluated in hamster,A,In vivo,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL625432,,BAO_0000218,,
13347,12793,Bioavailability in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625433,,BAO_0000218,,
13348,14793,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625434,,BAO_0000218,1969.0,
13349,14793,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL625435,,BAO_0000218,1969.0,
13350,14793,Bioavailability in rat (dose 10 mg/kg p.o.),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625436,,BAO_0000218,,
13351,14731,Bioavailability was measured in cynomolgus monkeys.,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL874588,,BAO_0000218,,
13352,14731,Bioavailability was measured in nude mice.,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625437,,BAO_0000218,,
13353,12187,Bioavailability in ferret (dose 10 mg/kg i.d.),A,In vivo,,Mustela putorius furo,9669.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625438,,BAO_0000218,,
13354,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625439,,BAO_0000218,,
13355,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625440,,BAO_0000218,,
13356,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),A,In vivo,,Simiiformes,314293.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625441,,BAO_0000218,,
13357,12187,Bioavailability in rat (dose 10 mg/kg i.d.),A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625442,,BAO_0000218,,
13358,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625443,,BAO_0000218,,
13359,17431,Bioavailability was determined; extremely poor,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625444,,BAO_0000218,,
13360,13318,% bioavailability in mice after oral administration of prodrug,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625445,,BAO_0000218,,
13361,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625446,,BAO_0000218,,
13362,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL882960,,BAO_0000218,,
13363,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625447,,BAO_0000218,,
13364,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625448,,BAO_0000218,,
13365,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625449,,BAO_0000218,,
13366,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL874589,,BAO_0000218,,
13367,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625450,,BAO_0000218,,
13368,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625451,,BAO_0000218,,
13369,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626584,,BAO_0000218,,
13370,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626585,,BAO_0000218,,
13371,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626586,,BAO_0000218,,
13372,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626587,,BAO_0000218,,
13373,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626588,,BAO_0000218,,
13374,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626589,,BAO_0000218,,
13375,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626590,,BAO_0000218,,
13376,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626591,,BAO_0000218,,
13377,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL627181,,BAO_0000218,,
13378,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628083,,BAO_0000218,,
13379,15173,IV clearance determined at an peroral dose of 15 mg/kg.,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628084,,BAO_0000218,,
13380,7732,Mouse oral clearance was measured against Hymenolepiasis nana.,F,In vivo,,Hymenolepis nana,102285.0,,,,,50064,N,1,Expert,1,,CHEMBL628085,,BAO_0000218,,
13381,7732,Mouse oral clearance was measured against Nematospiroides dubius,F,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Expert,1,,CHEMBL628086,,BAO_0000218,,
13382,7732,Mouse oral clearance was measured against N. dubius; NT is Not Tested,F,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628087,,BAO_0000218,,
13383,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628088,,BAO_0000218,,
13384,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,B,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628089,,BAO_0000218,,
13385,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628090,,BAO_0000218,,
13386,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628091,,BAO_0000218,,
13387,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628092,,BAO_0000218,,
13388,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628093,,BAO_0000218,,
13389,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875607,,BAO_0000218,,
13390,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625710,,BAO_0000218,,
13391,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625711,,BAO_0000218,,
13392,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625712,,BAO_0000218,,
13393,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625713,,BAO_0000218,,
13394,13376,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625714,,BAO_0000218,,
13395,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,A,In vivo,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL625715,,BAO_0000218,,
13396,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625716,,BAO_0000218,,
13397,13477,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625717,,BAO_0000218,,
13398,13313,Plasma clearance was determined for the compound in rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625718,,BAO_0000218,,
13399,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625719,,BAO_0000218,,
13400,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625720,,BAO_0000218,,
13401,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625721,,BAO_0000218,,
13402,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625722,,BAO_0000218,,
13403,13129,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625723,,BAO_0000218,,
13404,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,A,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Intermediate,1,,CHEMBL625724,,BAO_0000218,,
13405,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,A,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Intermediate,1,,CHEMBL625725,,BAO_0000218,,
13406,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,A,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Intermediate,1,,CHEMBL625726,,BAO_0000218,,
13407,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,A,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Intermediate,1,,CHEMBL875608,,BAO_0000218,,
13408,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,A,In vivo,,Heligmosomoides polygyrus,6339.0,,,,,50545,N,1,Intermediate,1,,CHEMBL625727,,BAO_0000218,,
13409,9278,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,A,In vivo,,Rattus norvegicus,10116.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL625728,,BAO_0000218,1088.0,
13410,9278,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625729,,BAO_0000218,,
13411,9278,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL625730,,BAO_0000218,,
13412,9278,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,A,In vivo,,Rattus norvegicus,10116.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL625731,,BAO_0000218,1088.0,
13413,9278,Urinary clearance was determined in rat at 25 mg/kg os dosage,A,In vivo,,Rattus norvegicus,10116.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL626417,,BAO_0000218,1088.0,
13414,9278,Urinary clearance was determined at 100 mg/kg oral dosage in human,A,In vivo,,Homo sapiens,9606.0,,Urine,,,50587,N,1,Intermediate,1,,CHEMBL626418,,BAO_0000218,1088.0,
13415,9278,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,A,In vivo,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL626419,,BAO_0000218,1088.0,
13416,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626592,,BAO_0000218,1969.0,
13417,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626593,,BAO_0000218,1969.0,
13418,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626594,,BAO_0000218,,
13419,10499,Clearance rate in dogs,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625035,,BAO_0000218,,
13420,6051,Compound was measured for intrinsic clearance,A,In vitro,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625036,,BAO_0000019,,
13421,17508,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625037,,BAO_0000100,,
13422,6228,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625038,,BAO_0000100,,
13423,6231,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625039,,BAO_0000100,,
13424,17740,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625040,,BAO_0000100,,
13425,6495,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625041,,BAO_0000100,,
13426,2171,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625042,,BAO_0000100,,
13427,3255,Partition coefficient of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874411,,BAO_0000019,,
13428,6821,Permeability,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625043,,BAO_0000019,,
13429,2685,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625044,,BAO_0000100,,
13430,17584,Partition coefficient (logD),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625045,,BAO_0000019,,
13431,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625046,,BAO_0000100,,
13432,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625047,,BAO_0000100,,
13433,16479,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625048,,BAO_0000100,,
13434,11997,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625049,,BAO_0000100,,
13435,2988,Calculated logarithm of partition coefficient (P) was determined,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625050,,BAO_0000100,,
13436,931,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625051,,BAO_0000100,,
13437,4381,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL874412,,BAO_0000100,,
13438,4397,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625052,,BAO_0000100,,
13439,5889,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL625053,,BAO_0000100,,
13440,6154,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623250,,BAO_0000019,,
13441,6154,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623251,,BAO_0000019,,
13442,6154,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623252,,BAO_0000019,,
13443,6154,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623253,,BAO_0000019,,
13444,6154,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623254,,BAO_0000019,,
13445,6154,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623255,,BAO_0000019,,
13446,6887,Percent degradation of compound at a pH of 1 over a 18 hr period,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626831,,BAO_0000019,,
13447,6887,Percent degradation of compound at pH of 1 over an 18 hr period,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877494,,BAO_0000019,,
13448,14116,Delta Logarithm of Partition Coefficient value was determined.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626832,,BAO_0000019,,
13449,11137,Delta logPoct-cyc,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626833,,BAO_0000019,,
13450,7230,Lipophilicity estimated on reversed phase TLC,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626834,,BAO_0000100,,
13451,15741,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626835,,BAO_0000019,,
13452,9663,Delta logPoct-cyc,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626836,,BAO_0000019,,
13453,9663,Change in logarithm of partition coefficient of the compound,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626837,,BAO_0000100,,
13454,13807,Delta logD (pH 6.5),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626838,,BAO_0000019,,
13455,13807,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626839,,BAO_0000100,,
13456,17425,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626840,,BAO_0000019,,
13457,12143,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626841,,BAO_0000019,,
13458,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626842,,BAO_0000219,,
13459,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626843,,BAO_0000219,,
13460,8649,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626844,,BAO_0000218,,
13461,8649,Amount of deuterium retained was reported after normal workup in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL877495,,BAO_0000218,,
13462,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626845,,BAO_0000218,,
13463,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626846,,BAO_0000218,,
13464,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626847,,BAO_0000218,,
13465,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628677,,BAO_0000218,,
13466,8649,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628678,,BAO_0000218,,
13467,9659,Compound was subjected to electrochemical oxidation,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628679,,BAO_0000019,,
13468,9659,Compound was subjected to photochemical oxidation,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628680,,BAO_0000019,,
13469,9659,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628681,,BAO_0000019,,
13470,9659,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628682,,BAO_0000019,,
13471,9659,Oxidation of compound by methemoglobin in presence of hydroperoxide,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628683,,BAO_0000019,,
13472,9607,Percent diffusion through fuzzy rat skin after 48 h of incubation,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628684,,BAO_0000218,,
13473,7057,Dissociation constant (pKa),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL877501,,BAO_0000100,,
13474,7057,Dissociation constant value of the compound; ND means not determined.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628685,,BAO_0000100,,
13475,7911,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628686,,BAO_0000218,178.0,
13476,7911,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL628687,,BAO_0000218,178.0,
13477,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628688,,BAO_0000218,,
13478,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628689,,BAO_0000218,,
13479,7911,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628690,,BAO_0000218,2107.0,
13480,7911,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL629363,,BAO_0000218,2107.0,
13481,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL629364,,BAO_0000218,2106.0,
13482,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL629365,,BAO_0000218,2106.0,
13483,7911,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629366,,BAO_0000218,,
13484,7911,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629367,,BAO_0000218,1088.0,
13485,7911,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL629368,,BAO_0000218,1988.0,
13486,7911,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL877502,,BAO_0000218,1088.0,
13487,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,A,,,Mus musculus,10090.0,,Cerebellum,,,50594,N,1,Intermediate,1,,CHEMBL629369,,BAO_0000218,2037.0,
13488,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL629370,,BAO_0000218,955.0,
13489,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL629371,,BAO_0000218,1088.0,
13490,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL626276,,BAO_0000218,1088.0,
13491,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL626277,,BAO_0000218,1088.0,
13492,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL631250,,BAO_0000218,1088.0,
13493,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631251,,BAO_0000218,1088.0,
13494,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631252,,BAO_0000218,1088.0,
13495,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631253,,BAO_0000218,1088.0,
13496,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631254,,BAO_0000218,1088.0,
13497,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631255,,BAO_0000218,1088.0,
13498,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631256,,BAO_0000218,1088.0,
13499,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631257,,BAO_0000218,1088.0,
13500,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628009,,BAO_0000218,1088.0,
13501,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628010,,BAO_0000218,1088.0,
13502,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628011,,BAO_0000218,1088.0,
13503,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628012,,BAO_0000218,1088.0,
13504,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628013,,BAO_0000218,1088.0,
13505,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628014,,BAO_0000218,1088.0,
13506,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628015,,BAO_0000218,1088.0,
13507,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628016,,BAO_0000218,1088.0,
13508,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL874461,,BAO_0000218,1088.0,
13509,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628017,,BAO_0000218,1088.0,
13510,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628018,,BAO_0000218,1088.0,
13511,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628019,,BAO_0000218,1088.0,
13512,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628020,,BAO_0000218,1088.0,
13513,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628021,,BAO_0000218,1088.0,
13514,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628022,,BAO_0000218,1088.0,
13515,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL628023,,BAO_0000218,1088.0,
13516,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628024,,BAO_0000218,1088.0,
13517,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628025,,BAO_0000218,1088.0,
13518,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628026,,BAO_0000218,1088.0,
13519,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628027,,BAO_0000218,1088.0,
13520,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",A,,,Simiiformes,314293.0,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628028,,BAO_0000218,1088.0,
13521,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628029,,BAO_0000218,1088.0,
13522,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628030,,BAO_0000218,1088.0,
13523,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628031,,BAO_0000218,1088.0,
13524,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628032,,BAO_0000218,1088.0,
13525,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628033,,BAO_0000218,1088.0,
13526,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628034,,BAO_0000218,1088.0,
13527,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628035,,BAO_0000218,1088.0,
13528,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628036,,BAO_0000218,1088.0,
13529,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL874462,,BAO_0000218,1088.0,
13530,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628037,,BAO_0000218,,
13531,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628123,,BAO_0000218,,
13532,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628124,,BAO_0000218,,
13533,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628125,,BAO_0000218,,
13534,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628126,,BAO_0000218,,
13535,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628127,,BAO_0000218,,
13536,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628128,,BAO_0000218,,
13537,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628129,,BAO_0000218,,
13538,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628130,,BAO_0000218,,
13539,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628131,,BAO_0000218,,
13540,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628132,,BAO_0000218,,
13541,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628133,,BAO_0000218,,
13542,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628134,,BAO_0000218,,
13543,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628135,,BAO_0000218,,
13544,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628136,,BAO_0000218,,
13545,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628137,,BAO_0000218,,
13546,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628138,,BAO_0000218,,
13547,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628139,,BAO_0000218,,
13548,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628140,,BAO_0000218,,
13549,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628141,,BAO_0000218,,
13550,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628142,,BAO_0000218,,
13551,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628143,,BAO_0000218,,
13552,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628144,,BAO_0000218,,
13553,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628145,,BAO_0000218,,
13554,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL628146,,BAO_0000218,,
13555,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625355,,BAO_0000218,,
13556,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625356,,BAO_0000218,,
13557,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625357,,BAO_0000218,,
13558,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625527,,BAO_0000218,,
13559,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL875473,,BAO_0000218,,
13560,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL625528,,BAO_0000218,,
13561,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626304,,BAO_0000218,,
13562,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,A,In vivo,,Canis lupus familiaris,9615.0,,Artery,,,50588,N,1,Intermediate,1,,CHEMBL624138,,BAO_0000218,1637.0,
13563,6448,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624139,,BAO_0000100,,
13564,17221,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624140,,BAO_0000100,,
13565,6545,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624141,,BAO_0000100,,
13566,577,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624142,,BAO_0000100,,
13567,6285,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624143,,BAO_0000100,,
13568,6500,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624144,,BAO_0000100,,
13569,6716,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624145,,BAO_0000100,,
13570,13658,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624146,,BAO_0000100,,
13571,6549,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624147,,BAO_0000100,,
13572,14685,Calculated partition coefficient (clogP) (MacLogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL883123,,BAO_0000100,,
13573,6893,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624148,,BAO_0000019,,
13574,3687,Kinetic parameter was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874416,,BAO_0000019,,
13575,4207,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624149,,BAO_0000100,,
13576,4626,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624150,,BAO_0000100,,
13577,1021,Lipophilicity was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624151,,BAO_0000100,,
13578,3777,Lipophilicity was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624152,,BAO_0000100,,
13579,17533,Lipophilicity was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622139,,BAO_0000100,,
13580,6524,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622140,,BAO_0000100,,
13581,17533,Lipophilicity was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622141,,BAO_0000100,,
13582,6480,Lipophilicity in octanol-water,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622142,,BAO_0000100,,
13583,17606,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622143,,BAO_0000100,,
13584,6863,Octanol-water partition coefficient was determined,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622144,,BAO_0000100,,
13585,1356,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877473,,BAO_0000019,,
13586,3326,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622145,,BAO_0000100,,
13587,1356,Partition coefficient was determined; ND means not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622146,,BAO_0000019,,
13588,12984,Calculated partition coefficient (clogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622147,,BAO_0000100,,
13589,17363,Partition coefficient of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622148,,BAO_0000019,,
13590,6827,Permeability was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL883124,,BAO_0000019,,
13591,261,The compound was evaluated for the partition coefficient,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622149,,BAO_0000100,,
13592,2685,Partition coefficient (logP),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622150,,BAO_0000019,,
13593,414,The lipophilicity was reported,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622151,,BAO_0000100,,
13594,15769,logarithm of the octanol-water partition coefficient for the compound,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL622152,,BAO_0000100,,
13595,17248,Clogp value was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622153,,BAO_0000019,,
13596,16935,Clp at a dose of 1.5 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877474,,BAO_0000218,,
13597,16935,Clp at a dose of 2.0 mg/kg,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622154,,BAO_0000218,,
13598,14832,"Clp, plasma clearance at a dose of 10 mg/kg",A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622155,,BAO_0000218,1969.0,
13599,14832,"Clp, plasma clearance at a dose of 50 mg/kg",A,In vivo,,,,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622156,,BAO_0000218,1969.0,
13600,2399,Compound was tested for plasma clearance in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622157,,BAO_0000218,1969.0,
13601,2399,Compound was tested for plasma clearance in rat; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622158,,BAO_0000218,1969.0,
13602,6227,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622807,,BAO_0000218,,
13603,6227,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,A,In vivo,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL622808,,BAO_0000218,,
13604,5623,Plasma clearance by iv administration at a dose 0.003 ug/mL,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622809,,BAO_0000218,,
13605,4854,Plasma clearance determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622810,,BAO_0000218,,
13606,4493,Plasma clearance after iv administration at 3 mg/kg in hamster,A,In vivo,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL876653,,BAO_0000218,,
13607,4493,Plasma clearance after iv administration at 4 mg/kg in hamster,A,In vivo,,Cricetinae,10026.0,,,,,100712,N,1,Intermediate,1,,CHEMBL622811,,BAO_0000218,,
13608,14956,Rate of clearance in rat was determined,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622986,,BAO_0000218,,
13609,15372,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622987,,BAO_0000218,1969.0,
13610,15372,Total plasma clearance after iv dose of 5.10 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622988,,BAO_0000218,1969.0,
13611,15372,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622989,,BAO_0000218,1969.0,
13612,15372,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622990,,BAO_0000218,1969.0,
13613,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,A,In vivo,,Simiiformes,314293.0,,Plasma,,,22224,U,0,Autocuration,1,,CHEMBL622991,,BAO_0000218,1969.0,
13614,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,A,In vivo,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL622227,,BAO_0000218,1969.0,
13615,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL622228,,BAO_0000218,1969.0,
13616,14964,Clpl value in rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622229,,BAO_0000218,,
13617,15240,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,A,In vivo,,Cavia porcellus,10141.0,,,,,50512,N,1,Intermediate,1,,CHEMBL622230,,BAO_0000218,,
13618,16449,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL622231,,BAO_0000218,,
13619,16449,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,A,In vivo,,Macaca fascicularis,9541.0,,,,,100710,N,1,Intermediate,1,,CHEMBL622232,,BAO_0000218,,
13620,12902,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622233,,BAO_0000218,,
13621,12902,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622234,,BAO_0000218,,
13622,12902,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622235,,BAO_0000218,,
13623,12902,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622236,,BAO_0000218,,
13624,12902,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622237,,BAO_0000218,,
13625,12902,Cmax in minutes at a po dose of 10.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877482,,BAO_0000218,,
13626,12902,Cmax in minutes at a po dose of 20.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622238,,BAO_0000218,,
13627,12902,Cmax in minutes at a po dose of 40.0(pmol/g/h).,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL622239,,BAO_0000218,,
13628,11149,Cmax was calculated as maximum concentration reached in the blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL622240,,BAO_0000218,178.0,
13629,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL622241,,BAO_0000218,178.0,
13630,5669,Cmax was determine after peroral administration at 10 mpk in Rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631013,,BAO_0000218,,
13631,5669,Cmax was determine after peroral administration at 10 mpk in Rhesus,A,In vivo,,Macaca mulatta,9544.0,,,,,50797,N,1,Intermediate,1,,CHEMBL631014,,BAO_0000218,,
13632,5669,Cmax was determine after peroral administration at 10 mpk in dog,A,In vivo,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631015,,BAO_0000218,,
13633,5669,Cmax was determine after peroral administration at 160 mpk in Rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631016,,BAO_0000218,,
13634,5669,Cmax was determine after peroral administration at 20 mpk in Rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631017,,BAO_0000218,,
13635,5669,Cmax was determine after peroral administration at 50 mpk in Rat,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631018,,BAO_0000218,,
13636,4236,Cmax was determined,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631019,,BAO_0000218,,
13637,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL875761,,BAO_0000218,955.0,
13638,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL631020,,BAO_0000218,955.0,
13639,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL631669,,BAO_0000218,955.0,
13640,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL631670,,BAO_0000218,955.0,
13641,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,A,,,Mus musculus,10090.0,,Striatum,,,50594,N,1,Intermediate,1,,CHEMBL631671,,BAO_0000218,2435.0,
13642,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631672,,BAO_0000218,178.0,
13643,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631673,,BAO_0000218,178.0,
13644,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631856,,BAO_0000218,178.0,
13645,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631857,,BAO_0000218,178.0,
13646,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631858,,BAO_0000218,178.0,
13647,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631859,,BAO_0000218,178.0,
13648,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631860,,BAO_0000218,178.0,
13649,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631861,,BAO_0000218,178.0,
13650,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631862,,BAO_0000218,178.0,
13651,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631863,,BAO_0000218,178.0,
13652,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631864,,BAO_0000218,178.0,
13653,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631865,,BAO_0000218,178.0,
13654,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631866,,BAO_0000218,178.0,
13655,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629360,,BAO_0000218,178.0,
13656,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629361,,BAO_0000218,178.0,
13657,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL629362,,BAO_0000218,178.0,
13658,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630740,,BAO_0000218,178.0,
13659,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630741,,BAO_0000218,178.0,
13660,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,A,,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630742,,BAO_0000218,178.0,
13661,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630743,,BAO_0000218,,
13662,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630744,,BAO_0000218,,
13663,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630745,,BAO_0000218,,
13664,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630746,,BAO_0000218,,
13665,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630747,,BAO_0000218,,
13666,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630748,,BAO_0000218,,
13667,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632056,,BAO_0000218,,
13668,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632057,,BAO_0000218,,
13669,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632058,,BAO_0000218,,
13670,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632059,,BAO_0000218,,
13671,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632060,,BAO_0000218,,
13672,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632061,,BAO_0000218,,
13673,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629207,,BAO_0000218,,
13674,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629208,,BAO_0000218,,
13675,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629209,,BAO_0000218,,
13676,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629210,,BAO_0000218,,
13677,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629211,,BAO_0000218,,
13678,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629212,,BAO_0000218,,
13679,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629213,,BAO_0000218,,
13680,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629214,,BAO_0000218,1088.0,
13681,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629215,,BAO_0000218,1088.0,
13682,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL635154,,BAO_0000218,1088.0,
13683,6996,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629216,,BAO_0000218,,
13684,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629217,,BAO_0000218,,
13685,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629218,,BAO_0000218,,
13686,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629219,,BAO_0000218,,
13687,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629220,,BAO_0000218,,
13688,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629221,,BAO_0000218,,
13689,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631127,,BAO_0000218,,
13690,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631128,,BAO_0000218,,
13691,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631129,,BAO_0000218,,
13692,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631130,,BAO_0000218,,
13693,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631131,,BAO_0000218,,
13694,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631132,,BAO_0000218,,
13695,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631133,,BAO_0000218,,
13696,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631134,,BAO_0000218,,
13697,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875120,,BAO_0000218,,
13698,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631135,,BAO_0000218,,
13699,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631136,,BAO_0000218,,
13700,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631137,,BAO_0000218,,
13701,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631138,,BAO_0000218,,
13702,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631139,,BAO_0000218,,
13703,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631140,,BAO_0000218,,
13704,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631141,,BAO_0000218,,
13705,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631142,,BAO_0000218,,
13706,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631143,,BAO_0000218,,
13707,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631144,,BAO_0000218,,
13708,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631145,,BAO_0000218,,
13709,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631146,,BAO_0000218,,
13710,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631147,,BAO_0000218,,
13711,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631148,,BAO_0000218,,
13712,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631149,,BAO_0000218,,
13713,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631150,,BAO_0000218,,
13714,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631151,,BAO_0000218,,
13715,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631152,,BAO_0000218,,
13716,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631443,,BAO_0000218,,
13717,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631444,,BAO_0000218,,
13718,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631445,,BAO_0000218,,
13719,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631446,,BAO_0000218,,
13720,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631447,,BAO_0000218,,
13721,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631448,,BAO_0000218,,
13722,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631449,,BAO_0000218,,
13723,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL631450,,BAO_0000218,,
13724,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629724,,BAO_0000218,,
13725,9716,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL629725,,BAO_0000218,14.0,
13726,9716,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Zone of skin,,,50594,N,1,Intermediate,1,,CHEMBL629726,,BAO_0000218,14.0,
13727,9716,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL629727,,BAO_0000218,2106.0,
13728,9716,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL630404,,BAO_0000218,2106.0,
13729,9716,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL630405,,BAO_0000218,2106.0,
13730,9716,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL630406,,BAO_0000218,2106.0,
13731,9716,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL630407,,BAO_0000218,945.0,
13732,9716,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL630573,,BAO_0000218,945.0,
13733,9716,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL630574,,BAO_0000218,945.0,
13734,9716,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL630575,,BAO_0000218,945.0,
13735,9716,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630576,,BAO_0000218,,
13736,9716,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630577,,BAO_0000218,,
13737,9716,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630578,,BAO_0000218,,
13738,9716,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630579,,BAO_0000218,,
13739,12192,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630580,,BAO_0000218,2113.0,
13740,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630581,,BAO_0000218,2113.0,
13741,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),A,,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630582,,BAO_0000218,2113.0,
13742,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630583,,BAO_0000218,,
13743,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630584,,BAO_0000218,,
13744,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630585,,BAO_0000218,,
13745,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630586,,BAO_0000218,,
13746,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630587,,BAO_0000218,,
13747,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630588,,BAO_0000218,,
13748,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630589,,BAO_0000218,,
13749,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL630590,,BAO_0000218,,
13750,12192,Removal of 238-Plutonium(IV) in feces at 24 h,A,,,,,,Feces,,,22224,U,0,Autocuration,1,,CHEMBL630591,,BAO_0000019,1988.0,
13751,12192,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),A,,,,,,Feces,,,22224,U,0,Autocuration,1,,CHEMBL630592,,BAO_0000019,1988.0,
13752,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630593,,BAO_0000019,,
13753,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630594,,BAO_0000019,,
13754,12192,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630595,,BAO_0000019,1088.0,
13755,12192,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630596,,BAO_0000019,1088.0,
13756,12192,Removal of 238-Plutonium(IV) in urine after 0-24 h,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630597,,BAO_0000019,1088.0,
13757,12192,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630598,,BAO_0000019,1088.0,
13758,12192,Removal of 238-Plutonium(IV) in urine after 0-4 h,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630599,,BAO_0000019,1088.0,
13759,12192,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630600,,BAO_0000019,1088.0,
13760,12192,Removal of 238-Plutonium(IV) in urine after 4-24 h,A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630601,,BAO_0000019,1088.0,
13761,12192,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630602,,BAO_0000019,1088.0,
13762,12192,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630603,,BAO_0000019,1088.0,
13763,12192,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),A,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL630604,,BAO_0000019,1088.0,
13764,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624869,,BAO_0000218,178.0,
13765,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL624870,,BAO_0000218,178.0,
13766,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623189,,BAO_0000218,178.0,
13767,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623190,,BAO_0000218,178.0,
13768,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623191,,BAO_0000218,178.0,
13769,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623192,,BAO_0000218,,
13770,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623193,,BAO_0000218,,
13771,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623194,,BAO_0000218,,
13772,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623195,,BAO_0000218,,
13773,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623196,,BAO_0000218,,
13774,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623197,,BAO_0000218,,
13775,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623198,,BAO_0000218,,
13776,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623199,,BAO_0000218,,
13777,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623200,,BAO_0000218,2385.0,
13778,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623201,,BAO_0000218,2385.0,
13779,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623202,,BAO_0000218,2385.0,
13780,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623203,,BAO_0000218,2385.0,
13781,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623204,,BAO_0000218,2385.0,
13782,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623205,,BAO_0000218,2385.0,
13783,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623206,,BAO_0000218,2385.0,
13784,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623207,,BAO_0000218,2385.0,
13785,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623208,,BAO_0000218,2385.0,
13786,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623209,,BAO_0000218,2385.0,
13787,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL623210,,BAO_0000218,2385.0,
13788,11836,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623211,,BAO_0000218,,
13789,11836,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,A,,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL623212,,BAO_0000218,995.0,
13790,12640,Tested in vitro for intrinsic activity relative to quinpirole,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623213,,BAO_0000019,,
13791,14218,"Relative ion enhancement, determined in pulsed ultrafiltration",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623214,,BAO_0000019,,
13792,11296,% ionization at the pH 7.4 at 37 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623215,,BAO_0000019,,
13793,10929,Percentage ionization was measured,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623216,,BAO_0000019,,
13794,13841,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,A,,,Bos taurus,9913.0,,,,,50591,N,1,Intermediate,1,,CHEMBL623217,,BAO_0000218,,
13795,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623218,,BAO_0000019,,
13796,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623913,,BAO_0000019,,
13797,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL623914,,BAO_0000019,,
13798,8826,Compound was evaluated for the partition coefficient in octanol/water,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL623915,,BAO_0000100,,
13799,8826,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL624080,,BAO_0000100,,
13800,9884,Equilibrium constant measured by the pulse radiolysis at pH 7,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL624081,,BAO_0000019,,
13801,9827,In vitro hydrolytic rate constant determined in human blood,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL624082,,BAO_0000218,,
13802,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL625054,,BAO_0000218,,
13803,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL877485,,BAO_0000019,,
13804,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625055,,BAO_0000218,,
13805,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625056,,BAO_0000218,,
13806,10009,In vitro oxidation of compound in presence of human plasma,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL625057,,BAO_0000218,,
13807,10009,In vitro oxidation of compound in presence of hydrogen peroxide,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625058,,BAO_0000019,,
13808,10009,In vitro oxidation of compound in presence of mouse brain homogenate,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625059,,BAO_0000218,,
13809,10009,In vitro oxidation of compound in presence of mouse liver homogenate,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629536,,BAO_0000218,,
13810,11510,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629537,,BAO_0000218,,
13811,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629538,,BAO_0000218,,
13812,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629539,,BAO_0000218,,
13813,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL874445,,BAO_0000218,,
13814,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629540,,BAO_0000218,,
13815,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629541,,BAO_0000218,,
13816,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629542,,BAO_0000218,,
13817,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630243,,BAO_0000218,,
13818,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630244,,BAO_0000218,,
13819,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630245,,BAO_0000218,,
13820,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630246,,BAO_0000218,,
13821,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630247,,BAO_0000218,,
13822,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630248,,BAO_0000218,,
13823,13100,Biodistribution in rat blood at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630249,,BAO_0000218,178.0,
13824,13100,Biodistribution in rat blood at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630250,,BAO_0000218,178.0,
13825,13100,Biodistribution in rat blood at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630251,,BAO_0000218,178.0,
13826,13100,Biodistribution in rat blood at 3 hr after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630252,,BAO_0000218,178.0,
13827,13100,Biodistribution in rat blood at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL630408,,BAO_0000218,178.0,
13828,13100,Biodistribution in rat cerebellum at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630409,,BAO_0000218,2037.0,
13829,13100,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL874446,,BAO_0000218,2037.0,
13830,13100,Biodistribution in rat cerebellum at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630410,,BAO_0000218,2037.0,
13831,13100,Biodistribution in rat cerebellum at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630411,,BAO_0000218,2037.0,
13832,13100,Biodistribution in rat cerebellum at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630412,,BAO_0000218,2037.0,
13833,13100,Biodistribution in rat cerebellum at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630413,,BAO_0000218,2037.0,
13834,13100,Biodistribution in rat cerebellum at 3 hr after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630414,,BAO_0000218,2037.0,
13835,13100,Biodistribution in rat cerebellum at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL630415,,BAO_0000218,2037.0,
13836,13100,Biodistribution in rat cortex at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630416,,BAO_0000218,,
13837,13100,Biodistribution in rat cortex at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630417,,BAO_0000218,,
13838,13100,Biodistribution in rat cortex at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630418,,BAO_0000218,,
13839,13100,Biodistribution in rat cortex at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630419,,BAO_0000218,,
13840,13100,Biodistribution in rat cortex at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630420,,BAO_0000218,,
13841,13100,Biodistribution in rat cortex at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630421,,BAO_0000218,,
13842,13100,Biodistribution in rat cortex at 3 hr after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630422,,BAO_0000218,,
13843,13100,Biodistribution in rat cortex at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630423,,BAO_0000218,,
13844,13100,Biodistribution in rat heart at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630424,,BAO_0000218,948.0,
13845,13100,Biodistribution in rat heart at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630425,,BAO_0000218,948.0,
13846,13100,Biodistribution in rat heart at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL629462,,BAO_0000218,948.0,
13847,13100,Biodistribution in rat heart at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630426,,BAO_0000218,948.0,
13848,13100,Biodistribution in rat heart at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL630427,,BAO_0000218,948.0,
13849,13100,Biodistribution in rat heart at 3 hr after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625877,,BAO_0000218,948.0,
13850,13100,Biodistribution in rat heart at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625878,,BAO_0000218,948.0,
13851,13100,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625879,,BAO_0000218,10000000.0,
13852,13100,Biodistribution in rat hippocampus at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625880,,BAO_0000218,10000000.0,
13853,13100,Biodistribution in rat hippocampus at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625881,,BAO_0000218,10000000.0,
13854,13100,Biodistribution in rat hippocampus at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625882,,BAO_0000218,10000000.0,
13855,13100,Biodistribution in rat hippocampus at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625883,,BAO_0000218,10000000.0,
13856,13100,Biodistribution in rat kidney at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625884,,BAO_0000218,2113.0,
13857,13100,Biodistribution in rat kidney at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625885,,BAO_0000218,2113.0,
13858,13100,Biodistribution in rat kidney at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628649,,BAO_0000218,2113.0,
13859,13100,Biodistribution in rat kidney at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628650,,BAO_0000218,2113.0,
13860,13100,Biodistribution in rat kidney at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628651,,BAO_0000218,2113.0,
13861,13100,Biodistribution in rat kidney at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628652,,BAO_0000218,2113.0,
13862,13100,Biodistribution in rat kidney at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL628653,,BAO_0000218,2113.0,
13863,13100,Biodistribution in rat liver at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628654,,BAO_0000218,2107.0,
13864,13100,Biodistribution in rat liver at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL628655,,BAO_0000218,2107.0,
13865,13100,Biodistribution in rat liver at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625238,,BAO_0000218,2107.0,
13866,13100,Biodistribution in rat liver at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625239,,BAO_0000218,2107.0,
13867,13100,Biodistribution in rat liver at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625240,,BAO_0000218,2107.0,
13868,13100,Biodistribution in rat liver at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625241,,BAO_0000218,2107.0,
13869,13100,Biodistribution in rat liver at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625242,,BAO_0000218,2107.0,
13870,13100,Biodistribution in rat lung at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL874587,,BAO_0000218,2048.0,
13871,13100,Biodistribution in rat lung at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625405,,BAO_0000218,2048.0,
13872,13100,Biodistribution in rat lung at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625406,,BAO_0000218,2048.0,
13873,13100,Biodistribution in rat lung at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625407,,BAO_0000218,2048.0,
13874,13100,Biodistribution in rat lung at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625408,,BAO_0000218,2048.0,
13875,13100,Biodistribution in rat lung at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625409,,BAO_0000218,2048.0,
13876,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625410,,BAO_0000218,1515.0,
13877,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625411,,BAO_0000218,1515.0,
13878,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625412,,BAO_0000218,1515.0,
13879,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625413,,BAO_0000218,1515.0,
13880,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips v,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625414,,BAO_0000218,1515.0,
13881,12361,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625415,,BAO_0000218,1515.0,
13882,12361,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,A,,,Rattus norvegicus,10116.0,,Thoracic aorta,,,50597,N,1,Intermediate,1,,CHEMBL625416,,BAO_0000218,1515.0,
13883,12712,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625417,,BAO_0000218,1088.0,
13884,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL625418,,BAO_0000218,1988.0,
13885,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625419,,BAO_0000218,1088.0,
13886,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625420,,BAO_0000218,,
13887,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626996,,BAO_0000218,,
13888,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL626997,,BAO_0000218,1988.0,
13889,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626998,,BAO_0000218,1088.0,
13890,7415,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626999,,BAO_0000218,,
13891,8050,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627000,,BAO_0000218,,
13892,8050,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627001,,BAO_0000218,,
13893,8050,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627002,,BAO_0000218,,
13894,8050,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627003,,BAO_0000218,,
13895,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627004,,BAO_0000218,1088.0,
13896,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627005,,BAO_0000218,1088.0,
13897,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL874594,,BAO_0000218,1088.0,
13898,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627006,,BAO_0000218,1088.0,
13899,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627007,,BAO_0000218,1088.0,
13900,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627884,,BAO_0000218,1088.0,
13901,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627885,,BAO_0000218,1088.0,
13902,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627886,,BAO_0000218,1088.0,
13903,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627887,,BAO_0000218,1088.0,
13904,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627888,,BAO_0000218,1088.0,
13905,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL628057,,BAO_0000218,1088.0,
13906,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627405,,BAO_0000218,1088.0,
13907,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627406,,BAO_0000218,1088.0,
13908,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627407,,BAO_0000218,1088.0,
13909,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627408,,BAO_0000218,1088.0,
13910,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627409,,BAO_0000218,1088.0,
13911,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL875486,,BAO_0000218,1088.0,
13912,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627410,,BAO_0000218,1088.0,
13913,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627411,,BAO_0000218,1088.0,
13914,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627412,,BAO_0000218,1088.0,
13915,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627413,,BAO_0000218,1088.0,
13916,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627414,,BAO_0000218,1088.0,
13917,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627415,,BAO_0000218,1088.0,
13918,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627416,,BAO_0000218,1088.0,
13919,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627417,,BAO_0000218,1088.0,
13920,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627418,,BAO_0000218,1088.0,
13921,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627419,,BAO_0000218,1088.0,
13922,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627320,,BAO_0000218,1088.0,
13923,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627321,,BAO_0000218,1088.0,
13924,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627322,,BAO_0000218,2113.0,
13925,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627323,,BAO_0000218,2113.0,
13926,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627491,,BAO_0000218,2113.0,
13927,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627492,,BAO_0000218,2113.0,
13928,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL627493,,BAO_0000218,2113.0,
13929,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627494,,BAO_0000218,2107.0,
13930,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627495,,BAO_0000218,2107.0,
13931,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627496,,BAO_0000218,2107.0,
13932,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627497,,BAO_0000218,2107.0,
13933,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL627498,,BAO_0000218,2107.0,
13934,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627499,,BAO_0000218,2048.0,
13935,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627500,,BAO_0000218,2048.0,
13936,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627501,,BAO_0000218,2048.0,
13937,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625616,,BAO_0000218,2048.0,
13938,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625617,,BAO_0000218,2048.0,
13939,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625618,,BAO_0000218,2385.0,
13940,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625619,,BAO_0000218,2385.0,
13941,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625620,,BAO_0000218,2385.0,
13942,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625621,,BAO_0000218,2385.0,
13943,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625622,,BAO_0000218,2385.0,
13944,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625788,,BAO_0000218,2106.0,
13945,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625789,,BAO_0000218,2106.0,
13946,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625790,,BAO_0000218,2106.0,
13947,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625791,,BAO_0000218,2106.0,
13948,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL622334,,BAO_0000218,2106.0,
13949,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622335,,BAO_0000218,2046.0,
13950,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622336,,BAO_0000218,2046.0,
13951,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622337,,BAO_0000218,2046.0,
13952,12017,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622338,,BAO_0000218,2046.0,
13953,12017,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL622339,,BAO_0000218,2046.0,
13954,12017,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL624153,,BAO_0000218,,
13955,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628430,,BAO_0000218,,
13956,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628431,,BAO_0000218,,
13957,12017,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628432,,BAO_0000218,,
13958,12017,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628433,,BAO_0000218,,
13959,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL628434,,BAO_0000218,2106.0,
13960,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL626789,,BAO_0000218,2106.0,
13961,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL626790,,BAO_0000218,2106.0,
13962,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL626791,,BAO_0000218,2106.0,
13963,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL626792,,BAO_0000218,2106.0,
13964,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL626793,,BAO_0000218,2106.0,
13965,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627436,,BAO_0000218,,
13966,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627437,,BAO_0000218,,
13967,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627438,,BAO_0000218,,
13968,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627439,,BAO_0000218,,
13969,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627440,,BAO_0000218,,
13970,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627602,,BAO_0000218,,
13971,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627603,,BAO_0000218,,
13972,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627604,,BAO_0000218,,
13973,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627605,,BAO_0000218,,
13974,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627606,,BAO_0000218,,
13975,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627607,,BAO_0000218,,
13976,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627608,,BAO_0000218,,
13977,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627609,,BAO_0000218,,
13978,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627610,,BAO_0000218,,
13979,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627611,,BAO_0000218,,
13980,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627612,,BAO_0000218,,
13981,8362,Octanol:water partition coefficient is evaluated,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL627613,,BAO_0000100,,
13982,8257,Partition coefficient in 1-octanol/water system,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627614,,BAO_0000100,,
13983,8257,Partition coefficient in 1-octanol/water system measured using radio active compounds,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627615,,BAO_0000100,,
13984,9468,Partition coefficient in octanol/water system was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627616,,BAO_0000100,,
13985,9468,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627617,,BAO_0000100,,
13986,10568,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627618,,BAO_0000019,,
13987,10568,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627619,,BAO_0000019,,
13988,15359,Pseudo-first-order rate constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627620,,BAO_0000019,,
13989,15359,Pseudo-first-order rate constant with 1-min time point,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627621,,BAO_0000019,,
13990,15359,Pseudo-first-order rate constant without 1-min time point,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627622,,BAO_0000019,,
13991,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627623,,BAO_0000019,,
13992,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627624,,BAO_0000019,,
13993,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627625,,BAO_0000019,,
13994,15704,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628523,,BAO_0000019,,
13995,15287,The alkaline hydrolysis second order rate constant(K OH) of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628524,,BAO_0000019,,
13996,7516,The efflux rate constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628525,,BAO_0000019,,
13997,12973,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625732,,BAO_0000019,,
13998,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625733,,BAO_0000019,,
13999,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625734,,BAO_0000019,,
14000,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625913,,BAO_0000019,,
14001,8696,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625914,,BAO_0000019,,
14002,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625915,,BAO_0000019,,
14003,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625916,,BAO_0000019,,
14004,10503,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625917,,BAO_0000019,,
14005,8354,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625918,,BAO_0000019,,
14006,8354,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625919,,BAO_0000019,,
14007,8354,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625920,,BAO_0000019,,
14008,8354,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874453,,BAO_0000019,,
14009,8354,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625921,,BAO_0000019,,
14010,10503,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625922,,BAO_0000019,,
14011,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625923,,BAO_0000019,,
14012,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625924,,BAO_0000019,,
14013,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625925,,BAO_0000019,,
14014,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625926,,BAO_0000019,,
14015,13100,Biodistribution in rat lung at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL627704,,BAO_0000218,2048.0,
14016,13100,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627705,,BAO_0000218,,
14017,13100,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627706,,BAO_0000218,,
14018,13100,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627707,,BAO_0000218,,
14019,13100,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627708,,BAO_0000218,,
14020,13100,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628361,,BAO_0000218,,
14021,13100,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628362,,BAO_0000218,,
14022,13100,Biodistribution in rat striatum at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628363,,BAO_0000218,2435.0,
14023,13100,Biodistribution in rat striatum at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628364,,BAO_0000218,2435.0,
14024,13100,Biodistribution in rat striatum at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628365,,BAO_0000218,2435.0,
14025,13100,Biodistribution in rat striatum at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL874454,,BAO_0000218,2435.0,
14026,13100,Biodistribution in rat striatum at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628531,,BAO_0000218,2435.0,
14027,13100,Biodistribution in rat striatum at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628532,,BAO_0000218,2435.0,
14028,13100,Biodistribution in rat striatum at 3 hr after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628533,,BAO_0000218,2435.0,
14029,13100,Biodistribution in rat striatum at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Striatum,,,50597,N,1,Intermediate,1,,CHEMBL628534,,BAO_0000218,2435.0,
14030,13100,Biodistribution in rat thyroid at 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628535,,BAO_0000218,2046.0,
14031,13100,Biodistribution in rat thyroid at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628536,,BAO_0000218,2046.0,
14032,13100,Biodistribution in rat thyroid at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628537,,BAO_0000218,2046.0,
14033,13100,Biodistribution in rat thyroid at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628538,,BAO_0000218,2046.0,
14034,13100,Biodistribution in rat thyroid at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL628539,,BAO_0000218,2046.0,
14035,13100,Biodistribution in rat thyroid at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630297,,BAO_0000218,2046.0,
14036,13100,Biodistribution in rat thyroid at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL630298,,BAO_0000218,2046.0,
14037,13100,Biodistribution in rest of brain of rat 120 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL630299,,BAO_0000218,955.0,
14038,13100,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL628094,,BAO_0000218,955.0,
14039,13100,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL628095,,BAO_0000218,955.0,
14040,13100,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL874648,,BAO_0000218,955.0,
14041,13100,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL628096,,BAO_0000218,955.0,
14042,13100,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL628097,,BAO_0000218,955.0,
14043,13100,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL628098,,BAO_0000218,955.0,
14044,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628099,,BAO_0000019,,
14045,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628100,,BAO_0000019,,
14046,13331,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628101,,BAO_0000019,,
14047,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628102,,BAO_0000019,,
14048,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628103,,BAO_0000019,,
14049,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628104,,BAO_0000019,,
14050,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628105,,BAO_0000019,,
14051,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628106,,BAO_0000019,,
14052,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628107,,BAO_0000218,1088.0,
14053,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,F,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL628108,,BAO_0000218,1088.0,
14054,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628109,,BAO_0000218,1088.0,
14055,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,F,,,,,,Urine,,,22224,U,0,Autocuration,1,,CHEMBL625299,,BAO_0000218,1088.0,
14056,10086,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625300,,BAO_0000218,1088.0,
14057,10086,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625301,,BAO_0000218,1088.0,
14058,10086,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625302,,BAO_0000218,1088.0,
14059,10086,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL874649,,BAO_0000218,1088.0,
14060,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625303,,BAO_0000218,,
14061,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625463,,BAO_0000218,,
14062,14527,In vitro metabolism in human liver microsomes,A,,,Homo sapiens,9606.0,,Liver,,,50587,N,1,Intermediate,1,,CHEMBL625464,,BAO_0000218,2107.0,
14063,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL625465,,BAO_0000218,,
14064,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625466,,BAO_0000218,1088.0,
14065,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625467,,BAO_0000218,1088.0,
14066,12582,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625468,,BAO_0000218,1088.0,
14067,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625469,,BAO_0000218,1088.0,
14068,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625470,,BAO_0000218,1088.0,
14069,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL632418,,BAO_0000218,1088.0,
14070,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627250,,BAO_0000218,1088.0,
14071,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627251,,BAO_0000218,1088.0,
14072,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627252,,BAO_0000218,1088.0,
14073,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627253,,BAO_0000218,1088.0,
14074,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627254,,BAO_0000218,1088.0,
14075,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875471,,BAO_0000218,1088.0,
14076,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627255,,BAO_0000218,1088.0,
14077,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627256,,BAO_0000218,1088.0,
14078,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627257,,BAO_0000218,1088.0,
14079,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627258,,BAO_0000218,1088.0,
14080,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627259,,BAO_0000218,1088.0,
14081,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627260,,BAO_0000218,1088.0,
14082,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623256,,BAO_0000218,1088.0,
14083,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL874413,,BAO_0000218,1088.0,
14084,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623257,,BAO_0000218,1088.0,
14085,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623258,,BAO_0000218,1088.0,
14086,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623259,,BAO_0000218,1088.0,
14087,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623260,,BAO_0000218,1088.0,
14088,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623261,,BAO_0000218,1088.0,
14089,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623262,,BAO_0000218,1088.0,
14090,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623263,,BAO_0000218,1088.0,
14091,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623264,,BAO_0000218,1088.0,
14092,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623265,,BAO_0000218,1088.0,
14093,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623266,,BAO_0000218,1088.0,
14094,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623267,,BAO_0000218,1088.0,
14095,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623268,,BAO_0000218,1088.0,
14096,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623269,,BAO_0000218,1088.0,
14097,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623270,,BAO_0000218,1088.0,
14098,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623271,,BAO_0000218,1088.0,
14099,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623272,,BAO_0000218,1088.0,
14100,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623273,,BAO_0000218,1088.0,
14101,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623274,,BAO_0000218,1088.0,
14102,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL874414,,BAO_0000218,1088.0,
14103,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623275,,BAO_0000218,1088.0,
14104,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629150,,BAO_0000218,1088.0,
14105,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623276,,BAO_0000218,1088.0,
14106,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623277,,BAO_0000218,1088.0,
14107,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623112,,BAO_0000218,1088.0,
14108,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623113,,BAO_0000218,1088.0,
14109,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623800,,BAO_0000218,1088.0,
14110,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623801,,BAO_0000218,1088.0,
14111,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL623802,,BAO_0000218,2106.0,
14112,12017,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL623803,,BAO_0000218,995.0,
14113,12017,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL623970,,BAO_0000218,995.0,
14114,12017,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Uterus,,,50597,N,1,Intermediate,1,,CHEMBL623971,,BAO_0000218,995.0,
14115,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623972,,BAO_0000218,178.0,
14116,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623973,,BAO_0000218,178.0,
14117,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623974,,BAO_0000218,178.0,
14118,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL623975,,BAO_0000218,178.0,
14119,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623976,,BAO_0000218,955.0,
14120,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623977,,BAO_0000218,955.0,
14121,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623978,,BAO_0000218,955.0,
14122,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL623979,,BAO_0000218,955.0,
14123,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623980,,BAO_0000218,,
14124,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL623981,,BAO_0000218,,
14125,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626278,,BAO_0000218,,
14126,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626279,,BAO_0000218,,
14127,14045,Biodistribution in mice bladder plus excreted urine was determined,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626280,,BAO_0000218,,
14128,14045,"Percentage biodistribution in mouse blood, 10 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626281,,BAO_0000218,,
14129,14045,"Percentage biodistribution in mouse blood, 30 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626282,,BAO_0000218,,
14130,14045,"Percentage biodistribution in mouse blood, 5 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626283,,BAO_0000218,,
14131,14045,"Percentage biodistribution in mouse blood, 60 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626284,,BAO_0000218,,
14132,14045,"Percentage biodistribution in mouse brain, 10 minutes post injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626285,,BAO_0000218,955.0,
14133,14045,"Percentage biodistribution in mouse brain, 30 minutes post injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626286,,BAO_0000218,955.0,
14134,14045,"Percentage biodistribution in mouse brain, 5 minutes post injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626287,,BAO_0000218,955.0,
14135,14045,"Percentage biodistribution in mouse brain, 60 minutes post injection",A,,,Mus musculus,10090.0,,Brain,,,50594,N,1,Intermediate,1,,CHEMBL626288,,BAO_0000218,955.0,
14136,14045,"Percentage biodistribution in mouse heart, 10 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626289,,BAO_0000218,,
14137,14045,"Percentage biodistribution in mouse heart, 30 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626290,,BAO_0000218,,
14138,14045,"Percentage biodistribution in mouse heart, 5 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL626291,,BAO_0000218,,
14139,14045,"Percentage biodistribution in mouse heart, 60 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL839888,,BAO_0000218,,
14140,14045,"Percentage biodistribution in mouse intestine, 10 minutes post injection",A,,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL626292,,BAO_0000218,160.0,
14141,14045,"Percentage biodistribution in mouse intestine, 30 minutes post injection",A,,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL626293,,BAO_0000218,160.0,
14142,14045,"Percentage biodistribution in mouse intestine, 5 minutes post injection",A,,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL626294,,BAO_0000218,160.0,
14143,14045,"Percentage biodistribution in mouse intestine, 60 minutes post injection",A,,,Mus musculus,10090.0,,Intestine,,,50594,N,1,Intermediate,1,,CHEMBL626295,,BAO_0000218,160.0,
14144,14045,"Percentage biodistribution in mouse liver, 10 minutes post injection",A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627659,,BAO_0000218,2107.0,
14145,14045,"Percentage biodistribution in mouse liver, 30 minutes of post injection",A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627660,,BAO_0000218,2107.0,
14146,14045,"Percentage biodistribution in mouse liver, 5 minutes post injection",A,,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627661,,BAO_0000218,2107.0,
14147,14045,Biodistribution in mice liver at 60 minutes of post injection,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL627662,,BAO_0000218,2107.0,
14148,14045,Biodistribution in mice lungs at 10 min of post injection,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL627663,,BAO_0000218,2048.0,
14149,14045,"Percentage biodistribution in mouse lung, 30 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627664,,BAO_0000218,,
14150,14045,"Percentage biodistribution in mousee lung, 5 minutes post injection",A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL627665,,BAO_0000218,,
14151,14045,Biodistribution in mice lungs at 60 min of post injection,A,In vivo,,Mus musculus,10090.0,,Lung,,,50594,N,1,Intermediate,1,,CHEMBL627666,,BAO_0000218,2048.0,
14152,14045,Percentage biodistribution in mouse spleen,A,,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL627667,,BAO_0000218,2106.0,
14153,14045,Percentage biodistribution in mouse stomach,A,,,Mus musculus,10090.0,,Stomach,,,50594,N,1,Intermediate,1,,CHEMBL627668,,BAO_0000218,945.0,
14154,11745,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,A,,,Mus musculus,10090.0,,Urine,,,50594,N,1,Intermediate,1,,CHEMBL627669,,BAO_0000218,1088.0,
14155,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,A,In vivo,,,,,Urinary bladder,,,22224,U,0,Autocuration,1,,CHEMBL627670,,BAO_0000218,1255.0,
14156,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL627671,,BAO_0000218,178.0,
14157,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,A,In vivo,,,,,Bone element,,,22224,U,0,Autocuration,1,,CHEMBL627672,,BAO_0000218,1474.0,
14158,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627673,,BAO_0000218,,
14159,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,A,In vivo,,,,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL627674,,BAO_0000218,2113.0,
14160,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,A,In vivo,,,,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL627675,,BAO_0000218,2107.0,
14161,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,A,In vivo,,,,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL627676,,BAO_0000218,2048.0,
14162,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627677,,BAO_0000218,2385.0,
14163,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627678,,BAO_0000019,,
14164,7095,Affinity for protein binding expressed as association constant in fresh rat serum,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL627679,,BAO_0000218,1977.0,
14165,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627680,,BAO_0000019,,
14166,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627681,,BAO_0000019,,
14167,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627682,,BAO_0000019,,
14168,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627683,,BAO_0000019,,
14169,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627684,,BAO_0000019,,
14170,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874441,,BAO_0000019,,
14171,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627685,,BAO_0000019,,
14172,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627686,,BAO_0000019,,
14173,8057,Apparent rate constant Koff for inactivation of dTMP synthase.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627687,,BAO_0000019,,
14174,15778,The irreversible inhibitor activity by second order rate equation.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627688,,BAO_0000019,,
14175,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628038,,BAO_0000218,,
14176,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628039,,BAO_0000218,,
14177,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628040,,BAO_0000218,,
14178,13588,Dissociation rate calculated from the first-order equation using t1/2 value,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628041,,BAO_0000019,,
14179,15039,The compound was tested for Binding constant against DNA,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630226,,BAO_0000019,,
14180,9500,First order rate constant for cyclization of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628042,,BAO_0000019,,
14181,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625232,,BAO_0000019,,
14182,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625233,,BAO_0000019,,
14183,568,Hydrolysis rate constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625979,,BAO_0000019,,
14184,10026,Observed first order rate constant,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625980,,BAO_0000019,,
14185,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625981,,BAO_0000019,,
14186,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625982,,BAO_0000019,,
14187,9680,Second-order rate constant for attack on PNPA at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625983,,BAO_0000019,,
14188,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625984,,BAO_0000019,,
14189,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625985,,BAO_0000019,,
14190,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625986,,BAO_0000019,,
14191,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625987,,BAO_0000019,,
14192,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625988,,BAO_0000019,,
14193,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625989,,BAO_0000019,,
14194,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625990,,BAO_0000019,,
14195,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625991,,BAO_0000019,,
14196,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625992,,BAO_0000019,,
14197,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625993,,BAO_0000019,,
14198,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631973,,BAO_0000019,,
14199,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632143,,BAO_0000019,,
14200,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632144,,BAO_0000019,,
14201,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632145,,BAO_0000019,,
14202,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632146,,BAO_0000019,,
14203,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632147,,BAO_0000019,,
14204,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632148,,BAO_0000019,,
14205,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632149,,BAO_0000019,,
14206,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632150,,BAO_0000019,,
14207,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632151,,BAO_0000019,,
14208,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL632152,,BAO_0000218,,
14209,4509,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL632153,,BAO_0000218,,
14210,4509,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,A,,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL632154,,BAO_0000218,,
14211,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632155,,BAO_0000218,,
14212,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632156,,BAO_0000218,,
14213,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632157,,BAO_0000218,,
14214,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632158,,BAO_0000218,,
14215,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL632159,,BAO_0000218,,
14216,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626305,,BAO_0000218,,
14217,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626306,,BAO_0000218,,
14218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626307,,BAO_0000218,,
14219,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626308,,BAO_0000218,,
14220,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626479,,BAO_0000218,,
14221,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,A,,,Human herpesvirus 1,10298.0,,,,,50602,N,1,Intermediate,1,,CHEMBL626480,,BAO_0000218,,
14222,6021,Calculated partition coefficient (clogP) (MlogP),P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626481,,BAO_0000100,,
14223,9348,Equipotent potent ratio relative to carbachol (nicotinic activity),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626482,,BAO_0000019,,
14224,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626483,,BAO_0000218,,
14225,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL626484,,BAO_0000218,,
14226,15592,Solubility at pH 7.4 in micro g/mL;NA denotes available,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626485,,BAO_0000100,,
14227,15592,Solubility at pH 7.4 in micro g/mL;NA denotes not available,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626486,,BAO_0000100,,
14228,15592,Solubility at pH 7.4 in ug/mL;NA denotes not available,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626487,,BAO_0000100,,
14229,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,A,In vivo,,Canis lupus familiaris,9615.0,,Plasma,,,50588,N,1,Intermediate,1,,CHEMBL626488,,BAO_0000218,1969.0,
14230,7095,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,A,,,Rattus norvegicus,10116.0,,Serum,,,50597,N,1,Intermediate,1,,CHEMBL626489,,BAO_0000218,1977.0,
14231,16618,Area under the MAP curve measured over 5 min; ND means Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626490,,BAO_0000019,,
14232,16835,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626491,,BAO_0000100,,
14233,15284,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL626492,,BAO_0000100,,
14234,15750,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626493,,BAO_0000019,,
14235,16618,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626494,,BAO_0000218,,
14236,16618,Half life after oral tested,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626495,,BAO_0000218,,
14237,15812,Half life was determined in plasma of rat; NT indicates not tested,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626496,,BAO_0000218,1969.0,
14238,16618,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626497,,BAO_0000218,,
14239,16618,Oral bioavailability after oral tested,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626498,,BAO_0000218,,
14240,13098,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626499,,BAO_0000218,,
14241,13098,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626500,,BAO_0000218,,
14242,15812,half life was determined in plasma of rat; NT indicates not tested,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626501,,BAO_0000218,1969.0,
14243,15812,half life was determined in plasma of rat; NT means not tested,A,,,Rattus norvegicus,10116.0,,Plasma,,,50597,N,1,Intermediate,1,,CHEMBL626502,,BAO_0000218,1969.0,
14244,11510,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626503,,BAO_0000218,,
14245,11510,Mean sodium excretion in rats (Control/Drug treatment value); inactive,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626504,,BAO_0000218,,
14246,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626505,,BAO_0000218,,
14247,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626506,,BAO_0000218,,
14248,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626507,,BAO_0000218,,
14249,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626508,,BAO_0000218,,
14250,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626509,,BAO_0000218,,
14251,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875480,,BAO_0000218,,
14252,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626510,,BAO_0000218,,
14253,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626511,,BAO_0000218,,
14254,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL626512,,BAO_0000218,,
14255,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628208,,BAO_0000218,,
14256,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628209,,BAO_0000218,,
14257,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628210,,BAO_0000218,,
14258,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628211,,BAO_0000218,,
14259,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628212,,BAO_0000218,,
14260,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628213,,BAO_0000218,,
14261,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628214,,BAO_0000218,1088.0,
14262,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628215,,BAO_0000218,1088.0,
14263,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628216,,BAO_0000218,1088.0,
14264,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626595,,BAO_0000218,1088.0,
14265,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626596,,BAO_0000218,1088.0,
14266,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626597,,BAO_0000218,1088.0,
14267,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626598,,BAO_0000218,1088.0,
14268,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622242,,BAO_0000218,1088.0,
14269,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622243,,BAO_0000218,1088.0,
14270,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622244,,BAO_0000218,1088.0,
14271,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622245,,BAO_0000218,1088.0,
14272,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622246,,BAO_0000218,1088.0,
14273,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622247,,BAO_0000218,1088.0,
14274,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622248,,BAO_0000218,1088.0,
14275,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL877483,,BAO_0000218,1088.0,
14276,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL622249,,BAO_0000218,1088.0,
14277,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622250,,BAO_0000218,1088.0,
14278,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622251,,BAO_0000218,1088.0,
14279,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622252,,BAO_0000218,1088.0,
14280,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622253,,BAO_0000218,1088.0,
14281,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622254,,BAO_0000218,1088.0,
14282,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622255,,BAO_0000218,1088.0,
14283,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622256,,BAO_0000218,1088.0,
14284,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622257,,BAO_0000218,1088.0,
14285,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622258,,BAO_0000218,1088.0,
14286,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622259,,BAO_0000218,1088.0,
14287,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622927,,BAO_0000218,1088.0,
14288,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622928,,BAO_0000218,1088.0,
14289,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL622929,,BAO_0000218,1088.0,
14290,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL623182,,BAO_0000218,1088.0,
14291,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL623183,,BAO_0000218,1088.0,
14292,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623184,,BAO_0000218,1088.0,
14293,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623185,,BAO_0000218,1088.0,
14294,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL877484,,BAO_0000218,1088.0,
14295,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL627274,,BAO_0000218,1088.0,
14296,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623186,,BAO_0000218,1088.0,
14297,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623187,,BAO_0000218,1088.0,
14298,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL623188,,BAO_0000218,1088.0,
14299,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628055,,BAO_0000218,1088.0,
14300,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628056,,BAO_0000218,1088.0,
14301,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628200,,BAO_0000218,1088.0,
14302,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628201,,BAO_0000218,1088.0,
14303,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628202,,BAO_0000218,1088.0,
14304,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628203,,BAO_0000218,1088.0,
14305,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628204,,BAO_0000218,1088.0,
14306,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628205,,BAO_0000218,1088.0,
14307,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628206,,BAO_0000218,1088.0,
14308,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL628207,,BAO_0000218,2367.0,
14309,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627220,,BAO_0000218,2367.0,
14310,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627221,,BAO_0000218,2385.0,
14311,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627222,,BAO_0000218,2367.0,
14312,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627223,,BAO_0000218,,
14313,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL632062,,BAO_0000218,2385.0,
14314,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,A,In vivo,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL632063,,BAO_0000218,2106.0,
14315,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,A,In vivo,,,,,Urinary bladder,,,22224,U,0,Autocuration,1,,CHEMBL632064,,BAO_0000218,1255.0,
14316,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL632065,,BAO_0000218,178.0,
14317,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,A,In vivo,,,,,Bone element,,,22224,U,0,Autocuration,1,,CHEMBL632066,,BAO_0000218,1474.0,
14318,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632067,,BAO_0000218,,
14319,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,A,In vivo,,,,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL629188,,BAO_0000218,2113.0,
14320,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,A,In vivo,,,,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL629189,,BAO_0000218,2107.0,
14321,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,A,In vivo,,,,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL629190,,BAO_0000218,2048.0,
14322,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629191,,BAO_0000218,2385.0,
14323,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629192,,BAO_0000218,2367.0,
14324,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629193,,BAO_0000218,2385.0,
14325,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629194,,BAO_0000218,2367.0,
14326,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629195,,BAO_0000218,,
14327,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629373,,BAO_0000218,2385.0,
14328,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,A,In vivo,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL629374,,BAO_0000218,2106.0,
14329,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629375,,BAO_0000218,2367.0,
14330,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,A,In vivo,,,,,Urinary bladder,,,22224,U,0,Autocuration,1,,CHEMBL629376,,BAO_0000218,1255.0,
14331,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL629377,,BAO_0000218,178.0,
14332,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,A,In vivo,,,,,Bone element,,,22224,U,0,Autocuration,1,,CHEMBL629378,,BAO_0000218,1474.0,
14333,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629379,,BAO_0000218,,
14334,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,A,In vivo,,,,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL629151,,BAO_0000218,2113.0,
14335,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,A,In vivo,,,,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL629152,,BAO_0000218,2107.0,
14336,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,A,In vivo,,,,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL629153,,BAO_0000218,2048.0,
14337,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629154,,BAO_0000218,2385.0,
14338,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629155,,BAO_0000218,2367.0,
14339,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629156,,BAO_0000218,2367.0,
14340,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629157,,BAO_0000218,2385.0,
14341,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL629158,,BAO_0000218,2367.0,
14342,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629159,,BAO_0000218,,
14343,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629160,,BAO_0000218,2385.0,
14344,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,A,In vivo,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL629161,,BAO_0000218,2106.0,
14345,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,A,In vivo,,,,,Urinary bladder,,,22224,U,0,Autocuration,1,,CHEMBL629162,,BAO_0000218,1255.0,
14346,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL629163,,BAO_0000218,178.0,
14347,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,A,In vivo,,,,,Bone element,,,22224,U,0,Autocuration,1,,CHEMBL629164,,BAO_0000218,1474.0,
14348,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629165,,BAO_0000218,,
14349,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,A,In vivo,,,,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL629166,,BAO_0000218,2107.0,
14350,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,A,In vivo,,,,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL629167,,BAO_0000218,2048.0,
14351,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL629168,,BAO_0000218,2385.0,
14352,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629169,,BAO_0000019,,
14353,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629170,,BAO_0000019,,
14354,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631153,,BAO_0000019,,
14355,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875121,,BAO_0000019,,
14356,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631154,,BAO_0000019,,
14357,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631155,,BAO_0000019,,
14358,568,Hydrolysis rate constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631156,,BAO_0000019,,
14359,9680,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631157,,BAO_0000019,,
14360,9680,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631158,,BAO_0000019,,
14361,9680,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631159,,BAO_0000019,,
14362,10026,Observed second order rate constant,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631160,,BAO_0000019,,
14363,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631161,,BAO_0000019,,
14364,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631162,,BAO_0000019,,
14365,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630313,,BAO_0000019,,
14366,9680,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630314,,BAO_0000019,,
14367,9680,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630315,,BAO_0000019,,
14368,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630316,,BAO_0000019,,
14369,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630986,,BAO_0000019,,
14370,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630987,,BAO_0000019,,
14371,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630988,,BAO_0000019,,
14372,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630989,,BAO_0000019,,
14373,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630990,,BAO_0000019,,
14374,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630991,,BAO_0000019,,
14375,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630992,,BAO_0000019,,
14376,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630993,,BAO_0000019,,
14377,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630994,,BAO_0000019,,
14378,10014,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630995,,BAO_0000218,,
14379,9962,Association constant for compound at 31 degree C was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629252,,BAO_0000019,,
14380,12029,Calculated antagonist equilibrium dissociation constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629253,,BAO_0000019,,
14381,12029,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629944,,BAO_0000019,,
14382,10583,Dissociation constants vs LTE4 on guinea pig trachea,A,,,Cavia porcellus,10141.0,,Trachea,,,50512,N,1,Intermediate,1,,CHEMBL629945,,BAO_0000218,3126.0,
14383,568,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629946,,BAO_0000019,,
14384,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629947,,BAO_0000019,,
14385,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629948,,BAO_0000019,,
14386,568,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL856024,,BAO_0000019,,
14387,7493,Affinity constant KD value was derived from TMP,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629949,,BAO_0000019,,
14388,8371,Apparent dissociation (binding) rate constant was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629950,,BAO_0000019,,
14389,13114,Dissociation constant (KD) of the compound,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630127,,BAO_0000100,,
14390,15515,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630128,,BAO_0000100,,
14391,522,Dissociation constant from ESR titration experiments,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630129,,BAO_0000100,,
14392,13888,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630130,,BAO_0000019,,
14393,2616,Dissociation constant was evaluated.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875234,,BAO_0000100,,
14394,3798,Dissociation constant was reported,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630131,,BAO_0000100,,
14395,8731,Dissociation constant was determined in rat pituitary cells.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630132,,BAO_0000218,,
14396,11892,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630133,,BAO_0000019,,
14397,11892,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630134,,BAO_0000019,,
14398,2582,Equilibrium dissociation constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630135,,BAO_0000019,,
14399,11892,Equilibrium dissociation constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630136,,BAO_0000019,,
14400,13396,Kinetic constant KD was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630137,,BAO_0000019,,
14401,603,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630138,,BAO_0000019,,
14402,15673,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630139,,BAO_0000019,,
14403,10368,Rate constant for hydrolysis in aqueous acetone.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630140,,BAO_0000019,,
14404,14228,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875235,,BAO_0000019,,
14405,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876439,,BAO_0000218,,
14406,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630605,,BAO_0000218,,
14407,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630606,,BAO_0000218,,
14408,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630607,,BAO_0000218,,
14409,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630608,,BAO_0000218,,
14410,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630609,,BAO_0000218,,
14411,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630610,,BAO_0000218,,
14412,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630611,,BAO_0000218,,
14413,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629552,,BAO_0000218,,
14414,11510,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629733,,BAO_0000218,,
14415,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629734,,BAO_0000218,,
14416,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629735,,BAO_0000218,,
14417,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629736,,BAO_0000218,,
14418,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629737,,BAO_0000218,,
14419,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629738,,BAO_0000218,,
14420,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629739,,BAO_0000218,,
14421,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629740,,BAO_0000218,,
14422,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629741,,BAO_0000218,,
14423,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629742,,BAO_0000218,,
14424,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629743,,BAO_0000218,,
14425,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629744,,BAO_0000218,,
14426,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629745,,BAO_0000218,,
14427,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629746,,BAO_0000218,,
14428,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629747,,BAO_0000218,,
14429,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629748,,BAO_0000218,,
14430,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629749,,BAO_0000218,,
14431,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629750,,BAO_0000218,,
14432,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629751,,BAO_0000218,,
14433,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629752,,BAO_0000218,,
14434,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629753,,BAO_0000218,,
14435,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629754,,BAO_0000218,,
14436,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629755,,BAO_0000218,,
14437,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629756,,BAO_0000218,,
14438,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629757,,BAO_0000218,,
14439,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629758,,BAO_0000218,,
14440,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629759,,BAO_0000218,,
14441,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL629760,,BAO_0000218,,
14442,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876443,,BAO_0000218,,
14443,8310,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629761,,BAO_0000218,,
14444,8310,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629762,,BAO_0000218,,
14445,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629763,,BAO_0000218,,
14446,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629764,,BAO_0000218,,
14447,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629765,,BAO_0000218,,
14448,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629766,,BAO_0000218,,
14449,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629767,,BAO_0000218,,
14450,8310,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629768,,BAO_0000218,,
14451,8310,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629769,,BAO_0000218,,
14452,8310,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629770,,BAO_0000218,,
14453,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,A,,,Canis lupus familiaris,9615.0,,,,,50588,N,1,Intermediate,1,,CHEMBL629771,,BAO_0000218,,
14454,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629772,,BAO_0000218,,
14455,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL629773,,BAO_0000218,,
14456,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625455,,BAO_0000218,,
14457,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625456,,BAO_0000218,,
14458,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL625457,,BAO_0000218,,
14459,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625458,,BAO_0000218,1088.0,
14460,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625459,,BAO_0000218,1088.0,
14461,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875483,,BAO_0000218,1088.0,
14462,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL634779,,BAO_0000218,1088.0,
14463,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625460,,BAO_0000218,1088.0,
14464,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626117,,BAO_0000218,1088.0,
14465,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626118,,BAO_0000218,1088.0,
14466,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628342,,BAO_0000218,1088.0,
14467,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628343,,BAO_0000218,1088.0,
14468,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628344,,BAO_0000218,1088.0,
14469,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628345,,BAO_0000218,1088.0,
14470,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628346,,BAO_0000218,1088.0,
14471,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628347,,BAO_0000218,1088.0,
14472,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628348,,BAO_0000218,1088.0,
14473,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628349,,BAO_0000218,1088.0,
14474,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875611,,BAO_0000218,1088.0,
14475,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628350,,BAO_0000218,1088.0,
14476,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628351,,BAO_0000218,1088.0,
14477,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628352,,BAO_0000218,1088.0,
14478,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628353,,BAO_0000218,1088.0,
14479,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628354,,BAO_0000218,1088.0,
14480,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626667,,BAO_0000218,1088.0,
14481,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626668,,BAO_0000218,1088.0,
14482,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626669,,BAO_0000218,1088.0,
14483,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626670,,BAO_0000218,1088.0,
14484,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626671,,BAO_0000218,1088.0,
14485,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626672,,BAO_0000218,1088.0,
14486,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626673,,BAO_0000218,1088.0,
14487,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626674,,BAO_0000218,1088.0,
14488,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626675,,BAO_0000218,1088.0,
14489,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626676,,BAO_0000218,1088.0,
14490,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626677,,BAO_0000218,1088.0,
14491,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626678,,BAO_0000218,1088.0,
14492,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626679,,BAO_0000218,1088.0,
14493,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875612,,BAO_0000218,1088.0,
14494,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626680,,BAO_0000218,1088.0,
14495,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626681,,BAO_0000218,1088.0,
14496,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626682,,BAO_0000218,1088.0,
14497,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626683,,BAO_0000218,1088.0,
14498,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626684,,BAO_0000218,1088.0,
14499,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626685,,BAO_0000218,1088.0,
14500,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626686,,BAO_0000218,1088.0,
14501,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626687,,BAO_0000218,1088.0,
14502,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624978,,BAO_0000218,1088.0,
14503,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624979,,BAO_0000218,1088.0,
14504,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624980,,BAO_0000218,1088.0,
14505,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL624981,,BAO_0000218,1088.0,
14506,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL624982,,BAO_0000218,1088.0,
14507,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627564,,BAO_0000218,2367.0,
14508,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627565,,BAO_0000218,2367.0,
14509,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627566,,BAO_0000218,,
14510,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627567,,BAO_0000218,2385.0,
14511,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,A,In vivo,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL627568,,BAO_0000218,2106.0,
14512,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,A,In vivo,,,,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL627569,,BAO_0000218,2113.0,
14513,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,A,In vivo,,,,,Urinary bladder,,,22224,U,0,Autocuration,1,,CHEMBL627570,,BAO_0000218,1255.0,
14514,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,A,In vivo,,,,,Blood,,,22224,U,0,Autocuration,1,,CHEMBL627571,,BAO_0000218,178.0,
14515,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,A,In vivo,,,,,Bone element,,,22224,U,0,Autocuration,1,,CHEMBL627572,,BAO_0000218,1474.0,
14516,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627573,,BAO_0000218,,
14517,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,A,In vivo,,,,,Kidney,,,22224,U,0,Autocuration,1,,CHEMBL627574,,BAO_0000218,2113.0,
14518,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,A,In vivo,,,,,Liver,,,22224,U,0,Autocuration,1,,CHEMBL627575,,BAO_0000218,2107.0,
14519,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,A,In vivo,,,,,Lung,,,22224,U,0,Autocuration,1,,CHEMBL627576,,BAO_0000218,2048.0,
14520,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627577,,BAO_0000218,2385.0,
14521,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627578,,BAO_0000218,2367.0,
14522,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627579,,BAO_0000218,2367.0,
14523,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627580,,BAO_0000218,2385.0,
14524,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627581,,BAO_0000218,2367.0,
14525,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,A,In vivo,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627582,,BAO_0000218,,
14526,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627583,,BAO_0000218,2385.0,
14527,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,A,In vivo,,,,,Spleen,,,22224,U,0,Autocuration,1,,CHEMBL627584,,BAO_0000218,2106.0,
14528,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,A,In vivo,,,,,Prostate gland,,,22224,U,0,Autocuration,1,,CHEMBL627585,,BAO_0000218,2367.0,
14529,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,A,In vivo,,,,,Muscle tissue,,,22224,U,0,Autocuration,1,,CHEMBL627586,,BAO_0000218,2385.0,
14530,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627587,,BAO_0000218,,
14531,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL627588,,BAO_0000218,,
14532,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628250,,BAO_0000218,,
14533,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628251,,BAO_0000218,,
14534,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628252,,BAO_0000218,10000000.0,
14535,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628253,,BAO_0000218,10000000.0,
14536,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL628254,,BAO_0000218,1898.0,
14537,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL877493,,BAO_0000218,1898.0,
14538,15413,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628255,,BAO_0000218,,
14539,15413,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628256,,BAO_0000218,,
14540,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL628257,,BAO_0000218,10000000.0,
14541,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL628258,,BAO_0000218,1898.0,
14542,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628259,,BAO_0000218,,
14543,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628429,,BAO_0000218,,
14544,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL626862,,BAO_0000218,10000000.0,
14545,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL626863,,BAO_0000218,1898.0,
14546,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL625886,,BAO_0000218,2037.0,
14547,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL625887,,BAO_0000218,2037.0,
14548,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625888,,BAO_0000218,,
14549,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625889,,BAO_0000218,,
14550,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625890,,BAO_0000218,10000000.0,
14551,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL625891,,BAO_0000218,10000000.0,
14552,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL625892,,BAO_0000218,1898.0,
14553,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL625893,,BAO_0000218,1898.0,
14554,15413,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,A,In vivo,,Rattus norvegicus,10116.0,,Cerebellum,,,50597,N,1,Intermediate,1,,CHEMBL625894,,BAO_0000218,2037.0,
14555,15413,Biodistribution of the [18F]-radiolabeled compound in rat cortex,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625895,,BAO_0000218,,
14556,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625896,,BAO_0000019,,
14557,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625897,,BAO_0000019,,
14558,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625898,,BAO_0000019,,
14559,568,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL625899,,BAO_0000019,,
14560,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL626124,,BAO_0000019,,
14561,7624,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,A,,,Escherichia coli,562.0,,,,,50212,N,1,Intermediate,1,,CHEMBL628500,,BAO_0000218,,
14562,7624,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL857856,,BAO_0000218,,
14563,7624,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628501,,BAO_0000218,,
14564,4643,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628502,,BAO_0000019,,
14565,11532,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628503,,BAO_0000019,,
14566,11018,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628504,,BAO_0000019,,
14567,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628505,,BAO_0000019,,
14568,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL874452,,BAO_0000019,,
14569,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628506,,BAO_0000019,,
14570,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628507,,BAO_0000019,,
14571,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628508,,BAO_0000019,,
14572,8949,Michaelis constant (KM) was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628509,,BAO_0000019,,
14573,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628510,,BAO_0000019,,
14574,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase I,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628511,,BAO_0000019,,
14575,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase II,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628512,,BAO_0000019,,
14576,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase III,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628513,,BAO_0000019,,
14577,7625,Substrate concentration for half maximal velocity was reported for yeast hexokinase,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628514,,BAO_0000019,,
14578,12908,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628515,,BAO_0000019,,
14579,10368,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628516,,BAO_0000019,,
14580,13108,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628517,,BAO_0000019,,
14581,13108,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628518,,BAO_0000019,,
14582,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628519,,BAO_0000019,,
14583,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628520,,BAO_0000019,,
14584,10933,Binding constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628521,,BAO_0000019,,
14585,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630443,,BAO_0000019,,
14586,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630444,,BAO_0000019,,
14587,2276,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL857732,,BAO_0000019,,
14588,14915,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630445,,BAO_0000100,,
14589,8847,Catalytic rate constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630446,,BAO_0000019,,
14590,15357,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630447,,BAO_0000019,,
14591,2869,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630448,,BAO_0000019,,
14592,3484,Catalytic rate constant against phospholipase A2 was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630449,,BAO_0000019,,
14593,1373,"Compound was evaluated for catalytic constant, Kcat",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630450,,BAO_0000019,,
14594,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630451,,BAO_0000019,,
14595,14131,Kcat calculated from 0.693/T1/2,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630452,,BAO_0000019,,
14596,17269,Kcat was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630453,,BAO_0000019,,
14597,3485,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630454,,BAO_0000019,,
14598,3485,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630455,,BAO_0000019,,
14599,3485,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631487,,BAO_0000019,,
14600,5962,Kcat value was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631488,,BAO_0000019,,
14601,3133,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL876440,,BAO_0000019,,
14602,3133,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631489,,BAO_0000019,,
14603,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL857742,,BAO_0000019,,
14604,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631490,,BAO_0000019,,
14605,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631491,,BAO_0000019,,
14606,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631492,,BAO_0000019,,
14607,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631493,,BAO_0000019,,
14608,4892,Kinetic parameter for rate of conversion to PABA was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631494,,BAO_0000019,,
14609,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631495,,BAO_0000019,,
14610,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",A,,,Rattus norvegicus,10116.0,,Feces,,,50597,N,1,Intermediate,1,,CHEMBL631496,,BAO_0000218,1988.0,
14611,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631497,,BAO_0000218,1088.0,
14612,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631498,,BAO_0000218,1088.0,
14613,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629776,,BAO_0000218,1088.0,
14614,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629777,,BAO_0000218,1088.0,
14615,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL629778,,BAO_0000218,1088.0,
14616,11488,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630456,,BAO_0000218,,
14617,11488,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630457,,BAO_0000218,,
14618,11488,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630458,,BAO_0000218,,
14619,11488,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630459,,BAO_0000218,,
14620,11488,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630460,,BAO_0000218,,
14621,11488,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL876550,,BAO_0000218,,
14622,11488,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630461,,BAO_0000218,,
14623,11488,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630462,,BAO_0000218,,
14624,11488,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630463,,BAO_0000218,,
14625,11488,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630464,,BAO_0000218,,
14626,11488,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630465,,BAO_0000218,,
14627,11488,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630466,,BAO_0000218,,
14628,11488,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630467,,BAO_0000218,,
14629,11488,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630633,,BAO_0000218,,
14630,11488,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630634,,BAO_0000218,,
14631,11488,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630635,,BAO_0000218,,
14632,11488,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630636,,BAO_0000218,,
14633,11488,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630637,,BAO_0000218,,
14634,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL630638,,BAO_0000218,1988.0,
14635,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL630639,,BAO_0000218,1988.0,
14636,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL630640,,BAO_0000218,1988.0,
14637,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL876551,,BAO_0000218,1988.0,
14638,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL630641,,BAO_0000218,1088.0,
14639,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL630642,,BAO_0000218,1088.0,
14640,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL630643,,BAO_0000218,1088.0,
14641,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL630644,,BAO_0000218,1088.0,
14642,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL630645,,BAO_0000218,1088.0,
14643,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL625599,,BAO_0000218,1988.0,
14644,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL625600,,BAO_0000218,1988.0,
14645,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL625601,,BAO_0000218,1988.0,
14646,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Feces,,,50592,N,1,Intermediate,1,,CHEMBL625602,,BAO_0000218,1988.0,
14647,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL627470,,BAO_0000218,1088.0,
14648,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL627471,,BAO_0000218,1088.0,
14649,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL627472,,BAO_0000218,1088.0,
14650,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL627473,,BAO_0000218,1088.0,
14651,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",A,,,Oryctolagus cuniculus,9986.0,,Urine,,,50592,N,1,Intermediate,1,,CHEMBL627474,,BAO_0000218,1088.0,
14652,13925,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627475,,BAO_0000218,178.0,
14653,13925,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL627476,,BAO_0000218,178.0,
14654,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627477,,BAO_0000218,1088.0,
14655,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627478,,BAO_0000218,1088.0,
14656,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627479,,BAO_0000218,1088.0,
14657,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627480,,BAO_0000218,1088.0,
14658,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627481,,BAO_0000218,1088.0,
14659,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627482,,BAO_0000218,1088.0,
14660,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL627483,,BAO_0000218,1088.0,
14661,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL875636,,BAO_0000218,1088.0,
14662,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625764,,BAO_0000218,1088.0,
14663,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625765,,BAO_0000218,1088.0,
14664,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625766,,BAO_0000218,1088.0,
14665,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625767,,BAO_0000218,1088.0,
14666,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625768,,BAO_0000218,1088.0,
14667,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625769,,BAO_0000218,1088.0,
14668,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625770,,BAO_0000218,1088.0,
14669,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625771,,BAO_0000218,1088.0,
14670,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625772,,BAO_0000218,1088.0,
14671,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,A,,,Canis lupus familiaris,9615.0,,Urine,,,50588,N,1,Intermediate,1,,CHEMBL625773,,BAO_0000218,1088.0,
14672,12582,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625774,,BAO_0000218,1088.0,
14673,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625775,,BAO_0000218,1088.0,
14674,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625776,,BAO_0000218,1088.0,
14675,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625777,,BAO_0000218,1088.0,
14676,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625778,,BAO_0000218,1088.0,
14677,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625779,,BAO_0000218,1088.0,
14678,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625780,,BAO_0000218,1088.0,
14679,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL625781,,BAO_0000218,1088.0,
14680,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875637,,BAO_0000218,1088.0,
14681,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626473,,BAO_0000218,1088.0,
14682,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626474,,BAO_0000218,1088.0,
14683,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626475,,BAO_0000218,1088.0,
14684,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626476,,BAO_0000218,1088.0,
14685,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL634397,,BAO_0000218,1088.0,
14686,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL626477,,BAO_0000218,1088.0,
14687,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631069,,BAO_0000218,1088.0,
14688,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631070,,BAO_0000218,1088.0,
14689,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631071,,BAO_0000218,1088.0,
14690,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631072,,BAO_0000218,1088.0,
14691,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631073,,BAO_0000218,1088.0,
14692,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631074,,BAO_0000218,1088.0,
14693,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631075,,BAO_0000218,1088.0,
14694,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631725,,BAO_0000218,1088.0,
14695,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631726,,BAO_0000218,1088.0,
14696,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631727,,BAO_0000218,1088.0,
14697,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631728,,BAO_0000218,1088.0,
14698,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631729,,BAO_0000218,1088.0,
14699,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631730,,BAO_0000218,1088.0,
14700,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631731,,BAO_0000218,1088.0,
14701,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631910,,BAO_0000218,1088.0,
14702,15413,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,A,In vivo,,Rattus norvegicus,10116.0,,Hippocampus,,,50597,N,1,Intermediate,1,,CHEMBL631911,,BAO_0000218,10000000.0,
14703,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL631912,,BAO_0000218,1898.0,
14704,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,A,In vivo,,Rattus norvegicus,10116.0,,Hypothalamus,,,50597,N,1,Intermediate,1,,CHEMBL631913,,BAO_0000218,1898.0,
14705,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631914,,BAO_0000218,178.0,
14706,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631915,,BAO_0000218,178.0,
14707,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL875778,,BAO_0000218,178.0,
14708,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631916,,BAO_0000218,178.0,
14709,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631917,,BAO_0000218,178.0,
14710,12017,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631918,,BAO_0000218,178.0,
14711,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631919,,BAO_0000218,178.0,
14712,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631920,,BAO_0000218,178.0,
14713,12017,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631921,,BAO_0000218,178.0,
14714,12017,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631922,,BAO_0000218,178.0,
14715,12017,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL631923,,BAO_0000218,178.0,
14716,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631924,,BAO_0000218,,
14717,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630234,,BAO_0000218,,
14718,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630235,,BAO_0000218,,
14719,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630236,,BAO_0000218,,
14720,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630237,,BAO_0000218,,
14721,12017,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630238,,BAO_0000218,,
14722,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630239,,BAO_0000218,,
14723,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630303,,BAO_0000218,,
14724,12017,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630304,,BAO_0000218,,
14725,12017,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630305,,BAO_0000218,,
14726,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630306,,BAO_0000218,2113.0,
14727,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630307,,BAO_0000218,2113.0,
14728,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630308,,BAO_0000218,2113.0,
14729,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL630309,,BAO_0000218,2113.0,
14730,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL629309,,BAO_0000218,2113.0,
14731,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL629993,,BAO_0000218,2113.0,
14732,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL629994,,BAO_0000218,2113.0,
14733,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL629995,,BAO_0000218,2113.0,
14734,12017,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631993,,BAO_0000218,2113.0,
14735,12017,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631994,,BAO_0000218,2113.0,
14736,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL631995,,BAO_0000218,2113.0,
14737,12017,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631996,,BAO_0000218,2107.0,
14738,12017,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631997,,BAO_0000218,2107.0,
14739,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631998,,BAO_0000218,2107.0,
14740,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631999,,BAO_0000218,2107.0,
14741,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL632000,,BAO_0000218,2107.0,
14742,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL632001,,BAO_0000218,2107.0,
14743,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL874424,,BAO_0000218,2107.0,
14744,12017,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL632002,,BAO_0000218,2107.0,
14745,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL632003,,BAO_0000218,2107.0,
14746,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632004,,BAO_0000019,,
14747,2742,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632005,,BAO_0000019,,
14748,2742,Compound was tested for amidase rate in the presence of N62C screen enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632006,,BAO_0000019,,
14749,2742,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632007,,BAO_0000019,,
14750,2742,Compound was tested for amidase rate in the presence of S166C screen enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632008,,BAO_0000019,,
14751,2742,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632009,,BAO_0000019,,
14752,2742,Compound was tested for esterase rate in the presence of N62C screen enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632010,,BAO_0000019,,
14753,2742,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL857750,,BAO_0000019,,
14754,2742,Compound was tested for esterase rate in the presence of S166C screen enzyme,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632011,,BAO_0000019,,
14755,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632012,,BAO_0000019,,
14756,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632013,,BAO_0000019,,
14757,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL632014,,BAO_0000019,,
14758,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629622,,BAO_0000019,,
14759,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629623,,BAO_0000019,,
14760,2276,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629624,,BAO_0000019,,
14761,17269,Ratio of Kcat to that of Km was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629625,,BAO_0000019,,
14762,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629626,,BAO_0000019,,
14763,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629627,,BAO_0000019,,
14764,15917,"Compound was evaluated for constant, Kd",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629628,,BAO_0000019,,
14765,10933,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629629,,BAO_0000019,,
14766,10933,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629630,,BAO_0000019,,
14767,14293,Dissociation Constant of compound determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL856030,,BAO_0000019,,
14768,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629631,,BAO_0000019,,
14769,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,B,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629632,,BAO_0000019,,
14770,4318,Dissociation constant of compound with Fructose was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629633,,BAO_0000100,,
14771,4318,Dissociation constant of compound with Fructose was determined; Not determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629634,,BAO_0000100,,
14772,4318,Dissociation constant of compound with Lactulose was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629635,,BAO_0000100,,
14773,4318,Dissociation constant of compound with Lactulose was determined; Not determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629636,,BAO_0000100,,
14774,14959,Dissociation constant of the Compound,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629637,,BAO_0000100,,
14775,5913,Dissociation constant by non-linear regression analysis,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629638,,BAO_0000100,,
14776,14218,Dissociation constant was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629639,,BAO_0000100,,
14777,10689,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629640,,BAO_0000100,,
14778,13925,Dissociation constant was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629641,,BAO_0000100,,
14779,16359,Dissociation constant was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631344,,BAO_0000100,,
14780,10944,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631345,,BAO_0000218,2385.0,
14781,11080,The dissociation constant determined by fluorescence displacement assay,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631346,,BAO_0000019,,
14782,17805,kd value surface plasmon resonance (SPR) method,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631524,,BAO_0000019,,
14783,10944,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631525,,BAO_0000218,2385.0,
14784,16645,First dissociation constant of the binding of compound to V30M TTR,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631526,,BAO_0000019,,
14785,16645,Second dissociation constant of the binding of compound to V30M TTR,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631527,,BAO_0000019,,
14786,7793,"Compound was evaluated for equilibrium constant, Ke",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631528,,BAO_0000019,,
14787,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,A,,,,,,Hypothalamus,,,22224,U,0,Autocuration,1,,CHEMBL631529,,BAO_0000019,1898.0,
14788,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,A,,,,,,Hypothalamus,,,22224,U,0,Autocuration,1,,CHEMBL631530,,BAO_0000019,1898.0,
14789,9680,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631531,,BAO_0000019,,
14790,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631532,,BAO_0000019,,
14791,9680,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL631533,,BAO_0000019,,
14792,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL876552,,BAO_0000218,,
14793,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631534,,BAO_0000218,,
14794,13758,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631535,,BAO_0000218,,
14795,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631536,,BAO_0000218,,
14796,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631537,,BAO_0000218,,
14797,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631538,,BAO_0000218,,
14798,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631539,,BAO_0000218,,
14799,13758,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,A,,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631540,,BAO_0000218,,
14800,14393,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625637,,BAO_0000218,,
14801,14393,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625638,,BAO_0000218,,
14802,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL625639,,BAO_0000218,,
14803,13925,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625640,,BAO_0000218,955.0,
14804,13925,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625641,,BAO_0000218,955.0,
14805,13925,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625642,,BAO_0000218,948.0,
14806,13925,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625643,,BAO_0000218,948.0,
14807,13925,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625644,,BAO_0000218,2113.0,
14808,13925,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Kidney,,,50597,N,1,Intermediate,1,,CHEMBL625645,,BAO_0000218,2113.0,
14809,13925,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625646,,BAO_0000218,2107.0,
14810,13925,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625647,,BAO_0000218,2107.0,
14811,13925,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625648,,BAO_0000218,2048.0,
14812,13925,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL625649,,BAO_0000218,2048.0,
14813,13925,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625650,,BAO_0000218,2385.0,
14814,13925,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL625651,,BAO_0000218,2385.0,
14815,13925,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL625652,,BAO_0000218,14.0,
14816,13925,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Zone of skin,,,50597,N,1,Intermediate,1,,CHEMBL625653,,BAO_0000218,14.0,
14817,13925,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625654,,BAO_0000218,2106.0,
14818,13925,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL625655,,BAO_0000218,2106.0,
14819,9712,Biodistribution of Compound in rat blood after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625656,,BAO_0000218,178.0,
14820,9712,Biodistribution of Compound in rat blood after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Blood,,,50597,N,1,Intermediate,1,,CHEMBL625657,,BAO_0000218,178.0,
14821,9712,Biodistribution of Compound in rat brain after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625658,,BAO_0000218,955.0,
14822,9712,Biodistribution of Compound in rat brain after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Brain,,,50597,N,1,Intermediate,1,,CHEMBL625659,,BAO_0000218,955.0,
14823,9712,Biodistribution of Compound in rat heart after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625660,,BAO_0000218,948.0,
14824,9712,Biodistribution of Compound in rat heart after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Heart,,,50597,N,1,Intermediate,1,,CHEMBL625661,,BAO_0000218,948.0,
14825,9712,Biodistribution of Compound in rat liver after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625662,,BAO_0000218,2107.0,
14826,9712,Biodistribution of Compound in rat liver after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL625663,,BAO_0000218,2107.0,
14827,9712,Biodistribution of Compound in rat lung after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL875621,,BAO_0000218,2048.0,
14828,9712,Biodistribution of Compound in rat lung after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL628382,,BAO_0000218,2048.0,
14829,9712,Biodistribution of Compound in rat muscle after 15 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL628383,,BAO_0000218,2385.0,
14830,9712,Biodistribution of Compound in rat muscle after 2 minutes of administration,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL628384,,BAO_0000218,2385.0,
14831,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628385,,BAO_0000218,,
14832,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875753,,BAO_0000218,,
14833,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628386,,BAO_0000218,,
14834,6941,Organ distribution in rat blood 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628387,,BAO_0000218,,
14835,6941,Organ distribution in rat blood 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628388,,BAO_0000218,,
14836,6941,Organ distribution in rat blood 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628389,,BAO_0000218,,
14837,6941,Organ distribution in rat blood 30 min after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL632756,,BAO_0000218,,
14838,6941,Organ distribution in rat brain 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628390,,BAO_0000218,,
14839,6941,Organ distribution in rat brain 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631811,,BAO_0000218,,
14840,6941,Organ distribution in rat brain 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631812,,BAO_0000218,,
14841,6941,Organ distribution in rat heart 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631813,,BAO_0000218,,
14842,6941,Organ distribution in rat heart 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631814,,BAO_0000218,,
14843,6941,Organ distribution in rat heart 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631815,,BAO_0000218,,
14844,6941,Organ distribution in rat kidney 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631816,,BAO_0000218,,
14845,6941,Organ distribution in rat kidney 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL875758,,BAO_0000218,,
14846,6941,Organ distribution in rat kidney 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631817,,BAO_0000218,,
14847,6941,Organ distribution in rat liver 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631818,,BAO_0000218,2107.0,
14848,6941,Organ distribution in rat liver 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631819,,BAO_0000218,2107.0,
14849,6941,Organ distribution in rat liver 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL631820,,BAO_0000218,2107.0,
14850,6941,Organ distribution in rat lung 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631821,,BAO_0000218,,
14851,6941,Organ distribution in rat lung 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631822,,BAO_0000218,,
14852,6941,Organ distribution in rat lung 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL631823,,BAO_0000218,,
14853,6941,Organ distribution in rat muscle 2 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631824,,BAO_0000218,2385.0,
14854,6941,Organ distribution in rat muscle 2 hr after intravenous injection,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631825,,BAO_0000218,2385.0,
14855,6941,Organ distribution in rat muscle 30 minutes after intravenous injection,A,,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631826,,BAO_0000218,2385.0,
14856,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631827,,BAO_0000218,,
14857,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631828,,BAO_0000218,,
14858,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL631829,,BAO_0000218,,
14859,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875759,,BAO_0000218,1088.0,
14860,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631830,,BAO_0000218,1088.0,
14861,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631831,,BAO_0000218,1088.0,
14862,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631832,,BAO_0000218,1088.0,
14863,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631833,,BAO_0000218,1088.0,
14864,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631834,,BAO_0000218,1088.0,
14865,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631835,,BAO_0000218,1088.0,
14866,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631836,,BAO_0000218,1088.0,
14867,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631837,,BAO_0000218,1088.0,
14868,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631838,,BAO_0000218,1088.0,
14869,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631839,,BAO_0000218,1088.0,
14870,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631840,,BAO_0000218,1088.0,
14871,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631841,,BAO_0000218,1088.0,
14872,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631842,,BAO_0000218,1088.0,
14873,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631843,,BAO_0000218,1088.0,
14874,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631844,,BAO_0000218,1088.0,
14875,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631845,,BAO_0000218,1088.0,
14876,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631846,,BAO_0000218,1088.0,
14877,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL875760,,BAO_0000218,1088.0,
14878,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL632199,,BAO_0000218,1088.0,
14879,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631847,,BAO_0000218,1088.0,
14880,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL631848,,BAO_0000218,1088.0,
14881,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628707,,BAO_0000218,1088.0,
14882,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628708,,BAO_0000218,1088.0,
14883,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628709,,BAO_0000218,1088.0,
14884,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628710,,BAO_0000218,1088.0,
14885,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628711,,BAO_0000218,1088.0,
14886,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628712,,BAO_0000218,1088.0,
14887,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628713,,BAO_0000218,1088.0,
14888,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,A,,,Rattus norvegicus,10116.0,,Urine,,,50597,N,1,Intermediate,1,,CHEMBL628714,,BAO_0000218,1088.0,
14889,7415,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL628715,,BAO_0000218,,
14890,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629179,,BAO_0000019,,
14891,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629180,,BAO_0000019,,
14892,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL875108,,BAO_0000019,,
14893,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629181,,BAO_0000019,1235.0,
14894,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629182,,BAO_0000019,1235.0,
14895,7570,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629183,,BAO_0000019,,
14896,7570,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629184,,BAO_0000019,,
14897,7570,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629185,,BAO_0000019,1235.0,
14898,7570,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629186,,BAO_0000019,1235.0,
14899,7570,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629187,,BAO_0000019,,
14900,7570,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629887,,BAO_0000019,,
14901,7570,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629888,,BAO_0000019,,
14902,7570,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629889,,BAO_0000019,,
14903,7570,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629890,,BAO_0000019,1235.0,
14904,7570,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629891,,BAO_0000019,,
14905,7570,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629892,,BAO_0000019,,
14906,7570,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,A,,,,,,Adrenal cortex,,,22224,U,0,Autocuration,1,,CHEMBL629893,,BAO_0000019,1235.0,
14907,7570,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629894,,BAO_0000019,,
14908,7570,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629895,,BAO_0000019,,
14909,14122,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",A,In vivo,,Canis lupus familiaris,9615.0,,,,,22224,U,0,Autocuration,1,,CHEMBL875109,,BAO_0000218,,
14910,16449,Absolute bioavailability in male cynomolgus monkeys,A,In vivo,,Macaca fascicularis,9541.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629896,,BAO_0000218,,
14911,16449,Absolute bioavailability in maleSprague-Dawley rats,A,In vivo,,Rattus norvegicus,10116.0,,,,,22224,U,0,Autocuration,1,,CHEMBL629897,,BAO_0000218,,
14912,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL629898,,BAO_0000218,2107.0,
14913,12017,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL630057,,BAO_0000218,2107.0,
14914,12017,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Liver,,,50597,N,1,Intermediate,1,,CHEMBL630058,,BAO_0000218,2107.0,
14915,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630059,,BAO_0000218,2048.0,
14916,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630060,,BAO_0000218,2048.0,
14917,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630061,,BAO_0000218,2048.0,
14918,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630062,,BAO_0000218,2048.0,
14919,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630063,,BAO_0000218,2048.0,
14920,12017,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630064,,BAO_0000218,2048.0,
14921,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630065,,BAO_0000218,2048.0,
14922,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630066,,BAO_0000218,2048.0,
14923,12017,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630067,,BAO_0000218,2048.0,
14924,12017,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Lung,,,50597,N,1,Intermediate,1,,CHEMBL630068,,BAO_0000218,2048.0,
14925,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631113,,BAO_0000218,2385.0,
14926,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631114,,BAO_0000218,2385.0,
14927,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631115,,BAO_0000218,2385.0,
14928,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL631116,,BAO_0000218,2385.0,
14929,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630528,,BAO_0000218,2385.0,
14930,12017,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630529,,BAO_0000218,2385.0,
14931,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630530,,BAO_0000218,2385.0,
14932,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630531,,BAO_0000218,2385.0,
14933,12017,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630532,,BAO_0000218,2385.0,
14934,12017,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Muscle tissue,,,50597,N,1,Intermediate,1,,CHEMBL630533,,BAO_0000218,2385.0,
14935,15045,Biodistribution in normal mice blood after 120 hr,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL630534,,BAO_0000218,178.0,
14936,15045,Biodistribution in normal mice blood after 24 hr,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL630535,,BAO_0000218,178.0,
14937,15045,Biodistribution in normal mice blood after 4 hr,A,In vivo,,Mus musculus,10090.0,,Blood,,,50594,N,1,Intermediate,1,,CHEMBL630536,,BAO_0000218,178.0,
14938,15045,Biodistribution in normal mice bone after 120 hr,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL630537,,BAO_0000218,10000001.0,
14939,15045,Biodistribution in normal mice bone after 24 hr,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL630538,,BAO_0000218,10000001.0,
14940,15045,Biodistribution in normal mice bone after 4 hr,A,In vivo,,Mus musculus,10090.0,,Bone,,,50594,N,1,Intermediate,1,,CHEMBL630539,,BAO_0000218,10000001.0,
14941,15045,Biodistribution in normal mice heart after 120 hr,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL630540,,BAO_0000218,948.0,
14942,15045,Biodistribution in normal mice heart after 24 hr,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL630541,,BAO_0000218,948.0,
14943,15045,Biodistribution in normal mice heart after 4 hr,A,In vivo,,Mus musculus,10090.0,,Heart,,,50594,N,1,Intermediate,1,,CHEMBL630542,,BAO_0000218,948.0,
14944,15045,Biodistribution in normal mice kidney after 120 hr,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630543,,BAO_0000218,2113.0,
14945,15045,Biodistribution in normal mice kidney after 24 hr,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630544,,BAO_0000218,2113.0,
14946,15045,Biodistribution in normal mice kidney after 4 hr,A,In vivo,,Mus musculus,10090.0,,Kidney,,,50594,N,1,Intermediate,1,,CHEMBL630545,,BAO_0000218,2113.0,
14947,15045,Biodistribution in normal mice liver after 120 hr,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL630546,,BAO_0000218,2107.0,
14948,15045,Biodistribution in normal mice liver after 24 hr,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL630547,,BAO_0000218,2107.0,
14949,15045,Biodistribution in normal mice liver after 4 hr,A,In vivo,,Mus musculus,10090.0,,Liver,,,50594,N,1,Intermediate,1,,CHEMBL630548,,BAO_0000218,2107.0,
14950,15045,Biodistribution in normal mice spleen after 120 hr,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL630549,,BAO_0000218,2106.0,
14951,15045,Biodistribution in normal mice spleen after 24 hr,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL630550,,BAO_0000218,2106.0,
14952,15045,Biodistribution in normal mice spleen after 4 hr,A,In vivo,,Mus musculus,10090.0,,Spleen,,,50594,N,1,Intermediate,1,,CHEMBL876426,,BAO_0000218,2106.0,
14953,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630551,,BAO_0000218,2106.0,
14954,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630552,,BAO_0000218,2106.0,
14955,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630553,,BAO_0000218,2106.0,
14956,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630554,,BAO_0000218,2106.0,
14957,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630555,,BAO_0000218,2106.0,
14958,12017,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630556,,BAO_0000218,2106.0,
14959,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630557,,BAO_0000218,2106.0,
14960,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630558,,BAO_0000218,2106.0,
14961,12017,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630559,,BAO_0000218,2106.0,
14962,12017,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Spleen,,,50597,N,1,Intermediate,1,,CHEMBL630560,,BAO_0000218,2106.0,
14963,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,A,In vivo,,Rattus norvegicus,10116.0,,Thyroid gland,,,50597,N,1,Intermediate,1,,CHEMBL876427,,BAO_0000218,2046.0,
14964,14941,The Kel values in female wistar rats.,A,,,Rattus norvegicus,10116.0,,,,,50597,N,1,Intermediate,1,,CHEMBL630561,,BAO_0000218,,
14965,4646,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630562,,BAO_0000019,,
14966,8847,Hydrolysis rate constant of the compound,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL630563,,BAO_0000019,,
14967,11778,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,P,,,,,,,,,22229,U,0,Autocuration,1,,CHEMBL629673,,BAO_0000100,,
14968,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629674,,BAO_0000019,,
14969,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629675,,BAO_0000019,,
14970,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629676,,BAO_0000019,,
14971,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629677,,BAO_0000019,,
14972,8371,Apparent inactivation rate constant was evaluated,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629678,,BAO_0000019,,
14973,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629679,,BAO_0000019,,
14974,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629680,,BAO_0000019,,
14975,4643,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629681,,BAO_0000019,,
14976,3519,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629682,,BAO_0000019,,
14977,10600,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629683,,BAO_0000019,,
14978,8501,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,F,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629684,,BAO_0000019,,
14979,8505,Dissociation constant was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629685,,BAO_0000100,,
14980,9778,Dissociation constant was determined,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629686,,BAO_0000100,,
14981,9778,Dissociation constant at pH 7.4,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL872932,,BAO_0000100,,
14982,9778,Dissociation constant in presence of 1 mM dithiothreitol,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL629687,,BAO_0000100,,
14983,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL872931,,BAO_0000019,,
14984,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628151,,BAO_0000019,,
14985,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628152,,BAO_0000019,,
14986,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628153,,BAO_0000019,,
14987,11482,Kinetic constant for aromatization of androstenedione,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628154,,BAO_0000019,,
14988,11482,Kinetic constant for aromatization of testosterone,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628155,,BAO_0000019,,
14989,2303,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628156,,BAO_0000019,,
14990,11964,Local inhibition constant was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628157,,BAO_0000019,,
14991,3140,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,A,,,Saccharomyces cerevisiae,4932.0,,,,,50347,N,1,Intermediate,1,,CHEMBL857533,,BAO_0000218,,
14992,10650,Dissociation constant value of the compound,P,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628158,,BAO_0000100,,
14993,4667,In vitro permeability through cornea without epithelium,A,,,,,,Cornea,,,22224,U,0,Autocuration,1,,CHEMBL628159,,BAO_0000019,964.0,
14994,4667,In vitro permeability through intact cornea,A,,,,,,Cornea,,,22224,U,0,Autocuration,1,,CHEMBL875616,,BAO_0000019,964.0,
14995,9199,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,A,,,Oryctolagus cuniculus,9986.0,,Cornea,,,50592,N,1,Intermediate,1,,CHEMBL628160,,BAO_0000218,964.0,
14996,11966,Rate of enzyme inactivation for the compound was determined,A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628161,,BAO_0000019,,
14997,4667,In vitro permeability through cornea without epithelium,A,,,,,,Cornea,,,22224,U,0,Autocuration,1,,CHEMBL628162,,BAO_0000019,964.0,
14998,4667,In vitro permeability through intact cornea,A,,,,,,Cornea,,,22224,U,0,Autocuration,1,,CHEMBL628163,,BAO_0000019,964.0,
14999,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628164,,BAO_0000019,,
15000,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628165,,BAO_0000019,,
15001,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628166,,BAO_0000019,,
15002,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628167,,BAO_0000019,,
15003,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628168,,BAO_0000019,,
15004,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628169,,BAO_0000019,,
15005,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628170,,BAO_0000019,,
15006,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628171,,BAO_0000019,,
15007,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627434,,BAO_0000019,,
15008,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL627435,,BAO_0000019,,
15009,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628110,,BAO_0000019,,
15010,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628111,,BAO_0000019,,
15011,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628112,,BAO_0000019,,
15012,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628260,,BAO_0000019,,
15013,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",A,,,,,,,,,22224,U,0,Autocuration,1,,CHEMBL628261,,BAO_0000019,,
15014,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628262,,BAO_0000218,,
15015,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,A,In vivo,,Homo sapiens,9606.0,,,,,50587,N,1,Intermediate,1,,CHEMBL628263,,BAO_0000218,,
15016,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628264,,BAO_0000218,,
15017,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628265,,BAO_0000218,,
15018,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628266,,BAO_0000218,,
15019,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628267,,BAO_0000218,,
15020,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628268,,BAO_0000218,,
15021,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628269,,BAO_0000218,,
15022,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628270,,BAO_0000218,,
15023,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628271,,BAO_0000218,,
15024,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),A,In vivo,,Mus musculus,10090.0,,,,,50594,N,1,Intermediate,1,,CHEMBL628272,,BAO_0000218,,
